
<html lang="en"     class="pb-page"  data-request-id="3e06a5e2-a0d9-495b-845a-e5b03b31ae71"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-13;requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.0c00595;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo" /></meta><meta name="dc.Creator" content="Claudia  Mugnaini" /></meta><meta name="dc.Creator" content="Magdalena  Kostrzewa" /></meta><meta name="dc.Creator" content="Marta  Bryk" /></meta><meta name="dc.Creator" content="Ali Mokhtar  Mahmoud" /></meta><meta name="dc.Creator" content="Antonella  Brizzi" /></meta><meta name="dc.Creator" content="Stefania  Lamponi" /></meta><meta name="dc.Creator" content="Gianluca  Giorgi" /></meta><meta name="dc.Creator" content="Francesca  Ferlenghi" /></meta><meta name="dc.Creator" content="Federica  Vacondio" /></meta><meta name="dc.Creator" content="Paola  Maccioni" /></meta><meta name="dc.Creator" content="Giancarlo  Colombo" /></meta><meta name="dc.Creator" content="Marco  Mor" /></meta><meta name="dc.Creator" content="Katarzyna  Starowicz" /></meta><meta name="dc.Creator" content="Vincenzo  Di Marzo" /></meta><meta name="dc.Creator" content="Alessia  Ligresti" /></meta><meta name="dc.Creator" content="Federico  Corelli" /></meta><meta name="dc.Description" content="The hallmark of joint diseases, such as osteoarthritis (OA), is pain, originating from both inflammatory and neuropathic components, and compounds able to modulate the signal transduction pathways ..." /></meta><meta name="Description" content="The hallmark of joint diseases, such as osteoarthritis (OA), is pain, originating from both inflammatory and neuropathic components, and compounds able to modulate the signal transduction pathways ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 9, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00595" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00595" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00595" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00595" /></link>
        
    
    

<title>Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00595" /></meta><meta property="og:title" content="Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0015.jpeg" /></meta><meta property="og:description" content="The hallmark of joint diseases, such as osteoarthritis (OA), is pain, originating from both inflammatory and neuropathic components, and compounds able to modulate the signal transduction pathways of the cannabinoid type-2 receptor (CB2R) can represent a helpful option in the treatment of OA. In this perspective, a set of 18 cannabinoid type-2 receptor (CB2R) ligands was developed based on an unprecedented structure. With the aim of improving the physicochemical properties of previously reported 4-hydroxy-2-quinolone-3-carboxamides, a structural optimization program led to the discovery of isosteric 7-hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide derivatives. These new compounds are endowed with high affinity for the CB2R and moderate to good selectivity over the cannabinoid type-1 receptor (CB1R), associated with good physicochemical characteristics. As to the functional activity at the CB2R, compounds able to act either as agonists or as inverse agonists/antagonists were discovered. Among them, compound 51 emerged as a potent CB2R agonist able to reduce pain in rats carrying OA induced by injection of monoiodoacetic acid (MIA)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00595"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00595">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00595&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00595&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00595&amp;href=/doi/10.1021/acs.jmedchem.0c00595" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 7369-7391</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00580" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00636" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.0c01567"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-<i>b</i>]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Claudia Mugnaini</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claudia Mugnaini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7f1c131e0a1b161e51120a18111e1611163f0a11160c1651160b"><span class="__cf_email__" data-cfemail="c1a2ada0b4a5a8a0efacb4a6afa0a8afa881b4afa8b2a8efa8b5">[email protected]</span></a>. Tel.: (+39)0577-234318. Fax: (+39)0577-234333.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claudia++Mugnaini">Claudia Mugnaini</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1998-732X" title="Orcid link">http://orcid.org/0000-0003-1998-732X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Magdalena Kostrzewa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Magdalena Kostrzewa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council of Italy, Via Campi Flegrei 34, 80078 Pozzuoli, Napoli, Italy</div><div class="loa-info-affiliations-info">Institute of Genetics and Biophysics, National Research Council of Italy, Via Pietro Castellino 111, 80131 Napoli, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Magdalena++Kostrzewa">Magdalena Kostrzewa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marta Bryk</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marta Bryk</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Genetics and Biophysics, National Research Council of Italy, Via Pietro Castellino 111, 80131 Napoli, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Bryk">Marta Bryk</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ali Mokhtar Mahmoud</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ali Mokhtar Mahmoud</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council of Italy, Via Campi Flegrei 34, 80078 Pozzuoli, Napoli, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ali+Mokhtar++Mahmoud">Ali Mokhtar Mahmoud</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2328-0060" title="Orcid link">http://orcid.org/0000-0003-2328-0060</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antonella Brizzi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonella Brizzi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonella++Brizzi">Antonella Brizzi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefania Lamponi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefania Lamponi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefania++Lamponi">Stefania Lamponi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gianluca Giorgi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gianluca Giorgi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gianluca++Giorgi">Gianluca Giorgi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Francesca Ferlenghi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francesca Ferlenghi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francesca++Ferlenghi">Francesca Ferlenghi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1061-1991" title="Orcid link">http://orcid.org/0000-0003-1061-1991</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Federica Vacondio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Federica Vacondio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Federica++Vacondio">Federica Vacondio</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0729-4385" title="Orcid link">http://orcid.org/0000-0002-0729-4385</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paola Maccioni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paola Maccioni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Neuroscience, National Research Council of Italy, S.S. 554, km 4,500, 09042 Monserrato, Cagliari, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paola++Maccioni">Paola Maccioni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giancarlo Colombo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giancarlo Colombo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Neuroscience, National Research Council of Italy, S.S. 554, km 4,500, 09042 Monserrato, Cagliari, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giancarlo++Colombo">Giancarlo Colombo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marco Mor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marco Mor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Mor">Marco Mor</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0199-1849" title="Orcid link">http://orcid.org/0000-0003-0199-1849</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katarzyna Starowicz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katarzyna Starowicz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neurochemistry, Institute of Pharmacology, Polish Academy of Sciences, ul. Smetna 12, 31-343 Cracow, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katarzyna++Starowicz">Katarzyna Starowicz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vincenzo Di Marzo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vincenzo Di Marzo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council of Italy, Via Campi Flegrei 34, 80078 Pozzuoli, Napoli, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vincenzo++Di+Marzo">Vincenzo Di Marzo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1490-3070" title="Orcid link">http://orcid.org/0000-0002-1490-3070</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alessia Ligresti</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alessia Ligresti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council of Italy, Via Campi Flegrei 34, 80078 Pozzuoli, Napoli, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#91f0fdf4e2e2f8f0bffdf8f6e3f4e2e5f8d1f8f2f3bff2ffe3bff8e5"><span class="__cf_email__" data-cfemail="ff9e939a8c8c969ed19396988d9a8c8b96bf969c9dd19c918dd1968b">[email protected]</span></a>. Tel.: (+39)081-5249573. Fax: (+39)081-8675340.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alessia++Ligresti">Alessia Ligresti</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1787-3900" title="Orcid link">http://orcid.org/0000-0003-1787-3900</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Federico Corelli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Federico Corelli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Federico++Corelli">Federico Corelli</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00595&amp;href=/doi/10.1021%2Facs.jmedchem.0c00595" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 7369–7391</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 9, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 April 2020</li><li><span class="item_label"><b>Published</b> online</span>9 June 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00595" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00595</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7369%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DClaudia%2BMugnaini%252C%2BMagdalena%2BKostrzewa%252C%2BMarta%2BBryk%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D13%26contentID%3Dacs.jmedchem.0c00595%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BPhysicochemical%2Band%2BPharmacological%2BProfiling%2Bof%2B7-Hydroxy-5-oxopyrazolo%255B4%252C3-b%255Dpyridine-6-carboxamide%2BDerivatives%2Bwith%2BAntiosteoarthritic%2BActivity%2BIn%2BVivo%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7391%26publicationDate%3DJuly%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00595"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1055</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00595" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;Mugnaini&quot;},{&quot;first_name&quot;:&quot;Magdalena&quot;,&quot;last_name&quot;:&quot;Kostrzewa&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Bryk&quot;},{&quot;first_name&quot;:&quot;Ali&quot;,&quot;last_name&quot;:&quot;Mokhtar Mahmoud&quot;},{&quot;first_name&quot;:&quot;Antonella&quot;,&quot;last_name&quot;:&quot;Brizzi&quot;},{&quot;first_name&quot;:&quot;Stefania&quot;,&quot;last_name&quot;:&quot;Lamponi&quot;},{&quot;first_name&quot;:&quot;Gianluca&quot;,&quot;last_name&quot;:&quot;Giorgi&quot;},{&quot;first_name&quot;:&quot;Francesca&quot;,&quot;last_name&quot;:&quot;Ferlenghi&quot;},{&quot;first_name&quot;:&quot;Federica&quot;,&quot;last_name&quot;:&quot;Vacondio&quot;},{&quot;first_name&quot;:&quot;Paola&quot;,&quot;last_name&quot;:&quot;Maccioni&quot;},{&quot;first_name&quot;:&quot;Giancarlo&quot;,&quot;last_name&quot;:&quot;Colombo&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Mor&quot;},{&quot;first_name&quot;:&quot;Katarzyna&quot;,&quot;last_name&quot;:&quot;Starowicz&quot;},{&quot;first_name&quot;:&quot;Vincenzo&quot;,&quot;last_name&quot;:&quot;Di Marzo&quot;},{&quot;first_name&quot;:&quot;Alessia&quot;,&quot;last_name&quot;:&quot;Ligresti&quot;},{&quot;first_name&quot;:&quot;Federico&quot;,&quot;last_name&quot;:&quot;Corelli&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;7369-7391&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00595&quot;},&quot;abstract&quot;:&quot;The hallmark of joint diseases, such as osteoarthritis (OA), is pain, originating from both inflammatory and neuropathic components, and compounds able to modulate the signal transduction pathways of the cannabinoid type-2 receptor (CB2R) can represent a helpful option in the treatment of OA. In this perspective, a set of 18 cannabinoid type-2 receptor (CB2R) ligands was developed based on an unprecedented structure. With the aim of improving the physicochemical properties of previously reported 4-hydroxy-2-quinolone-3-carboxamides, a structural optimization program led to the discovery of isosteric 7-hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide derivatives. These new compounds are endowed with high affinity for the CB2R and moderate to good selectivity over the cannabinoid type-1 receptor (CB1R), associated with good physicochemical characteristics. As to the functional activity at the CB2R, compounds able to act either as agonists or as inverse agonists/antagonists were discovered. Among them, compoun&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00595&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00595" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00595&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00595" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00595&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00595" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00595&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00595&amp;href=/doi/10.1021/acs.jmedchem.0c00595" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00595" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00595" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00595%26sid%3Dliteratum%253Aachs%26pmid%3D32515588%26genre%3Darticle%26aulast%3DMugnaini%26date%3D2020%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BPhysicochemical%2Band%2BPharmacological%2BProfiling%2Bof%2B7-Hydroxy-5-oxopyrazolo%255B4%252C3-b%255Dpyridine-6-carboxamide%2BDerivatives%2Bwith%2BAntiosteoarthritic%2BActivity%2BIn%2BVivo%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D13%26spage%3D7369%26epage%3D7391%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/jmcmar.2020.63.issue-13/20200709/jmcmar.2020.63.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The hallmark of joint diseases, such as osteoarthritis (OA), is pain, originating from both inflammatory and neuropathic components, and compounds able to modulate the signal transduction pathways of the cannabinoid type-2 receptor (CB2R) can represent a helpful option in the treatment of OA. In this perspective, a set of 18 cannabinoid type-2 receptor (CB2R) ligands was developed based on an unprecedented structure. With the aim of improving the physicochemical properties of previously reported 4-hydroxy-2-quinolone-3-carboxamides, a structural optimization program led to the discovery of isosteric 7-hydroxy-5-oxopyrazolo[4,3-<i>b</i>]pyridine-6-carboxamide derivatives. These new compounds are endowed with high affinity for the CB2R and moderate to good selectivity over the cannabinoid type-1 receptor (CB1R), associated with good physicochemical characteristics. As to the functional activity at the CB2R, compounds able to act either as agonists or as inverse agonists/antagonists were discovered. Among them, compound <b>51</b> emerged as a potent CB2R agonist able to reduce pain in rats carrying OA induced by injection of monoiodoacetic acid (MIA).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span></span> Note</h4><p class="last">This paper published ASAP on June 22, 2020. Due to production error, Table 1 was incomplete. The corrected version was reposted on June 24, 2020.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Painful and disabling pathologies shared by most people worldwide include rheumatic and joint diseases,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> whose prevalence is expected to rise mainly because the world population is growing older and medical advances are lengthening life expectancy. Osteoarthritis (OA), a prevalent disease accompanied by chronic, debilitating pain, is the most common form of arthritis and a leading cause of disability for older individuals in developed countries,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> where the increasingly higher incidence of obesity is an important factor besides aging. It is estimated that 25% of individuals affected by osteoarthritis are prevented from performing daily activities.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> OA-induced pain is related to activation and release of local proinflammatory mediators and is accompanied by the destruction of tissues. However, clinically, there is often disparity between the degree of pain perception and the extent of joint changes in subjects with OA.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Nowadays, a growing body of evidence shows that the development of damage to joints and bones, as well as joint-related functional impairment, involves both local and, even more, systemic inflammation.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The hallmark symptom of joint diseases is pain,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> which originates from both inflammatory and neuropathic components, the latter seemingly being the major determinant of the intensity and quality of pain, although specific nerve lesions have not yet been identified in these pathologies.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> While it is well established that osteoarthritis is a heterogeneous condition with a variety of pathophysiologic drivers leading to multiple phenotypes,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> the pathogenesis of this disease is an intricate multifactorial process not fully clarified yet. In this scenario, the existence of a robust cross-talk between cartilage and subchondral bone as well as the occurrence of alterations of all junction structures (cartilage, bone, synovium, matrix, nerve endings, and blood vessels) is widely recognized.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In joint diseases, dysregulation and persistent activation of mast cells play a role at different levels, by altering the balance between cartilage and subchondral bone, promoting degenerative processes, and favoring the development of spinal neuroinflammation.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Among the inflammatory mediators involved in this pathological mechanism, interleukin- (IL-) 1β has been recognized as an important initiator of OA pathophysiological development.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">The therapeutic options currently available for treatment of osteoarthritis remain limited.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The traditional pharmacological intervention addressing chronic pain in this condition basically relies on symptomatic use of paracetamol and nonsteroidal anti-inflammatory drugs. There is an urgent need for effective osteoarthritis pharmacotherapy, able to prevent joint degeneration, to delay disease progression, and to restore organ functionality in affected individuals.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Accordingly, a convincing approach to address effectively this problem focuses on the development of disease-modifying drugs, and compounds targeting cannabinoid receptors and peroxisome proliferator-activated receptors (PPARs) represent a potential answer to this therapeutic need.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Type-1 cannabinoid receptors (CB1Rs) and type-2 cannabinoid receptors (CB2Rs) are the main receptors of the endocannabinoid system that have been identified so far.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Given their wide distribution in the body, these CBRs are implicated in several physiological and pathological processes and can be regarded as intriguing targets for potential pharmacotherapies in a number of disorders.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In this context, CBRs draw special attention, as they play a key role in bone formation, resorption, and growth. In particular, both CBRs are present in the skeleton, with CB1R expressed on nerve endings, whereas CB2R is found in osteoblasts, osteocytes, and osteoclasts.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Under pathological conditions, hypertrophic chondrocytes express both receptors,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> while synovial tissue fibroblasts of individuals affected by rheumatoid arthritis<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and immune system cells like mast cells mainly express CB2R. Both CB1 and CB2 receptor agonists play a protective role in joint diseases, as these receptors are involved in age-related bone remodeling and bone loss; in addition, due to its localization on cells of the immune system, the CB2R mediates immunomodulatory and anti-inflammatory effects as well. As a result, the development of CB2R agonists, which are devoid of the unwanted psychotropic effects ensuing from CB1R activation in the central nervous system (CNS), may be a promising avenue for novel, disease-modifying drug candidates for the treatment of the osteoarthritis process and chronic pain.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Accordingly, many efforts were made by academic and industrial laboratories to identify novel CB2R selective agonists because of their therapeutic potential in the treatment of a number of pathological conditions, such as neurodegenerative diseases, pain, ischemic stroke, inflammation, autoimmune diseases, osteoporosis, and cancer.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> As a result of this endeavor, a significant number of CB2R agonists with even excellent in vitro activities have been discovered, and some of them have successfully passed the preclinical evaluation to enter clinical trials (selected examples are reported in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>),<a onclick="showRef(event, 'ref19 cit20a'); return false;" href="javascript:void(0);" class="ref ref19 cit20a">(19,20a)</a> also by virtue of balanced physicochemical properties and favorable pharmacokinetic characteristics.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Selected CB2 Agonists in Clinical Development</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">During the last decade, we were actively investigating new cannabinoid ligands based on the quinolone scaffold, and our endeavor led to the discovery of several compounds (e.g., <b>1</b>, <a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>) showing remarkable affinity and selectivity at CB2R.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Representative Examples of Quinolones as Potent and Selective CB2R Ligands</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> (usually referred to as COR167) behaved as a full agonist and was further assayed in in vitro, ex vivo, and in vivo tests, where it displayed (i) potent immunomodulatory activity on immune cells from healthy subjects and patients with multiple sclerosis,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (ii) protective effects on rat brain tissues toward ischemia and reperfusion-induced injury,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and (iii) antinociceptive properties,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> thereby validating CB2R as a therapeutic target and becoming a useful pharmacological tool for further investigations. Very recently, we and other groups had introduced significant modifications to the quinolone scaffold of CB2R ligands aimed at improving their general physicochemical properties. Thus, on the one hand, our approach relied on the modification of the 4-quinolones into 4-hydroxy-2-quinolones,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> such as compound <b>2</b>, to obtain slightly acidic compounds with p<i>K</i><sub>a</sub> values typically in the range 4.2–5.0<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and hence expected to show better aqueous solubility at physiological pH. On the other hand, Aghazadeh Tabrizi et al. opted for a scaffold hopping strategy, by replacing the benzene ring of 4-quinolones with pyrazole, giving rise to two isomeric series, namely, pyrazolo[3,4-<i>b</i>]pyridine-5-carboxamides (e.g., <b>3</b>, <a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxamides.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Both works led to some advances in terms of physicochemical optimization of the target cannabinoid ligands, associated with preservation of the binding affinity and receptor selectivity.</div><div class="NLM_p">As a further attempt to improve the hydrophilic/lipophilic balance of CB2R ligands, we conceived a more marked structural modification of the original 4-quinolone nucleus, stemming from the combination of both approaches mentioned above and leading to molecules based on the new scaffold 7-hydroxy-5-oxopyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<a class="ref internalNav" href="#cht3" aria-label="Chart 3">Chart 3</a>).</div><figure id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Design of Novel 7-Hydroxypyrazolo[4,3-<i>b</i>]pyridine-5-one Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Here, we describe the synthesis, druglike and physicochemical properties, and in vitro pharmacological profiling of novel CB2R selective ligands, as well as the in vivo evaluation of a selected CB2R agonist in a rat model of osteoarthritis.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p">The chemical synthesis to attain the target pyrazolo[4,3-<i>b</i>]pyridine derivatives started with the alkylation of commercially available methyl 4-nitro-1<i>H</i>-pyrazole-3-carboxylate (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) with either iodomethane or 2-bromoethyl acetate to introduce a first element of chemical diversity into the final compounds.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>, acetone, 50 °C, 2 h; (b) 2-bromoethyl acetate, KI, K<sub>2</sub>CO<sub>3</sub>, acetone, 50 °C, 24 h.</p></p></figure><div class="NLM_p">Both reactions produced a mixture of regioisomers <b>4</b>/<b>5</b> and <b>6</b>/<b>7</b>, which were separated by column chromatography on silica gel. Their structure was assigned by X-ray crystallographic analysis (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_001.pdf" class="ext-link">Supporting Information</a>), which unambiguously showed as in both cases the more polar isomers were <b>4</b> and <b>6</b>, alkylated at the 2-position, while the faster eluting isomers <b>5</b> and <b>7</b> were 1-substituted pyrazole derivatives. Regioisomers <b>4</b> and <b>6</b> were also obtained in slightly higher percentages (<b>4</b>:<b>5</b> = 1.3:1 and <b>6</b>:<b>7</b> = 2:1).</div><div class="NLM_p">Compounds <b>4</b>–<b>7</b> were the precursors of four different series of pyrazolo[4,3-<i>b</i>]pyridine derivatives (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Fe, CaCl<sub>2</sub>, EtOH, H<sub>2</sub>O, 60 °C, 3 h; (b) appropriate alkyl iodide or bromide, dry <i>N</i>,<i>N</i>-dimethylformamide (DMF), 50 °C, 6–8 h; (c) 3-chloro-3-oxopropionate, NEt<sub>3</sub>, dry DCM, room temperature (rt), 2 h.</p></p></figure><div class="NLM_p">Reduction of the nitro group was accomplished using Fe/CaCl<sub>2</sub> in ethanol/water, and amines <b>8</b>–<b>11</b> were subjected to alkylation with different haloalkyl derivatives. This reaction was best performed in DMF as the solvent and in the absence of any added base to prevent the formation of products doubly substituted on the amino group, likely due to the higher nucleophilic reactivity of secondary amines compared to primary ones. Being also the most basic species present in solution, the initially formed monoalkylated compounds preferentially acted as scavengers for the produced HX, making possible the selective conversion of the primary amines <b>8</b>–<b>11</b> into the corresponding secondary amines <b>12</b>–<b>22</b>. After all, this procedure allowed one to obtain the expected compounds <b>12</b>–<b>22</b> as the main reaction products, albeit in only moderate yields (30–44% after chromatographic purification), as well as to enhance their chemical diversity. Subsequent acylation of secondary amines <b>12</b>–<b>22</b> with methyl 3-chloro-3-oxopropionate led to the corresponding amides <b>23</b>–<b>33</b>, which in turn were subjected to the Dieckmann condensation (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) under classical conditions (NaH/cat. MeOH/tetrahydrofuran (THF)) to give the pyrazolo[4,3-<i>b</i>]pyridine esters <b>34</b>–<b>44</b>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, MeOH (cat.), dry THF, 60 °C, 2 h; (b) 1-aminoadamantane or 3-aminoadamantan-1-ol, THF, toluene, reflux, 1–2 h; (c) 10% NaOH, H<sub>2</sub>O, reflux, 1 h; (d) AcCl, NEt<sub>3</sub>, dry DCM, rt, 2.5 h.</p></p></figure><div class="NLM_p">Due to their remarkable polarity and very low solubility in most organic solvents, these compounds were directly used in the next reaction. Treatment of <b>34</b>–<b>44</b> with 1-adamantylamine or 3-amino-1-adamantanol in refluxing toluene, with azeotropic removal of formed methanol, provided in good yields the final adamantylamides <b>45</b>–<b>60</b>, which could be easily purified by chromatography and/or crystallization. This unexpectedly fast and high-yielding conversion of the ester group into an amide functionality without using specific catalysts can be rationalized by taking into account an elimination–addition equilibrium, leading to the formation of a highly electrophilic ketene intermediate, with the azeotropic removal of methanol driving the reaction to completion (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>), as already reported by Jansson et al. for similar substrates.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0012.jpeg" id="gr7" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly enough, during this reaction, diesters <b>41</b>–<b>44</b> underwent concurrent deacetylation on the pyrazole side chain so as to yield directly the final compounds <b>56</b>–<b>60</b>. Conversely, the acetoxy moiety of <b>37</b> outlasted those reaction conditions and provided a still acetylated compound <b>50</b>, which was then converted into <b>61</b> by basic hydrolysis. On the other hand, deacetylated compound <b>56</b> was reacetylated to <b>62</b> to evaluate the influence of this structural modification on receptor binding affinity in in vitro assays.</div><div class="NLM_p last">All of the final compounds were characterized by mass spectral (MS), <sup>1</sup>H NMR, and <sup>13</sup>C NMR. In particular, <sup>1</sup>H NMR spectra revealed the presence of double signals, as shown in the example by the <sup>1</sup>H NMR spectrum of compound <b>51</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_001.pdf" class="ext-link">Supporting Information</a>). The signals of interest are those concerning N1-methyl, C3–H, amide NH, and enolic OH, while the alkyl side chain at the N4 position and the adamantane moiety do not give rise to double signals. This outcome may account for possible tautomeric equilibria in solution, such as that highlighted in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_001.pdf" class="ext-link">Figure 1S</a> (Supporting Information), which involves two most likely tautomers, although we cannot rule out the possibility that other tautomeric forms might be present as well. Based on the <sup>1</sup>H NMR spectra registered in CDCl<sub>3</sub>, we were able to estimate the ratio between tautomers present in solution for the four families of final amides, which resulted to be roughly 99:1 for <b>45</b>, 3:1 for <b>51</b>, 8:1 for <b>57</b>, and 1.3:1 for <b>60</b>.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Affinity/Selectivity for Cannabinoid Receptors and Functional Activity</h3><div class="NLM_p">The binding affinities (<i>K</i><sub>i</sub> values) of compounds <b>45–62</b> for human recombinant CB1R and CB2R are reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. CB1R and CB2R Affinity Values for Compounds <b>45–62</b> in Comparison with the Selective CB2R Ligand SR144528<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0014.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data represent mean values ± SD for at least three separate experiments performed in duplicate and are expressed as <i>K</i><sub>i</sub> (nM).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">For both receptor binding assays, the new compounds were tested using membranes from HEK cells transfected with either CB1R or CB2R and [<sup>3</sup>H]-(−)-<i>cis</i>-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-<i>trans</i>-4-(3-hydroxypropyl)cyclohexanol ([<sup>3</sup>H]CP-55 940).</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">CB1R, human cannabinoid type-1 receptor.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">CB2R, human cannabinoid type-2 receptor.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">SI, selectivity index for CB2R, calculated as the <i>K</i><sub>i</sub>(CB1R)/<i>K</i><sub>i</sub>(CB2R) ratio.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last"><i>K</i><sub>i</sub>, inhibitor constant, i.e., the concentration of the competing ligand that will bind to half the binding sites at equilibrium in the absence of a radioligand or other competitors.</p></div><div class="footnote" id="t1fn7"><sup><sup>g</sup></sup><p class="last">CB2 reference compound.</p></div><div class="footnote" id="t1fn8"><sup><sup>h</sup></sup><p class="last">The binding affinities of reference compounds were evaluated in parallel with test compounds under the same conditions.</p></div></div><div></div></div><div class="NLM_p">The compounds were evaluated in parallel with compound SR144528<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> as the reference CB2R ligand, as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> All 18 compounds tested displayed a significant binding affinity for CB2R, with <i>K</i><sub>i</sub> values spanning 3 orders of magnitude (0.18–187 nM), and, with the only exception of compounds <b>56</b>, <b>59</b>, and <b>62</b>, 15 of them proved to be potent CB2R ligands with <i>K</i><sub>i</sub> values in the range 0.18–27.1 nM. Only compounds <b>49</b>, <b>51</b>, <b>52</b>, <b>53</b>, and <b>55</b> showed also significant affinity for CB1R, with <i>K</i><sub>i</sub> values in the medium nanomolar range (33.5–86.9 nM). Nevertheless, only compound <b>52</b> exhibited a low receptor selectivity, while the other four pyrazolopyridine derivatives <b>49</b>, <b>51</b>, <b>53</b>, and <b>55</b> had selectivity index values between 28 and 167. A higher SI (37–253) was found for compounds with a low CB1R affinity, except for compound <b>62</b> (SI = 5), which resulted in the poorest cannabinoid receptor ligand of the series.</div><div class="NLM_p">We selected the most potent and selective compounds (i.e., <b>45</b>, <b>47</b>, <b>48</b>, <b>50</b>, <b>51</b>, <b>53</b>, <b>54</b>, <b>58</b>, <b>60</b>, <b>61</b>) for additional in vitro pharmacological evaluation to assess their ability to functionally activate the CB2R. We performed the cAMP Hunter assay, to measure intracellular cAMP levels, with the enzyme fragment complementation technology in NKH-477-stimulated CHO cells optimized to overexpress CB2R. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, compounds <b>51</b>, <b>53</b>, <b>54</b>, <b>55</b>, and <b>60</b> activated the receptor with typical agonist behavior by reducing cAMP levels induced by the NKH-477 (a water-soluble analogue of forskolin) as expected for a Gi protein-coupled receptor agonist.</div><figure id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Concentration–response curves of compounds in the cAMP Hunter assay enzyme fragment complementation chemiluminescent detection kit. The curves show the effect of increasing concentrations of compounds on NKH-477-induced cAMP levels in stable CHO cells expressing the human CB2R. Effect of JWH-133 is reported as a reference compound. Data are reported as means ± standard error of the mean (SEM) of three independent experiments conducted in triplicate and were normalized considering the NKH-477 stimulus alone as 100% of the response as indicated in the experimental session. EC<sub>50</sub> was determined by GraphPad Prism 5 as the concentration that provokes the response halfway between the baseline (bottom) and maximum response (top) of the fitted dose–response.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Conversely, N2 substitution on the pyrazolopyridine moiety (compounds <b>45</b>, <b>47</b>, <b>48</b>, <b>49</b>, <b>50</b>, <b>58</b>, <b>61</b>) promoted a switch to an antagonist (<b>48</b> and <b>58</b>) or an inverse agonist (compounds <b>45</b>, <b>47</b>, <b>49</b>, <b>50</b>, <b>61</b>) behavior, the latter being suggested by the ability of these compounds to increase the levels of NKH-477-induced cAMP (not shown). To further confirm this hypothesis, compounds <b>45</b>, <b>47</b>, <b>48</b>, <b>50</b>, <b>58</b>, and <b>61</b> were also tested in the presence of an EC<sub>80</sub> concentration of a CB2-ligand (4 μM of JWH-133). The compounds were able to antagonize JWH-133-induced inhibition of NKH-477-induced cAMP formation and, with the exception of <b>48</b> and <b>58</b>, up to levels higher than those induced by NKH-477 alone (considered as 100% response), thus confirming their predicted behavior (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Concentration–response curves of compounds in the cAMP Hunter assay. Curves show the effect of increasing concentrations of compounds on NKH-477-induced cAMP levels and in the presence of an EC<sub>80</sub> CB2-ligand challenge (4 μM of JWH-133), in stable CHO cells expressing the human CB2. Data are reported as means ± SEM of three independent experiments conducted in triplicate and were normalized to the maximal and minimal responses as indicated in the experimental session. EC<sub>50</sub> was determined by GraphPad Prism 5 as the concentration that provokes the response halfway between the baseline (bottom) and maximum response (top) of the fitted dose–response.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Structure–Activity Relationship (SAR)</h3><div class="NLM_p">Based on our previous findings,<a onclick="showRef(event, 'ref21 ref25'); return false;" href="javascript:void(0);" class="ref ref21 ref25">(21,25)</a> in all compounds, the adamantane moiety was retained, with either no modification or the one modification represented by the insertion of a hydroxy group at the 3′-position. This change resulted in some decrease of affinity at CB2R, as evident by comparing couples of compounds (<b>45</b>/<b>46</b>, <b>47</b>/<b>48</b>, <b>51</b>/<b>52</b>, and <b>58</b>/<b>59</b>) differing from each other only in this respect.</div><div class="NLM_p">A major impact on receptor affinity was exerted by the alkyl chain at N4. The stepwise lengthening of this chain from 3 (<b>56</b>) to 4 <b>(57</b>) or 5 (<b>58</b>) carbon atoms caused a progressive improvement in CB2R binding, but the chain was not elongated further to avoid an excessive increase of lipophilicity. Conversely, we took into consideration the frequently used strategy of incorporating fluorine into drug molecules, aimed at improving potency and optimizing physicochemical and ADME properties.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> This approach has ensured beneficial effects during lead optimization programs, when attention was paid to the corresponding changes in a number of parameters of the drug candidate.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Accordingly, we opted for the replacement with fluorine of a hydrogen atom of the terminal methyl group in the 4-carbon atom chain, by evaluating at the same time the benefits of this modification in terms of binding affinity and lipophilic ligand efficiency (<i>vide infra</i>).</div><div class="NLM_p">Comparison among <b>45</b>/<b>47</b>, <b>46</b>/<b>48</b>, <b>51</b>/<b>53</b>, and <b>52</b>/<b>54</b> clearly shows that no substantial change in CB2R affinity occurred as a consequence of hydrogen/fluorine exchange; in all cases, a very slight increase in affinity could be measured instead, associated with an improvement in receptor selectivity. On the other hand, the insertion at the end of the alkyl chain of a hydroxyl (<b>61</b>) or an acetoxy (<b>50</b>) group led to a 6/7-fold decrease in binding affinity at CB2R with concurrent loss of affinity for the other receptor subtype.</div><div class="NLM_p">A longer chain with a H-bond donor/acceptor hydroxyl was also substituted for the N2-methyl group to obtain more information on the structure–activity relationship (SAR). Compounds <b>56</b>–<b>59</b> exhibited significantly lower CB2R affinity than their methylated counterparts; a similar result was also yielded by compound <b>60</b> compared to its N1-methyl analogue <b>51</b>.</div><div class="NLM_p">The structure–function relationship appears to be very well defined and strictly dependent on N1 or N2 substitution. N1-Methyl substituted derivatives <b>51</b>, <b>53</b>, <b>54</b>, <b>55</b>, and <b>60</b> show the ability to activate the CB2R, while the corresponding compounds with the methyl substituent at the N2 position behave as inverse agonists (<b>45</b>, <b>47</b>, <b>49</b>, <b>50</b>, <b>61</b>) or neutral antagonists (<b>48</b> and <b>58</b>) at the same receptor. Modification of other structural features, such as the N4 chain or the adamantane moiety, was irrelevant in this regard.</div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Estimated Druglike Properties</h4><div class="NLM_p last">The molecular properties of tested compounds <b>45</b>–<b>62</b> were estimated using the free web tool SwissADME [<a href="http://www.swissadme.ch" class="extLink">http://www.swissadme.ch</a>] and compared to those of compounds <b>1</b> and <b>2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_001.pdf" class="ext-link">Table 1S</a>, Supporting Information), which previously proved to be very potent and selective CB2R ligands but did not exhibit completely satisfactory physicochemical characteristics. Overall, the new pyrazolo[4,3-<i>b</i>]pyridine derivatives were in line with the general druglikeness requirements, possessing better virtual profiles than compounds <b>1</b> and <b>2</b> according to Lipinski’s “rule-of-five” (Ro5),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Veber’s parameters,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and the lipophilic ligand efficiency (LLE).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In particular, the calculated log <i>P</i> (clog <i>P</i>) and TPSA values for many of the compounds <b>45</b>–<b>62</b> fell within the optimal range for oral bioavailability and the blood–brain barrier (BBB) permeability (clog <i>P</i> = 2–4, TPSA = 50–90 Å<sup>2</sup>),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> while the higher polarity (TPSA = 109–129 Å<sup>2</sup>) estimated for some of them prompts the presumption that these compounds might be predominantly peripheral CB2R binders, as their ability to penetrate the CNS may be expected to be lower.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Sixteen of the eighteen compounds were characterized by a multiparameter score LLE within the optimal range for suitable drug candidates (5 < LLE < 7), since the reduction in overall lipophilicity, as predicted by clog <i>P</i> values, did not affect the CB2R affinity values (p<i>K</i><sub>iCB2</sub>).</div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vitro Physicochemical Characterization</h3><div class="NLM_p">The aqueous solubility of compounds <b>45–62</b> was then assessed measuring their kinetic solubility starting from dimethyl sulfoxide (DMSO) stock solutions.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This approach was preferred to measurements of equilibrium solubility from powder because they are significantly affected by the nature of the solid state (amorphous, crystalline, presence of different polymorphs, solvates), which, generally, is not thoroughly investigated at these stages of drug development.</div><div class="NLM_p">In <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, the values of kinetic solubility, at pH 1.0 and 7.4, expressed as μg/mL, are reported.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Experimental and Calculated Solubilities of Compounds <b>45–62</b> in Comparison with Compounds <b>1</b> and <b>2</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">kinetic solubility pH 1.0 (μg/mL)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">kinetic solubility pH 7.4 (μg/mL)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">kinetic solubility pH 7.4 log <i>S</i></th><th class="colsep0 rowsep0" align="center" char=".">calculated solubility ACD/Labs<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> log <i>S</i></th><th class="colsep0 rowsep0" align="center" char=".">calculated solubility ALOGPS<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> log <i>S</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">0.23 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">–5.32</td><td class="colsep0 rowsep0" align="char" char=".">–4.38</td><td class="colsep0 rowsep0" align="char" char=".">–3.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">15 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">20.9 ± 0.8</td><td class="colsep0 rowsep0" align="char" char=".">–4.32</td><td class="colsep0 rowsep0" align="char" char=".">–3.36</td><td class="colsep0 rowsep0" align="char" char=".">–2.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">–5.73</td><td class="colsep0 rowsep0" align="char" char=".">–4.51</td><td class="colsep0 rowsep0" align="char" char=".">–3.72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">39.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">37.6 ± 1.3</td><td class="colsep0 rowsep0" align="char" char=".">–4.06</td><td class="colsep0 rowsep0" align="char" char=".">–3.49</td><td class="colsep0 rowsep0" align="char" char=".">–2.72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">2.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">–5.35</td><td class="colsep0 rowsep0" align="char" char=".">–4.65</td><td class="colsep0 rowsep0" align="char" char=".">–4.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">–5.54</td><td class="colsep0 rowsep0" align="char" char=".">–4.26</td><td class="colsep0 rowsep0" align="char" char=".">–3.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">0.13 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.49 ± 0.06</td><td class="colsep0 rowsep0" align="char" char=".">–5.96</td><td class="colsep0 rowsep0" align="char" char=".">–4.32</td><td class="colsep0 rowsep0" align="char" char=".">–3.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">2.1 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">4.6 ± 0.3</td><td class="colsep0 rowsep0" align="char" char=".">–4.95</td><td class="colsep0 rowsep0" align="char" char=".">–3.32</td><td class="colsep0 rowsep0" align="char" char=".">–2.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">0.7 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.4</td><td class="colsep0 rowsep0" align="char" char=".">–5.52</td><td class="colsep0 rowsep0" align="char" char=".">–4.46</td><td class="colsep0 rowsep0" align="char" char=".">–3.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">9.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">15.1 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">–4.45</td><td class="colsep0 rowsep0" align="char" char=".">–3.45</td><td class="colsep0 rowsep0" align="char" char=".">–2.78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">0.4 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.08 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">–5.58</td><td class="colsep0 rowsep0" align="char" char=".">–4.65</td><td class="colsep0 rowsep0" align="char" char=".">–4.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">3.4 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">3.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">–5.03</td><td class="colsep0 rowsep0" align="char" char=".">–3.95</td><td class="colsep0 rowsep0" align="char" char=".">–2.99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">1.6 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">2.1 ± 0.4</td><td class="colsep0 rowsep0" align="char" char=".">–5.30</td><td class="colsep0 rowsep0" align="char" char=".">–4.22</td><td class="colsep0 rowsep0" align="char" char=".">–3.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">0.38 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.70 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">–5.80</td><td class="colsep0 rowsep0" align="char" char=".">–4.49</td><td class="colsep0 rowsep0" align="char" char=".">–3.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">9.70 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">15 ± 1</td><td class="colsep0 rowsep0" align="char" char=".">–4.49</td><td class="colsep0 rowsep0" align="char" char=".">–3.46</td><td class="colsep0 rowsep0" align="char" char=".">–2.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">0.11 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.24 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">–6.26</td><td class="colsep0 rowsep0" align="char" char=".">–4.20</td><td class="colsep0 rowsep0" align="char" char=".">–3.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">2.53 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">3.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">–5.11</td><td class="colsep0 rowsep0" align="char" char=".">–3.61</td><td class="colsep0 rowsep0" align="char" char=".">–3.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">–5.61</td><td class="colsep0 rowsep0" align="char" char=".">–4.28</td><td class="colsep0 rowsep0" align="char" char=".">–3.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">0.21± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">–5.64</td><td class="colsep0 rowsep0" align="char" char=".">–6.04</td><td class="colsep0 rowsep0" align="char" char=".">–6.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">0.23± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.1</td><td class="colsep0 rowsep0" align="char" char=".">–5.47</td><td class="colsep0 rowsep0" align="char" char=".">–4.47</td><td class="colsep0 rowsep0" align="char" char=".">–4.99</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Reported are mean values together with standard deviation (<i>n</i> = 4).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">ACD calculated solubility values (ACD/Labs I-Lab 2.0: <a href="http://www.ilab.acdlabs.com" class="extLink">http://www.ilab.acdlabs.com</a>).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">ALOGPS 2.1 calculated solubility values (<a href="http://www.vcclab.org" class="extLink">http://www.vcclab.org</a>). Reported are the mean solubility values of the neutral species calculated taking into account the different tautomeric forms reported in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_001.pdf" class="ext-link">Figure 2S</a> (Supporting Information).</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Not stable in the test time period (>25% hydrolysis of the side-chain ester group in 4 h).</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">See also ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a>.</p></div></div></div><div class="NLM_p">The corresponding log <i>S</i> values, in the log(mol/L) scale, are compared to calculated log <i>S</i> by ACD/Labs and ALOGPS software. In general, experimental log <i>S</i> at acidic pH (pH 1.0) ranged between −4.03 of the most soluble <b>48</b> and −6.59 of the least soluble <b>60</b> and between −4.06 (<b>48</b>) and −6.26 (<b>60)</b> at physiological pH, spanning over 2 orders of magnitude. The values of log <i>S</i> calculated by two software, ACD/Labs and ALOGPS, respectively, were mutually correlated (log <i>S</i><sub>ACD</sub> = 0.97(±0.08) log <i>S</i><sub>ALOGPS</sub> −0.77(±0.27); <i>n</i> = 18; <i>r</i><sup>2</sup> = 0.905; s = 0.15; <i>F</i> = 152) but tended to overestimate solubility in comparison with experimental results. The correlation between experimental and calculated values was significantly lower, with ACD/Labs (log <i>S</i><sub>exp</sub> = 1.01(±0.19) log <i>S</i><sub>ACD</sub> −1.15(±0.77); <i>n</i> = 18; <i>r</i><sup>2</sup> = 0.641; <i>s</i> = 0.37; <i>F</i> = 28.5) performing better than ALOGPS (log <i>S</i><sub>exp</sub> = 0.98(±0.21) log <i>S</i><sub>ALOGPS</sub> −1.93(±0.71); <i>n</i> = 18; <i>r</i><sup>2</sup> = 0.580; <i>s</i> = 0.40; <i>F</i> = 22.1).</div><div class="NLM_p">Considering experimental results, in the subset of N2-methyl derivatives <b>45–50</b> and <b>61</b>, hydroxylation of the adamantyl group (<b>46</b>) led to a 1-log unit increase in solubility at both pHs, if compared to the parent compound <b>45</b>. Fluorination of the butyl side chain at N4 (<b>47</b>) increased the solubility at acidic pH (3 times vs <b>45</b>) but led to a slight decrease at physiological pH. The combination of both hydroxylation and fluorination gave the best result, with the solubility for compound <b>48</b> being 170 times (pH 1.0) and 20 times (pH 7.4) higher than that of <b>45</b>. Within the subset of N2-methyl substituted derivatives, shifting from the <i>n-</i>butyl to <i>n-</i>pentyl side chain at N4 (<b>49</b>) did not significantly affect the kinetic solubility, especially at physiological pH, whereas hydroxylation of the side chain (<b>61</b>) led to an increase in the solubility at both pHs, even if the magnitude of the effect was not comparable to that obtained with 3′-hydroxylation at the adamantyl ring. Acetylation of the hydroxyl group in the side chain (<b>50)</b> did not significantly affect solubility at pH 7.4 and led to a stability issue owing to hydrolysis of this ester group at acidic pH. N1-Methyl derivatives <b>51–55</b> were in general less soluble at both pHs than the corresponding N2-methyl ones. For instance, the parent compound <b>51</b> was twice less soluble at pH 1.0 and four times less soluble at pH 7.4 than the corresponding <b>45</b>. Nevertheless, 3′-hydroxylation at the adamantyl group (<b>52</b>), fluorination on the <i>n</i>-butyl side chain at N4 (<b>53</b>), and the combination of both substitutions (<b>54</b>) paralleled the effects on kinetic solubility observed for the <b>46–48</b> subset. Compound <b>54</b> was the most soluble of N1-methyl derivatives with a log <i>S</i> at physiological pH around −4.45.</div><div class="NLM_p">Finally, the combined effect on kinetic solubility of introducing a hydroxyethyl side chain at N1 (<b>60</b>) or N2 (<b>56–59</b>) of the 5-oxopyrazolo[4,3-<i>b</i>]pyridine nucleus and of elongating the side chain at N4 was explored, looking for the right combination of both solubility and activity. As previously observed, the N1-substituted derivative (<b>60</b>) was much less soluble than the corresponding N2-substituted one (<b>57</b>) and also the pharmacological activity and selectivity for CB2R favored the latter. Elongation of the alkyl side chain at N4 led to a 1-log unit progressive decrease in kinetic solubility at both pHs (<b>56–58</b>). Compound <b>57</b> combined good selectivity for CB2R (SI > 54) with a log <i>S</i> = −5.30. The ionization constants (p<i>K</i><sub>a</sub>) and experimental lipophilicity (log <i>P</i><sub>oct</sub>) of compounds <b>45</b>, <b>46</b>, <b>48</b>, <b>51</b>, and <b>52</b> were also measured, by means of a UV-metric and potentiometric approach (see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Ionization Constants (p<i>K</i><sub>a</sub>) and Lipophilicity (Log <i>P</i><sub>oct</sub>) of Compounds <b>45</b>, <b>46</b>, <b>48</b>, <b>51</b>, and <b>52</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">p<i>K</i><sub>a</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±">log <i>P</i><sub>oct</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="char" char="±">8.6 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char="±">7.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">4.08 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="char" char="±">7.97 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">3.15 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="char" char="±">8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="char" char="±">7.56 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">4.85 ± 0.01</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Aqueous p<i>K</i><sub>a</sub> values extrapolated from MeOH/0.15 M ionic strength adjusted water solutions (see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Reported are mean values together with their standard deviations (<i>n</i> = 3).</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Measured by the potentiometric pH-metric approach.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></p></div></div></div><div class="NLM_p last">For all compounds, aqueous p<i>K</i><sub>a</sub> values were extrapolated starting from solutions at different percentages of the cosolvent (MeOH). In all of the cases, the slope of the extrapolation curve was typical of acidic compounds. Measured p<i>K</i><sub>a</sub> values ranged from 7.56 (<b>52</b>) to 8.56 (<b>45</b>). In both subsets of N2-methyl (<b>45</b>, <b>46</b>) and N1-methyl (<b>51</b>, <b>52</b>) substituted derivatives, the introduction of the hydroxyl group at 3′ on the adamantyl ring led to a significant decrease in the p<i>K</i><sub>a</sub> value, while no effect was seen for fluorination (<b>48</b>). The partition coefficients (log <i>P</i><sub>oct</sub>) were determined evaluating the shifts produced in the titration curves by different ratios of the partition solvent (<i>n-</i>octanol) and 0.15 M ionic strength adjusted water. Remarkably, in the N2-methyl derivatives (<b>45</b>, <b>46</b>, <b>48</b>), a 2-log unit decrease of lipophilicity was observed when 3′-hydroxylation on adamantane or N4-side-chain fluorination took place. Experimental log <i>P</i> values differed from calculated ones by a Δ(log <i>P</i><sub>oct</sub> – clog <i>P</i>) ranging between 1.2 and 1.6, except for compound <b>52</b>, which rather surprisingly showed an experimental log <i>P</i> value significantly higher than the corresponding N2-substituted isomer <b>46</b>. However, the experimental values paralleled the calculated ones, and compounds <b>45</b>, <b>46</b>, <b>48</b>, <b>51</b>, and <b>52</b> ranked in the same order based on both theoretical and experimental lipophilicities. Therefore, the calculation of druglikeness was useful to predict how structural modifications of compounds would affect their main physicochemical properties.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vitro Cytotoxicity</h3><div class="NLM_p">In vitro cytotoxicity and cytocompatibility testing provides a crucial means of ranking compounds for consideration in drug discovery. Although all of the molecules of the series were tested for cytotoxicity, only compounds that showed low cytotoxicity were reported.</div><div class="NLM_p">To check the potentiality of these compounds, in vitro cell toxicity up to 24 h toward either NIH3T3 fibroblasts or normal human articular chondrocytes (NHAC-kn) was assessed as a function of concentration, and results (IC<sub>50</sub> values) are reported in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Cytotoxicity Values of Selected Compounds <b>45–48</b>, <b>50–54</b>, and <b>57–61</b> toward NIH3T3 Fibroblasts and Normal Human Articular Chondrocytes (NHAC-kn)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">NIH3T3 (IC<sub>50</sub>, μM)</th><th class="colsep0 rowsep0" align="center" char=".">NHAC-kn (IC<sub>50</sub>, μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">12.5</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">12.5</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">12.5</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">12.5</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">12.5</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Cell viability measured by the neutral red uptake (NRU) test. All compounds were tested at increasing concentrations ranging from 2.5 to 50 μM. The assay was carried out three times in three replicates for each tested concentration. The standard deviation is less than 5%.</p></div></div></div><div class="NLM_p">Three compounds in particular (<b>48</b>, <b>51</b>, and <b>61</b>) showed low cytotoxicity (IC<sub>50</sub> > 10 μM) against both cell types. Based on its functionality at CB2R and druglike properties, we selected <b>51</b> as the lead compound, which was further investigated for its long-lasting cytotoxicity and capability of blocking the in vitro dedifferentiation process of human chondrocytes. Cell viability of NHAC-kn exposed to 7.5 μM, i.e., the highest nontoxic concentration, up to 14 days was assessed by the neutral red uptake assay. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, no toxic effect toward chondrocyte viability was observed as cell density was not statistically different (<i>p</i> < 0.05) in comparison with the vehicle at 1, 7, and 14 days, demonstrating that compound <b>51</b> does not interfere with NHAC-kn cell viability.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Percentage of Viable NHAC-kn in Contact with Compound <b>51</b> (7.5 μM) Evaluated by the Neutral Red Uptake Test as a Function of Incubation Time</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">percentage (±SD) of viable NHAC-kn as a function of incubation time</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center" char="±">1 day</th><th class="colsep0 rowsep0" align="center" char="±">7 days</th><th class="colsep0 rowsep0" align="center" char="±">14 day</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">negative control (growth medium)</td><td class="colsep0 rowsep0" align="char" char="±">47 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">73 ± 8</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>51</b> (7.5 μM)</td><td class="colsep0 rowsep0" align="char" char="±"><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a>51 ± 8</td><td class="colsep0 rowsep0" align="char" char="±"><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a>68 ± 6</td><td class="colsep0 rowsep0" align="char" char="±"><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a>94 ± 7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Data are means ± SD of three replicates for each tested concentration or incubation time. Data are not statistically different in comparison to the negative control, <i>p</i> < 0.05.</p></div></div></div><div class="NLM_p">NHAC-kn in contact with 7.5 μM compound <b>51</b> was analyzed for their content of major cartilaginous extracellular matrix (ECM) components, i.e., sulfated GAG and total collagen (HYP), to assess the ability of the test compound to prevent chondrocyte dedifferentiation. In fact, human chondrocytes dedifferentiate rapidly during monolayer culture, acquiring a fibroblast-like phenotype and decreasing the production of cartilaginous tissue. As reported in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, compound <b>51</b> statistically increased sGAG levels compared to the negative control, i.e., the growth medium not supplemented with growth factors able to decelerate the dedifferentiation process,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> already after 7 days, and its effect persisted after 14 days of incubation. The increase in sGAG levels is a significant result, as it shows that chondrocytes are not differentiated.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Extracellular Matrix Production in NHAC-kn Cultures in the Presence of a Growth Medium (Negative Control) or Compound <b>51</b> (7.5 μM) as a Function of Incubation Time</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char="±">extracellular matrix production</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">sGAG (μg ± SD)</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">HYP (μg ± SD)</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">sGAG/HYP ratio</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">incubation time</th><th class="colsep0 rowsep0" align="center" char="±">negative control</th><th class="colsep0 rowsep0" align="center" char="±">compound <b>51</b></th><th class="colsep0 rowsep0" align="center" char="±">negative control</th><th class="colsep0 rowsep0" align="center" char="±">compound <b>51</b></th><th class="colsep0 rowsep0" align="center" char="±">negative control</th><th class="colsep0 rowsep0" align="center" char="±">compound <b>51</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 day</td><td class="colsep0 rowsep0" align="char" char="±">9.3 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">8.9 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">9.9 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">10.1 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7 days</td><td class="colsep0 rowsep0" align="char" char="±">11.2 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±"><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>12.6 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">13.2 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">12.9 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">1 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">14 days</td><td class="colsep0 rowsep0" align="char" char="±">12.0 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±"><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>14.2 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">14.2 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">13.9 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">1 ± 0.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Data are means ± SD of three replicates for each incubation time.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Data are significantly different in comparison to the negative control. <i>p</i> < 0.05.</p></div></div></div><div class="NLM_p">Hydroxyproline (HYP) is a nonproteinogenic amino acid formed by the post-translational hydroxylation of proline. HYP is a major component of collagen, where it serves to stabilize the helical structure. Because HYP is largely restricted to collagen, the measurements of HYP levels can be used as an indicator of the collagen content.</div><div class="NLM_p">The results obtained regarding HYP production by human chondrocytes in contact with the negative control and 7.5 μM compound <b>51</b> are reported in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>.</div><div class="NLM_p last">The data demonstrate that the amount of HYP increased on increasing the incubation time for both the negative control and the test compound to the same extent. The increase in both sGAG and HYP levels, and the value of the sGAG/HYP ratio, calculated as an indicator for hyaline or fibrocartilage nature of the produced matrix (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), demonstrated that the negative control and compound <b>51</b> showed the same trend and that the sGAG/HYP ratio remained constant by increasing the incubation time. These results indicate that, although specific collagen was not measured, the produced extracellular matrix was hyaline. In addition, these results demonstrate the good ability of compound <b>51</b> to stimulate the production of hyaline ECM and to prevent the in vitro dedifferentiation of primary human chondrocytes (HCs), confirming its chondrogenic capacity.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Effect of CB2R Agonist Systemic Administration on Joint Hypersensitivity and Walking Pattern in MIA-Treated Rats</h3><div class="NLM_p">To evaluate the analgesic properties of the lead compound in vivo, we induced osteoarthritis in rats by intra-articular injection of sodium monoiodoacetate (MIA), which prompts rapid painlike responses in the ipsilateral limb and morphological changes of the articular cartilage. All changes of the microarchitecture of the subchondral bone in terms of bone volume, trabecular thickness, and trabecular number lead to bone disruption and cause knee joint hypersensitivity. Along with pain phenotype development, joint damage, and subchondral bone disruption, MIA injection induces weight-bearing deficits that are measurable and quantifiable, particularly 21 and 28 days post injection.<a onclick="showRef(event, 'cit40a'); return false;" href="javascript:void(0);" class="ref cit40a">(40a)</a> Moreover, osteoarthritis (OA) development is accompanied by dynamic changes of CB2 expression in the dorsal root ganglion (DRG) and cartilage in MIA rats.<a onclick="showRef(event, 'cit41a'); return false;" href="javascript:void(0);" class="ref cit41a">(41a)</a><a onclick="showRef(event, 'cit41b'); return false;" href="javascript:void(0);" class="ref cit41b">(41b)</a> Therefore, 21 days after OA induction, we assessed pain-related behaviors performing two different in vivo tests, test pressure applied measurement (PAM)<a onclick="showRef(event, 'cit40b'); return false;" href="javascript:void(0);" class="ref cit40b">(40b)</a><a onclick="showRef(event, 'cit40b'); return false;" href="javascript:void(0);" class="ref cit40b">(40b)</a><a onclick="showRef(event, 'cit40b'); return false;" href="javascript:void(0);" class="ref cit40b">(40b)</a> and the kinetic-weight-bearing (KWB) tests.<a onclick="showRef(event, 'cit40a'); return false;" href="javascript:void(0);" class="ref cit40a">(40a)</a> Two sensory systems were evaluated by joint hypersensitivity (PAM) and gait analysis (KWB) to well define the in vivo effect of compound <b>51</b> in OA-induced animals. In the PAM test, compound <b>51</b> triggered a statistically significant analgesic effect at 1 mg/kg dose 60, 120, and 180 min after administration (<i>p</i> < 0.05 and <i>p</i> < 0.01, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time course and effect of acute, systemic treatment with compound <b>51</b> alone or in combination with the CB2 receptor antagonist AM-630 on hind limb joint hypersensitivity in osteoarthritic rats (PAM test). After 21 or 28 days of injection with 1 mg of MIA, rats received compound <b>51</b> (1 mg/kg) intraperitoneally (i.p.), and the hind limb withdrawal threshold was assessed during a 300 min period. Compound <b>51</b> triggered a statistically significant analgesic effect (*<i>p</i> < 0.05 and **<i>p</i> < 0.01) compared to the vehicle group at 60, 120, and 180 min post administration recordings. A systemic preadministration of AM-630 (1 mg/kg, i.p.) reduced the analgesic effect of compound <b>51</b> with statistical significance (#<i>p</i> < 0.05) 120 min post injection. Data are presented as maximal possible effect (%MPE) ± SEM. Male Wistar rats were used in the study and divided into four experimental groups with <i>n</i> = 17 for vehicle, <i>n</i> = 10 for compound <b>51</b>, <i>n</i> = 10 for AM-630 + compound <b>51</b>, and <i>n</i> = 6 for AM-630. Statistical analysis was performed using analysis of variance (ANOVA) followed by the Tukey post hoc test. The values with *<i>p</i> < 0.05 were considered significant. * denotes significant differences vs the vehicle, and # denotes significant differences vs compound <b>51</b> (1 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The effect of compound <b>51</b> (1 mg/kg, i.p.) was blocked by the CBR2 antagonist AM-630 (1 mg/kg, i.p.) 120 min post administration (#<i>p</i> < 0.05, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The injection of the vehicle solution had no <i>per se</i> analgesic effect. In the KWB test, a strong and significant difference between left and right paw peak force was detected in the vehicle-treated group (<i>p</i> < 0.0001, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of acute systemic administration of compound <b>51</b> alone or in combination with the CB2R antagonist AM-630 on the kinetic-weight-bearing (KWB) test of MIA rats. On days 21 and 28 post OA induction, MIA rats were monitored for differences in forces applied on both rear paws during free walking movements and mechanical loading. The intraperitoneal (i.p.) administration of compound <b>51</b> (1 mg/kg) restored the differences in forces applied between rear left and rear right (injured) paws 60 min post administration. A systemic preadministration of AM-630 (1 mg/kg, i.p.) decreased the analgesic effect of compound <b>51</b> by reducing the force applied on the rear right (injured) paw, resulting in a disruption of rats’ walking patterns. Data are presented as means ± SEM. Male Wistar rats were used in the study and divided into four experimental groups with <i>n</i> = 22 for vehicle, <i>n</i> = 10 for compound <b>51</b>, <i>n</i> = 10 for AM-630 + compound <b>51</b>, and <i>n</i> = 5 for AM-630. Statistical analysis was performed using analysis of variance (ANOVA) followed by Bonferroni’s post hoc test. The values with *<i>p</i> < 0.05 were considered significant. * denotes significant differences between rear left vs rear right paws in each group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">After administration of compound <b>5</b>1 (1 mg/kg), no statistical difference was observed between paws with respect to the peak force (<i>p</i> > 0.5, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), indicating that the treatment restored disturbances in the walking pattern of MIA rats. The effect was effectively blocked by AM-630 (<i>p</i> < 0.0001), which <i>per se</i> was not able to restore the walking pattern (not shown). These findings indicate that compound <b>51</b> holds both analgesic and anti-inflammatory properties and that its actions are CB2-mediated.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Effect on Osteoarthritic Chondrocytes HC-OA Stimulated with TNFα</h3><div class="NLM_p">To better characterize the anti-inflammatory response of compound <b>51</b>, we stimulated human chondrocytes derived from human articular cartilage of donors with OA (HC-OA) with TNFα, and we measured the mRNA expression of the <i>I1B</i> gene encoding for IL-1β, a proinflammatory cytokine that has been implicated in pain, inflammation, and autoimmune conditions. Upon a 50 ng/mL stimulus with TNFα, we found a statistically significant increase of the IL-1β mRNA expression (<i>p</i> < 0.001) that was abolished (<i>p</i> < 0.05) in the presence of 10 μM of compound <b>51</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Coincubation with the CB2 antagonist AM-630 (1 μM) did not affect <i>per se</i> the expression of proinflammatory cytokine IL-1β (not shown) but was able to completely revert the anti-inflammatory effect of the full agonist compound <b>51</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound <b>51</b> treatment alone or in combination with the CB2R antagonist AM-630 on IL-1β expression in human osteoarthritic chondrocytes (HC-OA) stimulated with TNFα. HC-OAs derived from human articular cartilage of donors with OA were stimulated with TNFα (50 ng/mL), and the inflammatory responses were measured by expression of the <i>Il1B</i> gene encoding for IL-1β. Treatment with 10 μM of compound <b>51</b> significantly reduced (<i>p</i> < 0.001) the mRNA levels of IL-1β in the presence of TNFα. Cotreatment with AM-630 (1 μM) abolished the anti-inflammatory effect of compound <b>51</b>, restoring the high expression of <i>Il1B</i>. Data are presented as fold change (means ± SEM) normalized to expression of the reference gene <i>B2m</i> and compared to the vehicle-treated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">All of the test compounds showed good cell compatibility and demonstrated inhibition of cell viability at micromolar concentrations: from 7.5 to 25 μM for NIH3T3 fibroblasts and from 2.5 to 12.5 μM for NHAC-kn.</div><div class="NLM_p last">Statistical analysis was performed using analysis of variance (ANOVA) followed by Dunnet’s post hoc test; values with <i>p</i> < 0.05 were considered significant. * denotes significant differences vs the vehicle group; # denotes significant differences vs the TNFα group.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, we have designed and synthesized a series of substituted pyrazolopyridinone amides starting from a quinolone series previously developed as CB2R ligands but not showing completely satisfactory physicochemical characteristics. Structural optimization of quinolone derivatives was achieved by a scaffold hopping approach, involving the replacement of the benzene ring with the isosteric pyrazole, combined with the cautious introduction of the fluorine atom and/or the hydroxy group aimed at the fine modulation of the overall properties of compounds. Our efforts successfully provided 18 new cannabinoid ligands, most of which display CB2R affinity at low nanomolar or subnanomolar concentrations, with six of them also showing good selectivity (SI > 90) over CB1R. In this series of compounds, both agonists and inverse agonists/neutral antagonists were identified, with functional activity strongly and exclusively depending on the substitution pattern of the pyrazole moiety. Most compounds in the series also display excellent physicochemical properties, mainly lipophilicity values that determine LLE scores ranging between 5.5 and 6.5. However, in general, the experimental values of kinetic solubility at both acidic and neutral pH have not confirmed the calculated solubility, as most of the compounds still exhibit modest solubility in water despite a general reduction in lipophilicity. Nonetheless, four compounds (namely, <b>46</b>, <b>48</b>, <b>54</b>, <b>59</b>) exhibit experimental solubility values approximately 75–200 times higher at acidic pH and 10–25 times higher at physiological pH compared to initial compounds <b>1</b> and <b>2</b>. This significant increase in solubility cannot be ascribed solely to the isosteric replacement of benzene with pyrazole but rather to the concomitant contribution of other structural determinants, first of all, the 3′-OH group on the adamantane moiety.</div><div class="NLM_p last">The results of in vivo evaluation in rats carrying induced osteoarthritis indicate that compound <b>51</b> exhibits both analgesic and anti-inflammatory activities and that this pharmacological profile is mediated by CB2R, thereby further confirming that the CB2R is a promising therapeutic target for diverse forms of tissue damage and inflammatory diseases, including osteoarthritis. Taken together, these data suggest that the pyrazolopyrimidinone amides here described represent an excellent start toward further chemistry optimization of CB2R agonists and inverse agonists/antagonists as well as a remarkable tool for investigating the involvement of CB2R in diverse physiopathological conditions.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58237" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58237" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Information</h3><div class="NLM_p">Reagents were purchased from commercial suppliers and used without further purification. Anhydrous reactions were run under a positive pressure of dry N<sub>2</sub>. Merck silica gel 60 was used for flash chromatography (23–400 mesh). <sup>1</sup>H NMR and <sup>13</sup>C NMR were recorded at 400 and 100 MHz, respectively, on a Bruker Advance DPX400. Chemical shifts are reported relative to tetramethylsilane at 0.00 ppm. Mass spectral (MS) data were obtained using an Agilent 1100 LC/MSD VL system (G1946C) with a 0.4 mL/min flow rate using a binary solvent system of 95:5 methanol/water. UV detection was monitored at 254 nm. Mass spectra were acquired either in the positive or in the negative mode scanning over the mass range of 105–1500. High-resolution mass spectrometry (HRMS) measurements were performed using a Dionex Ultimate 3000 RS UHPLC system coupled to an Orbitrap Q-Exactive mass spectrometer (Thermo Scientific) operating in the electrospray ionization (ESI) positive ion mode full scan (<i>m</i>/<i>z</i> range 100–800 at resolution 70 000 FWHM at 200 <i>m</i>/<i>z</i>). Melting points were determined on a Gallenkamp apparatus and are uncorrected. Elemental analyses were performed on a Perkin-Elmer PE 2004 elemental analyzer, and the data for C, H, and N are within 0.4% of the theoretical values. The chemical purity of most of the target compounds was determined using an Acquity Waters UPLC-MS system under the following conditions: Waters BEH C18 (2.1 mm × 50 mm, 1.7 μm) reversed-phase column; method: gradient elution, solvent A (0.1% formic acid in water), solvent B (0.1% formic acid in acetonitrile) 90:10 to 0:100 over 2.9 min, flow rate of 0.5 mL/min, UV detector, 254 nm. The chemical purities of compounds <b>50</b>, <b>55</b>, and <b>61</b> were determined using an Agilent 1260 Infinity instrument comprising a binary pump, an autosampler, a UV-DAD, and an ESI-MS detector. Chromatographic separation was realized with a LiChrospher 60 RP-select B column (Merck) (4 mm × 150 mm, 5 μm) injecting 20 μL of the sample. Analysis was carried out with linear gradient elution of 0.1% (v/v) formic acid in water and acetonitrile/methanol mixture (50:50 v/v) at the flow rate of 0.6 mL/min. Gradient started from 100% of water reaching 2% in 12 min. UV detection was monitored at 254 nm. The purity of each compound was ≥95% in either analysis. All tested compounds were also subjected to the pan-assay interference compounds (PAINS) filter,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and none of them was filtered out as a problematic structure.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Methyl 1-Methyl-4-nitro-1<i>H</i>-pyrazole-3-carboxylate (<b>4</b>) and Methyl 1-Methyl-4-nitro-1<i>H</i>-pyrazole-5-carboxylate (<b>5</b>)</h4><div class="NLM_p last">Methyl iodide (8.5 g, 0.06 mol) and potassium carbonate (8.29 g, 0.06 mol) were added to a solution of methyl 4-nitro-1<i>H</i>-pyrazole-3-carboxylate (5.13 g, 0.03 mol) in acetone (60 mL). The resulting mixture was warmed at 50 °C for 2 h and then concentrated under reduced pressure. The residue was treated with dichloromethane and water, and the organic layer was washed with sodium thiosulfate solution and dried over anhydrous sodium sulfate. After evaporation of the solvent, the residue was purified by flash chromatography on silica gel. Elution with dichloromethane afforded the less polar isomer <b>5</b> (54% yield) as a light-yellow solid; mp 45–47 °C (from dichloromethane) (lit. 38–41 °C).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.00 (s, 1H), 3.99 (s, 6H). MS (ESI): <i>m</i>/<i>z</i> 186 [M + H]<sup>+</sup>. Further elution of the column with dichloromethane/methanol (99:1–95:5) gave compound <b>4</b>; yield, 40%; white solid; mp 130–131 °C (from dichloromethane) (lit. 122–123 °C).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.06 (s, 1H), 3.94 (s, 6H). MS (ESI): <i>m</i>/<i>z</i> 208 [M + Na]<sup>+</sup>, 186 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Methyl 1-(2-Acetoxyethyl)-4-nitro-1<i>H</i>-pyrazole-3-carboxylate (<b>6</b>) and Methyl 1-(2-Acetoxyethyl)-4-nitro-1<i>H</i>-pyrazole-5-carboxylate (<b>7</b>)</h4><div class="NLM_p last">To a solution of methyl 4-nitro-1<i>H</i>-pyrazole-3-carboxylate (5.13 g, 0.03 mol) in acetone (60 mL) were successively added potassium carbonate (8.29 g, 0.06 mol), 2-bromoethyl acetate (10.0 g, 0.06 mol), and potassium iodide (8.3 g, 0.05 mol). The mixture was stirred at 50 °C for 24 h while further 2-bromoethyl acetate (2 × 0.03 mol) was added. After cooling, the mixture was concentrated and diluted with dichloromethane and water. The organic layer was washed with sodium thiosulfate solution, dried over anhydrous sodium sulfate, and evaporated, to leave an oily residue, which was purified by flash column chromatography. Elution with dichloromethane gave the first eluted isomer <b>7</b> in 30% yield; light-yellow solid; mp 63–67 °C (from dichloromethane). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.00 (s, 1H), 4.50–4.48 (m, 2H), 4.37–4.35 (m, 2H), 3.95 (s, 3H), 1.95 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 258 [M + H]<sup>+</sup>. Further elution with dichloromethane/methanol (99:1–95:5) furnished compound <b>6</b>; yield, 60%; light-yellow solid; mp 67–71 °C (from dichloromethane). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.97 (s, 1H), 4.48–4.46 (m, 2H), 4.35–4.33 (m, 2H), 3.93 (s, 3H), 1.92 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 258 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl 4-Amino-1-methyl-1<i>H</i>-pyrazole-3-carboxylate (<b>8</b>)</h4><div class="NLM_p last">To a solution of <b>4</b> (2 g, 10.8 mmol) in ethanol (200 mL), kept under stirring at 60 °C, iron powder (2.42 g, 43.8 mmol), anhydrous calcium chloride (1.19 g, 10.8 mmol), and water (50 mL) were added, and the mixture was maintained at 60 °C for 3 h. After cooling to rt, the suspension was filtered through celite, concentrated to approximately 50 mL, and brought to pH 9 with 5% sodium carbonate solution. The white precipitate that formed was filtered out, and the aqueous solution was extracted with ethyl acetate. The organic phase was washed with water, dried over sodium sulfate, and evaporated to dryness to leave compound <b>8</b> (78% yield) as a pale-pink solid, which was used in the next reaction with no need of purification. Mp 114–116 °C (from ethyl acetate) (lit. 97–102 °C).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.80 (s, 1H), 3.95 (br s, 2H), 3.75 (s, 3H), 3.69 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 178 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl 4-Amino-1-methyl-1<i>H</i>-pyrazole-5-carboxylate (<b>9</b>)</h4><div class="NLM_p last">It was prepared from <b>5</b> according to the procedure described for the preparation of <b>8</b>. Yield, 91%; orange solid; mp 72–75 °C (from ethyl acetate) (lit. 65–68 °C).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.94 (s, 1H), 4.63 (br s, 1H), 3.86 (s, 3H), 3.77 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 156 [M + H]<sup>+</sup>, 178 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Methyl 1-(2-Acetoxyethyl)-4-amino-1<i>H</i>-pyrazole-3-carboxylate (<b>10</b>)</h4><div class="NLM_p last">It was prepared from <b>6</b> according to the procedure described for the preparation of <b>8</b>. Yield, 91%; reddish oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.93 (s, 1H), 4.30–4.27 (m, 2H), 4.20–4.71 (m, 2H), 3.79–3.77 (m, 3H), 1.92 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 228 [M + H]<sup>+</sup>, 250 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl 1-(2-Acetoxyethyl)-4-amino-1<i>H</i>-pyrazole-5-carboxylate (<b>11</b>)</h4><div class="NLM_p last">It was prepared from <b>7</b> according to the procedure described for the preparation of <b>8</b>. Yield, 73%; dark-red solid; mp 69–73 °C (from ethyl acetate). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.02–7.01 (m, 1H), 4.56–4.53 (m, 2H), 4.28–4.24 (m, 2H), 3.96 (br s, 2H), 3.80–3.79 (m, 3H), 1.89–1.88 (m, 3H). MS (ESI) <i>m</i>/<i>z</i> 228 [M + H]<sup>+</sup>, 250 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Methyl 4-(1-Butylamino)-1-methyl-1<i>H</i>-pyrazole-3-carboxylate (<b>12</b>)</h4><div class="NLM_p last">1-Iodobutane (416 mg, 2.26 mmol) was added to a solution of <b>8</b> (350 mg, 2.26 mmol) in dry DMF (3 mL) under a nitrogen atmosphere. The solution was gradually warmed to 50 °C and maintained at this temperature for 7 h. After cooling to rt, the solution was diluted with water (20 mL) and extracted with ethyl acetate. The organic layer was washed with 5% lithium chloride solution (4×), water (2×), and then brine and was dried over anhydrous sodium sulfate. Removal of the solvent gave an oily residue, which was purified by flash column chromatography on silica gel (petroleum ether/ethyl acetate, 1:1, as the eluent) to provide <b>12</b> as a reddish oil; yield, 34%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.74 (s, 1H), 4.70 (br s, 1H), 3.82 (s, 3H), 3.79 (s, 3H), 2.91 (t, <i>J</i> = 7.0 Hz, 2H), 1.55–1.48 (m, 2H), 1.38–1.28 (m, 2H), 0.86 (t, <i>J</i> = 7.3 Hz, 3H). MS (ESI): <i>m</i>/<i>z</i> 234 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Methyl 4-[(4-Fluoro-1-butyl)amino]-1-methyl-1<i>H</i>-pyrazole-3-carboxylate (<b>13</b>)</h4><div class="NLM_p last">It was prepared from <b>8</b> according to the procedure described for the preparation of <b>12</b> using 1-bromo-4-fluorobutane as the alkylating agent. Eluent, dichloromethane/methanol (100:1); yield, 30%; yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.75 (s, 1H), 4.73 (br s, 1H), 4.46–4.44 (m, 1H), 4.35–4.32 (m, 1H), 3.81 (s, 3H), 3.78 (s, 3H), 2.99–2.95 (m, 2H), 1.76–1.40 (m, 4H). MS (ESI): <i>m</i>/<i>z</i> 252 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Methyl 1-Methyl-4-(1-pentylamino)-1<i>H</i>-pyrazole-3-carboxylate (<b>14</b>)</h4><div class="NLM_p last">It was prepared from <b>8</b> according to the procedure described for the preparation of <b>12</b> using 1-iodopentane as the alkylating agent. Eluent, petroleum ether/ethyl acetate (1:1); yield, 51%; yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.79 (s, 1H), 3.86 (s, 3H), 3.82 (s, 3H), 2.94 (t, <i>J</i> = 6.9 Hz, 2H), 1.59–1.55 (m, 2H), 1.31–1.30 (m, 4H), 0.88–0.86 (m, 3H). MS (ESI): <i>m</i>/<i>z</i> 226 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Methyl 4-[(4-Acetoxy-1-butyl)amino]-1-methyl-1<i>H</i>-pyrazole-3-carboxylate (<b>15</b>)</h4><div class="NLM_p last">It was prepared from <b>8</b> according to the procedure described for the preparation of <b>12</b> using 4-iodobutyl acetate as the alkylating agent. Eluent, ethyl acetate; yield, 47%; yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.74 (s, 1H), δ 4.72 (br s, 1H), δ 4.00–3.91 (m, 2H), δ 3.80 (s, 3H), δ 3.77 (s, 3H), δ 2.94–2.93 (m, 2H), δ 1.94 (s, 3H), δ 1.63–1.50 (m, 4H). MS (ESI): <i>m</i>/<i>z</i> 270 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Methyl 4-(1-Butylamino)-1-methyl-1<i>H</i>-pyrazole-5-carboxylate (<b>16</b>)</h4><div class="NLM_p last">It was prepared from <b>9</b> according to the procedure described for the preparation of <b>12</b>. Eluent, petroleum ether/ethyl acetate (1:1); yield, 44%; yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.91 (s, 1H), 4.46 (br s, 1H), 3.89 (s, 3H), 3.75 (s, 3H), 2.98 (t, <i>J</i> = 7.0 Hz, 2H), 1.50–1.43 (m, 2H), 1.32–1.23 (m, 2H), 0.82 (t, <i>J</i> = 7.4 Hz, 3H). MS (ESI): <i>m</i>/<i>z</i> 212 [M + H]<sup>+</sup>, 234 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Methyl 4-[(4-Fluoro-1-butyl)amino]-1-methyl-1<i>H</i>-pyrazole-3-carboxylate (<b>17</b>)</h4><div class="NLM_p last">It was prepared from <b>9</b> using 1-bromo-4-fluorobutane as the alkylating agent according to the procedure described for the preparation of <b>12</b>, although with some minor modifications. Since the reaction did not go to completion, after 24 h the mixture was separated by flash chromatography on silica gel, eluting with petroleum ether/ethyl acetate (1:1), to get product <b>17</b> and the starting compound <b>9</b>, which was subjected again to the alkylation procedure, followed by product separation and purification. The title compound <b>17</b> could be obtained in this way in an overall yield of 30% for two runs as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.96 (s, 1H), 4.46–4.43 (m, 1H), 4.34–4.31 (m, 1H), 3.94 (s, 3H), 3.80 (s, 3H), 3.08 (t, <i>J</i> = 6.5 Hz, 2H), 1.76–1.62 (m, 4H). MS (ESI): <i>m</i>/<i>z</i> 230 [M + H]<sup>+</sup>, 252 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Methyl 1-Methyl-4-(1-pentylamino)-1<i>H</i>-pyrazole-5-carboxylate (<b>18</b>)</h4><div class="NLM_p last">It was prepared from <b>9</b> according to the procedure described for the preparation of <b>12</b> using 1-iodopentane as the alkylating agent. Eluent, petroleum ether/ethyl acetate (2:1); yield, 50%; yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.01 (s, 1H), 4.00 (s, 3H), 3.86 (s, 3H), 3.07 (t, <i>J</i> = 5.8 Hz, 2H), 1.60–1.57 (m, 2H), 1.33–1.32 (m, 4H), 0.88 (t, <i>J</i> = 4.5 Hz, 3H). MS (ESI): <i>m</i>/<i>z</i> 226 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Methyl 1-(2-Acetoxyethyl)-4-(1-propylamino)-1<i>H</i>-pyrazole-3-carboxylate (<b>19</b>)</h4><div class="NLM_p last">It was prepared from <b>10</b> according to the procedure described for the preparation of <b>12</b> using 1-iodopropane as the alkylating agent. Eluent, petroleum ether/ethyl acetate (1:1); yield, 48%; white crystals; mp 42–45 °C (from diethyl ether/petroleum ether, 1:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.78 (s, 1H), 4.70 (br s, 1H), 4.31 (m, 2H), 4.22 (m, 2H), 3.80 (s, 3H), 2.87 (m, 2H), 1.94 (s, 3H), 1.57–1.50 (m, 2H), 0.89 (m, 3H). MS (ESI): <i>m</i>/<i>z</i> 270 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Methyl 1-(2-Acetoxyethyl)-4-(1-butylamino)-1<i>H</i>-pyrazole-3-carboxylate (<b>20</b>)</h4><div class="NLM_p last">It was prepared from <b>10</b> according to the procedure described for the preparation of <b>12</b>. Eluent, petroleum ether/ethyl acetate (1:1); yield, 42%; yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.78 (s, 1H), 4.70 (br s, 1H), 4.31 (t, <i>J</i> = 5.3 Hz, 2H), 4.21 (t, <i>J</i> = 5.2 Hz, 2H), 3.79 (s, 3H), 2.89 (t, <i>J</i> = 6.9 Hz, 2H), 1.94 (s, 3H), 1.53–1.46 (m, 2H), 1.35–1.26 (m, 2H), 0.83 (t, <i>J</i> = 7.3 Hz, 3H). MS (ESI): <i>m</i>/<i>z</i> 284 [M + H]<sup>+</sup>, 306 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Methyl 1-(2-Acetoxyethyl)-4-(1-pentylamino)-1<i>H</i>-pyrazole-3-carboxylate (<b>21</b>)</h4><div class="NLM_p last">It was prepared from <b>10</b> according to the procedure described for the preparation of <b>12</b> using 1-iodopentane as the alkylating agent. Eluent, petroleum ether/ethyl acetate (1:1); yield, 40%; yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.77 (s, 1H), 4.64 (br s, 1H), 4.31 (t, <i>J</i> = 5.3 Hz, 2H), 4.21 (t, <i>J</i> = 5.2 Hz, 2H), 3.79 (s, 3H), 2.87 (t, <i>J</i> = 7.0 Hz, 2H), 1.93 (s, 3H), 1.52–1.49 (m, 2H), 1.25–1.23 (m, 4H), 0.91–0.78 (m, 3H). MS (ESI): <i>m</i>/<i>z</i> 298 [M + H]<sup>+</sup>, 320 [M + Na]<sup>+</sup>.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Methyl 1-(2-Acetoxyethyl)-4-(1-butylamino)-1<i>H</i>-pyrazole-5-carboxylate (<b>22</b>)</h4><div class="NLM_p last">It was prepared from <b>11</b> according to the procedure described for the preparation of <b>12</b>. Eluent, petroleum ether/ethyl acetate (1:1); yield, 34%; yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.01 (s, 1H), 4.73 (br s, 1H), 4.55 (t, <i>J</i> = 5.4 Hz, 2H), 4.27 (t, <i>J</i> = 5.4 Hz, 2H), 3.79 (s, 3H), 3.02 (t, <i>J</i> = 7.0 Hz, 2H), 1.90 (s, 3H), 1.54–1.46 (m, 2H), 1.36–1.27 (m, 2H), 0.85 (t, <i>J</i> = 7.3 Hz, 3H). MS (ESI): <i>m</i>/<i>z</i> 284 [M + H]<sup>+</sup>, 306 [M + Na]<sup>+</sup>.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> General Procedure for the Preparation of Derivatives <b>23</b>–<b>33</b></h3><div class="NLM_p">A solution of methyl 3-chloro-3-oxopropionate (0.12 mL, 1.11 mmol) in dry dichloromethane (2–3 mL) was added dropwise to an ice-cooled solution of amines <b>12–22</b> (0.74 mmol) and triethylamine (0.15 mL, 1.11 mmol) in dry dichloromethane (10 mL). After stirring at rt for 2 h, the solution was washed with a saturated solution of sodium hydrogen carbonate, 2 N HCl, and brine sequentially. The organic layer was dried over anhydrous sodium sulfate and evaporated to give an oily residue, which was purified by flash column chromatography on silica gel. Elution with ethyl acetate/petroleum ether (2:1) yielded the amide derivatives <b>22</b>–<b>33</b>.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-[<i>N</i>-(1-Butyl)-<i>N</i>-[3-(methoxycarbonyl)-1-methyl-1<i>H</i>-pyrazol-4-yl]amino]-3-oxopropanoic Acid Methyl Ester (<b>23</b>)</h4><div class="NLM_p last">It was prepared from <b>12</b>; yield, 75%; light-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.37 (s, 1H), 3.91 (s, 3H), 3.82 (s, 3H), 3.58 (s, 3H), 3.22–3.15 (m, 3H), 1.39–1.32 (m, 2H), 1.26–1.17 (m, 2H), 0.80 (t, <i>J</i> = 7.3 Hz, 3H). MS (ESI): <i>m</i>/<i>z</i> 312 [M + H]<sup>+</sup>, 334 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3-[<i>N</i>-(4-Fluoro-1-butyl)-<i>N</i>-[3-(methoxycarbonyl)-1-methyl-1<i>H</i>-pyrazol-4-yl]amino]-3-oxopropanoic Acid Methyl Ester (<b>24</b>)</h4><div class="NLM_p last">It was prepared from <b>13</b>; yield, 59%; light-yellow oil. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ 7.82 (s, 1H), 4.41 (t, <i>J</i> = 6.0 Hz, 1H), 4.29 (t, <i>J</i> = 5.9 Hz, 1H), 3.91 (s, 3H), 3.74 (s, 3H), 3.60–3.55 (m, 1H), 3.50 (s. 3H), 3.31–3.21 (m, 1H), 3.12 (s, 2H), 1.68–1.43 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 330 [M + H]<sup>+</sup>, 352 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3-[<i>N</i>-[3-(Methoxycarbonyl)-1-methyl-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-(1-pentyl)amino]-3-oxopropanoic Acid Methyl Ester (<b>25</b>)</h4><div class="NLM_p last">It was prepared from <b>14</b>; yield, 81%; light-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.42 (s, 1H), 3.96 (s, 3H), 3.88 (m, 5H), 3.64 (s, 3H), 3.20 (s, 2H), 1.45–1.41 (m, 2H), 1.27–1.24 (m, 4H), 0.83 (t, <i>J</i> = 6.7 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 326 [M + H]<sup>+</sup>, 348 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 3-[<i>N</i>-(4-Acetoxy-1-butyl)-<i>N</i>-[3-(methoxycarbonyl)-1-methyl-1<i>H</i>-pyrazol-4-yl]amino]-3-oxopropanoic Acid Methyl Ester (<b>26</b>)</h4><div class="NLM_p last">It was prepared from <b>15</b>; yield, 54%; light-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.37 (s, 1H), 3.87–3.86 (m, 2H), 3.84 (s, 3H), 3.73 (s, 3H), 3.45 (s, 3H), 3.22, (br s, 1H), 3.06 (m, 2H), 1.84 (s, 3H), 1.47–1.45 (m, 2H), 1.38–1.34 (m, 2H). MS (ESI) 392 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-[<i>N</i>-(1-Butyl)-<i>N</i>-[5-(methoxycarbonyl)-1-methyl-1<i>H</i>-pyrazol-4-yl]amino]-3-oxopropanoic Acid Methyl Ester (<b>27</b>)</h4><div class="NLM_p last">It was prepared from <b>16</b>; yield, 80%; light-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.33 (s, 1H), 4.11 (s, 3H), 3.92 (s, 3H), 3.59 (s, 3H), 3.25–3.12 (m, 3H), 1.42–1.34 (m, 2H), 1.26–1.18 (m, 2H), 0.82 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 312 [M + H]<sup>+</sup>, 334 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-[<i>N</i>-(4-Fluoro-1-butyl)-<i>N</i>-[5-(methoxycarbonyl)-1-methyl-1<i>H</i>-pyrazol-4-yl]amino]-3-oxopropanoic Acid Methyl Ester (<b>28</b>)</h4><div class="NLM_p last">It was prepared from <b>17</b>; yield, 58%; light-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.31 (s, 1H), 4.39 (t, <i>J</i> = 5.8 Hz, 1H), 4.27 (t, <i>J</i> = 5.6 Hz, 1H), 4.07 (s, 3H), 3.88 (br s, 1H), 3.79 (s, 3H), 3.55 (s, 3H), 3.21 (br s, 1H), 3.09 (s, 2H), 1.66–1.46 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> 330 [M + H]<sup>+</sup>, 352 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 3-[<i>N</i>-[5-(Methoxycarbonyl)-1-methyl-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-(1-pentyl)-amino]-3-oxopropanoic Acid Methyl Ester (<b>29</b>)</h4><div class="NLM_p last">It was prepared from <b>18</b>; yield, 73%; light-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub><sub>3</sub></sub>) δ 7.38 (s, 1H), 4.16 (s, 3H), 3.87 (s, 3H), 3.64 (s, 3H), 3.17 (s, 2H), 1.48–1.41 (m, 2H), 1.30–1.23 (m, 6H), 0.84 (t, <i>J</i> = 6.2 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 348 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 3-[<i>N</i>-[1-(2-Acetoxyethyl)-3-(methoxycarbonyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-(1-propyl)-amino]-3-oxopropanoic Acid Methyl Ester (<b>30</b>)</h4><div class="NLM_p last">It was prepared from <b>19</b>; yield, 70%; light-yellow solid; mp 73–75 °C (from diethyl ether). <sup>1</sup>H NMR (400 MHz, CDCl<sub><sub>3</sub></sub>) δ 7.44 (s, 1H), 4.34 (s, 4H), 3.80 (s, 3H), 3.55 (s, 3H), 3.12 (s, 2H), 1.93 (s, 3H), 1.42–1.33 (m, 2H), 0.78 (t, <i>J</i> = 8 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 370 [M + H]<sup>+</sup>, 392 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 3-[<i>N</i>-[1-(2-Acetoxyethyl)-3-(methoxycarbonyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-(1-butyl)-amino]-3-oxopropanoic Acid Methyl Ester (<b>31</b>)</h4><div class="NLM_p last">It was prepared from <b>20</b>; yield, 81%; light-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub><sub>3</sub></sub>) δ 7.44 (s, 1H), 4.39–4.35 (m, 4H), 3.91 (br s, 1H), 3.83 (s, 3H), 3.58 (s, 3H), 3.14 (s, 3H), 1.96 (s, 3H), 1.37–1.32 (m, 2H), 1.27–1.17 (m, 2H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 406 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 3-[<i>N</i>-[1-(2-Acetoxyethyl)-3-(methoxycarbonyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-(1-pentyl)-amino]-3-oxopropanoic Acid Methyl Ester (<b>32</b>)</h4><div class="NLM_p last">It was prepared from <b>21</b>; yield, 69%; light-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub><sub>3</sub></sub>) δ 7.43 (s, 1H), 4.32–4.30 (m, 4H), 3.78–3.75 (m, 4H), 3.53–3.49 (m, 3H), 3.10–3.08 (m, 3H), 1.94–1.88 (m, 3H), 1.33–1.30 (m, 2H), 1.14–1.10 (m, 4H), 0.73–0.70 (m, 3H). MS (ESI) <i>m</i>/<i>z</i> 398 [M + H]<sup>+</sup>, 420 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3-[<i>N</i>-[1-(2-Acetoxyethyl)-5-(methoxycarbonyl)-1<i>H</i>-pyrazol-4-yl]-<i>N</i>-(1-butyl)-amino]-3-oxopropanoic Acid Methyl Ester (<b>33</b>)</h4><div class="NLM_p last">It was prepared from <b>22</b>; yield, 75%; light-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.33 (s, 1H), 4.73–4.64 (m, 2H), 4.38–4.31 (m, 2H), 3.79 (s, 3H), 3.54 (s, 3H), 3.18–3.13 (m, 1H), 3.09 (s, 2H), 1.86 (s, 3H), 1.37–1.30 (m, 2H), 1.24–1.13 (m, 2H), 0.78 (t, <i>J</i> = 7.3 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 384 [M + H]<sup>+</sup>, 406 [M + Na]<sup>+</sup>.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> General Procedure for the Preparation of Amides <b>45–60</b></h3><div class="NLM_p">A solution of the appropriate precursor <b>23</b>–<b>33</b> (0.96 mmol) in anhydrous THF (35 mL) was added dropwise to a suspension of 60% sodium hydride (77 mg, 1.92 mmol) in the same solvent (20 mL) containing dry methanol (20 μL, 0.48 mmol). The reaction mixture was stirred at 60 °C for 2 h and then evaporated to leave a solid residue, which was taken up into 5% sodium carbonate solution. The aqueous solution was extracted with diethyl ether to remove some starting material and then brought to pH 1 by adding 6 N HCl and extracted with ethyl acetate (3 × 20 mL). The organic layer was dried over anhydrous sodium sulfate, filtered, and evaporated to give the Dieckmann condensation products <b>34</b>–<b>44</b> as a solid residue insoluble in most organic solvents, which was used in the next step without purification. A mixture of the appropriate ester <b>33</b>–<b>44</b> (0.96 mmol), 1-aminoadamantane, or 3-aminoadamantan-1-ol (1.92 mmol) in THF (3 mL) and toluene (10 mL) was refluxed for 1–2 h while adding dropwise further toluene and distilling out the azeotropic mixture methanol/toluene. After completion of the reaction, the solvent was removed under reduced pressure and the solid residue was taken up into ethyl acetate. The organic solution was washed successively with 2 N HCl and brine and then dried over anhydrous sodium sulfate, filtered, and concentrated to yield a solid residue that was purified by flash column chromatography on silica gel (ethyl acetate as the eluent unless otherwise stated) and/or recrystallization as specified below to provide compounds <b>45</b>–<b>60</b>.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(Adamantan-1-yl)-4-(1-butyl)-4,5-dihydro-7-hydroxy-2-methyl-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>45</b>)</h4><div class="NLM_p last">It was obtained from <b>34</b> and 1-aminoadamantane after recrystallization from methanol; yield, 67%; light-yellow needles; mp 101–105 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 17.68 (s, 1H), 11.30 and 10.21 (s, 1H), 7.22 (s, 1H), 4.01 (s, 3H), 3.83–3.78 (m, 2H), 2.07–2.03 (m, 10H), 1.70–1.56 (m, 7H), 1.35–1.26 (m, 2H), 0.87 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.3, 169.2, 162.6, 132.0, 128.8, 114.3, 96.7, 52.4, 50.7, 45.1, 41.5, 40.6, 36.4, 29.6, 29.4, 20.3, 13.8. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 399.2391, found 399.2390.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-(1-Butyl)-4,5-dihydro-7-hydroxy-<i>N</i>-(1-hydroxyadamantan-3-yl)-2-methyl-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>46</b>)</h4><div class="NLM_p last">It was obtained from <b>34</b> and 3-aminoadamantan-1-ol after recrystallization from ethyl acetate; yield, 45%; white needles; mp 216–218 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.61 and 17.47 (s, 1H), 11.41 and 10.32 (s, 1H), 7.26 and 7.23 (s, 1H), 4.02 (s, 3H), 3.83–3.79 (m, 2H), 2.23 (s, 2H), 2.07 (s, 2H), 1.97–1.94 (m, 2H), 1.69–1.46 (m, 11H), 1.36–1.27 (m, 2H), 0.88 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.4, 169.0, 162.5, 131.8, 128.9, 114.4, 96.8, 77.4, 77.1, 76.8, 69.1, 54.6, 49.0, 45.1, 44.1, 40.7, 40.2, 34.9, 30.6, 29.6, 20.3, 13.8. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 415.2340, found 415.2342.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(Adamantan-1-yl)-4,5-dihydro-4-(4-fluoro-1-butyl)-7-hydroxy-2-methyl-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>47</b>)</h4><div class="NLM_p last">It was obtained from <b>35</b> and 1-aminoadamantane and purified by chromatography and recrystallization from methanol; yield, 59%; white pasty solid; mp 191–192 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 17.74 (s, 1H), 11.38 and 10.18 (s, 1H), 7.25 (s, 1H), 4.48 (t, <i>J</i> = 5.4 Hz, 1H), 4.36 (t, <i>J</i> = 5.7 Hz, 1H), 4.02 (s, 3H), 3.90–3.86 (m, 2H), 2.07–2.04 (m, 8H), 1.82–1.64 (m, 11H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.3, 169.4, 162.6, 132.0, 128.6, 114.3, 96.6, 84.5, 82.8, 52.4, 44.6, 41.5, 40.6, 36.4, 29.4, 27.7, 27.5, 23.7, 23.6. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 417.2296, found 417.2294.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4,5-Dihydro-4-(4-fluoro-1-butyl)-7-hydroxy-<i>N</i>-(1-hydroxyadamantan-3-yl)-2-methyl-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>48</b>)</h4><div class="NLM_p last">It was obtained from <b>35</b> and 3-aminoadamantan-1-ol after recrystallization from ethyl acetate; yield, 66%; white solid; mp 209–211 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.53 and 17.52 (s, 1H), 11.43 and 10.27 (s, 1H), 7.26 (s, 1H), 4.50–4.47 (m, 1H), 4.38–4.35 (m, 1H), 4.02 (s, 3H), 3.90–3.87 (m, 2H), 2.24 (s, 2H), 2.07 (s, 2H), 2.02–1.95 (m, 2H), 1.80–1.62 (m, 11H), 1.59–1.46 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.4, 169.2, 162.6, 131.8, 128.7, 114.4, 96.7, 84.5, 82.8, 69.1, 54.7, 49.01, 44.7, 44.1, 40.7, 40.2, 34.9, 30.6, 27.7, 27.5, 23.7. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 433.2246, found 433.2249.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-(Adamantan-1-yl)-4,5-dihydro-7-hydroxy-2-methyl-5-oxo-4-(1-pentyl)-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>49</b>)</h4><div class="NLM_p last">It was prepared from <b>36</b> and 1-aminoadamantane and recrystallized from diethyl ether/petroleum ether; yield, 63%; white needles; mp 151–153 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.58 and 17.50 (s, 1H), 11.39 and 10.25 (s, 1H), 7.27 (s, 1H), 4.06 (s, 3H), 3.84 (t, <i>J</i> = 7.7 Hz, 2H), 2.12–1.98 (m, 9H), 1.68–164 (m, 8H), 1.33–1.30 (m, 4H), 0.87 (t, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.3, 169.2, 162.7, 132.1, 129.0, 114.2, 96.8, 52.4, 45.3, 41.6, 40.7, 36.4, 29.5, 29.1, 27.3, 22.5, 14.0. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 413.2547, found 413.2544.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(4-Acetoxy-1-butyl)-<i>N</i>-(adamantan-1-yl)-4,5-dihydro-7-hydroxy-2-methyl-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>50</b>)</h4><div class="NLM_p last">It was obtained from <b>37</b> and 1-aminoadamantane and purified by trituration with diethyl ether; yield, 49%; cream-colored solid; mp 209–210 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.50 and 17.64 (s, 1H), 10.17 (br s, 1H), 7.26 (s, 1H), 4.06–4.04 (m, 2H), 4.03 (s, 3H), 3.88–3.84 (m, 2H), 2.08–2.05 (m, 8H), 1.98 (s, 3H), 1.73–1.54 (m, 11H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.3, 171.1, 169.4, 162.7, 132.1, 128.7, 114.2, 103.9, 96.7, 63.7, 52.4, 44.7, 41.5, 40.6, 36.4, 36.2, 29.4, 26.1, 24.1, 20.9. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>32</sub>N<sub>4</sub>O<sub>5</sub> [M + H]<sup>+</sup> 457.2445, found 457.2442.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-(Adamantan-1-yl)-4-(1-butyl)-4,5-dihydro-7-hydroxy-1-methyl-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>51</b>)</h4><div class="NLM_p last">It was prepared from <b>38</b> and 1-aminoadamantane and purified by flash chromatography and recrystallization from methanol; yield, 52%; light-yellow solid; mp 131–134 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.72 and 18.20 (s, 1H), 11.02 and 10.41 (s, 1H), 7.35 and 7.32 (s, 1H), 4.22 and 4.16 (s, 3H), 3.93–3.88 (m, 2H), 2.07–2.04 (m, 10H), 1.69–1.58 (m, 7H), 1.37–1.28 (m, 2H), 0.88 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.7, 171.6, 169.3, 166.1, 166.0, 162.1, 130.3, 123.1, 122.9, 121.9, 95.5, 92.5, 53.1, 52.6, 44.4, 44.3, 41.6, 41.4, 39.2, 38.9, 36.3, 36.2, 30.2, 30.1, 29.4, 20.2, 20.0, 13.8, 13.7. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 399.2391, found 399.2390.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4-(1-Butyl)-4,5-dihydro-7-hydroxy-<i>N</i>-(1-hydroxyadamantan-3-yl)-1-methyl-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>52</b>)</h4><div class="NLM_p last">It was obtained from <b>38</b> and 3-aminoadamantan-1-ol after purification by flash chromatography followed by trituration with petroleum ether/diethyl ether (2:1); yield, 35%; white solid; mp 95–96 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.73 and 17.99 (s, 1H), 11.08 and 10.51 (s, 1H), 7.37 and 7.34 (s, 1H), 4.23 and 4.17 (s, 3H), 3.95–3.89 (m, 2H), 2.24 (s, 2H), 2.08 (s, 2H), 2.03–1.94 (m, 2H), 1.66–1.50 (m, 11H), 1.38–1.31 (m, 2H), 0.91–0.87 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.9, 171.7, 166.0, 165.7, 162.0, 130.4, 127.8, 126.7, 123.2, 122.9, 121.2, 95.6, 92.6, 69.1, 55.2, 54.8, 49.0, 48.9, 44.6, 44.4, 44.2, 44.0, 40.3, 40.2, 39.2, 39.0, 34.9, 34.8, 30.1, 30.1, 30.1, 20.2, 20.0, 13.8, 13.7. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 415.2340, found 415.2338.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-(Adamantan-1-yl)-4,5-dihydro-4-(4-fluoro-1-butyl)-7-hydroxy-1-methyl-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>53</b>)</h4><div class="NLM_p last">It was prepared from <b>39</b> and 1-aminoadamantane and purified by flash chromatography followed by recrystallization from methanol; yield, 30%; yellow crystals; mp 148–149 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.68 and 18.24 (s, 1H), 11.03 and 10.37 (s, 1H), 7.36 and 7.34 (s, 1H), 4.46 (t, <i>J</i> = 5.6 Hz, 1H), 4.35 (t, <i>J</i> = 5.7 Hz, 1H), 4.22 and 4.16 (s, 3H), 4.00–3.94 (m, 2H), 2.10–2.02 (m, 10H), 1.85–1.76 (m, 2H), 1.69–1.61 (m, 7H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.7, 171.6, 169.4, 166.3, 166.2, 162.2, 130.1, 123.0, 122.8, 121.5, 95.6, 84.4, 84.2, 82.7, 82.6, 53.2, 52.7, 44.0, 43.9, 41.6, 41.4, 39.3, 39.1, 39.0, 36.3, 36.3, 29.4, 27.8, 27.6, 27.4, 24.2, 24.1. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 417.2296, found 417.2297.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4,5-Dihydro-4-(4-fluoro-1-butyl)-7-hydroxy-<i>N</i>-(1-hydroxyadamantan-3-yl)-1-methyl-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>54</b>)</h4><div class="NLM_p">It was obtained from <b>39</b> with 3-aminoadamantan-1-ol and purified by flash chromatography followed by trituration with petroleum ether/diethyl ether (2:1); yield, 44%; white solid; mp 132–133 °C. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 18.08 (s, 1H), 10.46 (s, 1H), 7.58 (s, 1H), 4.44 (t, <i>J</i> = 5.5 Hz, 1H), 4.33 (t, <i>J</i> = 5.8 Hz, 1H), 4.11 (s, 3H), 4.00–3.92 (m, 2H), 2.22 (s, 2H), 2.04 (s, 2H), 1.99 (s, 2H), 1.71–1.51 (m, 13H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.7, 165.9, 162.0, 130.2, 123.1, 122.9, 95.5, 84.4, 82.7, 82.6, 69.0, 55.3, 54.9, 54.8, 49.0, 48.9, 44.2, 44.1, 44.0, 10.3, 40.2, 10.1, 39.3, 39.0, 34.9, 34.8, 30.6, 27.8, 27.6, 27.5, 27.4, 24.2, 24.1, 24.0.</div><div class="NLM_p last">HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 433.2246, found 433.2247.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i>-(Adamantan-1-yl)-4,5-dihydro-7-hydroxy-1-methyl-5-oxo-4-(1-pentyl)-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>55</b>)</h4><div class="NLM_p last">It was prepared from <b>40</b> and 1-aminoadamantane and purified by recrystallization from petroleum ether/diethyl ether (1:1); yield, 76%; white needles; mp 126–128 °C. <sup><sup>1</sup></sup>H NMR (400 MHz, CDCl<sub><sub>3</sub></sub>) δ: 17.78 (s, 1H), 10.32 (s, 1H), 7.38 (s, 1H), 4.22 (s, 3H), 3.95 (t, <i>J</i> = 7.6 Hz, 2H), 2.15–2.11 (m, 5H), 1.70–1.74 (m, 6H), 1.52 (s, 10H), 0.89 (t, <i>J</i> = 3.3 Hz, 3H). <sup><sup>13</sup></sup>C NMR (100 MHz, CDCl<sub><sub>3</sub></sub>): δ 171.6, 166.0, 161.9, 130.0, 122.9, 98.9, 96.68, 52.7, 44.6, 41.4, 39.2, 36.3, 29.4, 29.1, 27.8, 22.5, 13.9. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 413.2547, found 413.2544.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-(Adamantan-1-yl)-4,5-dihydro-7-hydroxy-2-(2-hydroxyethyl)-5-oxo-4-(1-propyl)-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>56</b>)</h4><div class="NLM_p last">It was prepared from <b>41</b> with 1-aminoadamantane and purified by flash chromatography (ethyl acetate/petroleum ether, 2:1) followed by trituration with petroleum ether; yield, 28%; white solid; mp 133–135 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub><sub>3</sub></sub>) δ: 18.67 and 17.77 (s, 1H), 11.18 and 10.25 (s, 1H), 7.34 and 7.19 (s, 1H), 4.33 (m, 2H), 4.05 (m, 2H), 3.75 (m, 2H), 2.06 (m, 9H), 1.64–1.61 (m, 8H), 0.89 (t, <i>J</i> = 7.8 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub><sub>3</sub></sub>): δ 171.3, 169.2, 162.4, 132.1, 128.4, 114.8, 96.6, 61.2, 65.2, 52.5, 46.7, 41.6, 41.5, 36.4, 36.2, 29.4, 20.8, 11.4. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 415.2340, found 415.2338.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-(Adamantan-1-yl)-4-(1-butyl)-4,5-dihydro-7-hydroxy-2-(2-hydroxyethyl)-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>57</b>)</h4><div class="NLM_p last">It was prepared from <b>42</b> with 1-aminoadamantane and purified by trituration with petroleum ether/diethyl ether (1:1); yield, 60%; light-pink solid; mp 204–205 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.62 and 17.83 (s, 1H), 10.99 and 10.25 (s, 1H), 7.35 (s, 1H), 4.33–4.31 (m, 2H), 4.07–4.03 (m, 2H), 3.77 (t, <i>J</i> = 7.6 Hz, 2H), 2.73 (br s, 1H), 2.07–2.04 (m, 10H), 167–1.54 (m, 7H), 1.34–1.25 (m, 2H), 0.87 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.3, 169.2, 162.4, 132.1, 128.4, 114.8, 96.6, 61.2, 56.2, 52.5, 45.0, 41.5, 36.4, 29.6, 29.4, 20.3, 13.8. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 429.2496, found 429.2499.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>N</i>-(Adamantan-1-yl)-4,5-dihydro-7-hydroxy-2-(2-hydroxyethyl)-5-oxo-4-(1-pentyl)-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>58</b>)</h4><div class="NLM_p last">It was prepared from <b>43</b> with 1-aminoadamantane and purified by flash chromatography (ethyl acetate/methanol, 50:1) followed by trituration with petroleum ether; yield, 52%; white solid; mp 156–157 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.57 and 17.83 (s, 1H), 11.12 and 10.25 (s, 1H), 7.34 (s, 1H), 4.35–4.33 (m, 2H), 4.07–4.05 (m, 2H), 3.80–3.76 (m, 2H), 2.08–2.05 (m, 10H), 1.65–1.61 (m, 7H), 1.30–1.25 (m, 4H), 0.83 (t, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 204.4, 171.3, 169.2, 162.4, 132.0, 128.3, 114.8, 96.6, 61.2, 56.3, 52.5, 45.2, 41.5, 36.4, 29.4, 29.1, 27.3, 22.4, 13.9. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>34</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 443.2652, found 443.2649.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 4,5-Dihydro-7-hydroxy-<i>N</i>-(1-hydroxyadamantan-3-yl)-2-(2-hydroxyethyl)-5-oxo-4-(1-pentyl)-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>59</b>)</h4><div class="NLM_p last">It was prepared from <b>43</b> with 3-aminoadamantan-1-ol and purified by flash chromatography (dichloromethane/methanol, 50:2) followed by trituration with petroleum ether; yield, 55%; light-yellow solid; mp 144–147 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.64 and 17.59 (s, 1H), 11.21 and 10.33 (s, 1H), 7.35 (s, 1H), 4.36–4.33 (m, 2H), 4.07–4.04 (m, 2H), 3.80–3.76 (m, 2H), 2.23 (s, 2H), 2.07–1.94 (m, 8H), 1.68–1.46 (m, 7H), 1.27–1.10 (m, 4H), 0.84–0.81 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.4, 169.0, 162.3, 131.9, 128.4, 115.0, 96.7, 69.2, 61.1, 56.2, 54.7, 48.9, 45.3, 44.0, 40.2, 34.9, 30.6, 29.1, 27.3, 22.4, 13.9. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>34</sub>N<sub>4</sub>O<sub>5</sub> [M + H]<sup>+</sup> 459.2602, found 459.2606.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>N</i>-(Adamantan-1-yl)-4-(1-butyl)-4,5-dihydro-7-hydroxy-1-(2-hydroxyethyl)-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (<b>60</b>)</h4><div class="NLM_p last">It was prepared from <b>44</b> and 1-aminoadamantane and purified by trituration with petroleum ether/diethyl ether (2:1); yield, 76%; white solid; mp 96–98 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.75 and 18.43 (s, 1H), 10.90 and 10.49 (s, 1H), 7.43 and 7.40 (s, 1H), 4.81–4.68 (m, 2H), 3.99–3.89 (m, 4H), 2.44 (br s, 1H), 2.07 (s, 8H), 1.65 (s, 7H), 1.37–1.31 (m, 4H), 0.88 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.6, 171.5, 169.2, 166.2, 166.0, 162.0, 130.3, 127.9, 123.8, 123.6, 121.6, 95.4, 92.6, 62.5, 62.1, 53.9, 53.8, 53.3, 52.8, 44.5, 44.3, 41.5, 41.4, 36.3, 36.2, 30.2, 30.1, 29.4, 20.2, 20.0, 13.7, 13.6. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 429.2496, found 429.2495.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-(Adamantan-1-yl)-4,5-dihydro-7-hydroxy-4-(4-hydroxy-1-butyl)-2-methyl-5-oxo-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (61)</h4><div class="NLM_p last">A suspension of <b>50</b> (270 mg, 0.6 mmol) in 10% NaOH solution (6 mL, 1.5 mmol) was refluxed for 1 h. After cooling, the suspension was brought to pH 1 with 4 N HCl and extracted with ethyl acetate. The organic layer was washed with water, dried over anhydrous sodium sulfate, and evaporated. The crude residue was purified by flash chromatography on silica gel, eluting with dichloromethane/methanol (10:1) to afford <b>61</b> (144 mg, 58%) as an oily compound that on treatment with dichloromethane and diethyl ether became a glassy solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 18.56 (s, 1H), 10.17 (br s, 1H), 7.29 (s, 1H), 4.01 (s, 3H), 3.90–3.87 (t, <i>J</i> = 7.3 Hz, 2H), 3.66–3.63 (m, 2H), 2.07–1.96 (m, 11H), 1.76–1.73 (m, 2H), 1.64 (m, 6H), 1.60–1.57 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.3, 169.4, 162.7, 132.1, 128.7, 114.5, 96.7, 62.3, 52.5, 44.9, 41.5, 40.6, 36.4, 36.2, 29.4, 24.2. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup> 415.2340, found 415.2338.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-(2-Acetoxyethyl)-<i>N</i>-(adamantan-1-yl)-4,5-dihydro-7-hydroxy-5-oxo-4-(1-propyl)-2<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridin-6-carboxamide (62)</h4><div class="NLM_p last">To an ice-cooled solution of <b>56</b> (103 mg, 0.25 mmol) in dry dichloromethane (10 mL) were added dropwise triethylamine (42 μL, 0.3 mmol) and acetyl chloride (18 μL, 0.3 mmol). After stirring at rt for 2 h, a further amount of both triethylamine and acetyl chloride was gradually added and stirring was continued for 30 min. The solution was washed with 1 N HCl and then 5% sodium hydrogen carbonate solution, dried over anhydrous sodium sulfate, and evaporated to dryness. The crude residue was purified by flash chromatography (ethyl acetate/petroleum ether, 2:1, as the eluent) to give pure <b>62</b> (48 mg, 43%) as a white solid; mp 168–169 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 17.81 (s, 1H), 10.21 (s, 1H), 7.30 (s, 1H), 4.45 (s, 4H), 3.80 (m, 2H), 2.08–2.05 (m, 9H), 1.94 (s, 3H), 1.70–1.65 (m, 8H), 0.91 (t, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 171.3, 170.4, 169.4, 162.7, 132.7, 128.7, 114.0, 97.0, 62.5, 52.6, 52.5, 46.8, 41.7, 36.4, 29.4, 29.0, 20.9, 20.7, 11.4. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>32</sub>N<sub>4</sub>O<sub>5</sub> [M + H]<sup>+</sup> 457.2445, found 457.2443.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> In Vitro Pharmacological Evaluation</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Competition Binding Assay</h4><div class="NLM_p last">Membranes from HEK-293 cells overexpressing the respective human recombinant CB1R (<i>B</i><sub>max</sub> = 2.5 pmol/mg protein) and human recombinant CB2R (<i>B</i><sub>max</sub> = 4.7 pmol/mg protein) were incubated with [<sup>3</sup>H]-CP-55,940 (0.14 nM/<i>K</i><sub>d</sub> = 0.18 nM and 0.084 nM/<i>K</i><sub>d</sub> = 0.31 nM, respectively, for CB1R and CB2R) as the high-affinity ligand. Competition curves were performed by displacing [<sup>3</sup>H]-CP-55 940 with an increasing concentration of compounds (0.1 nM–10 μM). Nonspecific binding was defined by 10 μM WIN55 212–2 as the heterologous competitor (<i>K</i><sub>i</sub> values 9.2 and 2.1 nM, respectively, for CB1R and CB2R). IC<sub>50</sub> values were determined for compounds showing >50% displacement at 10 μM. All compounds were tested following the procedure described by the manufacturer (Perkin-Elmer, Italy). Displacement curves were generated by incubating drugs with [<sup>3</sup>H]-CP-55 940 for 90 min at 30 °C. <i>K</i><sub>i</sub> values were calculated by applying the Cheng–Prusoff equation to the IC<sub>50</sub> values (obtained by GraphPad) for the displacement of the bound radioligand by increasing concentrations of the test compound. Data represent mean values for at least three independent experiments performed in duplicate and are expressed as the average of <i>K</i><sub>i</sub> (nM) ± standard deviation.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Functional Activity at CB2R In Vitro</h4><div class="NLM_p last">The cAMP Hunter assay enzyme fragment complementation chemiluminescent detection kit was used to characterize the functional activity in CB2 receptor-expressing cell lines. Gi-coupled cAMP modulation was measured following the manufacturer’s protocol (DiscoveRx, Fremont, CA). Briefly, CHO-K1 cells overexpressing the human CB2R were plated into a 96-well plate (30 000 cells/well) and incubated overnight at 37 °C, 5% CO<sub>2</sub>. Media was aspirated and replaced with 30 μL of assay buffer. Cells were incubated for 30 min at 37 °C with 15 μL of 3× dose–response solutions of samples prepared in the presence of a cell assay buffer containing 3× of 25 μM NKH-477 solution (a water-soluble analogue of Forskolin) to stimulate adenylate cyclase and enhance basal cAMP levels. For those compounds showing an increase of cAMP levels, we further investigated their effect upon receptor activation by testing compounds in the presence of the JWH-133 selective agonist. Cells were preincubated with samples (15 min at 37 °C at 6× the final desired concentration) followed by 30 min incubation with the JWH-133 agonist challenge at the EC<sub>80</sub> concentration (EC<sub>80</sub> = 4 μM, previously determined in separate experiments) in the presence of NKH-477 to stimulate adenylate cyclase and enhance cAMP levels. For all protocols, following stimulation, cell lysis and cAMP detection were performed as per the manufacturer’s protocol. Luminescence measurements were performed using a GloMax Multi Detection System (Promega, Italy). Data are reported as means ± SEM of three independent experiments conducted in triplicate and were normalized considering the NKH-477 stimulus alone as 100% of the response. The percentage of response was calculated using the following formula: % RESPONSE = 100% × (1 – (RLU of test sample – RLU of NKH-477 positive control)/(RLU of vehicle – RLU of NKH-477 positive control)). For those experiments where compounds were tested in the presence of an EC<sub>80</sub> CB2-ligand challenge, the percentage of response was calculated using the following formula: % RESPONSE =100% × (RLU of sample – RLU of EC<sub>80</sub> control)/(RLU of NKH-477 positive control – RLU of EC<sub>80</sub> control). Data were analyzed using PRISM.7 software (GraphPad Software Inc, San Diego, CA).</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Cytotoxicity and Cytocompatibility Assays</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Materials</h4><div class="NLM_p last">Normal human articular chondrocytes (NHAC-kn) and the chondrocyte growth medium were supplied by Lonza (Switzerland). Fibroblasts NIH3T3, DMEM, trypsin solution, and all of the reagents and solvents used for cell culture were purchased from Sigma-Aldrich (Germany).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Evaluation of In Vitro Cytotoxicity and Cytocompatibility</h4><div class="NLM_p">To evaluate the in vitro cytotoxicity of new products, the direct contact test, proposed by ISO 10995–5, was used.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> This test is suitable for samples with various shapes, sizes, or physical status (i.e., liquid or solid). The evaluation of in vitro acute toxicity does not depend on the final use for which the product is intended, and the document ISO 10995–5:2009 recommends many cell lines from American Type Collection. Among them, to test the sample cytotoxicity, NIH3T3 mouse fibroblasts were chosen.</div><div class="NLM_p">Cells for cytocompatibility tests are usually chosen according to the end-use of the products under investigation. To evaluate the use of compound <b>51</b> in the treatment of osteoarthritis, normal human chondrocytes derived from normal human articular cartilage were selected. Fibroblasts NIH3T3 and NHAC-kn were propagated in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum (FCS), 1% <span class="smallcaps smallerCapital">l</span>-glutamine, and 1% penicillin and in a chondrocyte growth medium. Once at confluence, the cells were washed with phosphate-buffered saline (PBS) 0.1 M, separated with trypsin-ethylenediamine tetraacetic acid (EDTA) solution, and centrifuged at 1000 rpm for 5 min. The pellet was resuspended in a complete medium (dilution 1:15).</div><div class="NLM_p">Cells (1.5 × 10<sup>4</sup>) suspended in 1 mL of complete medium were seeded in each well of a 24-well round multidish and incubated at 37 °C in 5% CO<sub>2</sub> for 24 h. Then, the culture medium was discharged, and each test compound was added to each well to test the following concentrations: 2.5, 7.5, 12.5, 25, 37.5, and 50 μM. After 24 h of incubation at 37 °C in 5% CO<sub>2</sub>, cell viability was determined by the neutral red uptake test. The assay was carried out three times in three replicates for each tested concentration. The complete medium was used as the negative control.</div><div class="NLM_p">Chondrocyte proliferation in contact with compound <b>51</b> as a function of incubation time (1, 7, and 14 days) was evaluated testing the highest nontoxic concentration, 7.5 μM, using the procedure described above. At any interval (1, 7, and 14 days), cell viability was evaluated by neutral red uptake. The assay was carried out three times in three replicates for each incubation time. The complete medium was used as a negative control. First of all, the following solutions were prepared to determine the percentage of viable cells.<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">1.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Neutral red (NR) stock solution: 0.33 g of NR dye powder in 100 mL of sterile H<sub>2</sub>O</p></td></tr><tr class="li1"><td valign="top">2.</td><td colspan="5" valign="top" class="paragraph"><p class="last">NR medium: 1.0 mL of NR stock solution + 99.0 routine culture medium prewarmed to 37 °C</p></td></tr><tr class="li1"><td valign="top">3.</td><td colspan="5" valign="top" class="paragraph"><p class="last">NR desorb solution: 1% glacial acetic acid solution + 50% ethanol + 49% H<sub>2</sub>O.</p></td></tr></table></div><div class="NLM_p last">At the end of incubation, the routine culture medium was removed from each plate and the cells were carefully rinsed with 1 mL of prewarmed <span class="smallcaps smallerCapital">d</span>-PBS 0.1 M. Plates were then gently blotted with paper towels. One milliliter NR medium was added to each dish and further incubated at 37 °C, 95% humidity, 5.0% CO<sub>2</sub> for 3 h. The cells were checked during incubation for NR crystal formation. After incubation, the NR medium was removed and the cells were carefully rinsed with 1 mL of prewarmed <span class="smallcaps smallerCapital">d</span>-PBS 0.1 M. PBS was decanted and blotted from the dishes, and exactly 1 mL of NR desorb solution was added to each sample. Plates were placed on a shaker for 20–45 min to extract NR from the cells and form a homogeneous solution. During this step, the samples were covered to protect them from light. Five minutes after removal from the shaker, absorbance was read at 540 nm with a UV–visible spectrophotometer (Ultraspec200, Pharmacia Biotech).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Determination of Sulfated Glycosaminoglycans (S-GAG) and Hydroxyproline (HYP) Content</h4><div class="NLM_p">The quantification of S-GAG was determined according to the methods of Farndale et al.,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> by the following procedure. At any interval (1, 7, 14 days of incubation), the culture supernatants were collected and the samples were treated overnight with 25 U/mL proteinase K at 56 °C. After the inactivation of the enzyme, performed at 90 °C for 10 min, the suspensions were pooled with their respective supernatants and centrifuged at 4000<i>g</i> for 10 min at room temperature. The supernatant was then collected, filtered by a 0.1 μm pore size syringe filter and centrifuged at 12 000<i>g</i> for 4 min at room temperature. One milliliter of a 1,9-dimethyl-methylene blue solution (DMMB) was added to 100 μL of the filtered supernatant and mixed to allow the formation of DMMB–S-GAG complexes in each sample. The complexes were then centrifuged at 12 000<i>g</i> for 10 min at room temperature, and the pellet was suspended in a decomplexation solution. After 30 min of shaking at room temperature, the absorbance of the solutions was spectrophotometrically read at 656 nm by a UV–visible spectrophotometer (Ultraspec200, Pharmacia Biotech). The amounts of S-GAG were determined using a standard curve obtained with chondroitin-sulfated sodium salt from shark cartilage.</div><div class="NLM_p last">The quantification of HYP in human chondrocytes in contact with compound <b>51</b> was performed by the HYP assay kit (Sigma-Aldrich, Germany). Briefly, adhered HCs were hydrolyzed in 100 μL of water and transferred to a pressure-tight vial with a PTFE-lined cap. Then, 100 μL of concentrated hydrochloric acid (HCl, 12 M) was added and the samples were hydrolyzed at 120 °C for 3 h. Ten microliters of supernatant was transferred to a 96-well plate. Then, 100 μL of the Chloramine T/Oxidation buffer mixture was added to each sample and standard well and incubated at room temperature for 5 min. Al last, 100 μL of the diluted DMAB reagent was added to each well and incubated for 90 min at room temperature, and the absorbance was read at 560 nm.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Physicochemical Characterization</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Determination of Kinetic Solubility</h4><div class="NLM_p last">Kinetic solubilities at pH 1.0 and pH 7.4 for compounds <b>45–62</b> were determined starting from freshly prepared 10 mM DMSO stock solutions. In a 96-well plate, 2 μL of stock solution was added to 198 μL of (i) HCl 0.1 M pH 1.0 or (ii) 10 mM phosphate-buffered saline (PBS) buffer pH 7.4, both adjusted to 0.15 M ionic strength by KCl addition. The plate was stirred (250 rpm, 4 h, room temperature). At the end of the incubation time, the precipitated compound was separated by centrifugation (1000<i>g</i>, 3 min, 20 °C) and an aliquot of the supernatant was diluted 1:100 with MeOH and injected in the HPLC-UV system for quantification. Calibration curves for each compound were built in MeOH. A Phenomenex Jupiter C18 column (150 mm × 4.6 mm; 5 μm particle size; Phenomenex Inc.) with gradient elution was employed for compound separation. Eluent A: water + 0.1% v/v HCOOH; eluent B: acetonitrile + 0.1% v/v HCOOH. A typical gradient was as follows: <i>t</i> = 0 min: A: 20%; B: 80%; <i>t</i> = 10 min: A: 5%; B: 95%; <i>t</i> = 12 min: A: 5%; B: 95%; <i>t</i> = 12.5 min: A: 20%; B: 80%, followed by a 3 min reconditioning time. HPLC flow was 1000 μL/min. A Shimadzu HPLC-UV gradient system (Shimadzu Corp., Kyoto, Japan) consisting of two Shimadzu LC-10ADvp modules, a 10 μL Rheodyne sample injector (Rheodyne LLC), and an SPD-10Avp UV–vis detector was employed for data acquisition. Acquisition wavelength was set at 254 nm. Reported in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> are mean values of four independent experiments together with their standard deviations.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Determination of Ionization Constants (p<i>K</i><sub>a</sub>) and Lipophilicity (Log <i>P</i><sub>oct</sub>)</h4><div class="NLM_p last">A Sirius T3 automatic titrator (Sirius Analytical Instruments, Forest Row, U.K.), equipped with a combined microelectrode, a microstirrer, a temperature probe, a UV–vis probe, and six precision dispensers for titrant and cosolvent pipetting, was employed to measure ionization constants (p<i>K</i><sub>a</sub>) and lipophilicity (log <i>P</i><sub>oct</sub>) of selected compounds <b>45–46</b>, <b>48</b>, and <b>51–52</b>. A UV-metric approach was applied for p<i>K</i><sub>a</sub> measurements. Briefly, 7 μL of a DMSO stock solution of each compound was poured into a 2 mL glass vial where different percentages of MeOH (55–35%) and 0.15 M ionic strength adjusted water were then added. Titrations occurred in the 12.0–2.0 pH range, employing 0.5 M HCl as the titrant. The system was kept at 25 ± 0.5 °C and under a nitrogen atmosphere throughout the experiments. For each titrant addition, UV–vis spectra were recorded in the 180–700 nm range and compared to those of control samples containing the same percentages of cosolvents (DMSO and MeOH) and no compound. Target factor analysis (TFA) was applied to rationalize the 3D matrix of absorbance at different wavelength vs pH (Sirius T3 Refine software package, version: 1.1.3.0), which provided the p<i>K</i><sub>a</sub> values at fixed MeOH percentages. Aqueous p<i>K</i><sub>a</sub> values were then extrapolated by the Yasuda–Shedlovsky model from data at decreasing MeOH percentages. Partition coefficients (log <i>P</i>) in the <i>n-</i>octanol/water partition system were determined by nonlinear fitting of the potentiometric titration curves, evaluating the shift produced by the different <i>n</i>-octanol/water ratios on the aqueous p<i>K</i><sub>a</sub> of each compound.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Reported in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> are mean values of three independent experiments together with their standard deviations.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> In Vivo Pharmacology</h3><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Animals</h4><div class="NLM_p last">Male 60 day-old Wistar rats (Charles River, Hamburg, Germany) initially weighing 225–250 g were used for all experiments. Animals were housed 4–6 per cage under a standard 12/12 h light/dark cycle with food and water available ad libitum. Experiments were performed between 7 am and 4 pm in the animal house (conventional, maintained in open conditions and specified pathogen-free [maintained in barrier conditions] standards). The procedures on animals were performed following the recommendations of the International Association of Studies on Pain and 3R policy. The study was approved by the Local Ethics Committee of the Maj Institute of Pharmacology PAS (Cracow, Poland, approval numbers 1130/2014 and 125/2018).</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> OA Induction</h4><div class="NLM_p last">To induce OA-like joint lesions, animals were deeply anesthetized with 5% isoflurane (Baxter, Chicago) in 100% O2 (3,5 l/min). The skin overlying the right knee joint was shaved and wiped with 100% ethanol. Then, 1 mg of monoiodoacetate (MIA; Sigma-Aldrich, Poznan, Poland) dissolved in 50 μL of 0.9% NaCl was injected intra-articular (i.a.) into the joint cavity with a 30G 1/2 0.3 mm ×13 mm needle. MIA is a glyceraldehyde-3-phosphate dehydrogenase inhibitor disrupting glycolysis in chondrocytes, which in consequence causes cell death, cartilage degeneration, and subchondral bone alterations.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Treatment Paradigm</h4><div class="NLM_p last">Compound <b>51</b> was dissolved in vehicle solution, which contained 85% NaCl, 5% DMSO, 5% kolliphor, and 5% EtOH (Sigma-Aldrich, Germany). Compound <b>51</b> was administrated intraperitoneally (i.p.) on days 21 and 28 post MIA injection at the dose of 1 mg/kg alone or prior to administration of 1 mg/kg of the CB2R antagonist AM-630 (Tocris, U.K.). Doses of compound <b>51</b> and AM-630 were selected on the basis of preliminary experiments (unpublished results). Rats of the control group were treated with an equal volume of the vehicle solution. Animals were sacrificed on day 28 after MIA injection.</div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Assessment of Pain-Related Responses</h4><div class="NLM_p last">After MIA injection, rats were maintained under standard conditions for 28 consecutive days, during which the animal’s welfare was carefully monitored. The MIA-induced model causes biphasic pain response with the chronic phase beginning on day 12 after OA induction and showing a stable pain threshold decrease from day 21 post MIA injection.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> In vivo experiments were performed on days 21 and 28 post MIA injection. Before experiments, animals were extensively habituated to handling to minimalize, on the test day, stress associated with handling by the experimenter. The tester was blinded to the experimental groups throughout the tests. Two different tests were used to assess pain-related responses.</div></div><div id="sec4_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Pressure Application Measurement Test</h4><div class="NLM_p last">The pressure application measurement (PAM) device (Ugo Basile, Italy) was used for the mechanical stimulation and assessment of joint pain. A detailed description of the experimental procedure has been given elsewhere.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> Briefly, a quantifiable force was applied for direct stimulation of the joint, and the automatic readout of the response was recorded. The animal was held lightly, and the operator placed a thumb with a force transducer mounted unit (circular contact 8 mm, joint surface area of 50.3 mm<sup>2</sup>) on one side of the animal’s knee joint and a forefinger on the other. A gradually increasing squeeze force was applied across the joint at a rate of approximately 300 g/s with a maximum test duration of 15 s. The peak gram force (gf) applied immediately before the limb base unit recorded withdrawal was noted, and this value was designated as the limb withdrawal threshold (LWT). On days 21 and 28, the basal measurements were performed before and 60, 120, 180, 240, and 300 min post drug injection. Two measurements of the ipsilateral limb were obtained, and the mean LWTs were calculated and converted to per cent of the maximum possible effect (% MPE) according to the formula % MPE = (test result – baseline result/cut-off result – baseline result) × 100.</div></div><div id="sec4_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Kinetic-Weight-Bearing Test</h4><div class="NLM_p last">To characterize the forces applied on the injured paw during mechanical loading and walking pattern in MIA rats, the kinetic-weight-bearing (KWB, Bioseb, France) instrument was used. It consists of a 1 m long corridor lined with piezoelectric sensors on the ground measuring the weight borne by each individual paw during a walking sequence of a freely moving animal. Moreover, at the same time, a built-in camera detects the center of gravity of the animal. Rats were trained to move to the corridor one week prior to the actual experiment. On days 21 and 28, basal measurements were performed immediately before and 60 min after drug injection. A single KWB measurement was recorded for 6 consecutive min; if an animal failed to make any correct run during this time period, it was excluded from data analysis. Based on the raw data, KWB software’s algorithms computed the peak force (cN) parameter as the mean of maximum forces of each rear left or right (injured) paw prints.</div></div><div id="sec4_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> RNA Isolation and Quantitative Polymerase Chain Reaction (qPCR) on Human Osteoarthritic Chondrocytes Stimulated with TNFα</h4><div class="NLM_p last">Human osteoarthritic chondrocytes (HC-OAs) derived from the human articular cartilage of donors with OA (Cell Applications, Inc.) were used in the study. HC-OA cells were stimulated with TNFα at a dose of 50 ng/mL 1 h after compound <b>51</b> (10 μM) alone or in combination with AM-630 (1 μM) was added to the media for the next 5 h. After stimulation, samples were collected in 1 mL of Trizol reagent (Invitrogen, Carlsbad, CA) and frozen at −80 °C until RNA isolation. RNA isolation was performed according to the manufacturer’s protocol. The total RNA quantity was assessed using a Nanodrop spectrophotometer (ND-1000, Nanodrop; Labtech International, United Kingdom). Each sample was equalized to a concentration of 1 μg/μL and reverse-transcribed to cDNA using iScript Reverse Transcription Supermix (BioRad, Valencia, CA) according to the manufacturer’s protocol. The qPCR reactions were carried out using SYBR Green MasterMix (BioRad). The reactions were run on a Real-Time PCR CFX96 TouchSystem (BioRad). Expression levels were assessed against the housekeeping gene—B2m. Cycle threshold values were calculated automatically by CFX Manager software. RNA abundance was calculated as 2<sup>–(threshold cycle)</sup>.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Statistical Analysis</h3><div class="NLM_p last">The analysis was performed using Statistica 10 (StatSoft Poland); graphs were prepared using Prism 5 (GraphPad Software, San Diego). All data are presented as the means ± SEM. The results of the in vivo experiments were evaluated by analysis of variance (ANOVA) followed by Tukey’s post hoc test (PAM test) and Bonferroni’s post hoc test (KWB test). Reverse-transcription (RT)-qPCR analysis was made by analysis of variance (ANOVA) followed by Dunnet’s post hoc test. All in vivo experiments were performed on male Wistar rats. Testing groups for KWB were assigned as follows: <i>n</i> = 22 for the vehicle; <i>n</i> = 10 for compound <b>51</b>; <i>n</i> = 10 for AM-630 + compound <b>51</b>; and <i>n</i> = 5 for AM-630. The PAM test includes groups as follows: <i>n</i> = 17 for the vehicle; <i>n</i> = 10 for compound <b>51</b>; <i>n</i> = 10 for AM-630 + compound <b>51</b>; and <i>n</i> = 6 for AM-630. The RT-qPCR experiments include 2–14 samples. All data were considered significant only when *<i>p</i> < 0.05; **<i>p</i> < 0.01; ***<i>p</i> < 0.001, ****<i>p</i> < 0.0001. * denotes significant differences vs the vehicle group (PAM, RT-qPCR) or vs the rear left paw (KWB). # denotes significant differences vs the TNFα group (RT-qPCR) or vs the compound <b>51</b> group (KWB).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00595" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00595?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00595</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figures illustrating X-ray crystallographic data for compounds <b>4</b> and <b>6;</b> tautomeric equilibrium data for compound <b>51</b>; HPLC-MS traces and elemental analysis of compounds <b>45–62;</b> Table 1S, estimated physicochemical characteristics of compounds <b>45</b>–<b>62</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_001.pdf">jm0c00595_si_001.pdf (1.8 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_002.csv">jm0c00595_si_002.csv (3.65 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00595" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85566" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85566" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia Mugnaini</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1998-732X" title="Orcid link">http://orcid.org/0000-0003-1998-732X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f6959a9783929f97d89b839198979f989fb683989f859fd89f82"><span class="__cf_email__" data-cfemail="3c5f505d4958555d1251495b525d5552557c4952554f55125548">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessia Ligresti</span> - <span class="hlFld-Affiliation affiliation">Endocannabinoid
Research Group, Institute of Biomolecular Chemistry, National Research Council of Italy, Via Campi Flegrei 34, 80078 Pozzuoli, Napoli, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1787-3900" title="Orcid link">http://orcid.org/0000-0003-1787-3900</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5d3c31382e2e343c7331343a2f382e29341d343e3f733e332f733429"><span class="__cf_email__" data-cfemail="07666b6274746e66296b6e60756274736e476e646529646975296e73">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Magdalena Kostrzewa</span> - <span class="hlFld-Affiliation affiliation">Endocannabinoid
Research Group, Institute of Biomolecular Chemistry, National Research Council of Italy, Via Campi Flegrei 34, 80078 Pozzuoli, Napoli, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Genetics and Biophysics, National Research Council of Italy, Via Pietro Castellino 111, 80131 Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Bryk</span> - <span class="hlFld-Affiliation affiliation">Institute
of Genetics and Biophysics, National Research Council of Italy, Via Pietro Castellino 111, 80131 Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ali Mokhtar Mahmoud</span> - <span class="hlFld-Affiliation affiliation">Endocannabinoid
Research Group, Institute of Biomolecular Chemistry, National Research Council of Italy, Via Campi Flegrei 34, 80078 Pozzuoli, Napoli, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2328-0060" title="Orcid link">http://orcid.org/0000-0003-2328-0060</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonella Brizzi</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefania Lamponi</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gianluca Giorgi</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesca Ferlenghi</span> - <span class="hlFld-Affiliation affiliation">Department
of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1061-1991" title="Orcid link">http://orcid.org/0000-0003-1061-1991</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federica Vacondio</span> - <span class="hlFld-Affiliation affiliation">Department
of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0729-4385" title="Orcid link">http://orcid.org/0000-0002-0729-4385</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paola Maccioni</span> - <span class="hlFld-Affiliation affiliation">Institute
of Neuroscience, National Research Council of Italy, S.S. 554, km 4,500, 09042 Monserrato, Cagliari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giancarlo Colombo</span> - <span class="hlFld-Affiliation affiliation">Institute
of Neuroscience, National Research Council of Italy, S.S. 554, km 4,500, 09042 Monserrato, Cagliari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Mor</span> - <span class="hlFld-Affiliation affiliation">Department
of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0199-1849" title="Orcid link">http://orcid.org/0000-0003-0199-1849</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katarzyna Starowicz</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurochemistry, Institute of Pharmacology, Polish Academy of Sciences, ul. Smetna 12, 31-343 Cracow, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenzo Di Marzo</span> - <span class="hlFld-Affiliation affiliation">Endocannabinoid
Research Group, Institute of Biomolecular Chemistry, National Research Council of Italy, Via Campi Flegrei 34, 80078 Pozzuoli, Napoli, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1490-3070" title="Orcid link">http://orcid.org/0000-0002-1490-3070</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federico Corelli</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>C.M. and M.K. are joint first authors. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6001-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The work of K.S. and M.B. was supported by Departmental Statutory funds (Maj Institute of Pharmacology, Polish Academy of Sciences) and by the National Science Centre, Poland, grant OPUS 2014/13/B/NZ7/02311. A.M.M. and M.K. are recipients of a scholarship from the INCIPIT Ph.D. program, which is cofunded by the COFUND scheme Marie Skłodowska-Curie Actions (HORIZON 2020/MSCA grant agreement 665403). We thank Marco Allarà, Endocannabinoid Research Group, for technical help with in vitro assays; Dr. Simone Esposito, Department of DMPK, IRBM, Pomezia (Rome), Italy, for HRMS determinations; and Dr. Elena Dreassi, Dipartimento di Biotecnologie, Chimica e Farmacia, for HPLC-MS analyses. The authors from Dipartimento di Biotecnologie, Chimica e Farmacia, acknowledge the partial support by MIUR Progetto <i>Dipartimenti di Eccellenza 2018–2022</i>, grant no. L. 232/2016.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AcCl</td><td class="NLM_def"><p class="first last">acetyl chloride</p></td></tr><tr><td class="NLM_term">ANOVA</td><td class="NLM_def"><p class="first last">analysis of variance</p></td></tr><tr><td class="NLM_term">CB1R</td><td class="NLM_def"><p class="first last">type-1 cannabinoid receptors</p></td></tr><tr><td class="NLM_term">CB2R</td><td class="NLM_def"><p class="first last">type-2 cannabinoid receptors</p></td></tr><tr><td class="NLM_term">Clog <i>P</i></td><td class="NLM_def"><p class="first last">calculated logarithm of the partition coefficient</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">DMMB</td><td class="NLM_def"><p class="first last">1,9-dimethyl-methylene blue</p></td></tr><tr><td class="NLM_term">DRG</td><td class="NLM_def"><p class="first last">dorsal root ganglion</p></td></tr><tr><td class="NLM_term">HBA</td><td class="NLM_def"><p class="first last">hydrogen-bond acceptor</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen-bond donor</p></td></tr><tr><td class="NLM_term">HC</td><td class="NLM_def"><p class="first last">human chondrocytes</p></td></tr><tr><td class="NLM_term">HC-OA</td><td class="NLM_def"><p class="first last">human osteoarthritic chondrocytes</p></td></tr><tr><td class="NLM_term">HYP</td><td class="NLM_def"><p class="first last">hydroxyproline</p></td></tr><tr><td class="NLM_term">IL-1β</td><td class="NLM_def"><p class="first last">interleukin-1β</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">KWB</td><td class="NLM_def"><p class="first last">kinetic weight bearing</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">MIA</td><td class="NLM_def"><p class="first last">sodium monoiodoacetate</p></td></tr><tr><td class="NLM_term">MPE</td><td class="NLM_def"><p class="first last">maximal possible effect</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">NHAC-kn</td><td class="NLM_def"><p class="first last">normal human articular chondrocytes</p></td></tr><tr><td class="NLM_term">NRU</td><td class="NLM_def"><p class="first last">neutral red uptake</p></td></tr><tr><td class="NLM_term">OA</td><td class="NLM_def"><p class="first last">osteoarthritis</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">pressure applied measurement</p></td></tr><tr><td class="NLM_term">qPCR</td><td class="NLM_def"><p class="first last">quantitative polymerase chain reaction</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation of the mean</p></td></tr><tr><td class="NLM_term">S-GAG</td><td class="NLM_def"><p class="first last">sulfated glycosaminoglycans</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84556" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84556" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridgett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laslett, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicuttini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchbinder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, L.</span></span> <span> </span><span class="NLM_article-title">The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1323</span>– <span class="NLM_lpage">1330</span>, <span class="refDoi"> DOI: 10.1136/annrheumdis-2013-204763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1136%2Fannrheumdis-2013-204763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=24553908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC2cvmsVyntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=1323-1330&author=M.+Crossauthor=E.+Smithauthor=D.+Hoyauthor=S.+Nolteauthor=I.+Ackermanauthor=M.+Fransenauthor=L.+Bridgettauthor=S.+Williamsauthor=F.+Guilleminauthor=C.+L.+Hillauthor=L.+L.+Laslettauthor=G.+Jonesauthor=F.+Cicuttiniauthor=R.+Osborneauthor=T.+Vosauthor=R.+Buchbinderauthor=A.+Woolfauthor=L.+March&title=The+global+burden+of+hip+and+knee+osteoarthritis%3A+estimates+from+the+global+burden+of+disease+2010+study&doi=10.1136%2Fannrheumdis-2013-204763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study</span></div><div class="casAuthors">Cross Marita; Smith Emma; March Lyn; Hoy Damian; Nolte Sandra; Ackerman Ilana; Fransen Marlene; Bridgett Lisa; Williams Sean; Guillemin Francis; Hill Catherine L; Laslett Laura L; Jones Graeme; Cicuttini Flavia; Osborne Richard; Vos Theo; Buchbinder Rachelle; Woolf Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the rheumatic diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1323-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To estimate the global burden of hip and knee osteoarthritis (OA) as part of the Global Burden of Disease 2010 study and to explore how the burden of hip and knee OA compares with other conditions.  METHODS:  Systematic reviews were conducted to source age-specific and sex-specific epidemiological data for hip and knee OA prevalence, incidence and mortality risk.  The prevalence and incidence of symptomatic, radiographic and self-reported hip or knee OA were included.  Three levels of severity were defined to derive disability weights (DWs) and severity distribution (proportion with mild, moderate and severe OA).  The prevalence by country and region was multiplied by the severity distribution and the appropriate disability weight to calculate years of life lived with disability (YLDs).  As there are no deaths directly attributed to OA, YLDs equate disability-adjusted life years (DALYs).  RESULTS:  Globally, of the 291 conditions, hip and knee OA was ranked as the 11th highest contributor to global disability and 38th highest in DALYs.  The global age-standardised prevalence of knee OA was 3.8% (95% uncertainty interval (UI) 3.6% to 4.1%) and hip OA was 0.85% (95% UI 0.74% to 1.02%), with no discernible change from 1990 to 2010.  Prevalence was higher in females than males.  YLDs for hip and knee OA increased from 10.5 million in 1990 (0.42% of total DALYs) to 17.1 million in 2010 (0.69% of total DALYs).  CONCLUSIONS:  Hip and knee OA is one of the leading causes of global disability.  Methodological issues within this study make it highly likely that the real burden of OA has been underestimated.  With the aging and increasing obesity of the world's population, health professions need to prepare for a large increase in the demand for health services to treat hip and knee OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTF9urCTR9QCN1QT_1O5WBYfW6udTcc2eab83Q7QRnKTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvmsVyntw%253D%253D&md5=d18c2d7ce5365e65cd7f2b62cceed20c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2013-204763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2013-204763%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DHoy%26aufirst%3DD.%26aulast%3DNolte%26aufirst%3DS.%26aulast%3DAckerman%26aufirst%3DI.%26aulast%3DFransen%26aufirst%3DM.%26aulast%3DBridgett%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DGuillemin%26aufirst%3DF.%26aulast%3DHill%26aufirst%3DC.%2BL.%26aulast%3DLaslett%26aufirst%3DL.%2BL.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DCicuttini%26aufirst%3DF.%26aulast%3DOsborne%26aufirst%3DR.%26aulast%3DVos%26aufirst%3DT.%26aulast%3DBuchbinder%26aufirst%3DR.%26aulast%3DWoolf%26aufirst%3DA.%26aulast%3DMarch%26aufirst%3DL.%26atitle%3DThe%2520global%2520burden%2520of%2520hip%2520and%2520knee%2520osteoarthritis%253A%2520estimates%2520from%2520the%2520global%2520burden%2520of%2520disease%25202010%2520study%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2014%26volume%3D73%26spage%3D1323%26epage%3D1330%26doi%3D10.1136%2Fannrheumdis-2013-204763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mobasheri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay-Jensen, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Spil, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, M. C.</span></span> <span> </span><span class="NLM_article-title">Osteoarthritis year in review 2016: biomarkers (biochemical markers)</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2016.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2016.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=28099838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC1c7mvFyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=199-208&author=A.+Mobasheriauthor=A.-C.+Bay-Jensenauthor=W.+E.+van+Spilauthor=J.+Larkinauthor=M.+C.+Levesque&title=Osteoarthritis+year+in+review+2016%3A+biomarkers+%28biochemical+markers%29&doi=10.1016%2Fj.joca.2016.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoarthritis Year in Review 2016: biomarkers (biochemical markers)</span></div><div class="casAuthors">Mobasheri A; Bay-Jensen A-C; van Spil W E; Larkin J; Levesque M C</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-208</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The aim of this "Year in Review" article is to summarize and discuss the implications of biochemical marker related articles published between the Osteoarthritis Research Society International (OARSI) 2015 Congress in Seattle and the OARSI 2016 Congress in Amsterdam.  METHODS:  The PubMed/MEDLINE bibliographic database was searched using the combined keywords: 'biomarker' and 'osteoarthritis'.  The PubMed/MEDLINE literature search was conducted using the Advanced Search Builder function (http://www.ncbi.nlm.nih.gov/pubmed/advanced).  RESULTS:  Over two hundred new biomarker-related papers were published during the literature search period.  Some papers identified new biomarkers whereas others explored the biological properties and clinical utility of existing markers.  There were specific references to several adipocytokines including leptin and adiponectin.  ADAM Metallopeptidase with Thrombospondin Type 1 motif 4 (ADAMTS-4) and aggrecan ARGS neo-epitope fragment (ARGS) in synovial fluid (SF) and plasma chemokine (CeC motif) ligand 3 (CCL3) were reported as potential new knee biomarkers.  New and refined proteomic technologies and novel assays including a fluoro-microbead guiding chip (FMGC) for measuring C-telopeptide of type II collagen (CTX-II) in serum and urine and a novel magnetic nanoparticle-based technology (termed magnetic capture) for collecting and concentrating CTX-II, were described this past year.  CONCLUSION:  There has been steady progress in osteoarthritis (OA) biomarker research in 2016.  Several novel biomarkers were identified and new technologies have been developed for measuring existing biomarkers.  However, there has been no "quantum leap" this past year and identification of novel early OA biomarkers remains challenging.  During the past year, OARSI published a set of recommendations for the use of soluble biomarkers in clinical trials, which is a major step forward in the clinical use of OA biomarkers and bodes well for future OA biomarker development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRh7LgapzYftZPq5LRczm8ffW6udTcc2eZYfvbUH1lZXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7mvFyhtQ%253D%253D&md5=2a7a089b856d23c825453f9587d62b41</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2016.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2016.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DMobasheri%26aufirst%3DA.%26aulast%3DBay-Jensen%26aufirst%3DA.-C.%26aulast%3Dvan%2BSpil%26aufirst%3DW.%2BE.%26aulast%3DLarkin%26aufirst%3DJ.%26aulast%3DLevesque%26aufirst%3DM.%2BC.%26atitle%3DOsteoarthritis%2520year%2520in%2520review%25202016%253A%2520biomarkers%2520%2528biochemical%2520markers%2529%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2017%26volume%3D25%26spage%3D199%26epage%3D208%26doi%3D10.1016%2Fj.joca.2016.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Schwefe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liedgens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergolizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrassi, G.</span></span> <span> </span><span class="NLM_article-title">The impact of pain on labor force participation, absenteeism and presenteeism in the European Union</span>. <i>J. Med. Econ.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">662</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.3111/13696998.2010.529379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.3111%2F13696998.2010.529379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=21034378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fitl2gtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=662-672&author=P.+Langleyauthor=G.+M%C3%BCller-Schwefeauthor=A.+Nicolaouauthor=H.+Liedgensauthor=J.+Pergolizziauthor=G.+Varrassi&title=The+impact+of+pain+on+labor+force+participation%2C+absenteeism+and+presenteeism+in+the+European+Union&doi=10.3111%2F13696998.2010.529379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of pain on labor force participation, absenteeism and presenteeism in the European Union</span></div><div class="casAuthors">Langley Paul; Muller-Schwefe Gerhard; Nicolaou Andrew; Liedgens Hiltrud; Pergolizzi Joseph; Varrassi Giustino</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medical economics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">662-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  The aims of this paper are to generate estimates of the association between the experience and burden of pain, by severity and frequency, with (1) labor force participation and workforce status in five EU countries (the UK, France, Spain, Germany and Italy) and (2) patterns of absenteeism and presenteeism for the employed workforce.  METHODS:  Data are from the internet-based 2008 National Health and Wellness Survey (NHWS).  This survey covers both those who report experiencing pain in the last month as well as the no pain population.  A series of regression models are developed with the no pain group as the reference category.  The impact of pain, categorized by severity and frequency reported, is assessed within a labor supply framework for (1) labor force participation and (2) absenteeism and presenteeism.  In the former case both binomial and multinomial logistic models are estimated; in the latter case ordered logit models are estimated.  RESULTS:  The results demonstrate that, in the context of health status, the experience of frequent severe and moderate pain has a dominant, independent and negative association with labor force participation and employment status as well as absenteeism and presenteeism.  The presence of severe daily pain is associated with a 20-point reduction in the probability of being employed full-time; with moderate daily pain associated with a 10-point reduction.  The impact of pain is far greater than the potential impact of other health status measures (e.g., chronic comorbidities and BMI).  The experience of pain, notably severe and frequent pain, also outstrips the impact of other health status factors in absenteeism and presenteeism.  CONCLUSIONS:  The experience of pain, in particular severe daily pain, has a substantial negative association with labor force participation in these five European countries as well as reported absenteeism and presenteeism.  As a measure of health status, it clearly outweighs other health status measures.  Whether or not pain is considered as a disease in its own right, the experience of chronic pain, as defined here, presents policy makers with a major challenge.  Programs to relieve the burden of pain in the community clearly have the potential for substantial benefits from societal, individual and employer perspectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSt1ZUAXLmuJJZoeNcnHOQ9fW6udTcc2eZYfvbUH1lZXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fitl2gtA%253D%253D&md5=46043ad4f0fdc5c8ba868d0e518138da</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3111%2F13696998.2010.529379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3111%252F13696998.2010.529379%26sid%3Dliteratum%253Aachs%26aulast%3DLangley%26aufirst%3DP.%26aulast%3DM%25C3%25BCller-Schwefe%26aufirst%3DG.%26aulast%3DNicolaou%26aufirst%3DA.%26aulast%3DLiedgens%26aufirst%3DH.%26aulast%3DPergolizzi%26aufirst%3DJ.%26aulast%3DVarrassi%26aufirst%3DG.%26atitle%3DThe%2520impact%2520of%2520pain%2520on%2520labor%2520force%2520participation%252C%2520absenteeism%2520and%2520presenteeism%2520in%2520the%2520European%2520Union%26jtitle%3DJ.%2520Med.%2520Econ.%26date%3D2010%26volume%3D13%26spage%3D662%26epage%3D672%26doi%3D10.3111%2F13696998.2010.529379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sofat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejindu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiely, P.</span></span> <span> </span><span class="NLM_article-title">What makes osteoarthritis painful? The evidence for local and central pain processing</span>. <i>Rheumatology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2157</span>– <span class="NLM_lpage">2165</span>, <span class="refDoi"> DOI: 10.1093/rheumatology/ker283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1093%2Frheumatology%2Fker283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=21954151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FhvFyquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=2157-2165&author=N.+Sofatauthor=V.+Ejinduauthor=P.+Kiely&title=What+makes+osteoarthritis+painful%3F+The+evidence+for+local+and+central+pain+processing&doi=10.1093%2Frheumatology%2Fker283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">What makes osteoarthritis painful? The evidence for local and central pain processing</span></div><div class="casAuthors">Sofat Nidhi; Ejindu Vivian; Kiely Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology (Oxford, England)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2157-65</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OA is a chronic arthritic disease characterized by pain, local tissue damage and attempts at tissue repair.  Historically, cartilage damage was believed to be the hallmark of OA.  However, since cartilage is an avascular, aneural tissue, the mechanisms of pain are likely to be complex and influenced by non-cartilaginous structures in the joint including the synovium, bone and soft tissue.  Imaging studies reveal the presence of synovitis and bone marrow lesions that may mediate pain.  The presence of local joint inflammation and altered cartilage and bone turnover in OA implicates a potential role for a range of molecular mediators in OA pain.  Mechanisms of pain perception may include the activation and release of local pro-inflammatory mediators such as prostaglandins and cytokines accompanied by the destruction of tissue, which is mediated by proteases.  However, clinically, there is often disparity between the degree of pain perception and the extent of joint changes in subjects with OA.  Such observations have prompted work to investigate the mechanisms of central pain perception in OA.  Functional MRI has identified multiple areas of the brain that are involved in OA pain processing.  These data demonstrate that pain perception in OA is complex in being influenced by local factors and activation of central pain-processing pathways.  In this review, we will discuss current concepts underlying the pathophysiology of pain perception in OA and suggest possible directions for the future management of pain in this condition based on recent clinical studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwAtVd0AxeVhfKb6ELK8t0fW6udTcc2eZYfvbUH1lZXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FhvFyquw%253D%253D&md5=901c18aa908bb43df2c5b0e6a77549bc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fker283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fker283%26sid%3Dliteratum%253Aachs%26aulast%3DSofat%26aufirst%3DN.%26aulast%3DEjindu%26aufirst%3DV.%26aulast%3DKiely%26aufirst%3DP.%26atitle%3DWhat%2520makes%2520osteoarthritis%2520painful%253F%2520The%2520evidence%2520for%2520local%2520and%2520central%2520pain%2520processing%26jtitle%3DRheumatology%26date%3D2011%26volume%3D50%26spage%3D2157%26epage%3D2165%26doi%3D10.1093%2Frheumatology%2Fker283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berenbaum, F.</span></span> <span> </span><span class="NLM_article-title">Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2012.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2012.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=23194896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3s7nsFakuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=16-21&author=F.+Berenbaum&title=Osteoarthritis+as+an+inflammatory+disease+%28osteoarthritis+is+not+osteoarthrosis%21%29&doi=10.1016%2Fj.joca.2012.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)</span></div><div class="casAuthors">Berenbaum F</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Osteoarthritis (OA) has long been considered a "wear and tear" disease leading to loss of cartilage.  OA used to be considered the sole consequence of any process leading to increased pressure on one particular joint or fragility of cartilage matrix.  Progress in molecular biology in the 1990s has profoundly modified this paradigm.  The discovery that many soluble mediators such as cytokines or prostaglandins can increase the production of matrix metalloproteinases by chondrocytes led to the first steps of an "inflammatory" theory.  However, it took a decade before synovitis was accepted as a critical feature of OA, and some studies are now opening the way to consider the condition a driver of the OA process.  Recent experimental data have shown that subchondral bone may have a substantial role in the OA process, as a mechanical damper, as well as a source of inflammatory mediators implicated in the OA pain process and in the degradation of the deep layer of cartilage.  Thus, initially considered cartilage driven, OA is a much more complex disease with inflammatory mediators released by cartilage, bone and synovium.  Low-grade inflammation induced by the metabolic syndrome, innate immunity and inflammaging are some of the more recent arguments in favor of the inflammatory theory of OA and highlighted in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1VMJujfUh4b5XHngOXiV_fW6udTcc2ebytGmBO5z8Srntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7nsFakuw%253D%253D&md5=b4f1d68adb7cab7b51f5aa5076c358a4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2012.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2012.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DBerenbaum%26aufirst%3DF.%26atitle%3DOsteoarthritis%2520as%2520an%2520inflammatory%2520disease%2520%2528osteoarthritis%2520is%2520not%2520osteoarthrosis%2521%2529%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2013%26volume%3D21%26spage%3D16%26epage%3D21%26doi%3D10.1016%2Fj.joca.2012.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neogi, T.</span></span> <span> </span><span class="NLM_article-title">The epidemiology and impact of pain in osteoarthritis</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1145</span>– <span class="NLM_lpage">1153</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2013.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2013.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=23973124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3sbitlCitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1145-1153&author=T.+Neogi&title=The+epidemiology+and+impact+of+pain+in+osteoarthritis&doi=10.1016%2Fj.joca.2013.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The epidemiology and impact of pain in osteoarthritis</span></div><div class="casAuthors">Neogi T</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1145-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Osteoarthritis (OA) is the most common form of arthritis and a leading cause of disability worldwide, largely due to pain, the primary symptom of the disease.  The pain experience in knee OA in particular is well-recognized as typically transitioning from intermittent weight-bearing pain to a more persistent, chronic pain.  Methods to validly assess pain in OA studies have been developed to address the complex nature of the pain experience.  The etiology of pain in OA is recognized to be multifactorial, with both intra-articular and extra-articular risk factors.  Nonetheless, greater insights are needed into pain mechanisms in OA to enable rational mechanism-based management of pain.  Consequences of pain related to OA contribute to a substantial socioeconomic burden.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRazKlkC8sbaX6HPRus0rAafW6udTcc2ebytGmBO5z8Srntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbitlCitw%253D%253D&md5=c1e5ce683218f7852814a8c6909b8143</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2013.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2013.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DNeogi%26aufirst%3DT.%26atitle%3DThe%2520epidemiology%2520and%2520impact%2520of%2520pain%2520in%2520osteoarthritis%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2013%26volume%3D21%26spage%3D1145%26epage%3D1153%26doi%3D10.1016%2Fj.joca.2013.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conaghan, P. G.</span></span> <span> </span><span class="NLM_article-title">Osteoarthritis in 2012: parallel evolution of OA phenotypes and therapies</span>. <i>Nat. Rev. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1038/nrrheum.2012.225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1038%2Fnrrheum.2012.225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=23296390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3s3nsVGrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=68-70&author=P.+G.+Conaghan&title=Osteoarthritis+in+2012%3A+parallel+evolution+of+OA+phenotypes+and+therapies&doi=10.1038%2Fnrrheum.2012.225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoarthritis in 2012: Parallel evolution of OA phenotypes and therapies</span></div><div class="casAuthors">Conaghan Philip G</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Rheumatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">68-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">2012 has witnessed new developments in targeted therapies for osteoarthritis, and in ways to identify those patients who might benefit most from their application.  Together, these advances could go some way to addressing the urgent need for disease-modifying treatments for this common disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmwv_ITNl9D-WhZTslLrfffW6udTcc2ebytGmBO5z8Srntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3nsVGrtg%253D%253D&md5=dd1cf013a65185a99dd25b18880b11c4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2012.225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2012.225%26sid%3Dliteratum%253Aachs%26aulast%3DConaghan%26aufirst%3DP.%2BG.%26atitle%3DOsteoarthritis%2520in%25202012%253A%2520parallel%2520evolution%2520of%2520OA%2520phenotypes%2520and%2520therapies%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2013%26volume%3D9%26spage%3D68%26epage%3D70%26doi%3D10.1038%2Fnrrheum.2012.225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsbury, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowes, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaghan, P. G.</span></span> <span> </span><span class="NLM_article-title">A systematic review of the relationship between subchondral bone features, pain and structural pathology in peripheral joint osteoarthritis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>, <span class="NLM_elocation-id">228</span> <span class="refDoi"> DOI: 10.1186/s13075-015-0735-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1186%2Fs13075-015-0735-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=26303219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC287mtVWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&author=A.+J.+Barrauthor=T.+M.+Campbellauthor=D.+Hopkinsonauthor=S.+R.+Kingsburyauthor=M.+A.+Bowesauthor=P.+G.+Conaghan&title=A+systematic+review+of+the+relationship+between+subchondral+bone+features%2C+pain+and+structural+pathology+in+peripheral+joint+osteoarthritis&doi=10.1186%2Fs13075-015-0735-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic review of the relationship between subchondral bone features, pain and structural pathology in peripheral joint osteoarthritis</span></div><div class="casAuthors">Barr Andrew J; Campbell T Mark; Kingsbury Sarah R; Conaghan Philip G; Campbell T Mark; Hopkinson Devan; Bowes Mike A</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis research & therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">228</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Bone is an integral part of the osteoarthritis (OA) process.  We conducted a systematic literature review in order to understand the relationship between non-conventional radiographic imaging of subchondral bone, pain, structural pathology and joint replacement in peripheral joint OA.  METHODS:  A search of the Medline, EMBASE and Cochrane library databases was performed for original articles reporting association between non-conventional radiographic imaging-assessed subchondral bone pathologies and joint replacement, pain or structural progression in knee, hip, hand, ankle and foot OA.  Each association was qualitatively characterised by a synthesis of the data from each analysis based upon study design, adequacy of covariate adjustment and quality scoring.  RESULTS:  In total 2456 abstracts were screened and 139 papers were included (70 cross-sectional, 71 longitudinal analyses; 116 knee, 15 hip, six hand, two ankle and involved 113 MRI, eight DXA, four CT, eight scintigraphic and eight 2D shape analyses).  BMLs, osteophytes and bone shape were independently associated with structural progression or joint replacement.  BMLs and bone shape were independently associated with longitudinal change in pain and incident frequent knee pain respectively.  CONCLUSION:  Subchondral bone features have independent associations with structural progression, pain and joint replacement in peripheral OA in the hip and hand but especially in the knee.  For peripheral OA sites other than the knee, there are fewer associations and independent associations of bone pathologies with these important OA outcomes which may reflect fewer studies; for example the foot and ankle were poorly studied.  Subchondral OA bone appears to be a relevant therapeutic target.  SYSTEMATIC REVIEW:  PROSPERO registration number: CRD 42013005009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6P81G1uHUXlUIs6wFK5xJfW6udTcc2ebytGmBO5z8Srntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287mtVWjtA%253D%253D&md5=99c251e15b807920260f218a33a29e6f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2Fs13075-015-0735-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13075-015-0735-x%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26aulast%3DCampbell%26aufirst%3DT.%2BM.%26aulast%3DHopkinson%26aufirst%3DD.%26aulast%3DKingsbury%26aufirst%3DS.%2BR.%26aulast%3DBowes%26aufirst%3DM.%2BA.%26aulast%3DConaghan%26aufirst%3DP.%2BG.%26atitle%3DA%2520systematic%2520review%2520of%2520the%2520relationship%2520between%2520subchondral%2520bone%2520features%252C%2520pain%2520and%2520structural%2520pathology%2520in%2520peripheral%2520joint%2520osteoarthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2015%26volume%3D17%26doi%3D10.1186%2Fs13075-015-0735-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fusco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaper, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coaccioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrassi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paladini, A.</span></span> <span> </span><span class="NLM_article-title">Degenerative joint diseases and neuroinflammation</span>. <i>Pain Pract.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.1111/papr.12551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1111%2Fpapr.12551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=28039964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC1c7htVSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=522-532&author=M.+Fuscoauthor=S.+D.+Skaperauthor=S.+Coaccioliauthor=G.+Varrassiauthor=A.+Paladini&title=Degenerative+joint+diseases+and+neuroinflammation&doi=10.1111%2Fpapr.12551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Degenerative Joint Diseases and Neuroinflammation</span></div><div class="casAuthors">Fusco Mariella; Skaper Stephen D; Coaccioli Stefano; Varrassi Giustino; Varrassi Giustino; Paladini Antonella</div><div class="citationInfo"><span class="NLM_cas:title">Pain practice : the official journal of World Institute of Pain</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">522-532</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Rheumatic and joint diseases, as exemplified by osteoarthritis and rheumatoid arthritis, are among the most widespread painful and disabling pathologies across the globe.  Given the continuing rise in life expectancy, their prevalence is destined to grow.  Osteoarthritis, a degenerative joint disease, is, in particular, on its way to becoming the fourth leading cause of disability worldwide by 2020, with the rising incidence of obesity in addition to age being important factors.  It is estimated that 25% of osteoarthritic individuals are unable to perform daily activities.  Accompanying osteoarthritis is rheumatoid arthritis, which is a chronic systemic disease that often causes pain and deformity.  At least 50% of those affected are unable to remain gainfully employed within 10 years of disease onset.  A growing body of evidence now points to inflammation, locally and more systemically, as a promoter of damage to joints and bones, as well as joint-related functional deficits.  The pathogenesis underlying joint diseases remains unclear; however, it is currently believed that cross-talk between cartilage and subchondral bone-and loss of balance between these two structures in joint diseases-is a critical element.  This view is amplified by the presence of mast cells, whose dysregulation is associated with alterations of junction structures (cartilage, bone, synovia, matrix, nerve endings, and blood vessels).  In addition, persistent activation of mast cells facilitates the development of spinal neuroinflammation mediated through their interaction with microglia.  Unfortunately, current treatment strategies for rheumatic and articular disease are symptomatic and do little to limit disease progression.  Research now should be directed at therapeutic modalities that target osteoarticular structural elements and thereby delaying disease progression and joint replacement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGgpNDCeoMfgpJitSxOdIlfW6udTcc2eZ21MoicK6ZI7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7htVSjuw%253D%253D&md5=63801b84dd343dcaf8f4f7b20cb9c51e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fpapr.12551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpapr.12551%26sid%3Dliteratum%253Aachs%26aulast%3DFusco%26aufirst%3DM.%26aulast%3DSkaper%26aufirst%3DS.%2BD.%26aulast%3DCoaccioli%26aufirst%3DS.%26aulast%3DVarrassi%26aufirst%3DG.%26aulast%3DPaladini%26aufirst%3DA.%26atitle%3DDegenerative%2520joint%2520diseases%2520and%2520neuroinflammation%26jtitle%3DPain%2520Pract.%26date%3D2017%26volume%3D17%26spage%3D522%26epage%3D532%26doi%3D10.1111%2Fpapr.12551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Luteolin inhibits IL-1β-induced inflammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">1586</span>– <span class="NLM_lpage">1592</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.09.161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.biopha.2018.09.161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=30551412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aqs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2019&pages=1586-1592&author=J.+Feiauthor=B.+Liangauthor=C.+Jiangauthor=H.+Niauthor=L.+Wang&title=Luteolin+inhibits+IL-1%CE%B2-induced+inflammation+in+rat+chondrocytes+and+attenuates+osteoarthritis+progression+in+a+rat+model&doi=10.1016%2Fj.biopha.2018.09.161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Luteolin inhibits IL-1β-induced inflammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model</span></div><div class="casAuthors">Fei, Junliang; Liang, Bin; Jiang, Chunzhi; Ni, Haifeng; Wang, Liming</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1586-1592</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Osteoarthritis (OA) is a joint disease characterized by inflammation and cartilage degrdn.  Accumulating evidence has demonstrated that luteolin, a natural flavonoid, has anti-inflammatory and anticatabolic effects.  The present study aimed to assess the protective effect of luteolin on interleukin (IL)-1β-stimulated rat chondrocytes and a monosodium iodoacetate (MIA)-induced model of OA.  Rat chondrocytes were pretreated with luteolin (0, 25, 50, and 100 μM for 12 h) prior to stimulation with IL-1β (10 ng/mL for 24 h).  Nitric oxide (NO) prodn. was detd. using the Griess method.  Prodn. of prostaglandin E2 (PGE2), tumor necrosis factor-α (TNF-α), and matrix metalloproteinase-2, -8, and -9 (MMP-2, MMP-8 and MMP-9) was measured by an ELISA (ELISA).  Protein levels of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), MMP-1, MMP-3, MMP-13, p65, p-p65, IκB, and p-IκB were detd. by Western blotting.  The OA rats received luteolin (10 mg/kg/day) by gavage in vivo.  Morphol. and ultrastructural SEM (SEM) observations were performed to assess the severity of OA at 45 days following MIA injection.  Collagen II protein expression was detd. by immunohistochem.  In this study, luteolin considerably reduced the IL-1β-induced prodn. of NO, PGE2, TNF-α, MMP-2, MMP-8 and MMP-9 and the expression of COX-2, iNOS, MMP-1, MMP-3 and MMP-13.  Luteolin reversed the degrdn. of collagen II induced by IL-1β.  Luteolin also significantly inhibited IL-1β-induced phosphorylation of NF-κB in vitro.  Luteolin treatment prevented cartilage destruction and enhanced collagen II expression in OA rats in vivo.  Overall, our findings suggest that luteolin may be a useful therapeutic agent for patients with OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCmRIMUgFbd7Vg90H21EOLACvtfcHk0lh6mARCEDX8ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aqs7zE&md5=3f1cd5e569c40fe51f3f638b1d108b3b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.09.161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.09.161%26sid%3Dliteratum%253Aachs%26aulast%3DFei%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DNi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26atitle%3DLuteolin%2520inhibits%2520IL-1%25CE%25B2-induced%2520inflammation%2520in%2520rat%2520chondrocytes%2520and%2520attenuates%2520osteoarthritis%2520progression%2520in%2520a%2520rat%2520model%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D109%26spage%3D1586%26epage%3D1592%26doi%3D10.1016%2Fj.biopha.2018.09.161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dass, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Current research on pharmacologic and regenerative therapies for osteoarthritis</span>. <i>Bone Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">15040</span> <span class="refDoi"> DOI: 10.1038/boneres.2015.40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1038%2Fboneres.2015.40" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=26962464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsVGrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&author=W.+Zhangauthor=H.+Ouyangauthor=C.+R.+Dassauthor=J.+Xu&title=Current+research+on+pharmacologic+and+regenerative+therapies+for+osteoarthritis&doi=10.1038%2Fboneres.2015.40"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Current research on pharmacologic and regenerative therapies for osteoarthritis</span></div><div class="casAuthors">Zhang, Wei; Ouyang, Hongwei; Dass, Crispin R.; Xu, Jiake</div><div class="citationInfo"><span class="NLM_cas:title">Bone Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15040</span>CODEN:
                <span class="NLM_cas:coden">BROEBB</span>;
        ISSN:<span class="NLM_cas:issn">2095-6231</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Osteoarthritis (OA) is a degenerative joint disorder commonly encountered in clin. practice, and is the leading cause of disability in elderly people.  Due to the poor self-healing capacity of articular cartilage and lack of specific diagnostic biomarkers, OA is a challenging disease with limited treatment options.  Traditional pharmacol. therapies such as acetaminophen, non-steroidal anti-inflammatory drugs, and opioids are effective in relieving pain but are incapable of reversing cartilage damage and are frequently assocd. with adverse events.  Current research focuses on the development of new OA drugs (such as sprifermin/recombinant human fibroblast growth factor-18, tanezumab/monoclonal antibody against β-nerve growth factor), which aims for more effectiveness and less incidence of adverse effects than the traditional ones.  Furthermore, regenerative therapies (such as autologous chondrocyte implantation (ACI), new generation of matrix-induced ACI, cell-free scaffolds, induced pluripotent stem cells (iPS cells or iPSCs), and endogenous cell homing) are also emerging as promising alternatives as they have potential to enhance cartilage repair, and ultimately restore healthy tissue.  However, despite currently available therapies and research advances, there remain unmet medical needs in the treatment of OA.  This review highlights current research progress on pharmacol. and regenerative therapies for OA including key advances and potential limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUE51uozYy4rVg90H21EOLACvtfcHk0lh6mARCEDX8ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsVGrsL8%253D&md5=db9760575108f854400d877b1b0ebe89</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fboneres.2015.40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fboneres.2015.40%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DOuyang%26aufirst%3DH.%26aulast%3DDass%26aufirst%3DC.%2BR.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DCurrent%2520research%2520on%2520pharmacologic%2520and%2520regenerative%2520therapies%2520for%2520osteoarthritis%26jtitle%3DBone%2520Res.%26date%3D2016%26volume%3D4%26doi%3D10.1038%2Fboneres.2015.40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mobasheri, A.</span></span> <span> </span><span class="NLM_article-title">The future of osteoarthritis therapeutics: targeted pharmacological therapy</span>. <i>Curr. Rheumatol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>, <span class="NLM_elocation-id">364</span> <span class="refDoi"> DOI: 10.1007/s11926-013-0364-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1007%2Fs11926-013-0364-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=24061701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252Fgs1ehuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&author=A.+Mobasheri&title=The+future+of+osteoarthritis+therapeutics%3A+targeted+pharmacological+therapy&doi=10.1007%2Fs11926-013-0364-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The future of osteoarthritis therapeutics: targeted pharmacological therapy</span></div><div class="casAuthors">Mobasheri A</div><div class="citationInfo"><span class="NLM_cas:title">Current rheumatology reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">364</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Osteoarthritis (OA) is one of the most common forms of degenerative joint disease and a major cause of pain and disability affecting the aging population.  It is estimated that more than 20 million Americans and 35 to 40 million Europeans suffer from OA.  Analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) are the only therapeutic treatment options for OA.  Effective pharmacotherapy for OA, capable of restoring the original structure and function of damaged cartilage and other synovial tissue, is urgently needed, and research into such disease-modifying osteoarthritis drugs (DMOADs) is in progress.  This is the first of three reviews focusing on OA therapeutics.  This paper provides an overview of current research into potential structure-modifying drugs and more appropriately targeted pharmacological therapy.  The challenges and opportunities in this area of research and development are reviewed, covering the most up-to-date initiatives, trends, and topics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRl0aBOqVQRApJitSxOdIlfW6udTcc2eYJYLnB56DeaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252Fgs1ehuw%253D%253D&md5=aa216df9e64e986e9df81a31427652cc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs11926-013-0364-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11926-013-0364-9%26sid%3Dliteratum%253Aachs%26aulast%3DMobasheri%26aufirst%3DA.%26atitle%3DThe%2520future%2520of%2520osteoarthritis%2520therapeutics%253A%2520targeted%2520pharmacological%2520therapy%26jtitle%3DCurr.%2520Rheumatol.%2520Rep.%26date%3D2013%26volume%3D15%26doi%3D10.1007%2Fs11926-013-0364-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolait, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brownstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, T. I.</span></span> <span> </span><span class="NLM_article-title">Structure of a cannabinoid receptor and functional expression of the cloned cDNA</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1038/346561a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1038%2F346561a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=2165569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=561-564&author=L.+A.+Matsudaauthor=S.+J.+Lolaitauthor=M.+J.+Brownsteinauthor=A.+C.+Youngauthor=T.+I.+Bonner&title=Structure+of+a+cannabinoid+receptor+and+functional+expression+of+the+cloned+cDNA&doi=10.1038%2F346561a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a cannabinoid receptor and functional expression of the cloned cDNA</span></div><div class="casAuthors">Matsuda, Lisa A.; Lolait, Stephen J.; Brownstein, Michael J.; Young, Alice C.; Bonner, Tom I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6284</span>),
    <span class="NLM_cas:pages">561-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner.  CNS depression and analgesia are well documented effects of the cannabinoids, but the mechanisms responsible for the cannabinoid-induced effects are not known.  The hydrophobic nature of these substances has suggested that cannabinoids resemble anesthetic agents in their action and nonspecifically disrupt cellular membranes.  Recent evidence has supported a mechanism involving a G-protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner.  Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids.  This study reported the cloning and expression of a cDNA that encodes a G-protein-coupled receptor with all of these properties.  Its mRNA is found in cell lines and regions of the brain that have cannabinoid receptors.  This protein may be involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrydatT83mLVg90H21EOLACvtfcHk0lgt-ysFIpLexg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D&md5=a99aeb39544d87392cee18b82a08003d</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2F346561a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F346561a0%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DL.%2BA.%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DBrownstein%26aufirst%3DM.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BC.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26atitle%3DStructure%2520of%2520a%2520cannabinoid%2520receptor%2520and%2520functional%2520expression%2520of%2520the%2520cloned%2520cDNA%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D561%26epage%3D564%26doi%3D10.1038%2F346561a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Shaar, M.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of a peripheral receptor for cannabinoids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/365061a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1038%2F365061a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=7689702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1993&pages=61-65&author=S.+Munroauthor=K.+L.+Thomasauthor=M.+Abu-Shaar&title=Molecular+characterization+of+a+peripheral+receptor+for+cannabinoids&doi=10.1038%2F365061a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of a peripheral receptor for cannabinoids</span></div><div class="casAuthors">Munro, Sean; Thomas, Kerrie L.; Abu-Shaar, Muna</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">6441</span>),
    <span class="NLM_cas:pages">61-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The major active ingredient of marijuana, Δ9-tetrahydrocannabinol (Δ-THC), has been used as a psychoactive agent for thousands of years.  Marijuana, and Δ9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting.  The clin. application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochem. bases of their action.  Progress stemmed initially from the synthesis of potent derivs. of Δ9-THC4,5, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids.  This receptor is expressed in the brain but not in the periphery, except for a low level in testes.  It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins.  Here the authors report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHsq4vy1XH17Vg90H21EOLACvtfcHk0lgt-ysFIpLexg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D&md5=476435b57bd0f24483e2f24b813cc32f</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1038%2F365061a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F365061a0%26sid%3Dliteratum%253Aachs%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DK.%2BL.%26aulast%3DAbu-Shaar%26aufirst%3DM.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520peripheral%2520receptor%2520for%2520cannabinoids%26jtitle%3DNature%26date%3D1993%26volume%3D365%26spage%3D61%26epage%3D65%26doi%3D10.1038%2F365061a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: A personal perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3891</span>– <span class="NLM_lpage">3911</span>, <span class="refDoi"> DOI: 10.1021/jm500220s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500220s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsl2ksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3891-3911&author=A.+Makriyannis&title=2012+Division+of+medicinal+chemistry+award+address.+Trekking+the+cannabinoid+road%3A+A+personal+perspective&doi=10.1021%2Fjm500220s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">2012 Division of Medicinal Chemistry Award Address. Trekking the Cannabinoid Road: A Personal Perspective</span></div><div class="casAuthors">Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3891-3911</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  My involvement with the field of cannabinoids spans close to 3 decades and covers a major part of my scientific career.  It also reflects the robust progress in this initially largely unexplored area of biol.  During this period of time, I have witnessed the growth of modern cannabinoid biol., starting from the discovery of its two receptors and followed by the characterization of its endogenous ligands and the identification of the enzyme systems involved in their biosynthesis and biotransformation.  I was fortunate enough to start at the beginning of this new era and participate in a no. of the new discoveries.  It has been a very exciting journey.  With coverage of some key aspects of my work during this period of "modern cannabinoid research," this Award Address, in part historical, intends to give an account of how the field grew, the key discoveries, and the most promising directions for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou2fYLXIvugrVg90H21EOLACvtfcHk0lhaLAJXUzHL_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsl2ksbk%253D&md5=8af59d7e9f5047d6c8fadabbb3ed9972</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm500220s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500220s%26sid%3Dliteratum%253Aachs%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3D2012%2520Division%2520of%2520medicinal%2520chemistry%2520award%2520address.%2520Trekking%2520the%2520cannabinoid%2520road%253A%2520A%2520personal%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3891%26epage%3D3911%26doi%3D10.1021%2Fjm500220s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trembovler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrosini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casap, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shteyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karsak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yirmiya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shohami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bab, I.</span></span> <span> </span><span class="NLM_article-title">The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1096/fj.06-7957com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1096%2Ffj.06-7957com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=17704191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=285-294&author=J.+Tamauthor=V.+Trembovlerauthor=V.+Di+Marzoauthor=S.+Petrosiniauthor=G.+Leoauthor=A.+Alexandrovichauthor=E.+Regevauthor=N.+Casapauthor=A.+Shteyerauthor=C.+Ledentauthor=M.+Karsakauthor=A.+Zimmerauthor=R.+Mechoulamauthor=R.+Yirmiyaauthor=E.+Shohamiauthor=I.+Bab&title=The+cannabinoid+CB1+receptor+regulates+bone+formation+by+modulating+adrenergic+signaling&doi=10.1096%2Ffj.06-7957com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling</span></div><div class="casAuthors">Tam, Joseph; Trembovler, Victoria; Di Marzo, Vincenzo; Petrosino, Stefania; Leo, Gabriella; Alexandrovich, Alex; Regev, Eran; Casap, Nardy; Shteyer, Arie; Ledent, Catherine; Karsak, Meliha; Zimmer, Andreas; Mechoulam, Raphael; Yirmiya, Raz; Shohami, Esther; Bab, Itai</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">285-294, 10.1096/fj.06-7957com</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">We have recently reported that in bone the cannabinoid CB1 receptor is present in sympathetic terminals.  Here we show that traumatic brain injury (TBI), which in humans enhances peripheral osteogenesis and fracture healing, acutely stimulates bone formation in a distant skeletal site.  At this site we demonstrate (i) a high level of the main endocannabinoid, 2-arachidonoylglycerol (2-AG), and expression of diacylglycerol lipases, enzymes essential for 2-AG synthesis; (ii) that the TBI-induced increase in bone formation is preceded by elevation of the 2-AG and a decrease in norepinephrine (NE) levels.  The TBI stimulation of bone formation was absent in CB1-null mice.  In wild-type animals it could be mimicked, including the suppression of NE levels, by 2-AG administration.  The TBI- and 2-AG-induced stimulation of osteogenesis was restrained by the β-adrenergic receptor agonist isoproterenol.  NE from sympathetic terminals is known to tonically inhibit bone formation by activating osteoblastic β2-adrenergic receptors.  The present findings further demonstrate that the sympathetic control of bone formation is regulated through 2-AG activation of prejunctional CB1.  Elevation of bone 2-AG apparently suppresses NE release from bone sympathetic terminals, thus alleviating the inhibition of bone formation.  The involvement of osteoblastic CB2 signaling in this process is minimal, if any.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHBWEs2cC3IrVg90H21EOLACvtfcHk0lhaLAJXUzHL_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslWmsw%253D%253D&md5=18848f3beebb92be4b7a354ba8d4ea4f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1096%2Ffj.06-7957com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.06-7957com%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DTrembovler%26aufirst%3DV.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DPetrosini%26aufirst%3DS.%26aulast%3DLeo%26aufirst%3DG.%26aulast%3DAlexandrovich%26aufirst%3DA.%26aulast%3DRegev%26aufirst%3DE.%26aulast%3DCasap%26aufirst%3DN.%26aulast%3DShteyer%26aufirst%3DA.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DKarsak%26aufirst%3DM.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DYirmiya%26aufirst%3DR.%26aulast%3DShohami%26aufirst%3DE.%26aulast%3DBab%26aufirst%3DI.%26atitle%3DThe%2520cannabinoid%2520CB1%2520receptor%2520regulates%2520bone%2520formation%2520by%2520modulating%2520adrenergic%2520signaling%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D22%26spage%3D285%26epage%3D294%26doi%3D10.1096%2Ffj.06-7957com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ofek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karsak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar-Namdar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shohami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bab, I.</span></span> <span> </span><span class="NLM_article-title">Peripheral cannabinoid receptor, CB2, regulates bone mass</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">696</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1073/pnas.0504187103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1073%2Fpnas.0504187103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=16407142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=696-701&author=O.+Ofekauthor=M.+Karsakauthor=N.+Leclercauthor=M.+Fogelauthor=B.+Frenkelauthor=K.+Wrightauthor=J.+Tamauthor=M.+Attar-Namdarauthor=V.+Kramauthor=E.+Shohamiauthor=R.+Mechoulamauthor=A.+Zimmerauthor=I.+Bab&title=Peripheral+cannabinoid+receptor%2C+CB2%2C+regulates+bone+mass&doi=10.1073%2Fpnas.0504187103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral cannabinoid receptor, CB2, regulates bone mass</span></div><div class="casAuthors">Ofek, Orr; Karsak, Meliha; Leclerc, Nathalie; Fogel, Meirav; Frenkel, Baruch; Wright, Karen; Tam, Joseph; Attar-Namdar, Malka; Kram, Vardit; Shohami, Esther; Mechoulam, Raphael; Zimmer, Andreas; Bab, Itai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">696-701</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The endogenous cannabinoids bind to and activate two G protein-coupled receptors, the predominantly central cannabinoid receptor type 1 (CB1) and peripheral cannabinoid receptor type 2 (CB2).  Whereas CB1 mediates the cannabinoid psychotropic, analgesic, and orectic effects, CB2 has been implicated recently in the regulation of liver fibrosis and atherosclerosis.  Here we show that CB2-deficient mice have a markedly accelerated age-related trabecular bone loss and cortical expansion, although cortical thickness remains unaltered.  These changes are reminiscent of human osteoporosis and may result from differential regulation of trabecular and cortical bone remodeling.  The CB2-/- phenotype is also characterized by increased activity of trabecular osteoblasts (bone-forming cells), increased osteoclast (the bone-resorbing cell) no., and a markedly decreased no. of diaphyseal osteoblast precursors.  CB2 is expressed in osteoblasts, osteocytes, and osteoclasts.  A CB2-specific agonist that does not have any psychotropic effects enhances endocortical osteoblast no. and activity and restrains trabecular osteoclastogenesis, apparently by inhibiting proliferation of osteoclast precursors and receptor activator of NF-κB ligand expression in bone marrow-derived osteoblasts/stromal cells.  The same agonist attenuates ovariectomy-induced bone loss and markedly stimulates cortical thickness through the resp. suppression of osteoclast no. and stimulation of endocortical bone formation.  These results demonstrate that the endocannabinoid system is essential for the maintenance of normal bone mass by osteoblastic and osteoclastic CB2 signaling.  Hence, CB2 offers a mol. target for the diagnosis and treatment of osteoporosis, the most prevalent degenerative disease in developed countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUeW3SSIrXSbVg90H21EOLACvtfcHk0lhaLAJXUzHL_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhsr4%253D&md5=222e7dfb53af21baf8c0bc4d7bb71eac</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0504187103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0504187103%26sid%3Dliteratum%253Aachs%26aulast%3DOfek%26aufirst%3DO.%26aulast%3DKarsak%26aufirst%3DM.%26aulast%3DLeclerc%26aufirst%3DN.%26aulast%3DFogel%26aufirst%3DM.%26aulast%3DFrenkel%26aufirst%3DB.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DAttar-Namdar%26aufirst%3DM.%26aulast%3DKram%26aufirst%3DV.%26aulast%3DShohami%26aufirst%3DE.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DBab%26aufirst%3DI.%26atitle%3DPeripheral%2520cannabinoid%2520receptor%252C%2520CB2%252C%2520regulates%2520bone%2520mass%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D696%26epage%3D701%26doi%3D10.1073%2Fpnas.0504187103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maor, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bab, I.</span></span> <span> </span><span class="NLM_article-title">CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1335</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1111/nyas.12642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1111%2Fnyas.12642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=25573322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps1OqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1335&publication_year=2015&pages=110-119&author=E.+Wassermanauthor=J.+Tamauthor=R.+Mechoulamauthor=A.+Zimmerauthor=G.+Maorauthor=I.+Bab&title=CB1+cannabinoid+receptors+mediate+endochondral+skeletal+growth+attenuation+by+%CE%949-tetrahydrocannabinol&doi=10.1111%2Fnyas.12642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol</span></div><div class="casAuthors">Wasserman, Elad; Tam, Joseph; Mechoulam, Raphael; Zimmer, Andreas; Maor, Gila; Bab, Itai</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1335</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-119</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The endocannabinoid (EC) system regulates bone mass.  Because cannabis use during pregnancy results in stature shorter than normal, we examd. the role of the EC system in skeletal elongation.  We show that CB1 and CB2 cannabinoid receptors are expressed specifically in hypertrophic chondrocytes of the epiphyseal growth cartilage (EGC), which drives vertebrate growth.  These cells also express diacylglycerol lipases, crit. biosynthetic enzymes of the main EC, and 2-arachidonoylglycerol (2-AG), which is present at significant levels in the EGC.  Femora of CB1-and/or CB2-deficient mice at the end of the rapid growth phase are longer compared to wild-type (WT) animals.  We find that Δ9-tetrahydrocannabinol (THC) slows skeletal elongation of female WT and CB2-, but not CB1-, deficient mice, which is reflected in femoral and lumbar vertebral body length.  This in turn results in lower body wt., but unaltered fat content.  THC inhibits EGC chondrocyte hypertrophy in ex vivo cultures and reduces the hypertrophic cell zone thickness of CB1-, but not CB2-, deficient mice.  These results demonstrate a local growth-restraining EC system in the EGC.  The relevance of the present findings to humans remains to be studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkQb7W1XsY1rVg90H21EOLACvtfcHk0limpjo_-zedTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps1OqsLk%253D&md5=8570b41e99a15f3b96974018505223ca</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fnyas.12642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.12642%26sid%3Dliteratum%253Aachs%26aulast%3DWasserman%26aufirst%3DE.%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DMaor%26aufirst%3DG.%26aulast%3DBab%26aufirst%3DI.%26atitle%3DCB1%2520cannabinoid%2520receptors%2520mediate%2520endochondral%2520skeletal%2520growth%2520attenuation%2520by%2520%25CE%25949-tetrahydrocannabinol%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2015%26volume%3D1335%26spage%3D110%26epage%3D119%26doi%3D10.1111%2Fnyas.12642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S. M.</span></span> <span> </span><span class="NLM_article-title">The endocannabinoid system and its therapeutic implications in rheumatoid arthritis</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2015.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.intimp.2015.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=25791728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksF2ms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=86-91&author=H.+Guiauthor=Q.+Tongauthor=W.+Quauthor=C.+M.+Maoauthor=S.+M.+Dai&title=The+endocannabinoid+system+and+its+therapeutic+implications+in+rheumatoid+arthritis&doi=10.1016%2Fj.intimp.2015.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system and its therapeutic implications in rheumatoid arthritis</span></div><div class="casAuthors">Gui, Huan; Tong, Qiang; Qu, Wenchun; Mao, Chen-Mei; Dai, Sheng-Ming</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-91</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Since the discovery of the endogenous receptor for Δ9-tetrahydrocannabinol, a main constituent of marijuana, the endocannabinoid system (comprising cannabinoid receptors and their endogenous ligands, as well as the enzymes involved in their metabolic processes) has been implicated as having multiple regulatory functions in many central and peripheral conditions, including rheumatoid arthritis (RA).  RA is an immune-mediated inflammatory disease that is assocd. with the involvement of many kinds of cells (such as fibroblastlike synoviocytes [FLSs], osteoclasts, T cells, B cells, and macrophages) and mols. (such as interleukin-1β, tumor necrosis factor-α, interleukin-6, matrix metalloproteinases [MMPs], and chemokines).  Increasing evidence suggests that the endocannabinoid system, esp. cannabinoid receptor 2 (CB2), has an important role in the pathophysiol. of RA.  Many members of the endocannabinoid system are reported to inhibit synovial inflammation, hyperplasia, and cartilage destruction in RA.  In particular, specific activation of CB2 may relieve RA by inhibiting not only the prodn. of autoantibodies, proinflammatory cytokines, and MMPs, but also bone erosion, immune response mediated by T cells, and the proliferation of FLSs.  In this review, we will discuss the possible functions of the endocannabinoid system in the modulation of RA, which may be a potential target for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmJMSR5f15V7Vg90H21EOLACvtfcHk0limpjo_-zedTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksF2ms7w%253D&md5=281afe1ba88b1c4e6b838c978df79f05</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2015.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2015.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DGui%26aufirst%3DH.%26aulast%3DTong%26aufirst%3DQ.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DMao%26aufirst%3DC.%2BM.%26aulast%3DDai%26aufirst%3DS.%2BM.%26atitle%3DThe%2520endocannabinoid%2520system%2520and%2520its%2520therapeutic%2520implications%2520in%2520rheumatoid%2520arthritis%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2015%26volume%3D26%26spage%3D86%26epage%3D91%26doi%3D10.1016%2Fj.intimp.2015.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoresen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidarov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardern, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semple, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grottick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Shamma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of APD371: Identification of a highly potent and selective CB<sub>2</sub> agonist for the treatment of chronic pain</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1309</span>– <span class="NLM_lpage">1313</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00396</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00396" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2mtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1309-1313&author=S.+Hanauthor=L.+Thoresenauthor=J.-K.+Jungauthor=X.+Zhuauthor=J.+Thatteauthor=M.+Solomonauthor=I.+Gaidarovauthor=D.+J.+Unettauthor=W.+H.+Yoonauthor=J.+Bardernauthor=A.+Sadequeauthor=A.+Usmaniauthor=C.+Chenauthor=G.+Sempleauthor=A.+J.+Grottickauthor=H.+Al-Shammaauthor=R.+Christopherauthor=R.+M.+Jones&title=Discovery+of+APD371%3A+Identification+of+a+highly+potent+and+selective+CB2+agonist+for+the+treatment+of+chronic+pain&doi=10.1021%2Facsmedchemlett.7b00396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of APD371: Identification of a Highly Potent and Selective CB2 Agonist for the Treatment of Chronic Pain</span></div><div class="casAuthors">Han, Sangdon; Thoresen, Lars; Jung, Jae-Kyu; Zhu, Xiuwen; Thatte, Jayant; Solomon, Michelle; Gaidarov, Ibragim; Unett, David J.; Yoon, Woo Hyun; Barden, Jeremy; Sadeque, Abu; Usmani, Amin; Chen, Chuan; Semple, Graeme; Grottick, Andrew J.; Al-Shamma, Hussein; Christopher, Ronald; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1309-1313</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of a novel, selective and fully efficacious CB2 agonist with satisfactory pharmacokinetic and pharmaceutical properties is described.  Compd. 6 was efficacious in a rat model of osteoarthritis pain following oral administration and, in contrast to morphine, maintained its analgesic effect throughout a 5-day subchronic treatment paradigm.  These data were consistent with our hypothesis that full agonist efficacy is required for efficient internalization and recycling of the CB2 receptor to avoid tachyphylaxis.  Based on its overall favorable preclin. profile, 6 (APD371) was selected for further development for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUco8f2j4V2LVg90H21EOLACvtfcHk0limpjo_-zedTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2mtL%252FK&md5=895f4ee02bc112e5d1a4ea6f79d9fb02</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00396%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DJ.-K.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DYoon%26aufirst%3DW.%2BH.%26aulast%3DBardern%26aufirst%3DJ.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DUsmani%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DChristopher%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520APD371%253A%2520Identification%2520of%2520a%2520highly%2520potent%2520and%2520selective%2520CB2%2520agonist%2520for%2520the%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1309%26epage%3D1313%26doi%3D10.1021%2Facsmedchemlett.7b00396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Aghazadeh Tabrizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB<sub>2</sub> receptor agonists</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=519-560&author=M.+Aghazadeh+Tabriziauthor=P.+G.+Baraldiauthor=P.+A.+Boreaauthor=K.+Varani&title=Medicinal+chemistry%2C+pharmacology%2C+and+potential+therapeutic+benefits+of+cannabinoid+CB2+receptor+agonists&doi=10.1021%2Facs.chemrev.5b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists</span></div><div class="casAuthors">Aghazadeh Tabrizi, Mojgan; Baraldi, Pier Giovanni; Borea, Pier Andrea; Varani, Katia</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">519-560</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The purpose of this review is to analyze the mol. characterization, distribution and signal transduction pathways of CB2 receptors together with their pharmacol. role in some of the most relevant biol. systems.  The structure-activity relationships of several interesting CB2 agonists, including synthetic schemes to clarify the chem. involved in this field, are reported.  Moreover, the corresponding pharmacol. and beneficial potentials of selected CB2 compds. have been focused as well as the patent literature and the identification of promising therapeutic candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7xG1QvGzO97Vg90H21EOLACvtfcHk0ljRc9A0fzhJ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGmsr8%253D&md5=261a0d3c6eec03978630759378834d6c</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00411%26sid%3Dliteratum%253Aachs%26aulast%3DAghazadeh%2BTabrizi%26aufirst%3DM.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26atitle%3DMedicinal%2520chemistry%252C%2520pharmacology%252C%2520and%2520potential%2520therapeutic%2520benefits%2520of%2520cannabinoid%2520CB2%2520receptor%2520agonists%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D519%26epage%3D560%26doi%3D10.1021%2Facs.chemrev.5b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span> <span> </span><span class="NLM_article-title">Therapeutic utility of cannabinoid receptor type 2 (CB<sub>2</sub>) selective agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8224</span>– <span class="NLM_lpage">8256</span>, <span class="refDoi"> DOI: 10.1021/jm4005626</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005626" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFeru7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8224-8256&author=S.+Hanauthor=J.+Thatteauthor=D.+J.+Buzardauthor=R.+M.+Jones&title=Therapeutic+utility+of+cannabinoid+receptor+type+2+%28CB2%29+selective+agonists&doi=10.1021%2Fjm4005626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists</span></div><div class="casAuthors">Han, Sangdon; Thatte, Jayant; Buzard, Daniel J.; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8224-8256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The cannabinoid receptor type 2 (CB2) is a class A GPCR that was cloned in 1993 while looking for an alternative receptor that could explain the pharmacol. properties of Δ9-tetrahydrocannabinol.  CB2 was identified among cDNAs based on its similarity in amino acid sequence to the CB1 receptor and helped provide an explanation for the established effects of cannabinoids on the immune system.  In addn. to the immune system, CB2 has widespread tissue expression and has been found in brain, peripheral nervous system, and gastrointestinal tract.  Several "mixed" cannabinoid agonists are currently in clin. use primarily for controlling pain, and it is believed that selective CB2 agonism may afford a superior analgesic agent devoid of the centrally mediated CB1 effects.  Thus, selective CB2 receptor agonists represent high value putative therapeutics for treating pain and other disease states.  In this Perspective, we seek to provide a concise update of progress in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqncpGbOhjA5bVg90H21EOLACvtfcHk0ljRc9A0fzhJ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFeru7bO&md5=bb532e5c81b475aa04a3311a017c82f1</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm4005626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005626%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DTherapeutic%2520utility%2520of%2520cannabinoid%2520receptor%2520type%25202%2520%2528CB2%2529%2520selective%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8224%26epage%3D8256%26doi%3D10.1021%2Fjm4005626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semeraro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5075</span>– <span class="NLM_lpage">5084</span>, <span class="refDoi"> DOI: 10.1021/jm800552f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800552f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptl2htro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5075-5084&author=S.+Pasquiniauthor=L.+Bottaauthor=T.+Semeraroauthor=C.+Mugnainiauthor=A.+Ligrestiauthor=E.+Palazzoauthor=S.+Maioneauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+2.+Synthesis+and+structure-activity+relationship+of+potent+and+selective+cannabinoid-2+receptor+agonists+endowed+with+analgesic+activity+in+vivo&doi=10.1021%2Fjm800552f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-quinolone-3-carboxylic acid motif. 2. synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo</span></div><div class="casAuthors">Pasquini, Serena; Botta, Lorenzo; Semeraro, Teresa; Mugnaini, Claudia; Ligresti, Alessia; Palazzo, Enza; Maione, Sabatino; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5075-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinolone-3-carboxamides bearing at position 5, 6, 7, or 8 diverse substituents such as halides, alkyl, aryl, alkoxy, and aryloxy groups differing in their steric/electronic properties, were prepd.  The new compds. were tested in vitro for CB1 and CB2 receptor affinity in comparison with the ref. compds. rimonabant and SR144528.  The tested compds. exhibited CB2 affinity in the range from 55.9 to 0.8 nM and CB1 affinity in the range from >10 000 to 5.3 nM, with selectivity indeces [Ki(CB1)/Ki(CB2)] varying from >2666.6 to 1.23.  On the basis of the structure-selectivity relationship developed, the presence of a substituent at C6/C8 or C7 well accounts for the high or low CB2 selectivity, resp.  Compd. I, characterized by high CB2 affinity and selectivity, showed analgesic activity in the formalin test of acute peripheral and inflammatory pain in mice as a result of selective CB2 agonistic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-nHfcuH__drVg90H21EOLACvtfcHk0ljRc9A0fzhJ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptl2htro%253D&md5=5c461877098aec3a53c31676ced30c98</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm800552f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800552f%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DBotta%26aufirst%3DL.%26aulast%3DSemeraro%26aufirst%3DT.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DPalazzo%26aufirst%3DE.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25202.%2520Synthesis%2520and%2520structure-activity%2520relationship%2520of%2520potent%2520and%2520selective%2520cannabinoid-2%2520receptor%2520agonists%2520endowed%2520with%2520analgesic%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5075%26epage%3D5084%26doi%3D10.1021%2Fjm800552f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semeraro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicione, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Chiaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5915</span>– <span class="NLM_lpage">5928</span>, <span class="refDoi"> DOI: 10.1021/jm100123x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100123x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5915-5928&author=S.+Pasquiniauthor=A.+Ligrestiauthor=C.+Mugnainiauthor=T.+Semeraroauthor=L.+Cicioneauthor=M.+De+Rosaauthor=F.+Guidaauthor=L.+Luongoauthor=M.+De+Chiaroauthor=M.+G.+Cascioauthor=D.+Bologniniauthor=P.+Mariniauthor=R.+Pertweeauthor=S.+Maioneauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+3.+Synthesis%2C+structure-affinity+relationships%2C+and+pharmacological+characterization+of+6-substituted+4-quinolone-3-carboxamides+as+highly+selective+cannabinoid-2+receptor+ligands&doi=10.1021%2Fjm100123x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 3. Synthesis, Structure-Affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-Quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands</span></div><div class="casAuthors">Pasquini, Serena; Ligresti, Alessia; Mugnaini, Claudia; Semeraro, Teresa; Cicione, Lavinia; De Rosa, Maria; Guida, Francesca; Luongo, Livio; De Chiaro, Maria; Cascio, Maria Grazia; Bolognini, Daniele; Marini, Pietro; Pertwee, Roger; Maione, Sabatino; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5915-5928</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of quinolone-3-carboxamides I [R1 = (un)substituted Ph, 2-furyl, 1-cyclohexenyl, 1-isobutylpyrazol-4-yl, etc.; R2 = 1-adamantyl, 1-fenchyl, hexyl, 1-piperidinyl; R3 = pentyl, 1-buten-4-yl, allyl] bearing diverse substituents at position 1, 3, and 6 of the bicyclic nucleus was prepd.  Except for six compds. exhibiting Ki > 100 nM, all the quinolone-3-carboxamides I proved to be high affinity CB2 ligands, with Ki values ranging from 73.2 to 0.7 nM and selectivity [SI = Ki(CB1)/Ki(CB2)] varying from >14285 to 1.9, with only one compd. exhibiting a reverse selectivity (SI < 1).  In the formalin test of peripheral acute and inflammatory pain in mice, I [R1 = CH2CH2Ph, R2 = 1-adamantyl, R3 = pentyl] showed analgesic activity that was antagonized by a selective CB2 antagonist.  By contrast, I [R1 = 2-furyl, R2 = 1-adamantyl, R3 = pentyl] was inactive per se and antagonized the effect of a selective CB2 agonist.  Also, two of these compds. exhibited CB2 inverse agonist-like behavior in this in vivo test.  However, two different functional assays carried out in vitro indicated for both compds. an overall inverse agonist activity at CB2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWqQVRHQABn7Vg90H21EOLACvtfcHk0liymY4e0szQUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCht78%253D&md5=642a103b93312fd2f1e124173143b656</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fjm100123x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100123x%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DSemeraro%26aufirst%3DT.%26aulast%3DCicione%26aufirst%3DL.%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DDe%2BChiaro%26aufirst%3DM.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DMarini%26aufirst%3DP.%26aulast%3DPertwee%26aufirst%3DR.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25203.%2520Synthesis%252C%2520structure-affinity%2520relationships%252C%2520and%2520pharmacological%2520characterization%2520of%25206-substituted%25204-quinolone-3-carboxamides%2520as%2520highly%2520selective%2520cannabinoid-2%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5915%26epage%3D5928%26doi%3D10.1021%2Fjm100123x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Chiaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and anti-hyperalgesic effects in mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5444</span>– <span class="NLM_lpage">5453</span>, <span class="refDoi"> DOI: 10.1021/jm200476p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200476p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFCgtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5444-5453&author=S.+Pasquiniauthor=M.+De+Rosaauthor=V.+Pedaniauthor=C.+Mugnainiauthor=F.+Guidaauthor=L.+Luongoauthor=M.+De+Chiaroauthor=S.+Maioneauthor=S.+Dragoniauthor=M.+Frosiniauthor=A.+Ligrestiauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+4.+Identification+of+new+potent+and+selective+ligands+for+the+cannabinoid+type+2+receptor+with+diverse+substitution+patterns+and+anti-hyperalgesic+effects+in+mice&doi=10.1021%2Fjm200476p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 4. Identification of New Potent and Selective Ligands for the Cannabinoid Type 2 Receptor with Diverse Substitution Patterns and Antihyperalgesic Effects in Mice</span></div><div class="casAuthors">Pasquini, Serena; De Rosa, Maria; Pedani, Valentina; Mugnaini, Claudia; Guida, Francesca; Luongo, Livio; De Chiaro, Maria; Maione, Sabatino; Dragoni, Stefania; Frosini, Maria; Ligresti, Alessia; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5444-5453</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Exptl. evidence suggests that selective CB2 receptor modulators may provide access to antihyperalgesic agents devoid of psychotropic effects.  Taking advantage of previous findings on structure-activity/selectivity relationships for a class of 4-quinolone-3-carboxamides, further structural modifications of the heterocyclic scaffold were explored, leading to the discovery of the 8-methoxy deriv. 4a endowed with the highest affinity and selectivity ever reported for a CB2 ligand.  The compd., evaluated in vivo in the formalin test, behaved as an inverse agonist by reducing at a dose of 6 mg/kg the second phase of the formalin-induced nocifensive response in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogKusJC-_IlLVg90H21EOLACvtfcHk0liymY4e0szQUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFCgtbo%253D&md5=4b9daccdccfddbbde2ef53fcca4a87bd</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1021%2Fjm200476p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200476p%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DPedani%26aufirst%3DV.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DDe%2BChiaro%26aufirst%3DM.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDragoni%26aufirst%3DS.%26aulast%3DFrosini%26aufirst%3DM.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25204.%2520Identification%2520of%2520new%2520potent%2520and%2520selective%2520ligands%2520for%2520the%2520cannabinoid%2520type%25202%2520receptor%2520with%2520diverse%2520substitution%2520patterns%2520and%2520anti-hyperalgesic%2520effects%2520in%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5444%26epage%3D5453%26doi%3D10.1021%2Fjm200476p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nocerino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tafi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Chiaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valoti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moaddel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 5. Modulation of the physicochemical profile of a set of potent and selective CB2 ligands through a bioisosteric approach</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1002%2Fcmdc.201100573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=22383251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFOhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=920-934&author=C.+Mugnainiauthor=S.+Nocerinoauthor=V.+Pedaniauthor=S.+Pasquiniauthor=A.+Tafiauthor=M.+De+Chiaroauthor=L.+Bellucciauthor=M.+Valotiauthor=F.+Guidaauthor=L.+Luongoauthor=S.+Dragoniauthor=A.+Ligrestiauthor=A.+Rosenbergauthor=D.+Bologniniauthor=M.+G.+Cascioauthor=R.+G.+Pertweeauthor=R.+Moaddelauthor=S.+Maioneauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+5.+Modulation+of+the+physicochemical+profile+of+a+set+of+potent+and+selective+CB2+ligands+through+a+bioisosteric+approach&doi=10.1002%2Fcmdc.201100573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21dR"><div class="casContent"><span class="casTitleNuber">21d</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-Quinolone-3-Carboxylic Acid Motif Part 5: Modulation of the Physicochemical Profile of a Set of Potent and Selective Cannabinoid-2 Receptor Ligands through a Bioisosteric Approach</span></div><div class="casAuthors">Mugnaini, Claudia; Nocerino, Stefania; Pedani, Valentina; Pasquini, Serena; Tafi, Andrea; De Chiaro, Maria; Bellucci, Luca; Valoti, Massimo; Guida, Francesca; Luongo, Livio; Dragoni, Stefania; Ligresti, Alessia; Rosenberg, Avraham; Bolognini, Daniele; Cascio, Maria Grazia; Pertwee, Roger G.; Moaddel, Ruin; Maione, Sabatino; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">920-934</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Three heterocyclic systems were selected as potential bioisosteres of the amide linker for a series of 1,6-disubstituted-4-quinolone-3-carboxamides, which are potent and selective CB2 ligands that exhibit poor water soly., with the aim of improving their physicochem. profile and also of clarifying properties of importance for amide bond mimicry.  Among the newly synthesized compds., a 1,2,3-triazole deriv. (1-(adamantan-1-yl)-4-[6-(furan-2-yl)-1,4-dihydro-4-oxo-1-pentylquinolin-3-yl]-1H-1,2,3-triazole) emerged as the most promising in terms of both physicochem. and pharmacodynamic properties.  When assayed in vitro, this deriv. exhibited inverse agonist activity, whereas, in the formalin test in mice, it produced analgesic effects antagonized by a well-established inverse agonist.  Metabolic studies allowed the identification of a side chain hydroxylated deriv. as its only metabolite, which, in its racemic form, still showed appreciable CB2 selectivity, but was 150-fold less potent than the parent compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-q6Lelcgsf7Vg90H21EOLACvtfcHk0liymY4e0szQUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFOhtbo%253D&md5=4ac67390a8af749cd21afd9ef894099f</span></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100573%26sid%3Dliteratum%253Aachs%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DNocerino%26aufirst%3DS.%26aulast%3DPedani%26aufirst%3DV.%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DTafi%26aufirst%3DA.%26aulast%3DDe%2BChiaro%26aufirst%3DM.%26aulast%3DBellucci%26aufirst%3DL.%26aulast%3DValoti%26aufirst%3DM.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DDragoni%26aufirst%3DS.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DRosenberg%26aufirst%3DA.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DMoaddel%26aufirst%3DR.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25205.%2520Modulation%2520of%2520the%2520physicochemical%2520profile%2520of%2520a%2520set%2520of%2520potent%2520and%2520selective%2520CB2%2520ligands%2520through%2520a%2520bioisosteric%2520approach%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D920%26epage%3D934%26doi%3D10.1002%2Fcmdc.201100573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caradonna, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted 4-quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.09.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.ejmech.2012.09.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=23085772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslOktb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=30-43&author=S.+Pasquiniauthor=M.+De+Rosaauthor=A.+Ligrestiauthor=C.+Mugnainiauthor=A.+Brizziauthor=N.+P.+Caradonnaauthor=M.+G.+Cascioauthor=D.+Bologniniauthor=R.+G.+Pertweeauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+6.+Synthesis+and+pharmacological+evaluation+of+7-substituted+4-quinolone-3-carboxamide+derivatives+as+high+affinity+ligands+for+cannabinoid+receptors&doi=10.1016%2Fj.ejmech.2012.09.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21eR"><div class="casContent"><span class="casTitleNuber">21e</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors</span></div><div class="casAuthors">Pasquini, Serena; De Rosa, Maria; Ligresti, Alessia; Mugnaini, Claudia; Brizzi, Antonella; Caradonna, Nicola P.; Cascio, Maria Grazia; Bolognini, Daniele; Pertwee, Roger G.; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30-43</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Within the authors' studies on structure-activity relationships of 4-quinolone-3-carboxamides as cannabinoid ligands, a new series of compds. characterized by a fluoro or phenylthio group at the 7-position and different substituents at N1 and the carboxamide nitrogen were synthesized and evaluated for their binding ability to cannabinoid type 1 (CB1) and type 2 (CB2) receptors.  Most of the compds. showed affinity for one or both cannabinoid receptors at nanomolar concn., with Ki(CB1) and Ki(CB2) values ranging from 2.45 to >10,000 nM and from 0.09 to 957 nM, resp.  The N-(3,4-dichlorobenzyl)amide derivs. I (R = Ph, PhS) displayed relatively low affinity, but high selectivity towards the CB1 receptor.  Compds. II and I (R = PhS), a CB2 and a CB1 ligand, resp., behaved as partial agonists in the [35S]GTPγS assay.  They showed very low permeability through (MDCK-MDR1) cells and might, therefore, represent possible lead structures for further optimization in the search for cannabinoid ligands unable to cross the blood-brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof4hRj9XhonrVg90H21EOLACvtfcHk0lhj6tA_WugwEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslOktb%252FM&md5=95ba92dca8488f8639aa8814d9ca4ea5</span></div><a href="/servlet/linkout?suffix=cit21e&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.09.035%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DBrizzi%26aufirst%3DA.%26aulast%3DCaradonna%26aufirst%3DN.%2BP.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25206.%2520Synthesis%2520and%2520pharmacological%2520evaluation%2520of%25207-substituted%25204-quinolone-3-carboxamide%2520derivatives%2520as%2520high%2520affinity%2520ligands%2520for%2520cannabinoid%2520receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D58%26spage%3D30%26epage%3D43%26doi%3D10.1016%2Fj.ejmech.2012.09.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Annunziata, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis</span>. <i>J. Neuroimmunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.jneuroim.2016.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.jneuroim.2016.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=28041663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1ejsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2017&pages=66-74&author=P.+Annunziataauthor=C.+Cioniauthor=C.+Mugnainiauthor=F.+Corelli&title=Potent+immunomodulatory+activity+of+a+highly+selective+cannabinoid+CB2+agonist+on+immune+cells+from+healthy+subjects+and+patients+with+multiple+sclerosis&doi=10.1016%2Fj.jneuroim.2016.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis</span></div><div class="casAuthors">Annunziata, Pasquale; Cioni, Chiara; Mugnaini, Claudia; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66-74</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">COR167, a novel CB2-selective high affinity agonist, was found to significantly inhibit, in a dose-dependent manner, the proliferation of both peripheral blood mononuclear cells and myelin basic protein-reactive T cell lines from normal healthy subjects and patients with relapsing-remitting multiple sclerosis (MS).  In MS, a significantly higher inhibition was obsd. in patients on treatment with disease modifying drugs compared to those naive to treatment.  The inhibitory activity of COR167 was exerted through a mixed mechanism involving atypical and incomplete shift of Th1 phenotype towards Th2 phenotype assocd. with slight redn. of IL-4 and IL-5 as well as strongly reduced levels of Th17-related cytokines.  COR167 was also able to reduce in vitro migration of stimulated immunocompetent cells through human brain endothelium assocd. with a significant redn. of levels of several chemokines.  These findings demonstrate that COR167 exerts potent immunomodulatory effects and confirm the cannabinoid CB2 receptor as a novel pharmacol. target to counteract neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorLYAjNuLf3LVg90H21EOLACvtfcHk0lhj6tA_WugwEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1ejsQ%253D%253D&md5=566c2002ead6c123648362bdb9c17dda</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2016.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2016.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DAnnunziata%26aufirst%3DP.%26aulast%3DCioni%26aufirst%3DC.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DPotent%2520immunomodulatory%2520activity%2520of%2520a%2520highly%2520selective%2520cannabinoid%2520CB2%2520agonist%2520on%2520immune%2520cells%2520from%2520healthy%2520subjects%2520and%2520patients%2520with%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2017%26volume%3D303%26spage%3D66%26epage%3D74%26doi%3D10.1016%2Fj.jneuroim.2016.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Contartese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valoti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgaragli, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frosini, M.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">A novel substituted 4-quinolone-3-carboxylic acid derivative CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2012.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.phrs.2012.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=23036353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmt7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=555-563&author=A.+Contarteseauthor=M.+Valotiauthor=F.+Corelliauthor=S.+Pasquiniauthor=C.+Mugnainiauthor=G.+P.+Sgaragliauthor=M.+Frosini&title=A+novel+substituted+4-quinolone-3-carboxylic+acid+derivative+CB2+agonist%2C+COR167%2C+potently+protects+rat+brain+cortical+slices+against+OGD+and+reperfusion+injury&doi=10.1016%2Fj.phrs.2012.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury</span></div><div class="casAuthors">Contartese, Antonella; Valoti, Massimo; Corelli, Federico; Pasquini, Serena; Mugnaini, Claudia; Pessina, Federica; Aldinucci, Carlo; Sgaragli, Giampietro; Frosini, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">555-563</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cannabinoid CB2 receptor activation has been shown to have many pharmacol. but not psychotropic effects.  The aim of this study was to investigate the potential protection of brain tissues afforded by the novel substituted 4-quinolone-3-carboxylic acid deriv. COR167, a selective CB2 agonist, toward ischemia and reperfusion-induced injury, as well as the mechanism of this potential effect.  Rat brain cortical slices subjected to oxygen and glucose deprivation (OGD) followed by re-oxygenation were used.  Cell damage was quantified by measuring at the end of the reperfusion phase the release into the artificial cerebrospinal fluid (ACSF) of lactate dehydrogenase (LDH), glutamate, IL-6 and TNF-α and by evaluating in tissue the lipid-peroxides (thiobarbituric acid-reactive substances, TBARS), the free, reduced glutathione content (GSH) and the water gain (TWG), taken as an index of cell swelling.  COR167 (10 nM or 100 nM), added to ACSF during the entire reperfusion phase, markedly reduced LDH and glutamate release, as well as TWG.  Lower (0.1-1 nM) or higher concns. (1000 nM) were ineffective, suggesting thereby an hormetic behavior.  COR167 at 10 nM concn. markedly reverted in tissues TBARS increase and GSH decrease, while reducing IL-6 and TNF-α release into ACSF.  COR167 effects on glutamate and LDH release were abrogated by the selective CB2 inverse-agonists COR170 (1 nM) and AM630 (1 μM) but not by the CB1 antagonist AM251 (1 μM).  COR170 as well as AM630 per se were able to revert TWG.  The CB2 receptor agonist COR167 potently protected rat brain cortical slices against OGD and reperfusion injury, partly through CB2 receptors activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoykTySTEplTbVg90H21EOLACvtfcHk0lhj6tA_WugwEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmt7fO&md5=1f633d2cf582ccadb99617db3fc49491</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2012.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2012.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DContartese%26aufirst%3DA.%26aulast%3DValoti%26aufirst%3DM.%26aulast%3DCorelli%26aufirst%3DF.%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DSgaragli%26aufirst%3DG.%2BP.%26aulast%3DFrosini%26aufirst%3DM.%26atitle%3DA%2520novel%2520substituted%25204-quinolone-3-carboxylic%2520acid%2520derivative%2520CB2%2520agonist%252C%2520COR167%252C%2520potently%2520protects%2520rat%2520brain%2520cortical%2520slices%2520against%2520OGD%2520and%2520reperfusion%2520injury%26jtitle%3DPharmacol.%2520Res.%26date%3D2012%26volume%3D66%26spage%3D555%26epage%3D563%26doi%3D10.1016%2Fj.phrs.2012.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB2 receptor inverse agonists</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2009.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.phrs.2009.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=19961936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1WjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2010&pages=349-354&author=M.+G.+Cascioauthor=D.+Bologniniauthor=R.+G.+Pertweeauthor=E.+Palazzoauthor=F.+Corelliauthor=S.+Pasquiniauthor=V.+Di+Marzoauthor=S.+Maione&title=In+vitro+and+in+vivo+pharmacological+characterization+of+two+novel+selective+cannabinoid+CB2+receptor+inverse+agonists&doi=10.1016%2Fj.phrs.2009.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB2 receptor inverse agonists</span></div><div class="casAuthors">Cascio, Maria Grazia; Bolognini, Daniele; Pertwee, Roger G.; Palazzo, Enza; Corelli, Federico; Pasquini, Serena; Di Marzo, Vincenzo; Maione, Sabatino</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-354</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We have previously developed quinolone-3-carboxamides with the aim of obtaining new ligands for both cannabinoid receptors, CB1 and CB2.  Our preliminary screening led to the identification of cannabinoid receptor ligands characterized by high affinity and, in some cases, also selectivity for CB2 receptors.  Specifically, three compds., 1, 2 and 3 showed high affinity for CB2 as well as high selectivity over CB1 receptors.  In addn., the activity shown by 1 against the formalin-induced nocifensive response in mice, reported in our previous paper, suggests that quinolone-3-carboxamides possess anti-nociceptive properties.  In the present work, we have performed functional in vitro bioassays with the aim of investigating the functional activity in the [35S]GTPγS binding assay of the other two compds. that, like 1, behave as CB2 selective ligands, and their potential analgesic actions in vivo.  We found that both 2 and 3 behave in vitro as CB2 inverse agonists and are able to decrease nociceptive behavior in the late phase of the formalin test only at the highest dose tested, although, at lower doses, they prevent the anti-nociceptive effects of a selective CB2 partial agonist in the formalin test.  These results identify in 2 and 3 two novel, potent and selective CB2 antagonists/inverse agonists and confirm previous reports in the literature that, in addn. to agonists at cannabinoid CB2 receptors, also inverse agonists/antagonists at these receptors show promise as anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE1cflt4iYUbVg90H21EOLACvtfcHk0lhzin4RjZ7Tew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1WjtLk%253D&md5=3af6a0824391d13ddd70f5f0099dcafd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2009.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2009.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DPalazzo%26aufirst%3DE.%26aulast%3DCorelli%26aufirst%3DF.%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DMaione%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520characterization%2520of%2520two%2520novel%2520selective%2520cannabinoid%2520CB2%2520receptor%2520inverse%2520agonists%26jtitle%3DPharmacol.%2520Res.%26date%3D2010%26volume%3D61%26spage%3D349%26epage%3D354%26doi%3D10.1016%2Fj.phrs.2009.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allarà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamponi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacondio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 7. Synthesis and pharmacological evaluation of 4-quinolone-3-carboxamides and 4-hydroxy-2-quinolone-3-carboxamides as high affinity cannabinoid receptor 2 (CB2R) ligands with improved aqueous solubility</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1052</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01559</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01559" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1052-1067&author=C.+Mugnainiauthor=A.+Brizziauthor=A.+Ligrestiauthor=M.+Allar%C3%A0author=S.+Lamponiauthor=F.+Vacondioauthor=C.+Silvaauthor=M.+Morauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+7.+Synthesis+and+pharmacological+evaluation+of+4-quinolone-3-carboxamides+and+4-hydroxy-2-quinolone-3-carboxamides+as+high+affinity+cannabinoid+receptor+2+%28CB2R%29+ligands+with+improved+aqueous+solubility&doi=10.1021%2Facs.jmedchem.5b01559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility</span></div><div class="casAuthors">Mugnaini, Claudia; Brizzi, Antonella; Ligresti, Alessia; Allara, Marco; Lamponi, Stefania; Vacondio, Federica; Silva, Claudia; Mor, Marco; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1052-1067</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-Quinolone-3-carboxamide derivs. have long been recognized as potent and selective cannabinoid type-2 receptor (CB2R) ligands.  With the aim to improve their physicochem. properties, basically aq. soly., two different approaches were followed, entailing the substitution of the alkyl chain with a basic replacement or scaffold modification to 4-hydroxy-2-quinolone structure.  According to the first approach, compd. I (R = NMe2) was obtained, showing slightly reduced receptor affinity (Ki = 60 nM) compared to the lead compd. I (R = n-Pr, Ki = 0.8 nM) but greatly enhanced soly. (400-3400 times depending on the pH of the medium).  On the other hand, shifting from 4-quinolone to 4-hydroxy-2-quinolone structure enabled the discovery of a novel class of CB2R ligands, such as II (R1 = 6-i-Pr, and 7-F), characterized by Ki < 1 nM and selectivity index [SI = Ki(CB1R)/Ki(CB2R)] > 1300.  At pH 7.4, compd. II (R1 = 7-F) resulted by 100-fold more sol. than I (R = n-Pr).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovdgV_KOadz7Vg90H21EOLACvtfcHk0lhzin4RjZ7Tew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslemsA%253D%253D&md5=303474ea5e8d265bf033c75c89e4ee9c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01559%26sid%3Dliteratum%253Aachs%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DBrizzi%26aufirst%3DA.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DAllar%25C3%25A0%26aufirst%3DM.%26aulast%3DLamponi%26aufirst%3DS.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25207.%2520Synthesis%2520and%2520pharmacological%2520evaluation%2520of%25204-quinolone-3-carboxamides%2520and%25204-hydroxy-2-quinolone-3-carboxamides%2520as%2520high%2520affinity%2520cannabinoid%2520receptor%25202%2520%2528CB2R%2529%2520ligands%2520with%2520improved%2520aqueous%2520solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1052%26epage%3D1067%26doi%3D10.1021%2Facs.jmedchem.5b01559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fex, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fristedt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedlung, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritzson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pekarski, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runström, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuvesson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björk, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2075</span>– <span class="NLM_lpage">2088</span>, <span class="refDoi"> DOI: 10.1021/jm031044w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031044w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BD2c7mtlOhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2075-2088&author=S.+J%C3%B6nssonauthor=G.+Anderssonauthor=T.+Fexauthor=T.+Fristedtauthor=G.+Hedlungauthor=K.+Janssonauthor=L.+Abramoauthor=I.+Fritzsonauthor=O.+Pekarskiauthor=A.+Runstr%C3%B6mauthor=H.+Sandinauthor=I.+Thuvessonauthor=A.+Bj%C3%B6rk&title=Synthesis+and+biological+evaluation+of+new+1%2C2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides+for+treatment+of+autoimmune+disorders%3A+structure-activity+relationship&doi=10.1021%2Fjm031044w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship</span></div><div class="casAuthors">Jonsson Stig; Andersson Gunnar; Fex Tomas; Fristedt Tomas; Hedlund Gunnar; Jansson Karl; Abramo Lisbeth; Fritzson Ingela; Pekarski Olga; Runstrom Anna; Sandin Helena; Thuvesson Ingela; Bjork Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2075-88</span>
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Roquinimex-related 3-quinolinecarboxamide derivatives were prepared and evaluated for treatment of autoimmune disorders.  The compounds were tested in mice for their inhibitory effects on disease development in the acute experimental autoimmune encephalomyelitis model and selected compounds in the beagle dog for induction of proinflammatory reaction.  Structure-activity relationships are discussed.  Compound 8c, laquinimod, showed improved potency and superior toxicological profile compared to the lead compound roquinimex (1b, Linomide) and was selected for clinical studies (currently in phase II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlqdPtLGowsC6Ufuk_1xoTfW6udTcc2eaYdQ2TkSy8fLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7mtlOhug%253D%253D&md5=5da6e891da9365fec5343a65338a84fd</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm031044w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031044w%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DS.%26aulast%3DAndersson%26aufirst%3DG.%26aulast%3DFex%26aufirst%3DT.%26aulast%3DFristedt%26aufirst%3DT.%26aulast%3DHedlung%26aufirst%3DG.%26aulast%3DJansson%26aufirst%3DK.%26aulast%3DAbramo%26aufirst%3DL.%26aulast%3DFritzson%26aufirst%3DI.%26aulast%3DPekarski%26aufirst%3DO.%26aulast%3DRunstr%25C3%25B6m%26aufirst%3DA.%26aulast%3DSandin%26aufirst%3DH.%26aulast%3DThuvesson%26aufirst%3DI.%26aulast%3DBj%25C3%25B6rk%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%25201%252C2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides%2520for%2520treatment%2520of%2520autoimmune%2520disorders%253A%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2075%26epage%3D2088%26doi%3D10.1021%2Fjm031044w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fristedt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and reactivity of laquinimod, a quinoline-3-carboxamide: intramolecular transfer of the enol proton to a nitrogen atom as a plausible mechanism for ketene formation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1658</span>– <span class="NLM_lpage">1667</span>, <span class="refDoi"> DOI: 10.1021/jo052368q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo052368q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFCrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1658-1667&author=K.+Janssonauthor=T.+Fristedtauthor=A.+Olssonauthor=B.+Svenssonauthor=S.+J%C3%B6nsson&title=Synthesis+and+reactivity+of+laquinimod%2C+a+quinoline-3-carboxamide%3A+intramolecular+transfer+of+the+enol+proton+to+a+nitrogen+atom+as+a+plausible+mechanism+for+ketene+formation&doi=10.1021%2Fjo052368q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Reactivity of Laquinimod, a Quinoline-3-carboxamide: Intramolecular Transfer of the Enol Proton to a Nitrogen Atom as a Plausible Mechanism for Ketene Formation</span></div><div class="casAuthors">Jansson, Karl; Fristedt, Tomas; Olsson, Arne; Svensson, Bo; Joensson, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1658-1667</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-Chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinolinecarboxamide (laquinimod, 2) is an oral drug in clin. trials for the treatment of multiple sclerosis.  The final step in the synthesis of 2 is a high-yielding aminolysis reaction of ester 1 with N-ethylaniline.  An equil. exists between 1 and 2, and removal of formed methanol during the reaction is a prerequisite for obtaining high yields of 2 from 1.  The reactivity of 1 and 2 is explained by a mechanistic model that involves a transfer of the enol proton to the exocyclic carbonyl substituent with concomitant formation of ketene 3.  This proton transfer is esp. facilitated for 2 because the intramol. hydrogen bond to the carbonyl oxygen is weakened due to steric interactions.  Both 1 and 2 undergo solvolysis reactions that obey first-order reaction kinetics, further supporting the theory that these two mols. are able to decomp. unimolecularly into ketene 3.  The solvent-dependent spectroscopic features of 2 indicate that the mol. mainly resides in two conformations.  One conformation is favored in nonpolar solvents and is likely the result of intramol. hydrogen bonding.  The other conformation is favored in polar solvents and probably exhibits less intramol. hydrogen bonding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquE1LlpDtCn7Vg90H21EOLACvtfcHk0ljmDFRojRho0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFCrtQ%253D%253D&md5=e2394ca26e6a60bc403dbcd626e19174</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fjo052368q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052368q%26sid%3Dliteratum%253Aachs%26aulast%3DJansson%26aufirst%3DK.%26aulast%3DFristedt%26aufirst%3DT.%26aulast%3DOlsson%26aufirst%3DA.%26aulast%3DSvensson%26aufirst%3DB.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520reactivity%2520of%2520laquinimod%252C%2520a%2520quinoline-3-carboxamide%253A%2520intramolecular%2520transfer%2520of%2520the%2520enol%2520proton%2520to%2520a%2520nitrogen%2520atom%2520as%2520a%2520plausible%2520mechanism%2520for%2520ketene%2520formation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D1658%26epage%3D1667%26doi%3D10.1021%2Fjo052368q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aghazadeh
Tabrizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saponaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corciulo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological properties of new heteroarylpyridine/heteroarylpyrimidine derivatives as CB<sub>2</sub> cannabinoid receptor partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1098</span>– <span class="NLM_lpage">1112</span>, <span class="refDoi"> DOI: 10.1021/jm301527r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301527r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1098-1112&author=M.+Aghazadeh%0ATabriziauthor=P.+G.+Baraldiauthor=G.+Saponaroauthor=A.+R.+Moormanauthor=R.+Romagnoliauthor=D.+Pretiauthor=S.+Baraldiauthor=C.+Corciuloauthor=F.+Vincenziauthor=P.+A.+Boreaauthor=K.+Varani&title=Design%2C+synthesis%2C+and+pharmacological+properties+of+new+heteroarylpyridine%2Fheteroarylpyrimidine+derivatives+as+CB2+cannabinoid+receptor+partial+agonists&doi=10.1021%2Fjm301527r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists</span></div><div class="casAuthors">Aghazadeh Tabrizi, Mojgan; Baraldi, Pier Giovanni; Saponaro, Giulia; Moorman, Allan R.; Romagnoli, Romeo; Preti, Delia; Baraldi, Stefania; Corciulo, Carmen; Vincenzi, Fabrizio; Borea, Pier Andrea; Varani, Katia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1098-1112</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent developments indicate that CB2 receptor ligands have the potential to become therapeutically important.  To explore this potential, it is necessary to develop compds. with high affinity for the CB2 receptor.  Very recently, we have identified the oxazinoquinoline carboxamides as a novel class of CB2 receptor full agonists.  In this paper we describe the medicinal chem. of a new series of heteroaryl-4-oxopyridine/7-oxopyrimidine derivs.  Some of the reported compds. showed high affinity and potency at the CB2 receptor while showing only modest affinity for the centrally expressed CB1 cannabinoid receptor.  Moreover, we found that the functionality of these ligands is controlled by the nature of the heteroaryl function condensed with the pyridine ring.  In 3,5-cyclic adenosine monophosphate (cAMP) assays, the novel series show dose-dependent effects on the modulation of forskolin-induced cAMP prodn., revealing different behaviors as full agonists, partial agonists, and inverse agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIywppexKde7Vg90H21EOLACvtfcHk0ljmDFRojRho0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFaqtbs%253D&md5=9004698567573376ebc0ff17b3deed45</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301527r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301527r%26sid%3Dliteratum%253Aachs%26aulast%3DAghazadeh%2BTabrizi%26aufirst%3DM.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DCorciulo%26aufirst%3DC.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520properties%2520of%2520new%2520heteroarylpyridine%252Fheteroarylpyrimidine%2520derivatives%2520as%2520CB2%2520cannabinoid%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1098%26epage%3D1112%26doi%3D10.1021%2Fjm301527r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aghazadeh
Tabrizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saponaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggiero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintori, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuccinardi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of 7-oxopyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxamides as potent and selective CB<sub>2</sub> cannabinoid receptor inverse agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4482</span>– <span class="NLM_lpage">4496</span>, <span class="refDoi"> DOI: 10.1021/jm400182t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400182t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotV2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4482-4496&author=M.+Aghazadeh%0ATabriziauthor=P.+G.+Baraldiauthor=G.+Saponaroauthor=A.+R.+Moormanauthor=R.+Romagnoliauthor=D.+Pretiauthor=S.+Baraldiauthor=E.+Ruggieroauthor=C.+Tintoriauthor=T.+Tuccinardiauthor=F.+Vincenziauthor=P.+A.+Boreaauthor=K.+Varani&title=Discovery+of+7-oxopyrazolo%5B1%2C5-a%5Dpyrimidine-6-carboxamides+as+potent+and+selective+CB2+cannabinoid+receptor+inverse+agonists&doi=10.1021%2Fjm400182t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 7-Oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists</span></div><div class="casAuthors">Aghazadeh Tabrizi, Mojgan; Baraldi, Pier Giovanni; Saponaro, Giulia; Moorman, Allan R.; Romagnoli, Romeo; Preti, Delia; Baraldi, Stefania; Ruggiero, Emanuela; Tintori, Cristina; Tuccinardi, Tiziano; Vincenzi, Fabrizio; Borea, Pier Andrea; Varani, Katia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4482-4496</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors recently described the medicinal chem. of a new series of heteroaryl-4-oxopyridine/7-oxopyrimidines as CB2 receptor partial agonists, showing that the functionality of these ligands is controlled by the nature of the heteroaryl function condensed with the pyridine ring.  They describe herein the design and synthesis of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides, structural isomers of their previously reported pyrazolo[3,4-b]pyridines.  All of the new compds. showed high affinity and selectivity for the CB2 receptor in the nanomolar range.  In 3,5-cyclic adenosine monophosphate (cAMP) assays, the novel series shows stimulatory effects on forskolin-induced cAMP prodn. acting as inverse agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8lM89CdRSlbVg90H21EOLACvtfcHk0ljmDFRojRho0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotV2nt7w%253D&md5=255d07e5bf6f193e79dd916944698fdb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm400182t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400182t%26sid%3Dliteratum%253Aachs%26aulast%3DAghazadeh%2BTabrizi%26aufirst%3DM.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DRuggiero%26aufirst%3DE.%26aulast%3DTintori%26aufirst%3DC.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26atitle%3DDiscovery%2520of%25207-oxopyrazolo%255B1%252C5-a%255Dpyrimidine-6-carboxamides%2520as%2520potent%2520and%2520selective%2520CB2%2520cannabinoid%2520receptor%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4482%26epage%3D4496%26doi%3D10.1021%2Fjm400182t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fristedt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and reactivity of laquinimod, a quinoline-3-carboxamide: intramolecular transfer of the enol proton to a nitrogen atom as a plausible mechanism for ketene formation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1658</span>– <span class="NLM_lpage">1667</span>, <span class="refDoi"> DOI: 10.1021/jo052368q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo052368q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFCrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1658-1667&author=K.+Janssonauthor=T.+Fristedtauthor=A.+Olssonauthor=B.+Svenssonauthor=S.+J%C3%B6nsson&title=Synthesis+and+reactivity+of+laquinimod%2C+a+quinoline-3-carboxamide%3A+intramolecular+transfer+of+the+enol+proton+to+a+nitrogen+atom+as+a+plausible+mechanism+for+ketene+formation&doi=10.1021%2Fjo052368q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Reactivity of Laquinimod, a Quinoline-3-carboxamide: Intramolecular Transfer of the Enol Proton to a Nitrogen Atom as a Plausible Mechanism for Ketene Formation</span></div><div class="casAuthors">Jansson, Karl; Fristedt, Tomas; Olsson, Arne; Svensson, Bo; Joensson, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1658-1667</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-Chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinolinecarboxamide (laquinimod, 2) is an oral drug in clin. trials for the treatment of multiple sclerosis.  The final step in the synthesis of 2 is a high-yielding aminolysis reaction of ester 1 with N-ethylaniline.  An equil. exists between 1 and 2, and removal of formed methanol during the reaction is a prerequisite for obtaining high yields of 2 from 1.  The reactivity of 1 and 2 is explained by a mechanistic model that involves a transfer of the enol proton to the exocyclic carbonyl substituent with concomitant formation of ketene 3.  This proton transfer is esp. facilitated for 2 because the intramol. hydrogen bond to the carbonyl oxygen is weakened due to steric interactions.  Both 1 and 2 undergo solvolysis reactions that obey first-order reaction kinetics, further supporting the theory that these two mols. are able to decomp. unimolecularly into ketene 3.  The solvent-dependent spectroscopic features of 2 indicate that the mol. mainly resides in two conformations.  One conformation is favored in nonpolar solvents and is likely the result of intramol. hydrogen bonding.  The other conformation is favored in polar solvents and probably exhibits less intramol. hydrogen bonding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquE1LlpDtCn7Vg90H21EOLACvtfcHk0lgmWbMY5wwz6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFCrtQ%253D%253D&md5=e2394ca26e6a60bc403dbcd626e19174</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo052368q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052368q%26sid%3Dliteratum%253Aachs%26aulast%3DJansson%26aufirst%3DK.%26aulast%3DFristedt%26aufirst%3DT.%26aulast%3DOlsson%26aufirst%3DA.%26aulast%3DSvensson%26aufirst%3DB.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520reactivity%2520of%2520laquinimod%252C%2520a%2520quinoline-3-carboxamide%253A%2520intramolecular%2520transfer%2520of%2520the%2520enol%2520proton%2520to%2520a%2520nitrogen%2520atom%2520as%2520a%2520plausible%2520mechanism%2520for%2520ketene%2520formation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D1658%26epage%3D1667%26doi%3D10.1021%2Fjo052368q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rinaldi-Carmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derocq, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casellas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oustric, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouaboula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calandra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shire, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breliere, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Fur, G. L.</span></span> <span> </span><span class="NLM_article-title">SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=9454810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaK1cXhtFWkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1998&pages=644-650&author=M.+Rinaldi-Carmonaauthor=F.+Barthauthor=J.+Millanauthor=J.+M.+Derocqauthor=P.+Casellasauthor=C.+Congyauthor=D.+Oustricauthor=M.+Sarranauthor=M.+Bouaboulaauthor=B.+Calandraauthor=M.+Portierauthor=D.+Shireauthor=J.+C.+Breliereauthor=G.+L.+Le+Fur&title=SR144528%2C+the+first+potent+and+selective+antagonist+of+the+CB2+cannabinoid+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor</span></div><div class="casAuthors">Rinaldi-Carmona, Murielle; Barth, Francis; Millan, Jose; Derocq, Jean-Marie; Casellas, Pierre; Congy, Christian; Oustric, Didier; Sarran, Martine; Bouaboula, Monsif; Calandra, Bernard; Portier, Marielle; Shire, David; Breliere, Jean-Claude; Le Fur, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">644-650</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Based on both binding and functional data, this study introduces SR 144528 as the first, highly potent, selective and orally active antagonist for the CB2 receptor.  This compd. which displays subnanomolar affinity (Ki = 0.6 nM) for both the rat spleen and cloned human CB2 receptors has a 700-fold lower affinity (Ki = 400 nM) for both the rat brain and cloned human CB1 receptors.  Furthermore it shows no affinity for any of the more than 70 receptors, ion channels or enzymes investigated (IC50 > 10 μM).  In vitro, SR 144528 antagonizes the inhibitory effects of the cannabinoid receptor agonist CP 55,940 on forskolin-stimulated adenylyl cyclase activity in cell lines permanently expressing the h CB2 receptor (EC50 = 10 nM) but not in cells expressing the h CB1 (no effect at 10 μM).  Furthermore, SR 144528 is able to selectively block the mitogen-activated protein kinase activity induced by CP 55,940 in cell lines expressing h CB2 (IC50 = 39 nM) whereas in cells expressing h CB1 an IC50 value of more than 1 μM is found.  In addn., SR 144528 is shown to antagonize the stimulating effects of CP 55,940 on human tonsillar B-cell activation evoked by crosslinking of surface Igs (IC50 = 20 nM).  In vivo, after oral administration SR 144528 totally displaced the ex vivo [3H]-CP 55,940 binding to mouse spleen membranes (ED50 = 0.35 mg/kg) with a long duration of action.  In contrast, after the oral route it does not interact with the cannabinoid receptor expressed in the mouse brain (CB1).  It is expected that SR 144528 will provide a powerful tool to investigate the in vivo functions of the cannabinoid system in the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLyEa8bHfntbVg90H21EOLACvtfcHk0lgmWbMY5wwz6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtFWkt78%253D&md5=c7ec1ad25da2567c186099934e0bb758</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRinaldi-Carmona%26aufirst%3DM.%26aulast%3DBarth%26aufirst%3DF.%26aulast%3DMillan%26aufirst%3DJ.%26aulast%3DDerocq%26aufirst%3DJ.%2BM.%26aulast%3DCasellas%26aufirst%3DP.%26aulast%3DCongy%26aufirst%3DC.%26aulast%3DOustric%26aufirst%3DD.%26aulast%3DSarran%26aufirst%3DM.%26aulast%3DBouaboula%26aufirst%3DM.%26aulast%3DCalandra%26aufirst%3DB.%26aulast%3DPortier%26aufirst%3DM.%26aulast%3DShire%26aufirst%3DD.%26aulast%3DBreliere%26aufirst%3DJ.%2BC.%26aulast%3DLe%2BFur%26aufirst%3DG.%2BL.%26atitle%3DSR144528%252C%2520the%2520first%2520potent%2520and%2520selective%2520antagonist%2520of%2520the%2520CB2%2520cannabinoid%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D284%26spage%3D644%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0lgmWbMY5wwz6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span> <span> </span><span class="NLM_article-title">Quantitative assessment of the impact of fluorine substitution on P-glycoprotein (P-gp) mediated efflux, permeability, lipophilicity, and metabolic stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5284</span>– <span class="NLM_lpage">5296</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1Kjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5284-5296&author=M.+Petterssonauthor=X.+Houauthor=M.+Kuhnauthor=T.+T.+Wagerauthor=G.+W.+Kauffmanauthor=P.+R.+Verhoest&title=Quantitative+assessment+of+the+impact+of+fluorine+substitution+on+P-glycoprotein+%28P-gp%29+mediated+efflux%2C+permeability%2C+lipophilicity%2C+and+metabolic+stability&doi=10.1021%2Facs.jmedchem.6b00027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Assessment of the Impact of Fluorine Substitution on P-Glycoprotein (P-gp) Mediated Efflux, Permeability, Lipophilicity, and Metabolic Stability</span></div><div class="casAuthors">Pettersson, Martin; Hou, Xinjun; Kuhn, Max; Wager, Travis T.; Kauffman, Gregory W.; Verhoest, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5284-5296</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Strategic replacement of one or more hydrogen atoms with fluorine atom(s) is a common tactic to improve potency at a given target and/or to modulate parameters such as metabolic stability and pKa.  Mol. wt. (MW) is a key parameter in design, and incorporation of fluorine is assocd. with a disproportionate increase in MW considering the van der Waals radius of fluorine vs. hydrogen.  Herein we examine a large compd. data set to understand the effect of introducing fluorine on the risk of encountering P-glycoprotein mediated efflux (as measured by MDR efflux ratio), passive permeability, lipophilicity, and metabolic stability.  Statistical modeling of the MDR ER data demonstrated that an increase in MW as a result of introducing fluorine atoms does not lead to higher risk of P-gp mediated efflux.  Fluorine-cor. mol. wt. (MWFC), where the mol. wt. of fluorine has been subtracted, was found to be a more relevant descriptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo732pO8BsloLVg90H21EOLACvtfcHk0lgcSR7XmkmGcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1Kjsro%253D&md5=7ca62f3c1100c6623d082d88b3113cf8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00027%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKuhn%26aufirst%3DM.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DQuantitative%2520assessment%2520of%2520the%2520impact%2520of%2520fluorine%2520substitution%2520on%2520P-glycoprotein%2520%2528P-gp%2529%2520mediated%2520efflux%252C%2520permeability%252C%2520lipophilicity%252C%2520and%2520metabolic%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5284%26epage%3D5296%26doi%3D10.1021%2Facs.jmedchem.6b00027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lgcSR7XmkmGcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopple, K. D.</span></span> <span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2615</span>– <span class="NLM_lpage">2623</span>, <span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lgcSR7XmkmGcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keserü, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, N. J.</span></span> <span> </span><span class="NLM_article-title">Validity of ligand efficiency metrics</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1021/ml500146d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500146d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=616-618&author=C.+W.+Murrayauthor=D.+A.+Erlansonauthor=A.+L.+Hopkinsauthor=G.+M.+Keser%C3%BCauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynoldsauthor=N.+J.+Richmond&title=Validity+of+ligand+efficiency+metrics&doi=10.1021%2Fml500146d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Validity of Ligand Efficiency Metrics</span></div><div class="casAuthors">Murray, Christopher W.; Erlanson, Daniel A.; Hopkins, Andrew L.; Keseru, Gyorgy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.; Richmond, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">616-618</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A recent viewpoint article (Improving the plausibility of success with inefficient metrics. ACS Med. Chem. Lett.2014, 5, 2-5) argued that the std. definition of ligand efficiency (LE) is math. invalid.  In this viewpoint, we address this criticism and show categorically that the definition of LE is math. valid.  LE and other metrics such as lipophilic ligand efficiency (LLE) can be useful during the multiparameter optimization challenge faced by medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraJHYI4FCEJbVg90H21EOLACvtfcHk0ljcAGEHL4zYVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D&md5=5bc436490def9fa7af0f3e7ed241ee4e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fml500146d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500146d%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DRichmond%26aufirst%3DN.%2BJ.%26atitle%3DValidity%2520of%2520ligand%2520efficiency%2520metrics%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D616%26epage%3D618%26doi%3D10.1021%2Fml500146d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span> <span> </span><span class="NLM_article-title">A new paradigm for navigating compound property related drug attrition</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.drudis.2015.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=26404453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC283ltl2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=72-81&author=P.+Bartonauthor=R.+J.+Riley&title=A+new+paradigm+for+navigating+compound+property+related+drug+attrition&doi=10.1016%2Fj.drudis.2015.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">A new paradigm for navigating compound property related drug attrition</span></div><div class="casAuthors">Barton Patrick; Riley Robert J</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Improving the efficiency of drug discovery remains a major focus for the pharmaceutical industry.  Toxicity accounts for 90% of withdrawals and major early-stage terminations relate to suboptimal efficacy and safety.  Traditional oral drug space is well defined with respect to physicochemical properties and ADMET risks but increased focus on ligand-lipophilicity efficiency, maximizing enthalpy contributions and new target classes challenge this paradigm.  A hybrid space has been identified that combines physical properties and key interactions attributable to drug transporters.  A novel algorithm is proposed that incorporates drug-transporter interactions and its utility evaluated against popular ligand efficiency indices.  Simply reducing the bulk properties of compounds can exchange one problem for another and creates high-risk areas that challenge the successful delivery from a balanced portfolio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTw28fh-W5ywlm8bhe6roZYfW6udTcc2eY14rKbnS3z9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283ltl2rtg%253D%253D&md5=8f9412912d498680db5bcc2d9880efe2</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DA%2520new%2520paradigm%2520for%2520navigating%2520compound%2520property%2520related%2520drug%2520attrition%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D72%26epage%3D81%26doi%3D10.1016%2Fj.drudis.2015.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0ljcAGEHL4zYVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7559</span>– <span class="NLM_lpage">7583</span>, <span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0ljcAGEHL4zYVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span> <span> </span><span class="NLM_article-title">Assessment of Distribution-pH Profiles</span>. In  <i>Lipophilicity in Drug Action</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pliska, V.</span>; <span class="NLM_string-name">Testa, B.</span>; <span class="NLM_string-name">Van de Waterbeemd, H.</span></span>, Eds.; <span class="NLM_publisher-name">VCH</span>: <span class="NLM_publisher-loc">Weinhem</span>, <span class="NLM_year">1995</span>; pp  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">139</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=109-139&author=A.+Avdeefauthor=V.+Pliska&author=B.+Testa&author=H.+Van+de+Waterbeemd&title=Lipophilicity+in+Drug+Action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26atitle%3DAssessment%2520of%2520Distribution-pH%2520Profiles%26btitle%3DLipophilicity%2520in%2520Drug%2520Action%26aulast%3DPliska%26aufirst%3DV.%26pub%3DVCH%26date%3D1995%26spage%3D109%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emans, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coolsen, M. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surtel, D. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rhijn, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welting, T. J. M.</span></span> <span> </span><span class="NLM_article-title">Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1170</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2012.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2012.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=22796508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC38fgtVertA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1170-1178&author=M.+M.+J.+Caronauthor=P.+J.+Emansauthor=M.+M.+E.+Coolsenauthor=L.+Vossauthor=D.+A.+M.+Surtelauthor=A.+Cremersauthor=L.+W.+van+Rhijnauthor=T.+J.+M.+Welting&title=Redifferentiation+of+dedifferentiated+human+articular+chondrocytes%3A+comparison+of+2D+and+3D+cultures&doi=10.1016%2Fj.joca.2012.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures</span></div><div class="casAuthors">Caron M M J; Emans P J; Coolsen M M E; Voss L; Surtel D A M; Cremers A; van Rhijn L W; Welting T J M</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1170-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Three-dimensional (3D) cultures are widely used to redifferentiate chondrocytes.  However, the rationale behind the choice for 3D above two-dimensional (2D) cultures is poorly systematically investigated and mainly based on mRNA expression and glycosaminoglycan (GAG) content.  The objective was to determine the differential redifferentiation characteristics of human articular chondrocytes (HACs) in monolayer, alginate beads and pellet culture by investigating mRNA expression, protein expression, GAG content and cell proliferation.  DESIGN:  Dedifferentiated HACs from six individuals were redifferentiated in identical medium conditions for 7 days in monolayer, alginate beads or pellet culture.  Read-out parameters were expression of chondrogenic and hypertrophic mRNAs and proteins, GAG content and cell proliferation.  RESULTS:  3D cultures specifically expressed chondrogenic mRNAs [collagen type II (COL2A1), SRY (sex determining region Y)-box 9 (SOX9), aggrecan (ACAN)), whereas 2D cultures did not.  Hypertrophic mRNAs (collagen type X (COL10A1), runt-related transcription factor 2 (RUNX2), matrix metalloproteinase 13 (MMP13), vascular endothelial growth factor A (VEGFA), osteopontin (OPN), alkaline phosphatase (ALP)) were highly increased in 2D cultures and lower in 3D cultures.  Collagen type I (COL1A1) mRNA expression was highest in 3D cultures.  Protein expression supports most of the mRNA data, although an important discrepancy was found between mRNA and protein expression of COL2A1 and SOX9 in monolayer culture, stressing on the importance of protein expression analysis.  GAG content was highest in 3D cultures, whereas chondrocyte proliferation was almost specific for 2D cultures.  CONCLUSIONS:  For redifferentiation of dedifferentiated HACs, 3D cultures exhibit the most potent chondrogenic potential, whereas a hypertrophic phenotype is best achieved in 2D cultures.  This is the first human study that systematically evaluates the differences between proliferation, GAG content, protein expression and mRNA expression of commonly used 2D and 3D chondrocyte culture techniques.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMGHYETnJ0Itts4TFFB11gfW6udTcc2ebEmJsun7-tlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fgtVertA%253D%253D&md5=3fc61862ae96c5495869be0471aec8e5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2012.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2012.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DCaron%26aufirst%3DM.%2BM.%2BJ.%26aulast%3DEmans%26aufirst%3DP.%2BJ.%26aulast%3DCoolsen%26aufirst%3DM.%2BM.%2BE.%26aulast%3DVoss%26aufirst%3DL.%26aulast%3DSurtel%26aufirst%3DD.%2BA.%2BM.%26aulast%3DCremers%26aufirst%3DA.%26aulast%3Dvan%2BRhijn%26aufirst%3DL.%2BW.%26aulast%3DWelting%26aufirst%3DT.%2BJ.%2BM.%26atitle%3DRedifferentiation%2520of%2520dedifferentiated%2520human%2520articular%2520chondrocytes%253A%2520comparison%2520of%25202D%2520and%25203D%2520cultures%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2012%26volume%3D20%26spage%3D1170%26epage%3D1178%26doi%3D10.1016%2Fj.joca.2012.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrzewa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starowicz, K.</span></span> <span> </span><span class="NLM_article-title">New tool to assess walking patterns in the development of OA pain: kinetic weight bearing</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">S136</span>– <span class="NLM_lpage">S137</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2017.02.221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2017.02.221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=S136-S137&author=N.+Malekauthor=J.+Mlostauthor=M.+Kostrzewaauthor=K.+Starowicz&title=New+tool+to+assess+walking+patterns+in+the+development+of+OA+pain%3A+kinetic+weight+bearing&doi=10.1016%2Fj.joca.2017.02.221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2017.02.221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2017.02.221%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DN.%26aulast%3DMlost%26aufirst%3DJ.%26aulast%3DKostrzewa%26aufirst%3DM.%26aulast%3DStarowicz%26aufirst%3DK.%26atitle%3DNew%2520tool%2520to%2520assess%2520walking%2520patterns%2520in%2520the%2520development%2520of%2520OA%2520pain%253A%2520kinetic%2520weight%2520bearing%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2017%26volume%3D25%26spage%3DS136%26epage%3DS137%26doi%3D10.1016%2Fj.joca.2017.02.221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit40b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leuchtweis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montechiaro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaible, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boettger, M. K.</span></span> <span> </span><span class="NLM_article-title">Validation of the digital pressure application measurement (PAM) device for detection of primary mechanical hyperalgesia in rat and mouse antigen-induced knee joint arthritis</span>. <i>Methods Find. Exp. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1358/mf.2010.32.8.1532102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1358%2Fmf.2010.32.8.1532102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=21132127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FhvFWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=575-583&author=J.+Leuchtweisauthor=A.-K.+Imhofauthor=F.+Montechiaroauthor=H.-G.+Schaibleauthor=M.+K.+Boettger&title=Validation+of+the+digital+pressure+application+measurement+%28PAM%29+device+for+detection+of+primary+mechanical+hyperalgesia+in+rat+and+mouse+antigen-induced+knee+joint+arthritis&doi=10.1358%2Fmf.2010.32.8.1532102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the digital pressure application measurement (PAM) device for detection of primary mechanical hyperalgesia in rat and mouse antigen-induced knee joint arthritis</span></div><div class="casAuthors">Leuchtweis J; Imhof A-K; Montechiaro F; Schaible H-G; Boettger M K</div><div class="citationInfo"><span class="NLM_cas:title">Methods and findings in experimental and clinical pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">575-83</span>
        ISSN:<span class="NLM_cas:issn">0379-0355</span>.
    </div><div class="casAbstract">Several tests have been developed to obtain mechanical nociceptive withdrawal thresholds for arthritis-associated pain research in preclinical animal models, which are routinely used for testing the efficacy of antinociceptive pharmaceutical candidates.  Here, we aimed to validate a recently introduced and commercially available digital pressure application measurement (PAM) device for the detection of primary mechanical hyperalgesia in a model of antigen-induced knee joint arthritis (AIA) in rats and mice.  Two particular advantages of the PAM device are visual feedback control of the force increase rate and the detection of the complete threshold range.  Using PAM, we were able to quantify mechanical thresholds at the knee joint in rats and mice (400 and 350 g, respectively) before and during the time course of AIA (approximately 100 g for rats and mice in the acute phase).  Inter-observer agreement was generally higher when using PAM instead of an analog dynamometer.  In conclusion, the digital PAM device is a suitable apparatus to detect primary mechanical hyperalgesia in experimental knee joint arthritis in rats and mice.  The use of this device allows visual feedback control of the stimulus rate, thus minimizing the chances of confounding factors arising from differences in ramp speed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTFggnlMhOZOkdrW1FkXG-fW6udTcc2ebEmJsun7-tlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FhvFWltg%253D%253D&md5=13acdad20c1bb490b2f495daea1f6f50</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1358%2Fmf.2010.32.8.1532102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fmf.2010.32.8.1532102%26sid%3Dliteratum%253Aachs%26aulast%3DLeuchtweis%26aufirst%3DJ.%26aulast%3DImhof%26aufirst%3DA.-K.%26aulast%3DMontechiaro%26aufirst%3DF.%26aulast%3DSchaible%26aufirst%3DH.-G.%26aulast%3DBoettger%26aufirst%3DM.%2BK.%26atitle%3DValidation%2520of%2520the%2520digital%2520pressure%2520application%2520measurement%2520%2528PAM%2529%2520device%2520for%2520detection%2520of%2520primary%2520mechanical%2520hyperalgesia%2520in%2520rat%2520and%2520mouse%2520antigen-induced%2520knee%2520joint%2520arthritis%26jtitle%3DMethods%2520Find.%2520Exp.%2520Clin.%2520Pharmacol.%26date%3D2010%26volume%3D32%26spage%3D575%26epage%3D583%26doi%3D10.1358%2Fmf.2010.32.8.1532102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit40c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brash, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bate, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessell, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeve, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQueen, D. S.</span></span> <span> </span><span class="NLM_article-title">Pressure application measurement (PAM): A novel behavioural technique for measuring hypersensitivity in a rat model of joint pain</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.jneumeth.2007.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.jneumeth.2007.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=17383008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mvVamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2007&pages=67-75&author=N.+J.+Bartonauthor=I.+T.+Stricklandauthor=S.+M.+Bondauthor=H.+M.+Brashauthor=S.+T.+Bateauthor=A.+W.+Wilsonauthor=I.+P.+Chessellauthor=A.+J.+Reeveauthor=D.+S.+McQueen&title=Pressure+application+measurement+%28PAM%29%3A+A+novel+behavioural+technique+for+measuring+hypersensitivity+in+a+rat+model+of+joint+pain&doi=10.1016%2Fj.jneumeth.2007.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40cR"><div class="casContent"><span class="casTitleNuber">40c</span><div class="casTitle"><span class="NLM_cas:atitle">Pressure application measurement (PAM): a novel behavioural technique for measuring hypersensitivity in a rat model of joint pain</span></div><div class="casAuthors">Barton Nicola J; Strickland Iain T; Bond Susan M; Brash Harry M; Bate Simon T; Wilson Alex W; Chessell Iain P; Reeve Alison J; McQueen Daniel S</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-75</span>
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">Chronic joint pain affects physical well being and can lead to severe psychological and social problems, therefore successful long-term management is highly sought-after.  No current behavioural measures of pain used in pre-clinical models mimic the clinical dolorimeter, which provides an objective measure of joint hypersensitivity.  In this study we aim to use a novel behavioural readout alongside an established measure to mimic the multifactorial measurements taken in the clinic.  Using the pressure application measurement (PAM) device a gradually increasing squeeze was applied across the knee joint of rats until the animal gave an indication of pain or discomfort.  PAM and the incapacitance tester were used to detect joint hypersensitivity in a well-established rodent model of adjuvant-induced arthritis.  Subsequently, the analgesic effects of prednisolone (1, 3 or 10 mg kg(-1)), morphine (3 mg kg(-1)) and celecoxib (15 mg kg(-1)) were assessed.  Both PAM and the incapacitance tester detected a reversal of hypersensitivity 1h post-drug administration.  Furthermore, the two readouts were highly correlated, and power analysis indicated that PAM was highly reproducible.  In conclusion, PAM provides a novel, accurate behavioural tool for detecting a primary mechanical hypersensitivity in a rat model of chronic inflammatory joint pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROrJznTHfjh8ERNNga7KD-fW6udTcc2ebEmJsun7-tlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mvVamtQ%253D%253D&md5=88318b1b76edecc4fb113673c2111d22</span></div><a href="/servlet/linkout?suffix=cit40c&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2007.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2007.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DN.%2BJ.%26aulast%3DStrickland%26aufirst%3DI.%2BT.%26aulast%3DBond%26aufirst%3DS.%2BM.%26aulast%3DBrash%26aufirst%3DH.%2BM.%26aulast%3DBate%26aufirst%3DS.%2BT.%26aulast%3DWilson%26aufirst%3DA.%2BW.%26aulast%3DChessell%26aufirst%3DI.%2BP.%26aulast%3DReeve%26aufirst%3DA.%2BJ.%26aulast%3DMcQueen%26aufirst%3DD.%2BS.%26atitle%3DPressure%2520application%2520measurement%2520%2528PAM%2529%253A%2520A%2520novel%2520behavioural%2520technique%2520for%2520measuring%2520hypersensitivity%2520in%2520a%2520rat%2520model%2520of%2520joint%2520pain%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2007%26volume%3D163%26spage%3D67%26epage%3D75%26doi%3D10.1016%2Fj.jneumeth.2007.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrzewa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starowicz, K.</span></span> <span> </span><span class="NLM_article-title">New tool to assess walking patterns in the development of OA pain: kinetic weight bearing</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">S136</span>– <span class="NLM_lpage">S137</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2017.02.221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2017.02.221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=S136-S137&author=N.+Malekauthor=J.+Mlostauthor=M.+Kostrzewaauthor=K.+Starowicz&title=New+tool+to+assess+walking+patterns+in+the+development+of+OA+pain%3A+kinetic+weight+bearing&doi=10.1016%2Fj.joca.2017.02.221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2017.02.221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2017.02.221%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DN.%26aulast%3DMlost%26aufirst%3DJ.%26aulast%3DKostrzewa%26aufirst%3DM.%26aulast%3DStarowicz%26aufirst%3DK.%26atitle%3DNew%2520tool%2520to%2520assess%2520walking%2520patterns%2520in%2520the%2520development%2520of%2520OA%2520pain%253A%2520kinetic%2520weight%2520bearing%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2017%26volume%3D25%26spage%3DS136%26epage%3DS137%26doi%3D10.1016%2Fj.joca.2017.02.221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leuchtweis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montechiaro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaible, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boettger, M. K.</span></span> <span> </span><span class="NLM_article-title">Validation of the digital pressure application measurement (PAM) device for detection of primary mechanical hyperalgesia in rat and mouse antigen-induced knee joint arthritis</span>. <i>Methods Find. Exp. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1358/mf.2010.32.8.1532102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1358%2Fmf.2010.32.8.1532102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=21132127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FhvFWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=575-583&author=J.+Leuchtweisauthor=A.-K.+Imhofauthor=F.+Montechiaroauthor=H.-G.+Schaibleauthor=M.+K.+Boettger&title=Validation+of+the+digital+pressure+application+measurement+%28PAM%29+device+for+detection+of+primary+mechanical+hyperalgesia+in+rat+and+mouse+antigen-induced+knee+joint+arthritis&doi=10.1358%2Fmf.2010.32.8.1532102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the digital pressure application measurement (PAM) device for detection of primary mechanical hyperalgesia in rat and mouse antigen-induced knee joint arthritis</span></div><div class="casAuthors">Leuchtweis J; Imhof A-K; Montechiaro F; Schaible H-G; Boettger M K</div><div class="citationInfo"><span class="NLM_cas:title">Methods and findings in experimental and clinical pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">575-83</span>
        ISSN:<span class="NLM_cas:issn">0379-0355</span>.
    </div><div class="casAbstract">Several tests have been developed to obtain mechanical nociceptive withdrawal thresholds for arthritis-associated pain research in preclinical animal models, which are routinely used for testing the efficacy of antinociceptive pharmaceutical candidates.  Here, we aimed to validate a recently introduced and commercially available digital pressure application measurement (PAM) device for the detection of primary mechanical hyperalgesia in a model of antigen-induced knee joint arthritis (AIA) in rats and mice.  Two particular advantages of the PAM device are visual feedback control of the force increase rate and the detection of the complete threshold range.  Using PAM, we were able to quantify mechanical thresholds at the knee joint in rats and mice (400 and 350 g, respectively) before and during the time course of AIA (approximately 100 g for rats and mice in the acute phase).  Inter-observer agreement was generally higher when using PAM instead of an analog dynamometer.  In conclusion, the digital PAM device is a suitable apparatus to detect primary mechanical hyperalgesia in experimental knee joint arthritis in rats and mice.  The use of this device allows visual feedback control of the stimulus rate, thus minimizing the chances of confounding factors arising from differences in ramp speed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTFggnlMhOZOkdrW1FkXG-fW6udTcc2eYRyTvHanZqWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FhvFWltg%253D%253D&md5=13acdad20c1bb490b2f495daea1f6f50</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1358%2Fmf.2010.32.8.1532102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fmf.2010.32.8.1532102%26sid%3Dliteratum%253Aachs%26aulast%3DLeuchtweis%26aufirst%3DJ.%26aulast%3DImhof%26aufirst%3DA.-K.%26aulast%3DMontechiaro%26aufirst%3DF.%26aulast%3DSchaible%26aufirst%3DH.-G.%26aulast%3DBoettger%26aufirst%3DM.%2BK.%26atitle%3DValidation%2520of%2520the%2520digital%2520pressure%2520application%2520measurement%2520%2528PAM%2529%2520device%2520for%2520detection%2520of%2520primary%2520mechanical%2520hyperalgesia%2520in%2520rat%2520and%2520mouse%2520antigen-induced%2520knee%2520joint%2520arthritis%26jtitle%3DMethods%2520Find.%2520Exp.%2520Clin.%2520Pharmacol.%26date%3D2010%26volume%3D32%26spage%3D575%26epage%3D583%26doi%3D10.1358%2Fmf.2010.32.8.1532102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kostrzewa, M.</span>; <span class="NLM_string-name">Malek, N.</span>; <span class="NLM_string-name">Pajak, A.</span>; <span class="NLM_string-name">Starowicz, K.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Benefits of Targeting CB2 Receptors in the MIA Model of Osteoarthritis. 16th World Congress on Pain, Yokohama, Japan, Sep 26-30</span> <span class="NLM_year">2016</span>, Poster Number PTH120.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+Kostrzewa&author=N.+Malek&author=A.+Pajak&author=K.+Starowicz&title=Therapeutic+Benefits+of+Targeting+CB2+Receptors+in+the+MIA+Model+of+Osteoarthritis.+16th+World+Congress+on+Pain%2C+Yokohama%2C+Japan%2C+Sep+26-30"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKostrzewa%26aufirst%3DM.%26atitle%3DTherapeutic%2520Benefits%2520of%2520Targeting%2520CB2%2520Receptors%2520in%2520the%2520MIA%2520Model%2520of%2520Osteoarthritis.%252016th%2520World%2520Congress%2520on%2520Pain%252C%2520Yokohama%252C%2520Japan%252C%2520Sep%252026-30%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pajak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrzewa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korostynski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starowicz, K.</span></span> <span> </span><span class="NLM_article-title">Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritis</span>. <i>J. Pain Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1973</span>– <span class="NLM_lpage">1989</span>, <span class="refDoi"> DOI: 10.2147/JPR.S132682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.2147%2FJPR.S132682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=28860852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktlGltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=1973-1989&author=A.+Pajakauthor=M.+Kostrzewaauthor=N.+Malekauthor=M.+Korostynskiauthor=K.+Starowicz&title=Expression+of+matrix+metalloproteinases+and+components+of+the+endocannabinoid+system+in+the+knee+joint+are+associated+with+biphasic+pain+progression+in+a+rat+model+of+osteoarthritis&doi=10.2147%2FJPR.S132682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritis</span></div><div class="casAuthors">Pajak, Agnieszka; Kostrzewa, Magdalena; Malek, Natalia; Korostynski, Michal; Starowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1973-1989</span>CODEN:
                <span class="NLM_cas:coden">JPROEV</span>;
        ISSN:<span class="NLM_cas:issn">1178-7090</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are considered important in articular cartilage breakdown during osteoarthritis (OA).  Similarly, the endocannabinoid system (ECS) is implicated in joint function and modulation of nociceptive processing.  Functional interplay between ECS and MMPs has been recently indicated.  Here, we tested if changes in the expression of selected MMPs and major ECS elements temporally correlate with the intensity of OA-related pain.  Knee OA was induced in male Wistar rats by intra-articular sodium monoiodoacetate injection.  OA-like pain behavior was tested using the dynamic wt. bearing.  Joint tissue samples at different time points after OA induction were subjected to gene (quant. polymerase chain reaction) and protein (Western blot) expression analyses.  Monoiodoacetate-induced nocifensive responses in rats showed a biphasic progression pattern.  The alterations in expression of selected MMPs elegantly corresponded to the two-stage development of OA pain.  The most substantial changes in the expression of the ECS system were revealed at a later stage of OA progression.  Alterations within ECS are involved in the process of adaptation to persistent painful stimuli.  The accumulation of MMPs in osteoarthritic cartilage may have a role in the biphasic progression of OA-related pain.  Temporal assocn. of changes in ECS and MMPs expression shows a potential therapeutic approach that utilizes the concept of combining indirect ECS-mediated MMP inhibition and ECS modulation of pain transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonhr9634T6ELVg90H21EOLACvtfcHk0lieucb5tPkT3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktlGltLc%253D&md5=31cc9d5693d569d761b8675b434ed737</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.2147%2FJPR.S132682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJPR.S132682%26sid%3Dliteratum%253Aachs%26aulast%3DPajak%26aufirst%3DA.%26aulast%3DKostrzewa%26aufirst%3DM.%26aulast%3DMalek%26aufirst%3DN.%26aulast%3DKorostynski%26aufirst%3DM.%26aulast%3DStarowicz%26aufirst%3DK.%26atitle%3DExpression%2520of%2520matrix%2520metalloproteinases%2520and%2520components%2520of%2520the%2520endocannabinoid%2520system%2520in%2520the%2520knee%2520joint%2520are%2520associated%2520with%2520biphasic%2520pain%2520progression%2520in%2520a%2520rat%2520model%2520of%2520osteoarthritis%26jtitle%3DJ.%2520Pain%2520Res.%26date%3D2017%26volume%3D10%26spage%3D1973%26epage%3D1989%26doi%3D10.2147%2FJPR.S132682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepartz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">The ecstasy and agony of assay interference compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2165</span>– <span class="NLM_lpage">2168</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00229</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00229" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2165-2168&author=C.+Aldrichauthor=C.+Bertozziauthor=G.+I.+Georgauthor=L.+Kiesslingauthor=C.+Lindsleyauthor=D.+Liottaauthor=K.+M.+Merzauthor=A.+Schepartzauthor=S.+Wang&title=The+ecstasy+and+agony+of+assay+interference+compounds&doi=10.1021%2Facs.jmedchem.7b00229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Ecstasy and Agony of Assay Interference Compounds</span></div><div class="casAuthors">Aldrich, Courtney; Bertozzi, Carolyn; Georg, Gunda I.; Kiessling, Laura; Lindsley, Craig; Liotta, Dennis; Merz, Kenneth M.; Schepartz, Alanna; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2165-2168</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ecstasy of discovering a new hit from screening can lead to a highly productive research effort to discover new bioactive compds.  However, in too many cases this ecstasy is followed by the agony of realizing that the compds. are not active against the desired target.  Many of these false hits are Pan Assay INterference compds. (PAINS) 1 or colloidal aggregators.  Whether the screen is conducted in silico or in the lab. and whether screening libraries, natural products, or drugs are used, all discovery efforts that rely on some form of screening to identify bioactivity are susceptible to this phenomenon.  Studies that omit crit. controls against exptl. artifacts caused by PAINS may waste years of research effort as useless compds. are progressed.  The American Chem. Society (ACS) is eager to alert the scientific community to this problem and to recommend protocols that will eliminate the publication of research articles based on compds. with artificial activity.  This editorial aims to summarize relevant concepts and to set the framework by which relevant ACS journals will address this issue going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUf5u51VEpbVg90H21EOLACvtfcHk0lgJMamlNTSi1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D&md5=64bf087659a47fe7769208217ef8c989</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00229%26sid%3Dliteratum%253Aachs%26aulast%3DAldrich%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DC.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DKiessling%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DSchepartz%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DThe%2520ecstasy%2520and%2520agony%2520of%2520assay%2520interference%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2165%26epage%3D2168%26doi%3D10.1021%2Facs.jmedchem.7b00229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regiec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastalarz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastalarz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochel, A.</span></span> <span> </span><span class="NLM_article-title">Methylation of 4-nitro-3(5)-pyrazolecarboxylic acid</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2624</span>– <span class="NLM_lpage">2627</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2009.02.223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.tetlet.2009.02.223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=2624-2627&author=A.+Regiecauthor=H.+Mastalarzauthor=A.+Mastalarzauthor=A.+Kochel&title=Methylation+of+4-nitro-3%285%29-pyrazolecarboxylic+acid&doi=10.1016%2Fj.tetlet.2009.02.223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Methylation of 4-nitro-3(5)-pyrazolecarboxylic acid</span></div><div class="casAuthors">Regiec, Andrzej; Mastalarz, Henryk; Mastalarz, Agnieszka; Kochel, Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2624-2627</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Reactions of 4-nitro-3(5)-pyrazolecarboxylic acid dipotassium salt with different methylating agents in various solvents were investigated to improve the synthesis of isomeric 1-methyl-4-nitro-3- and -5-pyrazolecarboxylates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCJWQVZw-F47Vg90H21EOLACvtfcHk0lgJMamlNTSi1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslygu74%253D&md5=c4cc72d9ddfb134b088617602d1911b3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.02.223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.02.223%26sid%3Dliteratum%253Aachs%26aulast%3DRegiec%26aufirst%3DA.%26aulast%3DMastalarz%26aufirst%3DH.%26aulast%3DMastalarz%26aufirst%3DA.%26aulast%3DKochel%26aufirst%3DA.%26atitle%3DMethylation%2520of%25204-nitro-3%25285%2529-pyrazolecarboxylic%2520acid%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D2624%26epage%3D2627%26doi%3D10.1016%2Fj.tetlet.2009.02.223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span> </span><span class="NLM_article-title">ISO 10993-5:2009. Biological Evaluation of Medical
Devices - Part
5: Tests for in Vitro Cytotoxicity</span>. <a href="https://www.iso.org/standard/36406.html" class="extLink">https://www.iso.org/standard/36406.html</a>, (accessed Mar, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ISO+10993-5%3A2009.+Biological+Evaluation+of+Medical%0ADevices+-+Part%0A5%3A+Tests+for+in+Vitro+Cytotoxicity.+https%3A%2F%2Fwww.iso.org%2Fstandard%2F36406.html%2C+%28accessed+Mar%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DISO%252010993-5%253A2009.%2520Biological%2520Evaluation%2520of%2520Medical%250ADevices%2520-%2520Part%250A5%253A%2520Tests%2520for%2520in%2520Vitro%2520Cytotoxicity%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farndale, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayers, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, A. J.</span></span> <span> </span><span class="NLM_article-title">A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures</span>. <i>Connect. Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.3109/03008208209160269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.3109%2F03008208209160269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=6215207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaL38XlslyitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1982&pages=247-248&author=R.+W.+Farndaleauthor=C.+A.+Sayersauthor=A.+J.+Barrett&title=A+direct+spectrophotometric+microassay+for+sulfated+glycosaminoglycans+in+cartilage+cultures&doi=10.3109%2F03008208209160269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures</span></div><div class="casAuthors">Farndale, Richard W.; Sayers, Christine A.; Barrett, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Connective Tissue Research</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">247-8</span>CODEN:
                <span class="NLM_cas:coden">CVTRBC</span>;
        ISSN:<span class="NLM_cas:issn">0300-8207</span>.
    </div><div class="casAbstract">Sulfated glycosaminoglycans (GAGs) were detd. in cartilage or cartilage cultures by an improved microspectrophotometric method with 1,9-dimethylmethylene blue (DMB).  The reagent was stabilized by dissolving the DMB in formate buffer, instead of the citrate-phosphate buffer previously used.  The samples were digested with papain in phosphate buffer contg. N-acetylcysteine and EDTA and, following addn. of DMB and mixing, the absorbance was measured immediately at 535 nm.  The method is simple, rapid, and reproducible. It is substantially free from interferences, and the sensitivity was 1 μg (4 μg/mL chondroitin sulfate).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru0KlPe79ZK7Vg90H21EOLACvtfcHk0lgJMamlNTSi1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlslyitLY%253D&md5=9164ecb7d6a84c7b1c2464befe891e51</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3109%2F03008208209160269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03008208209160269%26sid%3Dliteratum%253Aachs%26aulast%3DFarndale%26aufirst%3DR.%2BW.%26aulast%3DSayers%26aufirst%3DC.%2BA.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26atitle%3DA%2520direct%2520spectrophotometric%2520microassay%2520for%2520sulfated%2520glycosaminoglycans%2520in%2520cartilage%2520cultures%26jtitle%3DConnect.%2520Tissue%2520Res.%26date%3D1982%26volume%3D9%26spage%3D247%26epage%3D248%26doi%3D10.3109%2F03008208209160269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guingamp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gegout-Pottie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terlain, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillet, P.</span></span> <span> </span><span class="NLM_article-title">Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1670</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.1002/art.1780400917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1002%2Fart.1780400917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=9324022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaK2sXms1eit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1670-1679&author=C.+Guingampauthor=P.+Gegout-Pottieauthor=L.+Philippeauthor=B.+Terlainauthor=P.+Netterauthor=P.+Gillet&title=Mono-iodoacetate-induced+experimental+osteoarthritis%3A+a+dose-response+study+of+loss+of+mobility%2C+morphology%2C+and+biochemistry&doi=10.1002%2Fart.1780400917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47aR"><div class="casContent"><span class="casTitleNuber">47a</span><div class="casTitle"><span class="NLM_cas:atitle">Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry</span></div><div class="casAuthors">Guingamp, Corinne; Gegout-Pottie, Pascale; Philippe, Lionel; Terlain, Bernard; Netter, Patrick; Gillet, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1670-1679</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">To characterize the dose-responsiveness of morphol. and biochem. chondral changes relative to mobility in mono-iodoacetate (MIA)-induced osteoarthritis (OA) in rats, rat mobility was assessed by biotelemetry.  Articular lesions were characterized by macroscopic and histol. examns.  Cartilage proteoglycan metab. was evaluated by the 1,9-dimethylmethylene blue dye binding assay and by radiosulfate incorporation in patellar cartilage.  Spontaneous locomotor activity was rapidly, transiently, and dose-dependently decreased after MIA injection into rat knees (primary response).  Thereafter, only high doses (0.3 mg and 3.0 mg) led to a secondary progressive long-term loss of spontaneous mobility on day 15, when subchondral bone was exposed.  These 2 doses resulted in significant changes in cartilage proteoglycan concn. at day 15 and a strong inhibition of anabolism in the peripheral patellae by day 2, contrasting with the effects of lower doses (0.01, 0.03, and 0.1 mg).  When a sufficient dose of MIA is used, this model can easily and quickly reproduce OA-like lesions and functional impairment in rats, similar to that obsd. in human disease.  These parameters, as well as proteoglycan metab., could serve as indicators for studying chondroprotective drugs, or for evaluating the ability of imaging techniques to detect and evaluate chondral lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3wKbDs2TonrVg90H21EOLACvtfcHk0ljXLmXRAFMWkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXms1eit7w%253D&md5=1e37fe9fae0bcc612f44fd27149b6138</span></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=10.1002%2Fart.1780400917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.1780400917%26sid%3Dliteratum%253Aachs%26aulast%3DGuingamp%26aufirst%3DC.%26aulast%3DGegout-Pottie%26aufirst%3DP.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DTerlain%26aufirst%3DB.%26aulast%3DNetter%26aufirst%3DP.%26aulast%3DGillet%26aufirst%3DP.%26atitle%3DMono-iodoacetate-induced%2520experimental%2520osteoarthritis%253A%2520a%2520dose-response%2520study%2520of%2520loss%2520of%2520mobility%252C%2520morphology%252C%2520and%2520biochemistry%26jtitle%3DArthritis%2520Rheum.%26date%3D1997%26volume%3D40%26spage%3D1670%26epage%3D1679%26doi%3D10.1002%2Fart.1780400917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit47b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Janusz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hookfin, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitmeyer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woessner, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freemont, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyland, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almstead, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natchus, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiwo, Y. O.</span></span> <span> </span><span class="NLM_article-title">Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.1053/joca.2001.0472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1053%2Fjoca.2001.0472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=11795995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FmvVyluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=751-760&author=M.+J.+Januszauthor=E.+B.+Hookfinauthor=S.+A.+Heitmeyerauthor=J.+F.+Woessnerauthor=A.+J.+Freemontauthor=J.+A.+Hoylandauthor=K.+K.+Brownauthor=L.+C.+Hsiehauthor=N.+G.+Almsteadauthor=B.+Deauthor=M.+G.+Natchusauthor=S.+Pikulauthor=Y.+O.+Taiwo&title=Moderation+of+iodoacetate-induced+experimental+osteoarthritis+in+rats+by+matrix+metalloproteinase+inhibitors&doi=10.1053%2Fjoca.2001.0472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47bR"><div class="casContent"><span class="casTitleNuber">47b</span><div class="casTitle"><span class="NLM_cas:atitle">Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Janusz M J; Hookfin E B; Heitmeyer S A; Woessner J F; Freemont A J; Hoyland J A; Brown K K; Hsieh L C; Almstead N G; De B; Natchus M G; Pikul S; Taiwo Y O</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">751-60</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine the effect of matrix metalloproteinase (MMP) inhibitors in mono-iodoacetate-induced arthritis in rats.  DESIGN:  The ability of compounds to inhibit MMPs in vitro was assessed kinetically using a quenched fluorescent substrate.  Rats were injected with iodoacetate intraarticularly in one knee joint and damage to the tibial plateau was evaluated from digitized images captured using an image analyser and by histology.  Collagenase and gelatinase activity in cartilage from iodoacetate injected knees were evaluated using(3)H-rat type I collagen and gelatin zymography, respectively.  RESULTS:  Collagenase and gelatinase activity significantly increased in the knee cartilage of rats injected with iodoacetate with peak activity by day 7.  Three MMP inhibitors were examined for their efficacy in the rat iodoacetate-induced arthritis model.  Significant (P< 0.05) inhibition of cartilage damage was observed in animals treated orally with 35 mg/kg b.i.d. of the three different MMP inhibitors.  Inhibition of cartilage damage by the MMP inhibitors ranged from 36-42%.  CONCLUSION:  MMP inhibitors are partially protective against cartilage and subchondral bone damage induced by iodoacetate.  These results support an important role for MMPs in mediating the joint damage in this model of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTG5mJMbt3ZGNHxxy173TfNfW6udTcc2ea8cocej8SWp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FmvVyluw%253D%253D&md5=3413cc14d140f1cb499e0e34d6fbc40a</span></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=10.1053%2Fjoca.2001.0472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fjoca.2001.0472%26sid%3Dliteratum%253Aachs%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26aulast%3DHookfin%26aufirst%3DE.%2BB.%26aulast%3DHeitmeyer%26aufirst%3DS.%2BA.%26aulast%3DWoessner%26aufirst%3DJ.%2BF.%26aulast%3DFreemont%26aufirst%3DA.%2BJ.%26aulast%3DHoyland%26aufirst%3DJ.%2BA.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DHsieh%26aufirst%3DL.%2BC.%26aulast%3DAlmstead%26aufirst%3DN.%2BG.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DPikul%26aufirst%3DS.%26aulast%3DTaiwo%26aufirst%3DY.%2BO.%26atitle%3DModeration%2520of%2520iodoacetate-induced%2520experimental%2520osteoarthritis%2520in%2520rats%2520by%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2001%26volume%3D9%26spage%3D751%26epage%3D760%26doi%3D10.1053%2Fjoca.2001.0472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrugala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makuch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolosowska, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przewlocka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czaja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morera, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starowicz, K.</span></span> <span> </span><span class="NLM_article-title">A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">903</span>, <span class="refDoi"> DOI: 10.1097/j.pain.0000000000000132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1097%2Fj.pain.0000000000000132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=25719612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1Cmu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=890-903&author=N.+Malekauthor=M.+Mrugalaauthor=W.+Makuchauthor=N.+Kolosowskaauthor=B.+Przewlockaauthor=M.+Binkowskiauthor=M.+Czajaauthor=E.+Moreraauthor=V.+Di+Marzoauthor=K.+Starowicz&title=A+multi-target+approach+for+pain+treatment%3A+dual+inhibition+of+fatty+acid+amide+hydrolase+and+TRPV1+in+a+rat+model+of+osteoarthritis&doi=10.1097%2Fj.pain.0000000000000132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis</span></div><div class="casAuthors">Malek, Natalia; Mrugala, Monika; Makuch, Wioletta; Kolosowska, Natalia; Przewlocka, Barbara; Binkowski, Marcin; Czaja, Martyna; Morera, Enrico; Di Marzo, Vincenzo; Starowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">890-903</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The pharmacol. inhibition of anandamide (AEA) hydrolysis by fatty acid amide hydrolase (FAAH) attenuates pain in animal models of osteoarthritis (OA) but has failed in clin. trials.  This may have occurred because AEA also activates transient receptor potential vanilloid type 1 (TRPV1), which contributes to pain development.  Therefore, we investigated the effectiveness of the dual FAAH-TRPV1 blocker OMDM-198 in an MIA-model of osteoarthritic pain.  We first investigated the MIA-induced model of OA by (1) characterizing the pain phenotype and degenerative changes within the joint using X-ray microtomog. and (2) evaluating nerve injury and inflammation marker (ATF-3 and IL-6) expression in the lumbar dorsal root ganglia of osteoarthritic rats and differences in gene and protein expression of the cannabinoid CB1 receptors FAAH and TRPV1.  Furthermore, we compared OMDM-198 with compds. acting exclusively on FAAH or TRPV1.  Osteoarthritis was accompanied by the fragmentation of bone microstructure and destroyed cartilage.  An increase of the mRNA levels of ATF3 and IL-6 and an upregulation of AEA receptors and FAAH in the dorsal root ganglia were obsd.  OMDM-198 showed antihyperalgesic effects in the OA model, which were comparable with those of a selective TRPV1 antagonist, SB-366,791, and a selective FAAH inhibitor, URB-597.  The effect of OMDM-198 was attenuated by the CB1 receptor antagonist, AM-251, and by the nonpungent TRPV1 agonist, olvanil, suggesting its action as an "indirect" CB1 agonist and TRPV1 antagonist.  These results suggest an innovative strategy for the treatment of OA, which may yield more satisfactory results than those obtained so far with selective FAAH inhibitors in human OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFhqnavzLgp7Vg90H21EOLACvtfcHk0ljXLmXRAFMWkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1Cmu78%253D&md5=d02e442c4b7afec3fd514aed9efe70a2</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1097%2Fj.pain.0000000000000132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fj.pain.0000000000000132%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DN.%26aulast%3DMrugala%26aufirst%3DM.%26aulast%3DMakuch%26aufirst%3DW.%26aulast%3DKolosowska%26aufirst%3DN.%26aulast%3DPrzewlocka%26aufirst%3DB.%26aulast%3DBinkowski%26aufirst%3DM.%26aulast%3DCzaja%26aufirst%3DM.%26aulast%3DMorera%26aufirst%3DE.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DStarowicz%26aufirst%3DK.%26atitle%3DA%2520multi-target%2520approach%2520for%2520pain%2520treatment%253A%2520dual%2520inhibition%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520and%2520TRPV1%2520in%2520a%2520rat%2520model%2520of%2520osteoarthritis%26jtitle%3DPain%26date%3D2015%26volume%3D156%26spage%3D890%26epage%3D903%26doi%3D10.1097%2Fj.pain.0000000000000132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21a','cit21b','cit21c','cit21d','cit21e'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36a','cit36b'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40a','cit40b','cit40c'],'ref41':['cit41a','cit41b'],'ref42':['cit42a','cit42b'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47a','cit47b'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Bryk</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Starowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reports</span><span> <strong>2021,</strong> <em>73 </em>
                                    (3)
                                     , 681-699. <a href="https://doi.org/10.1007/s43440-021-00270-y" title="DOI URL">https://doi.org/10.1007/s43440-021-00270-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s43440-021-00270-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs43440-021-00270-y%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reports%26atitle%3DCannabinoid-based%252Btherapy%252Bas%252Ba%252Bfuture%252Bfor%252Bjoint%252Bdegeneration.%252BFocus%252Bon%252Bthe%252Brole%252Bof%252BCB2%252Breceptor%252Bin%252Bthe%252Barthritis%252Bprogression%252Band%252Bpain%25253A%252Ban%252Bupdated%252Breview%26aulast%3DBryk%26aufirst%3DMarta%26date%3D2021%26date%3D2021%26volume%3D73%26issue%3D3%26spage%3D681%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Bryk</span>, <span class="hlFld-ContribAuthor ">Jakub  Chwastek</span>, <span class="hlFld-ContribAuthor ">Jakub  Mlost</span>, <span class="hlFld-ContribAuthor ">Magdalena  Kostrzewa</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Starowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Sodium Monoiodoacetate Dose-Dependent Changes in Matrix Metalloproteinases and Inflammatory Components as Prognostic Factors for the Progression of Osteoarthritis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphar.2021.643605" title="DOI URL">https://doi.org/10.3389/fphar.2021.643605</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2021.643605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2021.643605%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DSodium%252BMonoiodoacetate%252BDose-Dependent%252BChanges%252Bin%252BMatrix%252BMetalloproteinases%252Band%252BInflammatory%252BComponents%252Bas%252BPrognostic%252BFactors%252Bfor%252Bthe%252BProgression%252Bof%252BOsteoarthritis%26aulast%3DBryk%26aufirst%3DMarta%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jakub  Mlost</span>, <span class="hlFld-ContribAuthor ">Magdalena  Kostrzewa</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Borczyk</span>, <span class="hlFld-ContribAuthor ">Marta  Bryk</span>, <span class="hlFld-ContribAuthor ">Jakub  Chwastek</span>, <span class="hlFld-ContribAuthor ">Michał  Korostyński</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Starowicz</span>. </span><span class="cited-content_cbyCitation_article-title">CB2 agonism controls pain and subchondral bone degeneration induced by mono-iodoacetate: Implications GPCR functional bias and tolerance development. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2021,</strong> <em>136 </em>, 111283. <a href="https://doi.org/10.1016/j.biopha.2021.111283" title="DOI URL">https://doi.org/10.1016/j.biopha.2021.111283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2021.111283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2021.111283%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DCB2%252Bagonism%252Bcontrols%252Bpain%252Band%252Bsubchondral%252Bbone%252Bdegeneration%252Binduced%252Bby%252Bmono-iodoacetate%25253A%252BImplications%252BGPCR%252Bfunctional%252Bbias%252Band%252Btolerance%252Bdevelopment%26aulast%3DMlost%26aufirst%3DJakub%26date%3D2021%26volume%3D136%26spage%3D111283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander S.  Kulikov</span>, <span class="hlFld-ContribAuthor ">Margarita A.  Epishina</span>, <span class="hlFld-ContribAuthor ">Egor S.  Zhilin</span>, <span class="hlFld-ContribAuthor ">Alexander D.  Shuvaev</span>, <span class="hlFld-ContribAuthor ">Leonid L.  Fershtat</span>, <span class="hlFld-ContribAuthor ">Nina N.  Makhova</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of pyrazolo[3,4-d]pyridazine 5,6-dioxides as novel NO-donors. </span><span class="cited-content_cbyCitation_journal-name">Mendeleev Communications</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 42-45. <a href="https://doi.org/10.1016/j.mencom.2021.01.012" title="DOI URL">https://doi.org/10.1016/j.mencom.2021.01.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mencom.2021.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mencom.2021.01.012%26sid%3Dliteratum%253Aachs%26jtitle%3DMendeleev%2520Communications%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bpyrazolo%25255B3%25252C4-d%25255Dpyridazine%252B5%25252C6-dioxides%252Bas%252Bnovel%252BNO-donors%26aulast%3DKulikov%26aufirst%3DAlexander%2BS.%26date%3D2021%26volume%3D31%26issue%3D1%26spage%3D42%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wan Pyo  Hong</span>, <span class="hlFld-ContribAuthor ">Inji  Shin</span>, <span class="hlFld-ContribAuthor ">Hee Nam  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in One-Pot Modular Synthesis of 2-Quinolones. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (22)
                                     , 5450. <a href="https://doi.org/10.3390/molecules25225450" title="DOI URL">https://doi.org/10.3390/molecules25225450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25225450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25225450%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252BOne-Pot%252BModular%252BSynthesis%252Bof%252B2-Quinolones%26aulast%3DHong%26aufirst%3DWan%2BPyo%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D22%26spage%3D5450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Mugnaini</span>, <span class="hlFld-ContribAuthor ">Antonella  Brizzi</span>, <span class="hlFld-ContribAuthor ">Giorgia  Vinciarelli</span>, <span class="hlFld-ContribAuthor ">Marco  Paolino</span>, <span class="hlFld-ContribAuthor ">Federico  Corelli</span>. </span><span class="cited-content_cbyCitation_article-title">New synthesis of N1- and N2-substituted pyrazolo[4,3-
              b
              ]pyridine-5-one derivatives as CB2 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (37)
                                     , 16218-16226. <a href="https://doi.org/10.1039/D0NJ03400B" title="DOI URL">https://doi.org/10.1039/D0NJ03400B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ03400B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ03400B%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DNew%252Bsynthesis%252Bof%252BN1-%252Band%252BN2-substituted%252Bpyrazolo%25255B4%25252C3-%252Bb%252B%25255Dpyridine-5-one%252Bderivatives%252Bas%252BCB2%252Breceptor%252Bligands%26aulast%3DMugnaini%26aufirst%3DClaudia%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D37%26spage%3D16218%26epage%3D16226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Selected CB2 Agonists in Clinical Development</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Representative Examples of Quinolones as Potent and Selective CB2R Ligands</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Design of Novel 7-Hydroxypyrazolo[4,3-<i>b</i>]pyridine-5-one Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>, acetone, 50 °C, 2 h; (b) 2-bromoethyl acetate, KI, K<sub>2</sub>CO<sub>3</sub>, acetone, 50 °C, 24 h.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Fe, CaCl<sub>2</sub>, EtOH, H<sub>2</sub>O, 60 °C, 3 h; (b) appropriate alkyl iodide or bromide, dry <i>N</i>,<i>N</i>-dimethylformamide (DMF), 50 °C, 6–8 h; (c) 3-chloro-3-oxopropionate, NEt<sub>3</sub>, dry DCM, room temperature (rt), 2 h.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, MeOH (cat.), dry THF, 60 °C, 2 h; (b) 1-aminoadamantane or 3-aminoadamantan-1-ol, THF, toluene, reflux, 1–2 h; (c) 10% NaOH, H<sub>2</sub>O, reflux, 1 h; (d) AcCl, NEt<sub>3</sub>, dry DCM, rt, 2.5 h.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0012.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Concentration–response curves of compounds in the cAMP Hunter assay enzyme fragment complementation chemiluminescent detection kit. The curves show the effect of increasing concentrations of compounds on NKH-477-induced cAMP levels in stable CHO cells expressing the human CB2R. Effect of JWH-133 is reported as a reference compound. Data are reported as means ± standard error of the mean (SEM) of three independent experiments conducted in triplicate and were normalized considering the NKH-477 stimulus alone as 100% of the response as indicated in the experimental session. EC<sub>50</sub> was determined by GraphPad Prism 5 as the concentration that provokes the response halfway between the baseline (bottom) and maximum response (top) of the fitted dose–response.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Concentration–response curves of compounds in the cAMP Hunter assay. Curves show the effect of increasing concentrations of compounds on NKH-477-induced cAMP levels and in the presence of an EC<sub>80</sub> CB2-ligand challenge (4 μM of JWH-133), in stable CHO cells expressing the human CB2. Data are reported as means ± SEM of three independent experiments conducted in triplicate and were normalized to the maximal and minimal responses as indicated in the experimental session. EC<sub>50</sub> was determined by GraphPad Prism 5 as the concentration that provokes the response halfway between the baseline (bottom) and maximum response (top) of the fitted dose–response.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time course and effect of acute, systemic treatment with compound <b>51</b> alone or in combination with the CB2 receptor antagonist AM-630 on hind limb joint hypersensitivity in osteoarthritic rats (PAM test). After 21 or 28 days of injection with 1 mg of MIA, rats received compound <b>51</b> (1 mg/kg) intraperitoneally (i.p.), and the hind limb withdrawal threshold was assessed during a 300 min period. Compound <b>51</b> triggered a statistically significant analgesic effect (*<i>p</i> < 0.05 and **<i>p</i> < 0.01) compared to the vehicle group at 60, 120, and 180 min post administration recordings. A systemic preadministration of AM-630 (1 mg/kg, i.p.) reduced the analgesic effect of compound <b>51</b> with statistical significance (#<i>p</i> < 0.05) 120 min post injection. Data are presented as maximal possible effect (%MPE) ± SEM. Male Wistar rats were used in the study and divided into four experimental groups with <i>n</i> = 17 for vehicle, <i>n</i> = 10 for compound <b>51</b>, <i>n</i> = 10 for AM-630 + compound <b>51</b>, and <i>n</i> = 6 for AM-630. Statistical analysis was performed using analysis of variance (ANOVA) followed by the Tukey post hoc test. The values with *<i>p</i> < 0.05 were considered significant. * denotes significant differences vs the vehicle, and # denotes significant differences vs compound <b>51</b> (1 mg/kg).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of acute systemic administration of compound <b>51</b> alone or in combination with the CB2R antagonist AM-630 on the kinetic-weight-bearing (KWB) test of MIA rats. On days 21 and 28 post OA induction, MIA rats were monitored for differences in forces applied on both rear paws during free walking movements and mechanical loading. The intraperitoneal (i.p.) administration of compound <b>51</b> (1 mg/kg) restored the differences in forces applied between rear left and rear right (injured) paws 60 min post administration. A systemic preadministration of AM-630 (1 mg/kg, i.p.) decreased the analgesic effect of compound <b>51</b> by reducing the force applied on the rear right (injured) paw, resulting in a disruption of rats’ walking patterns. Data are presented as means ± SEM. Male Wistar rats were used in the study and divided into four experimental groups with <i>n</i> = 22 for vehicle, <i>n</i> = 10 for compound <b>51</b>, <i>n</i> = 10 for AM-630 + compound <b>51</b>, and <i>n</i> = 5 for AM-630. Statistical analysis was performed using analysis of variance (ANOVA) followed by Bonferroni’s post hoc test. The values with *<i>p</i> < 0.05 were considered significant. * denotes significant differences between rear left vs rear right paws in each group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/medium/jm0c00595_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound <b>51</b> treatment alone or in combination with the CB2R antagonist AM-630 on IL-1β expression in human osteoarthritic chondrocytes (HC-OA) stimulated with TNFα. HC-OAs derived from human articular cartilage of donors with OA were stimulated with TNFα (50 ng/mL), and the inflammatory responses were measured by expression of the <i>Il1B</i> gene encoding for IL-1β. Treatment with 10 μM of compound <b>51</b> significantly reduced (<i>p</i> < 0.001) the mRNA levels of IL-1β in the presence of TNFα. Cotreatment with AM-630 (1 μM) abolished the anti-inflammatory effect of compound <b>51</b>, restoring the high expression of <i>Il1B</i>. Data are presented as fold change (means ± SEM) normalized to expression of the reference gene <i>B2m</i> and compared to the vehicle-treated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00595/20200701/images/large/jm0c00595_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00595&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridgett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laslett, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicuttini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchbinder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, L.</span></span> <span> </span><span class="NLM_article-title">The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study</span>. <i>Ann. Rheum. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">1323</span>– <span class="NLM_lpage">1330</span>, <span class="refDoi"> DOI: 10.1136/annrheumdis-2013-204763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1136%2Fannrheumdis-2013-204763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=24553908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC2cvmsVyntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=1323-1330&author=M.+Crossauthor=E.+Smithauthor=D.+Hoyauthor=S.+Nolteauthor=I.+Ackermanauthor=M.+Fransenauthor=L.+Bridgettauthor=S.+Williamsauthor=F.+Guilleminauthor=C.+L.+Hillauthor=L.+L.+Laslettauthor=G.+Jonesauthor=F.+Cicuttiniauthor=R.+Osborneauthor=T.+Vosauthor=R.+Buchbinderauthor=A.+Woolfauthor=L.+March&title=The+global+burden+of+hip+and+knee+osteoarthritis%3A+estimates+from+the+global+burden+of+disease+2010+study&doi=10.1136%2Fannrheumdis-2013-204763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study</span></div><div class="casAuthors">Cross Marita; Smith Emma; March Lyn; Hoy Damian; Nolte Sandra; Ackerman Ilana; Fransen Marlene; Bridgett Lisa; Williams Sean; Guillemin Francis; Hill Catherine L; Laslett Laura L; Jones Graeme; Cicuttini Flavia; Osborne Richard; Vos Theo; Buchbinder Rachelle; Woolf Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the rheumatic diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1323-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To estimate the global burden of hip and knee osteoarthritis (OA) as part of the Global Burden of Disease 2010 study and to explore how the burden of hip and knee OA compares with other conditions.  METHODS:  Systematic reviews were conducted to source age-specific and sex-specific epidemiological data for hip and knee OA prevalence, incidence and mortality risk.  The prevalence and incidence of symptomatic, radiographic and self-reported hip or knee OA were included.  Three levels of severity were defined to derive disability weights (DWs) and severity distribution (proportion with mild, moderate and severe OA).  The prevalence by country and region was multiplied by the severity distribution and the appropriate disability weight to calculate years of life lived with disability (YLDs).  As there are no deaths directly attributed to OA, YLDs equate disability-adjusted life years (DALYs).  RESULTS:  Globally, of the 291 conditions, hip and knee OA was ranked as the 11th highest contributor to global disability and 38th highest in DALYs.  The global age-standardised prevalence of knee OA was 3.8% (95% uncertainty interval (UI) 3.6% to 4.1%) and hip OA was 0.85% (95% UI 0.74% to 1.02%), with no discernible change from 1990 to 2010.  Prevalence was higher in females than males.  YLDs for hip and knee OA increased from 10.5 million in 1990 (0.42% of total DALYs) to 17.1 million in 2010 (0.69% of total DALYs).  CONCLUSIONS:  Hip and knee OA is one of the leading causes of global disability.  Methodological issues within this study make it highly likely that the real burden of OA has been underestimated.  With the aging and increasing obesity of the world's population, health professions need to prepare for a large increase in the demand for health services to treat hip and knee OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTF9urCTR9QCN1QT_1O5WBYfW6udTcc2ebKOgCaQxy_Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvmsVyntw%253D%253D&md5=d18c2d7ce5365e65cd7f2b62cceed20c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2013-204763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2013-204763%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DHoy%26aufirst%3DD.%26aulast%3DNolte%26aufirst%3DS.%26aulast%3DAckerman%26aufirst%3DI.%26aulast%3DFransen%26aufirst%3DM.%26aulast%3DBridgett%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DGuillemin%26aufirst%3DF.%26aulast%3DHill%26aufirst%3DC.%2BL.%26aulast%3DLaslett%26aufirst%3DL.%2BL.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DCicuttini%26aufirst%3DF.%26aulast%3DOsborne%26aufirst%3DR.%26aulast%3DVos%26aufirst%3DT.%26aulast%3DBuchbinder%26aufirst%3DR.%26aulast%3DWoolf%26aufirst%3DA.%26aulast%3DMarch%26aufirst%3DL.%26atitle%3DThe%2520global%2520burden%2520of%2520hip%2520and%2520knee%2520osteoarthritis%253A%2520estimates%2520from%2520the%2520global%2520burden%2520of%2520disease%25202010%2520study%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2014%26volume%3D73%26spage%3D1323%26epage%3D1330%26doi%3D10.1136%2Fannrheumdis-2013-204763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mobasheri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bay-Jensen, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Spil, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, M. C.</span></span> <span> </span><span class="NLM_article-title">Osteoarthritis year in review 2016: biomarkers (biochemical markers)</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2016.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2016.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=28099838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC1c7mvFyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=199-208&author=A.+Mobasheriauthor=A.-C.+Bay-Jensenauthor=W.+E.+van+Spilauthor=J.+Larkinauthor=M.+C.+Levesque&title=Osteoarthritis+year+in+review+2016%3A+biomarkers+%28biochemical+markers%29&doi=10.1016%2Fj.joca.2016.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoarthritis Year in Review 2016: biomarkers (biochemical markers)</span></div><div class="casAuthors">Mobasheri A; Bay-Jensen A-C; van Spil W E; Larkin J; Levesque M C</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-208</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The aim of this "Year in Review" article is to summarize and discuss the implications of biochemical marker related articles published between the Osteoarthritis Research Society International (OARSI) 2015 Congress in Seattle and the OARSI 2016 Congress in Amsterdam.  METHODS:  The PubMed/MEDLINE bibliographic database was searched using the combined keywords: 'biomarker' and 'osteoarthritis'.  The PubMed/MEDLINE literature search was conducted using the Advanced Search Builder function (http://www.ncbi.nlm.nih.gov/pubmed/advanced).  RESULTS:  Over two hundred new biomarker-related papers were published during the literature search period.  Some papers identified new biomarkers whereas others explored the biological properties and clinical utility of existing markers.  There were specific references to several adipocytokines including leptin and adiponectin.  ADAM Metallopeptidase with Thrombospondin Type 1 motif 4 (ADAMTS-4) and aggrecan ARGS neo-epitope fragment (ARGS) in synovial fluid (SF) and plasma chemokine (CeC motif) ligand 3 (CCL3) were reported as potential new knee biomarkers.  New and refined proteomic technologies and novel assays including a fluoro-microbead guiding chip (FMGC) for measuring C-telopeptide of type II collagen (CTX-II) in serum and urine and a novel magnetic nanoparticle-based technology (termed magnetic capture) for collecting and concentrating CTX-II, were described this past year.  CONCLUSION:  There has been steady progress in osteoarthritis (OA) biomarker research in 2016.  Several novel biomarkers were identified and new technologies have been developed for measuring existing biomarkers.  However, there has been no "quantum leap" this past year and identification of novel early OA biomarkers remains challenging.  During the past year, OARSI published a set of recommendations for the use of soluble biomarkers in clinical trials, which is a major step forward in the clinical use of OA biomarkers and bodes well for future OA biomarker development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRh7LgapzYftZPq5LRczm8ffW6udTcc2ebKOgCaQxy_Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7mvFyhtQ%253D%253D&md5=2a7a089b856d23c825453f9587d62b41</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2016.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2016.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DMobasheri%26aufirst%3DA.%26aulast%3DBay-Jensen%26aufirst%3DA.-C.%26aulast%3Dvan%2BSpil%26aufirst%3DW.%2BE.%26aulast%3DLarkin%26aufirst%3DJ.%26aulast%3DLevesque%26aufirst%3DM.%2BC.%26atitle%3DOsteoarthritis%2520year%2520in%2520review%25202016%253A%2520biomarkers%2520%2528biochemical%2520markers%2529%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2017%26volume%3D25%26spage%3D199%26epage%3D208%26doi%3D10.1016%2Fj.joca.2016.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Schwefe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liedgens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergolizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrassi, G.</span></span> <span> </span><span class="NLM_article-title">The impact of pain on labor force participation, absenteeism and presenteeism in the European Union</span>. <i>J. Med. Econ.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">662</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.3111/13696998.2010.529379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.3111%2F13696998.2010.529379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=21034378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fitl2gtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=662-672&author=P.+Langleyauthor=G.+M%C3%BCller-Schwefeauthor=A.+Nicolaouauthor=H.+Liedgensauthor=J.+Pergolizziauthor=G.+Varrassi&title=The+impact+of+pain+on+labor+force+participation%2C+absenteeism+and+presenteeism+in+the+European+Union&doi=10.3111%2F13696998.2010.529379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of pain on labor force participation, absenteeism and presenteeism in the European Union</span></div><div class="casAuthors">Langley Paul; Muller-Schwefe Gerhard; Nicolaou Andrew; Liedgens Hiltrud; Pergolizzi Joseph; Varrassi Giustino</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medical economics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">662-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  The aims of this paper are to generate estimates of the association between the experience and burden of pain, by severity and frequency, with (1) labor force participation and workforce status in five EU countries (the UK, France, Spain, Germany and Italy) and (2) patterns of absenteeism and presenteeism for the employed workforce.  METHODS:  Data are from the internet-based 2008 National Health and Wellness Survey (NHWS).  This survey covers both those who report experiencing pain in the last month as well as the no pain population.  A series of regression models are developed with the no pain group as the reference category.  The impact of pain, categorized by severity and frequency reported, is assessed within a labor supply framework for (1) labor force participation and (2) absenteeism and presenteeism.  In the former case both binomial and multinomial logistic models are estimated; in the latter case ordered logit models are estimated.  RESULTS:  The results demonstrate that, in the context of health status, the experience of frequent severe and moderate pain has a dominant, independent and negative association with labor force participation and employment status as well as absenteeism and presenteeism.  The presence of severe daily pain is associated with a 20-point reduction in the probability of being employed full-time; with moderate daily pain associated with a 10-point reduction.  The impact of pain is far greater than the potential impact of other health status measures (e.g., chronic comorbidities and BMI).  The experience of pain, notably severe and frequent pain, also outstrips the impact of other health status factors in absenteeism and presenteeism.  CONCLUSIONS:  The experience of pain, in particular severe daily pain, has a substantial negative association with labor force participation in these five European countries as well as reported absenteeism and presenteeism.  As a measure of health status, it clearly outweighs other health status measures.  Whether or not pain is considered as a disease in its own right, the experience of chronic pain, as defined here, presents policy makers with a major challenge.  Programs to relieve the burden of pain in the community clearly have the potential for substantial benefits from societal, individual and employer perspectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSt1ZUAXLmuJJZoeNcnHOQ9fW6udTcc2ebKOgCaQxy_Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fitl2gtA%253D%253D&md5=46043ad4f0fdc5c8ba868d0e518138da</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3111%2F13696998.2010.529379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3111%252F13696998.2010.529379%26sid%3Dliteratum%253Aachs%26aulast%3DLangley%26aufirst%3DP.%26aulast%3DM%25C3%25BCller-Schwefe%26aufirst%3DG.%26aulast%3DNicolaou%26aufirst%3DA.%26aulast%3DLiedgens%26aufirst%3DH.%26aulast%3DPergolizzi%26aufirst%3DJ.%26aulast%3DVarrassi%26aufirst%3DG.%26atitle%3DThe%2520impact%2520of%2520pain%2520on%2520labor%2520force%2520participation%252C%2520absenteeism%2520and%2520presenteeism%2520in%2520the%2520European%2520Union%26jtitle%3DJ.%2520Med.%2520Econ.%26date%3D2010%26volume%3D13%26spage%3D662%26epage%3D672%26doi%3D10.3111%2F13696998.2010.529379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sofat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejindu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiely, P.</span></span> <span> </span><span class="NLM_article-title">What makes osteoarthritis painful? The evidence for local and central pain processing</span>. <i>Rheumatology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2157</span>– <span class="NLM_lpage">2165</span>, <span class="refDoi"> DOI: 10.1093/rheumatology/ker283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1093%2Frheumatology%2Fker283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=21954151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FhvFyquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=2157-2165&author=N.+Sofatauthor=V.+Ejinduauthor=P.+Kiely&title=What+makes+osteoarthritis+painful%3F+The+evidence+for+local+and+central+pain+processing&doi=10.1093%2Frheumatology%2Fker283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">What makes osteoarthritis painful? The evidence for local and central pain processing</span></div><div class="casAuthors">Sofat Nidhi; Ejindu Vivian; Kiely Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology (Oxford, England)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2157-65</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OA is a chronic arthritic disease characterized by pain, local tissue damage and attempts at tissue repair.  Historically, cartilage damage was believed to be the hallmark of OA.  However, since cartilage is an avascular, aneural tissue, the mechanisms of pain are likely to be complex and influenced by non-cartilaginous structures in the joint including the synovium, bone and soft tissue.  Imaging studies reveal the presence of synovitis and bone marrow lesions that may mediate pain.  The presence of local joint inflammation and altered cartilage and bone turnover in OA implicates a potential role for a range of molecular mediators in OA pain.  Mechanisms of pain perception may include the activation and release of local pro-inflammatory mediators such as prostaglandins and cytokines accompanied by the destruction of tissue, which is mediated by proteases.  However, clinically, there is often disparity between the degree of pain perception and the extent of joint changes in subjects with OA.  Such observations have prompted work to investigate the mechanisms of central pain perception in OA.  Functional MRI has identified multiple areas of the brain that are involved in OA pain processing.  These data demonstrate that pain perception in OA is complex in being influenced by local factors and activation of central pain-processing pathways.  In this review, we will discuss current concepts underlying the pathophysiology of pain perception in OA and suggest possible directions for the future management of pain in this condition based on recent clinical studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwAtVd0AxeVhfKb6ELK8t0fW6udTcc2ebQrqA-BC2gkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FhvFyquw%253D%253D&md5=901c18aa908bb43df2c5b0e6a77549bc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fker283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fker283%26sid%3Dliteratum%253Aachs%26aulast%3DSofat%26aufirst%3DN.%26aulast%3DEjindu%26aufirst%3DV.%26aulast%3DKiely%26aufirst%3DP.%26atitle%3DWhat%2520makes%2520osteoarthritis%2520painful%253F%2520The%2520evidence%2520for%2520local%2520and%2520central%2520pain%2520processing%26jtitle%3DRheumatology%26date%3D2011%26volume%3D50%26spage%3D2157%26epage%3D2165%26doi%3D10.1093%2Frheumatology%2Fker283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berenbaum, F.</span></span> <span> </span><span class="NLM_article-title">Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2012.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2012.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=23194896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3s7nsFakuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=16-21&author=F.+Berenbaum&title=Osteoarthritis+as+an+inflammatory+disease+%28osteoarthritis+is+not+osteoarthrosis%21%29&doi=10.1016%2Fj.joca.2012.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)</span></div><div class="casAuthors">Berenbaum F</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Osteoarthritis (OA) has long been considered a "wear and tear" disease leading to loss of cartilage.  OA used to be considered the sole consequence of any process leading to increased pressure on one particular joint or fragility of cartilage matrix.  Progress in molecular biology in the 1990s has profoundly modified this paradigm.  The discovery that many soluble mediators such as cytokines or prostaglandins can increase the production of matrix metalloproteinases by chondrocytes led to the first steps of an "inflammatory" theory.  However, it took a decade before synovitis was accepted as a critical feature of OA, and some studies are now opening the way to consider the condition a driver of the OA process.  Recent experimental data have shown that subchondral bone may have a substantial role in the OA process, as a mechanical damper, as well as a source of inflammatory mediators implicated in the OA pain process and in the degradation of the deep layer of cartilage.  Thus, initially considered cartilage driven, OA is a much more complex disease with inflammatory mediators released by cartilage, bone and synovium.  Low-grade inflammation induced by the metabolic syndrome, innate immunity and inflammaging are some of the more recent arguments in favor of the inflammatory theory of OA and highlighted in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1VMJujfUh4b5XHngOXiV_fW6udTcc2ebQrqA-BC2gkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7nsFakuw%253D%253D&md5=b4f1d68adb7cab7b51f5aa5076c358a4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2012.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2012.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DBerenbaum%26aufirst%3DF.%26atitle%3DOsteoarthritis%2520as%2520an%2520inflammatory%2520disease%2520%2528osteoarthritis%2520is%2520not%2520osteoarthrosis%2521%2529%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2013%26volume%3D21%26spage%3D16%26epage%3D21%26doi%3D10.1016%2Fj.joca.2012.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neogi, T.</span></span> <span> </span><span class="NLM_article-title">The epidemiology and impact of pain in osteoarthritis</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1145</span>– <span class="NLM_lpage">1153</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2013.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2013.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=23973124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3sbitlCitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1145-1153&author=T.+Neogi&title=The+epidemiology+and+impact+of+pain+in+osteoarthritis&doi=10.1016%2Fj.joca.2013.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The epidemiology and impact of pain in osteoarthritis</span></div><div class="casAuthors">Neogi T</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1145-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Osteoarthritis (OA) is the most common form of arthritis and a leading cause of disability worldwide, largely due to pain, the primary symptom of the disease.  The pain experience in knee OA in particular is well-recognized as typically transitioning from intermittent weight-bearing pain to a more persistent, chronic pain.  Methods to validly assess pain in OA studies have been developed to address the complex nature of the pain experience.  The etiology of pain in OA is recognized to be multifactorial, with both intra-articular and extra-articular risk factors.  Nonetheless, greater insights are needed into pain mechanisms in OA to enable rational mechanism-based management of pain.  Consequences of pain related to OA contribute to a substantial socioeconomic burden.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRazKlkC8sbaX6HPRus0rAafW6udTcc2ebQrqA-BC2gkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbitlCitw%253D%253D&md5=c1e5ce683218f7852814a8c6909b8143</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2013.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2013.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DNeogi%26aufirst%3DT.%26atitle%3DThe%2520epidemiology%2520and%2520impact%2520of%2520pain%2520in%2520osteoarthritis%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2013%26volume%3D21%26spage%3D1145%26epage%3D1153%26doi%3D10.1016%2Fj.joca.2013.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conaghan, P. G.</span></span> <span> </span><span class="NLM_article-title">Osteoarthritis in 2012: parallel evolution of OA phenotypes and therapies</span>. <i>Nat. Rev. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1038/nrrheum.2012.225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1038%2Fnrrheum.2012.225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=23296390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3s3nsVGrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=68-70&author=P.+G.+Conaghan&title=Osteoarthritis+in+2012%3A+parallel+evolution+of+OA+phenotypes+and+therapies&doi=10.1038%2Fnrrheum.2012.225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoarthritis in 2012: Parallel evolution of OA phenotypes and therapies</span></div><div class="casAuthors">Conaghan Philip G</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Rheumatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">68-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">2012 has witnessed new developments in targeted therapies for osteoarthritis, and in ways to identify those patients who might benefit most from their application.  Together, these advances could go some way to addressing the urgent need for disease-modifying treatments for this common disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmwv_ITNl9D-WhZTslLrfffW6udTcc2eZKcSKLdyTU27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3nsVGrtg%253D%253D&md5=dd1cf013a65185a99dd25b18880b11c4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2012.225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2012.225%26sid%3Dliteratum%253Aachs%26aulast%3DConaghan%26aufirst%3DP.%2BG.%26atitle%3DOsteoarthritis%2520in%25202012%253A%2520parallel%2520evolution%2520of%2520OA%2520phenotypes%2520and%2520therapies%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2013%26volume%3D9%26spage%3D68%26epage%3D70%26doi%3D10.1038%2Fnrrheum.2012.225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barr, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kingsbury, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowes, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaghan, P. G.</span></span> <span> </span><span class="NLM_article-title">A systematic review of the relationship between subchondral bone features, pain and structural pathology in peripheral joint osteoarthritis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>, <span class="NLM_elocation-id">228</span> <span class="refDoi"> DOI: 10.1186/s13075-015-0735-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1186%2Fs13075-015-0735-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=26303219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC287mtVWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&author=A.+J.+Barrauthor=T.+M.+Campbellauthor=D.+Hopkinsonauthor=S.+R.+Kingsburyauthor=M.+A.+Bowesauthor=P.+G.+Conaghan&title=A+systematic+review+of+the+relationship+between+subchondral+bone+features%2C+pain+and+structural+pathology+in+peripheral+joint+osteoarthritis&doi=10.1186%2Fs13075-015-0735-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic review of the relationship between subchondral bone features, pain and structural pathology in peripheral joint osteoarthritis</span></div><div class="casAuthors">Barr Andrew J; Campbell T Mark; Kingsbury Sarah R; Conaghan Philip G; Campbell T Mark; Hopkinson Devan; Bowes Mike A</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis research & therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">228</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Bone is an integral part of the osteoarthritis (OA) process.  We conducted a systematic literature review in order to understand the relationship between non-conventional radiographic imaging of subchondral bone, pain, structural pathology and joint replacement in peripheral joint OA.  METHODS:  A search of the Medline, EMBASE and Cochrane library databases was performed for original articles reporting association between non-conventional radiographic imaging-assessed subchondral bone pathologies and joint replacement, pain or structural progression in knee, hip, hand, ankle and foot OA.  Each association was qualitatively characterised by a synthesis of the data from each analysis based upon study design, adequacy of covariate adjustment and quality scoring.  RESULTS:  In total 2456 abstracts were screened and 139 papers were included (70 cross-sectional, 71 longitudinal analyses; 116 knee, 15 hip, six hand, two ankle and involved 113 MRI, eight DXA, four CT, eight scintigraphic and eight 2D shape analyses).  BMLs, osteophytes and bone shape were independently associated with structural progression or joint replacement.  BMLs and bone shape were independently associated with longitudinal change in pain and incident frequent knee pain respectively.  CONCLUSION:  Subchondral bone features have independent associations with structural progression, pain and joint replacement in peripheral OA in the hip and hand but especially in the knee.  For peripheral OA sites other than the knee, there are fewer associations and independent associations of bone pathologies with these important OA outcomes which may reflect fewer studies; for example the foot and ankle were poorly studied.  Subchondral OA bone appears to be a relevant therapeutic target.  SYSTEMATIC REVIEW:  PROSPERO registration number: CRD 42013005009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6P81G1uHUXlUIs6wFK5xJfW6udTcc2eZKcSKLdyTU27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287mtVWjtA%253D%253D&md5=99c251e15b807920260f218a33a29e6f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2Fs13075-015-0735-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13075-015-0735-x%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26aulast%3DCampbell%26aufirst%3DT.%2BM.%26aulast%3DHopkinson%26aufirst%3DD.%26aulast%3DKingsbury%26aufirst%3DS.%2BR.%26aulast%3DBowes%26aufirst%3DM.%2BA.%26aulast%3DConaghan%26aufirst%3DP.%2BG.%26atitle%3DA%2520systematic%2520review%2520of%2520the%2520relationship%2520between%2520subchondral%2520bone%2520features%252C%2520pain%2520and%2520structural%2520pathology%2520in%2520peripheral%2520joint%2520osteoarthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2015%26volume%3D17%26doi%3D10.1186%2Fs13075-015-0735-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fusco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaper, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coaccioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrassi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paladini, A.</span></span> <span> </span><span class="NLM_article-title">Degenerative joint diseases and neuroinflammation</span>. <i>Pain Pract.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.1111/papr.12551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1111%2Fpapr.12551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=28039964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC1c7htVSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=522-532&author=M.+Fuscoauthor=S.+D.+Skaperauthor=S.+Coaccioliauthor=G.+Varrassiauthor=A.+Paladini&title=Degenerative+joint+diseases+and+neuroinflammation&doi=10.1111%2Fpapr.12551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Degenerative Joint Diseases and Neuroinflammation</span></div><div class="casAuthors">Fusco Mariella; Skaper Stephen D; Coaccioli Stefano; Varrassi Giustino; Varrassi Giustino; Paladini Antonella</div><div class="citationInfo"><span class="NLM_cas:title">Pain practice : the official journal of World Institute of Pain</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">522-532</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Rheumatic and joint diseases, as exemplified by osteoarthritis and rheumatoid arthritis, are among the most widespread painful and disabling pathologies across the globe.  Given the continuing rise in life expectancy, their prevalence is destined to grow.  Osteoarthritis, a degenerative joint disease, is, in particular, on its way to becoming the fourth leading cause of disability worldwide by 2020, with the rising incidence of obesity in addition to age being important factors.  It is estimated that 25% of osteoarthritic individuals are unable to perform daily activities.  Accompanying osteoarthritis is rheumatoid arthritis, which is a chronic systemic disease that often causes pain and deformity.  At least 50% of those affected are unable to remain gainfully employed within 10 years of disease onset.  A growing body of evidence now points to inflammation, locally and more systemically, as a promoter of damage to joints and bones, as well as joint-related functional deficits.  The pathogenesis underlying joint diseases remains unclear; however, it is currently believed that cross-talk between cartilage and subchondral bone-and loss of balance between these two structures in joint diseases-is a critical element.  This view is amplified by the presence of mast cells, whose dysregulation is associated with alterations of junction structures (cartilage, bone, synovia, matrix, nerve endings, and blood vessels).  In addition, persistent activation of mast cells facilitates the development of spinal neuroinflammation mediated through their interaction with microglia.  Unfortunately, current treatment strategies for rheumatic and articular disease are symptomatic and do little to limit disease progression.  Research now should be directed at therapeutic modalities that target osteoarticular structural elements and thereby delaying disease progression and joint replacement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGgpNDCeoMfgpJitSxOdIlfW6udTcc2eZKcSKLdyTU27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7htVSjuw%253D%253D&md5=63801b84dd343dcaf8f4f7b20cb9c51e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fpapr.12551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpapr.12551%26sid%3Dliteratum%253Aachs%26aulast%3DFusco%26aufirst%3DM.%26aulast%3DSkaper%26aufirst%3DS.%2BD.%26aulast%3DCoaccioli%26aufirst%3DS.%26aulast%3DVarrassi%26aufirst%3DG.%26aulast%3DPaladini%26aufirst%3DA.%26atitle%3DDegenerative%2520joint%2520diseases%2520and%2520neuroinflammation%26jtitle%3DPain%2520Pract.%26date%3D2017%26volume%3D17%26spage%3D522%26epage%3D532%26doi%3D10.1111%2Fpapr.12551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Luteolin inhibits IL-1β-induced inflammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">1586</span>– <span class="NLM_lpage">1592</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.09.161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.biopha.2018.09.161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=30551412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aqs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2019&pages=1586-1592&author=J.+Feiauthor=B.+Liangauthor=C.+Jiangauthor=H.+Niauthor=L.+Wang&title=Luteolin+inhibits+IL-1%CE%B2-induced+inflammation+in+rat+chondrocytes+and+attenuates+osteoarthritis+progression+in+a+rat+model&doi=10.1016%2Fj.biopha.2018.09.161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Luteolin inhibits IL-1β-induced inflammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model</span></div><div class="casAuthors">Fei, Junliang; Liang, Bin; Jiang, Chunzhi; Ni, Haifeng; Wang, Liming</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1586-1592</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Osteoarthritis (OA) is a joint disease characterized by inflammation and cartilage degrdn.  Accumulating evidence has demonstrated that luteolin, a natural flavonoid, has anti-inflammatory and anticatabolic effects.  The present study aimed to assess the protective effect of luteolin on interleukin (IL)-1β-stimulated rat chondrocytes and a monosodium iodoacetate (MIA)-induced model of OA.  Rat chondrocytes were pretreated with luteolin (0, 25, 50, and 100 μM for 12 h) prior to stimulation with IL-1β (10 ng/mL for 24 h).  Nitric oxide (NO) prodn. was detd. using the Griess method.  Prodn. of prostaglandin E2 (PGE2), tumor necrosis factor-α (TNF-α), and matrix metalloproteinase-2, -8, and -9 (MMP-2, MMP-8 and MMP-9) was measured by an ELISA (ELISA).  Protein levels of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), MMP-1, MMP-3, MMP-13, p65, p-p65, IκB, and p-IκB were detd. by Western blotting.  The OA rats received luteolin (10 mg/kg/day) by gavage in vivo.  Morphol. and ultrastructural SEM (SEM) observations were performed to assess the severity of OA at 45 days following MIA injection.  Collagen II protein expression was detd. by immunohistochem.  In this study, luteolin considerably reduced the IL-1β-induced prodn. of NO, PGE2, TNF-α, MMP-2, MMP-8 and MMP-9 and the expression of COX-2, iNOS, MMP-1, MMP-3 and MMP-13.  Luteolin reversed the degrdn. of collagen II induced by IL-1β.  Luteolin also significantly inhibited IL-1β-induced phosphorylation of NF-κB in vitro.  Luteolin treatment prevented cartilage destruction and enhanced collagen II expression in OA rats in vivo.  Overall, our findings suggest that luteolin may be a useful therapeutic agent for patients with OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCmRIMUgFbd7Vg90H21EOLACvtfcHk0ljpKyjzj76nww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aqs7zE&md5=3f1cd5e569c40fe51f3f638b1d108b3b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.09.161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.09.161%26sid%3Dliteratum%253Aachs%26aulast%3DFei%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DNi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26atitle%3DLuteolin%2520inhibits%2520IL-1%25CE%25B2-induced%2520inflammation%2520in%2520rat%2520chondrocytes%2520and%2520attenuates%2520osteoarthritis%2520progression%2520in%2520a%2520rat%2520model%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D109%26spage%3D1586%26epage%3D1592%26doi%3D10.1016%2Fj.biopha.2018.09.161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dass, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Current research on pharmacologic and regenerative therapies for osteoarthritis</span>. <i>Bone Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">15040</span> <span class="refDoi"> DOI: 10.1038/boneres.2015.40</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1038%2Fboneres.2015.40" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=26962464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsVGrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&author=W.+Zhangauthor=H.+Ouyangauthor=C.+R.+Dassauthor=J.+Xu&title=Current+research+on+pharmacologic+and+regenerative+therapies+for+osteoarthritis&doi=10.1038%2Fboneres.2015.40"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Current research on pharmacologic and regenerative therapies for osteoarthritis</span></div><div class="casAuthors">Zhang, Wei; Ouyang, Hongwei; Dass, Crispin R.; Xu, Jiake</div><div class="citationInfo"><span class="NLM_cas:title">Bone Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15040</span>CODEN:
                <span class="NLM_cas:coden">BROEBB</span>;
        ISSN:<span class="NLM_cas:issn">2095-6231</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Osteoarthritis (OA) is a degenerative joint disorder commonly encountered in clin. practice, and is the leading cause of disability in elderly people.  Due to the poor self-healing capacity of articular cartilage and lack of specific diagnostic biomarkers, OA is a challenging disease with limited treatment options.  Traditional pharmacol. therapies such as acetaminophen, non-steroidal anti-inflammatory drugs, and opioids are effective in relieving pain but are incapable of reversing cartilage damage and are frequently assocd. with adverse events.  Current research focuses on the development of new OA drugs (such as sprifermin/recombinant human fibroblast growth factor-18, tanezumab/monoclonal antibody against β-nerve growth factor), which aims for more effectiveness and less incidence of adverse effects than the traditional ones.  Furthermore, regenerative therapies (such as autologous chondrocyte implantation (ACI), new generation of matrix-induced ACI, cell-free scaffolds, induced pluripotent stem cells (iPS cells or iPSCs), and endogenous cell homing) are also emerging as promising alternatives as they have potential to enhance cartilage repair, and ultimately restore healthy tissue.  However, despite currently available therapies and research advances, there remain unmet medical needs in the treatment of OA.  This review highlights current research progress on pharmacol. and regenerative therapies for OA including key advances and potential limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUE51uozYy4rVg90H21EOLACvtfcHk0ljpKyjzj76nww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsVGrsL8%253D&md5=db9760575108f854400d877b1b0ebe89</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fboneres.2015.40&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fboneres.2015.40%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DOuyang%26aufirst%3DH.%26aulast%3DDass%26aufirst%3DC.%2BR.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DCurrent%2520research%2520on%2520pharmacologic%2520and%2520regenerative%2520therapies%2520for%2520osteoarthritis%26jtitle%3DBone%2520Res.%26date%3D2016%26volume%3D4%26doi%3D10.1038%2Fboneres.2015.40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mobasheri, A.</span></span> <span> </span><span class="NLM_article-title">The future of osteoarthritis therapeutics: targeted pharmacological therapy</span>. <i>Curr. Rheumatol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>, <span class="NLM_elocation-id">364</span> <span class="refDoi"> DOI: 10.1007/s11926-013-0364-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1007%2Fs11926-013-0364-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=24061701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252Fgs1ehuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&author=A.+Mobasheri&title=The+future+of+osteoarthritis+therapeutics%3A+targeted+pharmacological+therapy&doi=10.1007%2Fs11926-013-0364-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The future of osteoarthritis therapeutics: targeted pharmacological therapy</span></div><div class="casAuthors">Mobasheri A</div><div class="citationInfo"><span class="NLM_cas:title">Current rheumatology reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">364</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Osteoarthritis (OA) is one of the most common forms of degenerative joint disease and a major cause of pain and disability affecting the aging population.  It is estimated that more than 20 million Americans and 35 to 40 million Europeans suffer from OA.  Analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) are the only therapeutic treatment options for OA.  Effective pharmacotherapy for OA, capable of restoring the original structure and function of damaged cartilage and other synovial tissue, is urgently needed, and research into such disease-modifying osteoarthritis drugs (DMOADs) is in progress.  This is the first of three reviews focusing on OA therapeutics.  This paper provides an overview of current research into potential structure-modifying drugs and more appropriately targeted pharmacological therapy.  The challenges and opportunities in this area of research and development are reviewed, covering the most up-to-date initiatives, trends, and topics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRl0aBOqVQRApJitSxOdIlfW6udTcc2eZQjpbbA7VMb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252Fgs1ehuw%253D%253D&md5=aa216df9e64e986e9df81a31427652cc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs11926-013-0364-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11926-013-0364-9%26sid%3Dliteratum%253Aachs%26aulast%3DMobasheri%26aufirst%3DA.%26atitle%3DThe%2520future%2520of%2520osteoarthritis%2520therapeutics%253A%2520targeted%2520pharmacological%2520therapy%26jtitle%3DCurr.%2520Rheumatol.%2520Rep.%26date%3D2013%26volume%3D15%26doi%3D10.1007%2Fs11926-013-0364-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolait, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brownstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, T. I.</span></span> <span> </span><span class="NLM_article-title">Structure of a cannabinoid receptor and functional expression of the cloned cDNA</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1038/346561a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1038%2F346561a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=2165569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=561-564&author=L.+A.+Matsudaauthor=S.+J.+Lolaitauthor=M.+J.+Brownsteinauthor=A.+C.+Youngauthor=T.+I.+Bonner&title=Structure+of+a+cannabinoid+receptor+and+functional+expression+of+the+cloned+cDNA&doi=10.1038%2F346561a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a cannabinoid receptor and functional expression of the cloned cDNA</span></div><div class="casAuthors">Matsuda, Lisa A.; Lolait, Stephen J.; Brownstein, Michael J.; Young, Alice C.; Bonner, Tom I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6284</span>),
    <span class="NLM_cas:pages">561-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner.  CNS depression and analgesia are well documented effects of the cannabinoids, but the mechanisms responsible for the cannabinoid-induced effects are not known.  The hydrophobic nature of these substances has suggested that cannabinoids resemble anesthetic agents in their action and nonspecifically disrupt cellular membranes.  Recent evidence has supported a mechanism involving a G-protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner.  Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids.  This study reported the cloning and expression of a cDNA that encodes a G-protein-coupled receptor with all of these properties.  Its mRNA is found in cell lines and regions of the brain that have cannabinoid receptors.  This protein may be involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrydatT83mLVg90H21EOLACvtfcHk0ljpKyjzj76nww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D&md5=a99aeb39544d87392cee18b82a08003d</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2F346561a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F346561a0%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DL.%2BA.%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DBrownstein%26aufirst%3DM.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BC.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26atitle%3DStructure%2520of%2520a%2520cannabinoid%2520receptor%2520and%2520functional%2520expression%2520of%2520the%2520cloned%2520cDNA%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D561%26epage%3D564%26doi%3D10.1038%2F346561a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Shaar, M.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of a peripheral receptor for cannabinoids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/365061a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1038%2F365061a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=7689702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1993&pages=61-65&author=S.+Munroauthor=K.+L.+Thomasauthor=M.+Abu-Shaar&title=Molecular+characterization+of+a+peripheral+receptor+for+cannabinoids&doi=10.1038%2F365061a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of a peripheral receptor for cannabinoids</span></div><div class="casAuthors">Munro, Sean; Thomas, Kerrie L.; Abu-Shaar, Muna</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">6441</span>),
    <span class="NLM_cas:pages">61-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The major active ingredient of marijuana, Δ9-tetrahydrocannabinol (Δ-THC), has been used as a psychoactive agent for thousands of years.  Marijuana, and Δ9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting.  The clin. application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochem. bases of their action.  Progress stemmed initially from the synthesis of potent derivs. of Δ9-THC4,5, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids.  This receptor is expressed in the brain but not in the periphery, except for a low level in testes.  It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins.  Here the authors report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHsq4vy1XH17Vg90H21EOLACvtfcHk0lhchkoLmd20RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D&md5=476435b57bd0f24483e2f24b813cc32f</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1038%2F365061a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F365061a0%26sid%3Dliteratum%253Aachs%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DK.%2BL.%26aulast%3DAbu-Shaar%26aufirst%3DM.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520peripheral%2520receptor%2520for%2520cannabinoids%26jtitle%3DNature%26date%3D1993%26volume%3D365%26spage%3D61%26epage%3D65%26doi%3D10.1038%2F365061a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: A personal perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">3891</span>– <span class="NLM_lpage">3911</span>, <span class="refDoi"> DOI: 10.1021/jm500220s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500220s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsl2ksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=3891-3911&author=A.+Makriyannis&title=2012+Division+of+medicinal+chemistry+award+address.+Trekking+the+cannabinoid+road%3A+A+personal+perspective&doi=10.1021%2Fjm500220s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">2012 Division of Medicinal Chemistry Award Address. Trekking the Cannabinoid Road: A Personal Perspective</span></div><div class="casAuthors">Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3891-3911</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  My involvement with the field of cannabinoids spans close to 3 decades and covers a major part of my scientific career.  It also reflects the robust progress in this initially largely unexplored area of biol.  During this period of time, I have witnessed the growth of modern cannabinoid biol., starting from the discovery of its two receptors and followed by the characterization of its endogenous ligands and the identification of the enzyme systems involved in their biosynthesis and biotransformation.  I was fortunate enough to start at the beginning of this new era and participate in a no. of the new discoveries.  It has been a very exciting journey.  With coverage of some key aspects of my work during this period of "modern cannabinoid research," this Award Address, in part historical, intends to give an account of how the field grew, the key discoveries, and the most promising directions for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou2fYLXIvugrVg90H21EOLACvtfcHk0lhchkoLmd20RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsl2ksbk%253D&md5=8af59d7e9f5047d6c8fadabbb3ed9972</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm500220s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500220s%26sid%3Dliteratum%253Aachs%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3D2012%2520Division%2520of%2520medicinal%2520chemistry%2520award%2520address.%2520Trekking%2520the%2520cannabinoid%2520road%253A%2520A%2520personal%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D3891%26epage%3D3911%26doi%3D10.1021%2Fjm500220s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trembovler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrosini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casap, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shteyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karsak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yirmiya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shohami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bab, I.</span></span> <span> </span><span class="NLM_article-title">The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1096/fj.06-7957com</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1096%2Ffj.06-7957com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=17704191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=285-294&author=J.+Tamauthor=V.+Trembovlerauthor=V.+Di+Marzoauthor=S.+Petrosiniauthor=G.+Leoauthor=A.+Alexandrovichauthor=E.+Regevauthor=N.+Casapauthor=A.+Shteyerauthor=C.+Ledentauthor=M.+Karsakauthor=A.+Zimmerauthor=R.+Mechoulamauthor=R.+Yirmiyaauthor=E.+Shohamiauthor=I.+Bab&title=The+cannabinoid+CB1+receptor+regulates+bone+formation+by+modulating+adrenergic+signaling&doi=10.1096%2Ffj.06-7957com"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling</span></div><div class="casAuthors">Tam, Joseph; Trembovler, Victoria; Di Marzo, Vincenzo; Petrosino, Stefania; Leo, Gabriella; Alexandrovich, Alex; Regev, Eran; Casap, Nardy; Shteyer, Arie; Ledent, Catherine; Karsak, Meliha; Zimmer, Andreas; Mechoulam, Raphael; Yirmiya, Raz; Shohami, Esther; Bab, Itai</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">285-294, 10.1096/fj.06-7957com</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">We have recently reported that in bone the cannabinoid CB1 receptor is present in sympathetic terminals.  Here we show that traumatic brain injury (TBI), which in humans enhances peripheral osteogenesis and fracture healing, acutely stimulates bone formation in a distant skeletal site.  At this site we demonstrate (i) a high level of the main endocannabinoid, 2-arachidonoylglycerol (2-AG), and expression of diacylglycerol lipases, enzymes essential for 2-AG synthesis; (ii) that the TBI-induced increase in bone formation is preceded by elevation of the 2-AG and a decrease in norepinephrine (NE) levels.  The TBI stimulation of bone formation was absent in CB1-null mice.  In wild-type animals it could be mimicked, including the suppression of NE levels, by 2-AG administration.  The TBI- and 2-AG-induced stimulation of osteogenesis was restrained by the β-adrenergic receptor agonist isoproterenol.  NE from sympathetic terminals is known to tonically inhibit bone formation by activating osteoblastic β2-adrenergic receptors.  The present findings further demonstrate that the sympathetic control of bone formation is regulated through 2-AG activation of prejunctional CB1.  Elevation of bone 2-AG apparently suppresses NE release from bone sympathetic terminals, thus alleviating the inhibition of bone formation.  The involvement of osteoblastic CB2 signaling in this process is minimal, if any.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHBWEs2cC3IrVg90H21EOLACvtfcHk0lhchkoLmd20RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslWmsw%253D%253D&md5=18848f3beebb92be4b7a354ba8d4ea4f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1096%2Ffj.06-7957com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.06-7957com%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DTrembovler%26aufirst%3DV.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DPetrosini%26aufirst%3DS.%26aulast%3DLeo%26aufirst%3DG.%26aulast%3DAlexandrovich%26aufirst%3DA.%26aulast%3DRegev%26aufirst%3DE.%26aulast%3DCasap%26aufirst%3DN.%26aulast%3DShteyer%26aufirst%3DA.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DKarsak%26aufirst%3DM.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DYirmiya%26aufirst%3DR.%26aulast%3DShohami%26aufirst%3DE.%26aulast%3DBab%26aufirst%3DI.%26atitle%3DThe%2520cannabinoid%2520CB1%2520receptor%2520regulates%2520bone%2520formation%2520by%2520modulating%2520adrenergic%2520signaling%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D22%26spage%3D285%26epage%3D294%26doi%3D10.1096%2Ffj.06-7957com" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ofek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karsak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar-Namdar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shohami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bab, I.</span></span> <span> </span><span class="NLM_article-title">Peripheral cannabinoid receptor, CB2, regulates bone mass</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">696</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1073/pnas.0504187103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1073%2Fpnas.0504187103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=16407142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=696-701&author=O.+Ofekauthor=M.+Karsakauthor=N.+Leclercauthor=M.+Fogelauthor=B.+Frenkelauthor=K.+Wrightauthor=J.+Tamauthor=M.+Attar-Namdarauthor=V.+Kramauthor=E.+Shohamiauthor=R.+Mechoulamauthor=A.+Zimmerauthor=I.+Bab&title=Peripheral+cannabinoid+receptor%2C+CB2%2C+regulates+bone+mass&doi=10.1073%2Fpnas.0504187103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral cannabinoid receptor, CB2, regulates bone mass</span></div><div class="casAuthors">Ofek, Orr; Karsak, Meliha; Leclerc, Nathalie; Fogel, Meirav; Frenkel, Baruch; Wright, Karen; Tam, Joseph; Attar-Namdar, Malka; Kram, Vardit; Shohami, Esther; Mechoulam, Raphael; Zimmer, Andreas; Bab, Itai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">696-701</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The endogenous cannabinoids bind to and activate two G protein-coupled receptors, the predominantly central cannabinoid receptor type 1 (CB1) and peripheral cannabinoid receptor type 2 (CB2).  Whereas CB1 mediates the cannabinoid psychotropic, analgesic, and orectic effects, CB2 has been implicated recently in the regulation of liver fibrosis and atherosclerosis.  Here we show that CB2-deficient mice have a markedly accelerated age-related trabecular bone loss and cortical expansion, although cortical thickness remains unaltered.  These changes are reminiscent of human osteoporosis and may result from differential regulation of trabecular and cortical bone remodeling.  The CB2-/- phenotype is also characterized by increased activity of trabecular osteoblasts (bone-forming cells), increased osteoclast (the bone-resorbing cell) no., and a markedly decreased no. of diaphyseal osteoblast precursors.  CB2 is expressed in osteoblasts, osteocytes, and osteoclasts.  A CB2-specific agonist that does not have any psychotropic effects enhances endocortical osteoblast no. and activity and restrains trabecular osteoclastogenesis, apparently by inhibiting proliferation of osteoclast precursors and receptor activator of NF-κB ligand expression in bone marrow-derived osteoblasts/stromal cells.  The same agonist attenuates ovariectomy-induced bone loss and markedly stimulates cortical thickness through the resp. suppression of osteoclast no. and stimulation of endocortical bone formation.  These results demonstrate that the endocannabinoid system is essential for the maintenance of normal bone mass by osteoblastic and osteoclastic CB2 signaling.  Hence, CB2 offers a mol. target for the diagnosis and treatment of osteoporosis, the most prevalent degenerative disease in developed countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUeW3SSIrXSbVg90H21EOLACvtfcHk0lgqF0ehosPoUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhsr4%253D&md5=222e7dfb53af21baf8c0bc4d7bb71eac</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0504187103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0504187103%26sid%3Dliteratum%253Aachs%26aulast%3DOfek%26aufirst%3DO.%26aulast%3DKarsak%26aufirst%3DM.%26aulast%3DLeclerc%26aufirst%3DN.%26aulast%3DFogel%26aufirst%3DM.%26aulast%3DFrenkel%26aufirst%3DB.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DAttar-Namdar%26aufirst%3DM.%26aulast%3DKram%26aufirst%3DV.%26aulast%3DShohami%26aufirst%3DE.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DBab%26aufirst%3DI.%26atitle%3DPeripheral%2520cannabinoid%2520receptor%252C%2520CB2%252C%2520regulates%2520bone%2520mass%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D696%26epage%3D701%26doi%3D10.1073%2Fpnas.0504187103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maor, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bab, I.</span></span> <span> </span><span class="NLM_article-title">CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1335</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1111/nyas.12642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1111%2Fnyas.12642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=25573322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps1OqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1335&publication_year=2015&pages=110-119&author=E.+Wassermanauthor=J.+Tamauthor=R.+Mechoulamauthor=A.+Zimmerauthor=G.+Maorauthor=I.+Bab&title=CB1+cannabinoid+receptors+mediate+endochondral+skeletal+growth+attenuation+by+%CE%949-tetrahydrocannabinol&doi=10.1111%2Fnyas.12642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol</span></div><div class="casAuthors">Wasserman, Elad; Tam, Joseph; Mechoulam, Raphael; Zimmer, Andreas; Maor, Gila; Bab, Itai</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1335</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-119</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The endocannabinoid (EC) system regulates bone mass.  Because cannabis use during pregnancy results in stature shorter than normal, we examd. the role of the EC system in skeletal elongation.  We show that CB1 and CB2 cannabinoid receptors are expressed specifically in hypertrophic chondrocytes of the epiphyseal growth cartilage (EGC), which drives vertebrate growth.  These cells also express diacylglycerol lipases, crit. biosynthetic enzymes of the main EC, and 2-arachidonoylglycerol (2-AG), which is present at significant levels in the EGC.  Femora of CB1-and/or CB2-deficient mice at the end of the rapid growth phase are longer compared to wild-type (WT) animals.  We find that Δ9-tetrahydrocannabinol (THC) slows skeletal elongation of female WT and CB2-, but not CB1-, deficient mice, which is reflected in femoral and lumbar vertebral body length.  This in turn results in lower body wt., but unaltered fat content.  THC inhibits EGC chondrocyte hypertrophy in ex vivo cultures and reduces the hypertrophic cell zone thickness of CB1-, but not CB2-, deficient mice.  These results demonstrate a local growth-restraining EC system in the EGC.  The relevance of the present findings to humans remains to be studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkQb7W1XsY1rVg90H21EOLACvtfcHk0lgqF0ehosPoUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps1OqsLk%253D&md5=8570b41e99a15f3b96974018505223ca</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fnyas.12642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.12642%26sid%3Dliteratum%253Aachs%26aulast%3DWasserman%26aufirst%3DE.%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DMaor%26aufirst%3DG.%26aulast%3DBab%26aufirst%3DI.%26atitle%3DCB1%2520cannabinoid%2520receptors%2520mediate%2520endochondral%2520skeletal%2520growth%2520attenuation%2520by%2520%25CE%25949-tetrahydrocannabinol%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2015%26volume%3D1335%26spage%3D110%26epage%3D119%26doi%3D10.1111%2Fnyas.12642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S. M.</span></span> <span> </span><span class="NLM_article-title">The endocannabinoid system and its therapeutic implications in rheumatoid arthritis</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2015.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.intimp.2015.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=25791728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksF2ms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=86-91&author=H.+Guiauthor=Q.+Tongauthor=W.+Quauthor=C.+M.+Maoauthor=S.+M.+Dai&title=The+endocannabinoid+system+and+its+therapeutic+implications+in+rheumatoid+arthritis&doi=10.1016%2Fj.intimp.2015.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system and its therapeutic implications in rheumatoid arthritis</span></div><div class="casAuthors">Gui, Huan; Tong, Qiang; Qu, Wenchun; Mao, Chen-Mei; Dai, Sheng-Ming</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-91</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Since the discovery of the endogenous receptor for Δ9-tetrahydrocannabinol, a main constituent of marijuana, the endocannabinoid system (comprising cannabinoid receptors and their endogenous ligands, as well as the enzymes involved in their metabolic processes) has been implicated as having multiple regulatory functions in many central and peripheral conditions, including rheumatoid arthritis (RA).  RA is an immune-mediated inflammatory disease that is assocd. with the involvement of many kinds of cells (such as fibroblastlike synoviocytes [FLSs], osteoclasts, T cells, B cells, and macrophages) and mols. (such as interleukin-1β, tumor necrosis factor-α, interleukin-6, matrix metalloproteinases [MMPs], and chemokines).  Increasing evidence suggests that the endocannabinoid system, esp. cannabinoid receptor 2 (CB2), has an important role in the pathophysiol. of RA.  Many members of the endocannabinoid system are reported to inhibit synovial inflammation, hyperplasia, and cartilage destruction in RA.  In particular, specific activation of CB2 may relieve RA by inhibiting not only the prodn. of autoantibodies, proinflammatory cytokines, and MMPs, but also bone erosion, immune response mediated by T cells, and the proliferation of FLSs.  In this review, we will discuss the possible functions of the endocannabinoid system in the modulation of RA, which may be a potential target for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmJMSR5f15V7Vg90H21EOLACvtfcHk0lgqF0ehosPoUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksF2ms7w%253D&md5=281afe1ba88b1c4e6b838c978df79f05</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2015.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2015.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DGui%26aufirst%3DH.%26aulast%3DTong%26aufirst%3DQ.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DMao%26aufirst%3DC.%2BM.%26aulast%3DDai%26aufirst%3DS.%2BM.%26atitle%3DThe%2520endocannabinoid%2520system%2520and%2520its%2520therapeutic%2520implications%2520in%2520rheumatoid%2520arthritis%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2015%26volume%3D26%26spage%3D86%26epage%3D91%26doi%3D10.1016%2Fj.intimp.2015.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoresen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidarov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardern, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semple, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grottick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Shamma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of APD371: Identification of a highly potent and selective CB<sub>2</sub> agonist for the treatment of chronic pain</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1309</span>– <span class="NLM_lpage">1313</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00396</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00396" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2mtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1309-1313&author=S.+Hanauthor=L.+Thoresenauthor=J.-K.+Jungauthor=X.+Zhuauthor=J.+Thatteauthor=M.+Solomonauthor=I.+Gaidarovauthor=D.+J.+Unettauthor=W.+H.+Yoonauthor=J.+Bardernauthor=A.+Sadequeauthor=A.+Usmaniauthor=C.+Chenauthor=G.+Sempleauthor=A.+J.+Grottickauthor=H.+Al-Shammaauthor=R.+Christopherauthor=R.+M.+Jones&title=Discovery+of+APD371%3A+Identification+of+a+highly+potent+and+selective+CB2+agonist+for+the+treatment+of+chronic+pain&doi=10.1021%2Facsmedchemlett.7b00396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of APD371: Identification of a Highly Potent and Selective CB2 Agonist for the Treatment of Chronic Pain</span></div><div class="casAuthors">Han, Sangdon; Thoresen, Lars; Jung, Jae-Kyu; Zhu, Xiuwen; Thatte, Jayant; Solomon, Michelle; Gaidarov, Ibragim; Unett, David J.; Yoon, Woo Hyun; Barden, Jeremy; Sadeque, Abu; Usmani, Amin; Chen, Chuan; Semple, Graeme; Grottick, Andrew J.; Al-Shamma, Hussein; Christopher, Ronald; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1309-1313</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of a novel, selective and fully efficacious CB2 agonist with satisfactory pharmacokinetic and pharmaceutical properties is described.  Compd. 6 was efficacious in a rat model of osteoarthritis pain following oral administration and, in contrast to morphine, maintained its analgesic effect throughout a 5-day subchronic treatment paradigm.  These data were consistent with our hypothesis that full agonist efficacy is required for efficient internalization and recycling of the CB2 receptor to avoid tachyphylaxis.  Based on its overall favorable preclin. profile, 6 (APD371) was selected for further development for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUco8f2j4V2LVg90H21EOLACvtfcHk0lh3ZJqRkgO1FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2mtL%252FK&md5=895f4ee02bc112e5d1a4ea6f79d9fb02</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00396%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DJ.-K.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DYoon%26aufirst%3DW.%2BH.%26aulast%3DBardern%26aufirst%3DJ.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DUsmani%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DChristopher%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520APD371%253A%2520Identification%2520of%2520a%2520highly%2520potent%2520and%2520selective%2520CB2%2520agonist%2520for%2520the%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1309%26epage%3D1313%26doi%3D10.1021%2Facsmedchemlett.7b00396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Aghazadeh Tabrizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB<sub>2</sub> receptor agonists</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=519-560&author=M.+Aghazadeh+Tabriziauthor=P.+G.+Baraldiauthor=P.+A.+Boreaauthor=K.+Varani&title=Medicinal+chemistry%2C+pharmacology%2C+and+potential+therapeutic+benefits+of+cannabinoid+CB2+receptor+agonists&doi=10.1021%2Facs.chemrev.5b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists</span></div><div class="casAuthors">Aghazadeh Tabrizi, Mojgan; Baraldi, Pier Giovanni; Borea, Pier Andrea; Varani, Katia</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">519-560</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The purpose of this review is to analyze the mol. characterization, distribution and signal transduction pathways of CB2 receptors together with their pharmacol. role in some of the most relevant biol. systems.  The structure-activity relationships of several interesting CB2 agonists, including synthetic schemes to clarify the chem. involved in this field, are reported.  Moreover, the corresponding pharmacol. and beneficial potentials of selected CB2 compds. have been focused as well as the patent literature and the identification of promising therapeutic candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7xG1QvGzO97Vg90H21EOLACvtfcHk0lh3ZJqRkgO1FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGmsr8%253D&md5=261a0d3c6eec03978630759378834d6c</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00411%26sid%3Dliteratum%253Aachs%26aulast%3DAghazadeh%2BTabrizi%26aufirst%3DM.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26atitle%3DMedicinal%2520chemistry%252C%2520pharmacology%252C%2520and%2520potential%2520therapeutic%2520benefits%2520of%2520cannabinoid%2520CB2%2520receptor%2520agonists%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D519%26epage%3D560%26doi%3D10.1021%2Facs.chemrev.5b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span> <span> </span><span class="NLM_article-title">Therapeutic utility of cannabinoid receptor type 2 (CB<sub>2</sub>) selective agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8224</span>– <span class="NLM_lpage">8256</span>, <span class="refDoi"> DOI: 10.1021/jm4005626</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005626" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFeru7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8224-8256&author=S.+Hanauthor=J.+Thatteauthor=D.+J.+Buzardauthor=R.+M.+Jones&title=Therapeutic+utility+of+cannabinoid+receptor+type+2+%28CB2%29+selective+agonists&doi=10.1021%2Fjm4005626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists</span></div><div class="casAuthors">Han, Sangdon; Thatte, Jayant; Buzard, Daniel J.; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8224-8256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The cannabinoid receptor type 2 (CB2) is a class A GPCR that was cloned in 1993 while looking for an alternative receptor that could explain the pharmacol. properties of Δ9-tetrahydrocannabinol.  CB2 was identified among cDNAs based on its similarity in amino acid sequence to the CB1 receptor and helped provide an explanation for the established effects of cannabinoids on the immune system.  In addn. to the immune system, CB2 has widespread tissue expression and has been found in brain, peripheral nervous system, and gastrointestinal tract.  Several "mixed" cannabinoid agonists are currently in clin. use primarily for controlling pain, and it is believed that selective CB2 agonism may afford a superior analgesic agent devoid of the centrally mediated CB1 effects.  Thus, selective CB2 receptor agonists represent high value putative therapeutics for treating pain and other disease states.  In this Perspective, we seek to provide a concise update of progress in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqncpGbOhjA5bVg90H21EOLACvtfcHk0lh3ZJqRkgO1FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFeru7bO&md5=bb532e5c81b475aa04a3311a017c82f1</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm4005626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005626%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DTherapeutic%2520utility%2520of%2520cannabinoid%2520receptor%2520type%25202%2520%2528CB2%2529%2520selective%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8224%26epage%3D8256%26doi%3D10.1021%2Fjm4005626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semeraro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5075</span>– <span class="NLM_lpage">5084</span>, <span class="refDoi"> DOI: 10.1021/jm800552f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800552f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptl2htro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5075-5084&author=S.+Pasquiniauthor=L.+Bottaauthor=T.+Semeraroauthor=C.+Mugnainiauthor=A.+Ligrestiauthor=E.+Palazzoauthor=S.+Maioneauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+2.+Synthesis+and+structure-activity+relationship+of+potent+and+selective+cannabinoid-2+receptor+agonists+endowed+with+analgesic+activity+in+vivo&doi=10.1021%2Fjm800552f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-quinolone-3-carboxylic acid motif. 2. synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo</span></div><div class="casAuthors">Pasquini, Serena; Botta, Lorenzo; Semeraro, Teresa; Mugnaini, Claudia; Ligresti, Alessia; Palazzo, Enza; Maione, Sabatino; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5075-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinolone-3-carboxamides bearing at position 5, 6, 7, or 8 diverse substituents such as halides, alkyl, aryl, alkoxy, and aryloxy groups differing in their steric/electronic properties, were prepd.  The new compds. were tested in vitro for CB1 and CB2 receptor affinity in comparison with the ref. compds. rimonabant and SR144528.  The tested compds. exhibited CB2 affinity in the range from 55.9 to 0.8 nM and CB1 affinity in the range from >10 000 to 5.3 nM, with selectivity indeces [Ki(CB1)/Ki(CB2)] varying from >2666.6 to 1.23.  On the basis of the structure-selectivity relationship developed, the presence of a substituent at C6/C8 or C7 well accounts for the high or low CB2 selectivity, resp.  Compd. I, characterized by high CB2 affinity and selectivity, showed analgesic activity in the formalin test of acute peripheral and inflammatory pain in mice as a result of selective CB2 agonistic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-nHfcuH__drVg90H21EOLACvtfcHk0lhFDNjP-90sUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptl2htro%253D&md5=5c461877098aec3a53c31676ced30c98</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm800552f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800552f%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DBotta%26aufirst%3DL.%26aulast%3DSemeraro%26aufirst%3DT.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DPalazzo%26aufirst%3DE.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25202.%2520Synthesis%2520and%2520structure-activity%2520relationship%2520of%2520potent%2520and%2520selective%2520cannabinoid-2%2520receptor%2520agonists%2520endowed%2520with%2520analgesic%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5075%26epage%3D5084%26doi%3D10.1021%2Fjm800552f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semeraro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicione, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Chiaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5915</span>– <span class="NLM_lpage">5928</span>, <span class="refDoi"> DOI: 10.1021/jm100123x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100123x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5915-5928&author=S.+Pasquiniauthor=A.+Ligrestiauthor=C.+Mugnainiauthor=T.+Semeraroauthor=L.+Cicioneauthor=M.+De+Rosaauthor=F.+Guidaauthor=L.+Luongoauthor=M.+De+Chiaroauthor=M.+G.+Cascioauthor=D.+Bologniniauthor=P.+Mariniauthor=R.+Pertweeauthor=S.+Maioneauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+3.+Synthesis%2C+structure-affinity+relationships%2C+and+pharmacological+characterization+of+6-substituted+4-quinolone-3-carboxamides+as+highly+selective+cannabinoid-2+receptor+ligands&doi=10.1021%2Fjm100123x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 3. Synthesis, Structure-Affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-Quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands</span></div><div class="casAuthors">Pasquini, Serena; Ligresti, Alessia; Mugnaini, Claudia; Semeraro, Teresa; Cicione, Lavinia; De Rosa, Maria; Guida, Francesca; Luongo, Livio; De Chiaro, Maria; Cascio, Maria Grazia; Bolognini, Daniele; Marini, Pietro; Pertwee, Roger; Maione, Sabatino; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5915-5928</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of quinolone-3-carboxamides I [R1 = (un)substituted Ph, 2-furyl, 1-cyclohexenyl, 1-isobutylpyrazol-4-yl, etc.; R2 = 1-adamantyl, 1-fenchyl, hexyl, 1-piperidinyl; R3 = pentyl, 1-buten-4-yl, allyl] bearing diverse substituents at position 1, 3, and 6 of the bicyclic nucleus was prepd.  Except for six compds. exhibiting Ki > 100 nM, all the quinolone-3-carboxamides I proved to be high affinity CB2 ligands, with Ki values ranging from 73.2 to 0.7 nM and selectivity [SI = Ki(CB1)/Ki(CB2)] varying from >14285 to 1.9, with only one compd. exhibiting a reverse selectivity (SI < 1).  In the formalin test of peripheral acute and inflammatory pain in mice, I [R1 = CH2CH2Ph, R2 = 1-adamantyl, R3 = pentyl] showed analgesic activity that was antagonized by a selective CB2 antagonist.  By contrast, I [R1 = 2-furyl, R2 = 1-adamantyl, R3 = pentyl] was inactive per se and antagonized the effect of a selective CB2 agonist.  Also, two of these compds. exhibited CB2 inverse agonist-like behavior in this in vivo test.  However, two different functional assays carried out in vitro indicated for both compds. an overall inverse agonist activity at CB2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWqQVRHQABn7Vg90H21EOLACvtfcHk0lhFDNjP-90sUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCht78%253D&md5=642a103b93312fd2f1e124173143b656</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fjm100123x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100123x%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DSemeraro%26aufirst%3DT.%26aulast%3DCicione%26aufirst%3DL.%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DDe%2BChiaro%26aufirst%3DM.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DMarini%26aufirst%3DP.%26aulast%3DPertwee%26aufirst%3DR.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25203.%2520Synthesis%252C%2520structure-affinity%2520relationships%252C%2520and%2520pharmacological%2520characterization%2520of%25206-substituted%25204-quinolone-3-carboxamides%2520as%2520highly%2520selective%2520cannabinoid-2%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5915%26epage%3D5928%26doi%3D10.1021%2Fjm100123x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Chiaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and anti-hyperalgesic effects in mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5444</span>– <span class="NLM_lpage">5453</span>, <span class="refDoi"> DOI: 10.1021/jm200476p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200476p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFCgtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5444-5453&author=S.+Pasquiniauthor=M.+De+Rosaauthor=V.+Pedaniauthor=C.+Mugnainiauthor=F.+Guidaauthor=L.+Luongoauthor=M.+De+Chiaroauthor=S.+Maioneauthor=S.+Dragoniauthor=M.+Frosiniauthor=A.+Ligrestiauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+4.+Identification+of+new+potent+and+selective+ligands+for+the+cannabinoid+type+2+receptor+with+diverse+substitution+patterns+and+anti-hyperalgesic+effects+in+mice&doi=10.1021%2Fjm200476p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 4. Identification of New Potent and Selective Ligands for the Cannabinoid Type 2 Receptor with Diverse Substitution Patterns and Antihyperalgesic Effects in Mice</span></div><div class="casAuthors">Pasquini, Serena; De Rosa, Maria; Pedani, Valentina; Mugnaini, Claudia; Guida, Francesca; Luongo, Livio; De Chiaro, Maria; Maione, Sabatino; Dragoni, Stefania; Frosini, Maria; Ligresti, Alessia; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5444-5453</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Exptl. evidence suggests that selective CB2 receptor modulators may provide access to antihyperalgesic agents devoid of psychotropic effects.  Taking advantage of previous findings on structure-activity/selectivity relationships for a class of 4-quinolone-3-carboxamides, further structural modifications of the heterocyclic scaffold were explored, leading to the discovery of the 8-methoxy deriv. 4a endowed with the highest affinity and selectivity ever reported for a CB2 ligand.  The compd., evaluated in vivo in the formalin test, behaved as an inverse agonist by reducing at a dose of 6 mg/kg the second phase of the formalin-induced nocifensive response in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogKusJC-_IlLVg90H21EOLACvtfcHk0lhFDNjP-90sUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFCgtbo%253D&md5=4b9daccdccfddbbde2ef53fcca4a87bd</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1021%2Fjm200476p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200476p%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DPedani%26aufirst%3DV.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DDe%2BChiaro%26aufirst%3DM.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDragoni%26aufirst%3DS.%26aulast%3DFrosini%26aufirst%3DM.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25204.%2520Identification%2520of%2520new%2520potent%2520and%2520selective%2520ligands%2520for%2520the%2520cannabinoid%2520type%25202%2520receptor%2520with%2520diverse%2520substitution%2520patterns%2520and%2520anti-hyperalgesic%2520effects%2520in%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5444%26epage%3D5453%26doi%3D10.1021%2Fjm200476p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nocerino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tafi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Chiaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valoti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moaddel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 5. Modulation of the physicochemical profile of a set of potent and selective CB2 ligands through a bioisosteric approach</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1002%2Fcmdc.201100573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=22383251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFOhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=920-934&author=C.+Mugnainiauthor=S.+Nocerinoauthor=V.+Pedaniauthor=S.+Pasquiniauthor=A.+Tafiauthor=M.+De+Chiaroauthor=L.+Bellucciauthor=M.+Valotiauthor=F.+Guidaauthor=L.+Luongoauthor=S.+Dragoniauthor=A.+Ligrestiauthor=A.+Rosenbergauthor=D.+Bologniniauthor=M.+G.+Cascioauthor=R.+G.+Pertweeauthor=R.+Moaddelauthor=S.+Maioneauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+5.+Modulation+of+the+physicochemical+profile+of+a+set+of+potent+and+selective+CB2+ligands+through+a+bioisosteric+approach&doi=10.1002%2Fcmdc.201100573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21dR"><div class="casContent"><span class="casTitleNuber">21d</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-Quinolone-3-Carboxylic Acid Motif Part 5: Modulation of the Physicochemical Profile of a Set of Potent and Selective Cannabinoid-2 Receptor Ligands through a Bioisosteric Approach</span></div><div class="casAuthors">Mugnaini, Claudia; Nocerino, Stefania; Pedani, Valentina; Pasquini, Serena; Tafi, Andrea; De Chiaro, Maria; Bellucci, Luca; Valoti, Massimo; Guida, Francesca; Luongo, Livio; Dragoni, Stefania; Ligresti, Alessia; Rosenberg, Avraham; Bolognini, Daniele; Cascio, Maria Grazia; Pertwee, Roger G.; Moaddel, Ruin; Maione, Sabatino; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">920-934</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Three heterocyclic systems were selected as potential bioisosteres of the amide linker for a series of 1,6-disubstituted-4-quinolone-3-carboxamides, which are potent and selective CB2 ligands that exhibit poor water soly., with the aim of improving their physicochem. profile and also of clarifying properties of importance for amide bond mimicry.  Among the newly synthesized compds., a 1,2,3-triazole deriv. (1-(adamantan-1-yl)-4-[6-(furan-2-yl)-1,4-dihydro-4-oxo-1-pentylquinolin-3-yl]-1H-1,2,3-triazole) emerged as the most promising in terms of both physicochem. and pharmacodynamic properties.  When assayed in vitro, this deriv. exhibited inverse agonist activity, whereas, in the formalin test in mice, it produced analgesic effects antagonized by a well-established inverse agonist.  Metabolic studies allowed the identification of a side chain hydroxylated deriv. as its only metabolite, which, in its racemic form, still showed appreciable CB2 selectivity, but was 150-fold less potent than the parent compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-q6Lelcgsf7Vg90H21EOLACvtfcHk0lgP1Z6_Qt3Ifg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFOhtbo%253D&md5=4ac67390a8af749cd21afd9ef894099f</span></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100573%26sid%3Dliteratum%253Aachs%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DNocerino%26aufirst%3DS.%26aulast%3DPedani%26aufirst%3DV.%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DTafi%26aufirst%3DA.%26aulast%3DDe%2BChiaro%26aufirst%3DM.%26aulast%3DBellucci%26aufirst%3DL.%26aulast%3DValoti%26aufirst%3DM.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DDragoni%26aufirst%3DS.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DRosenberg%26aufirst%3DA.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DMoaddel%26aufirst%3DR.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25205.%2520Modulation%2520of%2520the%2520physicochemical%2520profile%2520of%2520a%2520set%2520of%2520potent%2520and%2520selective%2520CB2%2520ligands%2520through%2520a%2520bioisosteric%2520approach%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D920%26epage%3D934%26doi%3D10.1002%2Fcmdc.201100573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caradonna, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted 4-quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.09.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.ejmech.2012.09.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=23085772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslOktb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=30-43&author=S.+Pasquiniauthor=M.+De+Rosaauthor=A.+Ligrestiauthor=C.+Mugnainiauthor=A.+Brizziauthor=N.+P.+Caradonnaauthor=M.+G.+Cascioauthor=D.+Bologniniauthor=R.+G.+Pertweeauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+6.+Synthesis+and+pharmacological+evaluation+of+7-substituted+4-quinolone-3-carboxamide+derivatives+as+high+affinity+ligands+for+cannabinoid+receptors&doi=10.1016%2Fj.ejmech.2012.09.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21eR"><div class="casContent"><span class="casTitleNuber">21e</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors</span></div><div class="casAuthors">Pasquini, Serena; De Rosa, Maria; Ligresti, Alessia; Mugnaini, Claudia; Brizzi, Antonella; Caradonna, Nicola P.; Cascio, Maria Grazia; Bolognini, Daniele; Pertwee, Roger G.; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30-43</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Within the authors' studies on structure-activity relationships of 4-quinolone-3-carboxamides as cannabinoid ligands, a new series of compds. characterized by a fluoro or phenylthio group at the 7-position and different substituents at N1 and the carboxamide nitrogen were synthesized and evaluated for their binding ability to cannabinoid type 1 (CB1) and type 2 (CB2) receptors.  Most of the compds. showed affinity for one or both cannabinoid receptors at nanomolar concn., with Ki(CB1) and Ki(CB2) values ranging from 2.45 to >10,000 nM and from 0.09 to 957 nM, resp.  The N-(3,4-dichlorobenzyl)amide derivs. I (R = Ph, PhS) displayed relatively low affinity, but high selectivity towards the CB1 receptor.  Compds. II and I (R = PhS), a CB2 and a CB1 ligand, resp., behaved as partial agonists in the [35S]GTPγS assay.  They showed very low permeability through (MDCK-MDR1) cells and might, therefore, represent possible lead structures for further optimization in the search for cannabinoid ligands unable to cross the blood-brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof4hRj9XhonrVg90H21EOLACvtfcHk0lgP1Z6_Qt3Ifg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslOktb%252FM&md5=95ba92dca8488f8639aa8814d9ca4ea5</span></div><a href="/servlet/linkout?suffix=cit21e&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.09.035%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DBrizzi%26aufirst%3DA.%26aulast%3DCaradonna%26aufirst%3DN.%2BP.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25206.%2520Synthesis%2520and%2520pharmacological%2520evaluation%2520of%25207-substituted%25204-quinolone-3-carboxamide%2520derivatives%2520as%2520high%2520affinity%2520ligands%2520for%2520cannabinoid%2520receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D58%26spage%3D30%26epage%3D43%26doi%3D10.1016%2Fj.ejmech.2012.09.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Annunziata, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis</span>. <i>J. Neuroimmunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.jneuroim.2016.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.jneuroim.2016.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=28041663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1ejsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2017&pages=66-74&author=P.+Annunziataauthor=C.+Cioniauthor=C.+Mugnainiauthor=F.+Corelli&title=Potent+immunomodulatory+activity+of+a+highly+selective+cannabinoid+CB2+agonist+on+immune+cells+from+healthy+subjects+and+patients+with+multiple+sclerosis&doi=10.1016%2Fj.jneuroim.2016.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis</span></div><div class="casAuthors">Annunziata, Pasquale; Cioni, Chiara; Mugnaini, Claudia; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66-74</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">COR167, a novel CB2-selective high affinity agonist, was found to significantly inhibit, in a dose-dependent manner, the proliferation of both peripheral blood mononuclear cells and myelin basic protein-reactive T cell lines from normal healthy subjects and patients with relapsing-remitting multiple sclerosis (MS).  In MS, a significantly higher inhibition was obsd. in patients on treatment with disease modifying drugs compared to those naive to treatment.  The inhibitory activity of COR167 was exerted through a mixed mechanism involving atypical and incomplete shift of Th1 phenotype towards Th2 phenotype assocd. with slight redn. of IL-4 and IL-5 as well as strongly reduced levels of Th17-related cytokines.  COR167 was also able to reduce in vitro migration of stimulated immunocompetent cells through human brain endothelium assocd. with a significant redn. of levels of several chemokines.  These findings demonstrate that COR167 exerts potent immunomodulatory effects and confirm the cannabinoid CB2 receptor as a novel pharmacol. target to counteract neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorLYAjNuLf3LVg90H21EOLACvtfcHk0lgP1Z6_Qt3Ifg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1ejsQ%253D%253D&md5=566c2002ead6c123648362bdb9c17dda</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2016.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2016.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DAnnunziata%26aufirst%3DP.%26aulast%3DCioni%26aufirst%3DC.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DPotent%2520immunomodulatory%2520activity%2520of%2520a%2520highly%2520selective%2520cannabinoid%2520CB2%2520agonist%2520on%2520immune%2520cells%2520from%2520healthy%2520subjects%2520and%2520patients%2520with%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2017%26volume%3D303%26spage%3D66%26epage%3D74%26doi%3D10.1016%2Fj.jneuroim.2016.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Contartese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valoti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgaragli, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frosini, M.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">A novel substituted 4-quinolone-3-carboxylic acid derivative CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2012.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.phrs.2012.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=23036353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmt7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=555-563&author=A.+Contarteseauthor=M.+Valotiauthor=F.+Corelliauthor=S.+Pasquiniauthor=C.+Mugnainiauthor=G.+P.+Sgaragliauthor=M.+Frosini&title=A+novel+substituted+4-quinolone-3-carboxylic+acid+derivative+CB2+agonist%2C+COR167%2C+potently+protects+rat+brain+cortical+slices+against+OGD+and+reperfusion+injury&doi=10.1016%2Fj.phrs.2012.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury</span></div><div class="casAuthors">Contartese, Antonella; Valoti, Massimo; Corelli, Federico; Pasquini, Serena; Mugnaini, Claudia; Pessina, Federica; Aldinucci, Carlo; Sgaragli, Giampietro; Frosini, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">555-563</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cannabinoid CB2 receptor activation has been shown to have many pharmacol. but not psychotropic effects.  The aim of this study was to investigate the potential protection of brain tissues afforded by the novel substituted 4-quinolone-3-carboxylic acid deriv. COR167, a selective CB2 agonist, toward ischemia and reperfusion-induced injury, as well as the mechanism of this potential effect.  Rat brain cortical slices subjected to oxygen and glucose deprivation (OGD) followed by re-oxygenation were used.  Cell damage was quantified by measuring at the end of the reperfusion phase the release into the artificial cerebrospinal fluid (ACSF) of lactate dehydrogenase (LDH), glutamate, IL-6 and TNF-α and by evaluating in tissue the lipid-peroxides (thiobarbituric acid-reactive substances, TBARS), the free, reduced glutathione content (GSH) and the water gain (TWG), taken as an index of cell swelling.  COR167 (10 nM or 100 nM), added to ACSF during the entire reperfusion phase, markedly reduced LDH and glutamate release, as well as TWG.  Lower (0.1-1 nM) or higher concns. (1000 nM) were ineffective, suggesting thereby an hormetic behavior.  COR167 at 10 nM concn. markedly reverted in tissues TBARS increase and GSH decrease, while reducing IL-6 and TNF-α release into ACSF.  COR167 effects on glutamate and LDH release were abrogated by the selective CB2 inverse-agonists COR170 (1 nM) and AM630 (1 μM) but not by the CB1 antagonist AM251 (1 μM).  COR170 as well as AM630 per se were able to revert TWG.  The CB2 receptor agonist COR167 potently protected rat brain cortical slices against OGD and reperfusion injury, partly through CB2 receptors activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoykTySTEplTbVg90H21EOLACvtfcHk0lg1sJVnefNS8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmt7fO&md5=1f633d2cf582ccadb99617db3fc49491</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2012.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2012.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DContartese%26aufirst%3DA.%26aulast%3DValoti%26aufirst%3DM.%26aulast%3DCorelli%26aufirst%3DF.%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DSgaragli%26aufirst%3DG.%2BP.%26aulast%3DFrosini%26aufirst%3DM.%26atitle%3DA%2520novel%2520substituted%25204-quinolone-3-carboxylic%2520acid%2520derivative%2520CB2%2520agonist%252C%2520COR167%252C%2520potently%2520protects%2520rat%2520brain%2520cortical%2520slices%2520against%2520OGD%2520and%2520reperfusion%2520injury%26jtitle%3DPharmacol.%2520Res.%26date%3D2012%26volume%3D66%26spage%3D555%26epage%3D563%26doi%3D10.1016%2Fj.phrs.2012.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB2 receptor inverse agonists</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2009.11.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.phrs.2009.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=19961936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1WjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2010&pages=349-354&author=M.+G.+Cascioauthor=D.+Bologniniauthor=R.+G.+Pertweeauthor=E.+Palazzoauthor=F.+Corelliauthor=S.+Pasquiniauthor=V.+Di+Marzoauthor=S.+Maione&title=In+vitro+and+in+vivo+pharmacological+characterization+of+two+novel+selective+cannabinoid+CB2+receptor+inverse+agonists&doi=10.1016%2Fj.phrs.2009.11.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB2 receptor inverse agonists</span></div><div class="casAuthors">Cascio, Maria Grazia; Bolognini, Daniele; Pertwee, Roger G.; Palazzo, Enza; Corelli, Federico; Pasquini, Serena; Di Marzo, Vincenzo; Maione, Sabatino</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-354</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We have previously developed quinolone-3-carboxamides with the aim of obtaining new ligands for both cannabinoid receptors, CB1 and CB2.  Our preliminary screening led to the identification of cannabinoid receptor ligands characterized by high affinity and, in some cases, also selectivity for CB2 receptors.  Specifically, three compds., 1, 2 and 3 showed high affinity for CB2 as well as high selectivity over CB1 receptors.  In addn., the activity shown by 1 against the formalin-induced nocifensive response in mice, reported in our previous paper, suggests that quinolone-3-carboxamides possess anti-nociceptive properties.  In the present work, we have performed functional in vitro bioassays with the aim of investigating the functional activity in the [35S]GTPγS binding assay of the other two compds. that, like 1, behave as CB2 selective ligands, and their potential analgesic actions in vivo.  We found that both 2 and 3 behave in vitro as CB2 inverse agonists and are able to decrease nociceptive behavior in the late phase of the formalin test only at the highest dose tested, although, at lower doses, they prevent the anti-nociceptive effects of a selective CB2 partial agonist in the formalin test.  These results identify in 2 and 3 two novel, potent and selective CB2 antagonists/inverse agonists and confirm previous reports in the literature that, in addn. to agonists at cannabinoid CB2 receptors, also inverse agonists/antagonists at these receptors show promise as anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE1cflt4iYUbVg90H21EOLACvtfcHk0lg1sJVnefNS8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1WjtLk%253D&md5=3af6a0824391d13ddd70f5f0099dcafd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2009.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2009.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DPalazzo%26aufirst%3DE.%26aulast%3DCorelli%26aufirst%3DF.%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DMaione%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520characterization%2520of%2520two%2520novel%2520selective%2520cannabinoid%2520CB2%2520receptor%2520inverse%2520agonists%26jtitle%3DPharmacol.%2520Res.%26date%3D2010%26volume%3D61%26spage%3D349%26epage%3D354%26doi%3D10.1016%2Fj.phrs.2009.11.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allarà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamponi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacondio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-quinolone-3-carboxylic acid motif. 7. Synthesis and pharmacological evaluation of 4-quinolone-3-carboxamides and 4-hydroxy-2-quinolone-3-carboxamides as high affinity cannabinoid receptor 2 (CB2R) ligands with improved aqueous solubility</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1052</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01559</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01559" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1052-1067&author=C.+Mugnainiauthor=A.+Brizziauthor=A.+Ligrestiauthor=M.+Allar%C3%A0author=S.+Lamponiauthor=F.+Vacondioauthor=C.+Silvaauthor=M.+Morauthor=V.+Di+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-quinolone-3-carboxylic+acid+motif.+7.+Synthesis+and+pharmacological+evaluation+of+4-quinolone-3-carboxamides+and+4-hydroxy-2-quinolone-3-carboxamides+as+high+affinity+cannabinoid+receptor+2+%28CB2R%29+ligands+with+improved+aqueous+solubility&doi=10.1021%2Facs.jmedchem.5b01559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility</span></div><div class="casAuthors">Mugnaini, Claudia; Brizzi, Antonella; Ligresti, Alessia; Allara, Marco; Lamponi, Stefania; Vacondio, Federica; Silva, Claudia; Mor, Marco; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1052-1067</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-Quinolone-3-carboxamide derivs. have long been recognized as potent and selective cannabinoid type-2 receptor (CB2R) ligands.  With the aim to improve their physicochem. properties, basically aq. soly., two different approaches were followed, entailing the substitution of the alkyl chain with a basic replacement or scaffold modification to 4-hydroxy-2-quinolone structure.  According to the first approach, compd. I (R = NMe2) was obtained, showing slightly reduced receptor affinity (Ki = 60 nM) compared to the lead compd. I (R = n-Pr, Ki = 0.8 nM) but greatly enhanced soly. (400-3400 times depending on the pH of the medium).  On the other hand, shifting from 4-quinolone to 4-hydroxy-2-quinolone structure enabled the discovery of a novel class of CB2R ligands, such as II (R1 = 6-i-Pr, and 7-F), characterized by Ki < 1 nM and selectivity index [SI = Ki(CB1R)/Ki(CB2R)] > 1300.  At pH 7.4, compd. II (R1 = 7-F) resulted by 100-fold more sol. than I (R = n-Pr).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovdgV_KOadz7Vg90H21EOLACvtfcHk0lg1sJVnefNS8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslemsA%253D%253D&md5=303474ea5e8d265bf033c75c89e4ee9c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01559%26sid%3Dliteratum%253Aachs%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DBrizzi%26aufirst%3DA.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DAllar%25C3%25A0%26aufirst%3DM.%26aulast%3DLamponi%26aufirst%3DS.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-quinolone-3-carboxylic%2520acid%2520motif.%25207.%2520Synthesis%2520and%2520pharmacological%2520evaluation%2520of%25204-quinolone-3-carboxamides%2520and%25204-hydroxy-2-quinolone-3-carboxamides%2520as%2520high%2520affinity%2520cannabinoid%2520receptor%25202%2520%2528CB2R%2529%2520ligands%2520with%2520improved%2520aqueous%2520solubility%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1052%26epage%3D1067%26doi%3D10.1021%2Facs.jmedchem.5b01559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fex, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fristedt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedlung, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abramo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritzson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pekarski, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runström, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuvesson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björk, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2075</span>– <span class="NLM_lpage">2088</span>, <span class="refDoi"> DOI: 10.1021/jm031044w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031044w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BD2c7mtlOhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2075-2088&author=S.+J%C3%B6nssonauthor=G.+Anderssonauthor=T.+Fexauthor=T.+Fristedtauthor=G.+Hedlungauthor=K.+Janssonauthor=L.+Abramoauthor=I.+Fritzsonauthor=O.+Pekarskiauthor=A.+Runstr%C3%B6mauthor=H.+Sandinauthor=I.+Thuvessonauthor=A.+Bj%C3%B6rk&title=Synthesis+and+biological+evaluation+of+new+1%2C2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides+for+treatment+of+autoimmune+disorders%3A+structure-activity+relationship&doi=10.1021%2Fjm031044w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship</span></div><div class="casAuthors">Jonsson Stig; Andersson Gunnar; Fex Tomas; Fristedt Tomas; Hedlund Gunnar; Jansson Karl; Abramo Lisbeth; Fritzson Ingela; Pekarski Olga; Runstrom Anna; Sandin Helena; Thuvesson Ingela; Bjork Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2075-88</span>
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Roquinimex-related 3-quinolinecarboxamide derivatives were prepared and evaluated for treatment of autoimmune disorders.  The compounds were tested in mice for their inhibitory effects on disease development in the acute experimental autoimmune encephalomyelitis model and selected compounds in the beagle dog for induction of proinflammatory reaction.  Structure-activity relationships are discussed.  Compound 8c, laquinimod, showed improved potency and superior toxicological profile compared to the lead compound roquinimex (1b, Linomide) and was selected for clinical studies (currently in phase II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlqdPtLGowsC6Ufuk_1xoTfW6udTcc2eYC7vUoISJ3Lrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7mtlOhug%253D%253D&md5=5da6e891da9365fec5343a65338a84fd</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm031044w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031044w%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DS.%26aulast%3DAndersson%26aufirst%3DG.%26aulast%3DFex%26aufirst%3DT.%26aulast%3DFristedt%26aufirst%3DT.%26aulast%3DHedlung%26aufirst%3DG.%26aulast%3DJansson%26aufirst%3DK.%26aulast%3DAbramo%26aufirst%3DL.%26aulast%3DFritzson%26aufirst%3DI.%26aulast%3DPekarski%26aufirst%3DO.%26aulast%3DRunstr%25C3%25B6m%26aufirst%3DA.%26aulast%3DSandin%26aufirst%3DH.%26aulast%3DThuvesson%26aufirst%3DI.%26aulast%3DBj%25C3%25B6rk%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%25201%252C2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides%2520for%2520treatment%2520of%2520autoimmune%2520disorders%253A%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2075%26epage%3D2088%26doi%3D10.1021%2Fjm031044w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fristedt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and reactivity of laquinimod, a quinoline-3-carboxamide: intramolecular transfer of the enol proton to a nitrogen atom as a plausible mechanism for ketene formation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1658</span>– <span class="NLM_lpage">1667</span>, <span class="refDoi"> DOI: 10.1021/jo052368q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo052368q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFCrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1658-1667&author=K.+Janssonauthor=T.+Fristedtauthor=A.+Olssonauthor=B.+Svenssonauthor=S.+J%C3%B6nsson&title=Synthesis+and+reactivity+of+laquinimod%2C+a+quinoline-3-carboxamide%3A+intramolecular+transfer+of+the+enol+proton+to+a+nitrogen+atom+as+a+plausible+mechanism+for+ketene+formation&doi=10.1021%2Fjo052368q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Reactivity of Laquinimod, a Quinoline-3-carboxamide: Intramolecular Transfer of the Enol Proton to a Nitrogen Atom as a Plausible Mechanism for Ketene Formation</span></div><div class="casAuthors">Jansson, Karl; Fristedt, Tomas; Olsson, Arne; Svensson, Bo; Joensson, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1658-1667</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-Chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinolinecarboxamide (laquinimod, 2) is an oral drug in clin. trials for the treatment of multiple sclerosis.  The final step in the synthesis of 2 is a high-yielding aminolysis reaction of ester 1 with N-ethylaniline.  An equil. exists between 1 and 2, and removal of formed methanol during the reaction is a prerequisite for obtaining high yields of 2 from 1.  The reactivity of 1 and 2 is explained by a mechanistic model that involves a transfer of the enol proton to the exocyclic carbonyl substituent with concomitant formation of ketene 3.  This proton transfer is esp. facilitated for 2 because the intramol. hydrogen bond to the carbonyl oxygen is weakened due to steric interactions.  Both 1 and 2 undergo solvolysis reactions that obey first-order reaction kinetics, further supporting the theory that these two mols. are able to decomp. unimolecularly into ketene 3.  The solvent-dependent spectroscopic features of 2 indicate that the mol. mainly resides in two conformations.  One conformation is favored in nonpolar solvents and is likely the result of intramol. hydrogen bonding.  The other conformation is favored in polar solvents and probably exhibits less intramol. hydrogen bonding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquE1LlpDtCn7Vg90H21EOLACvtfcHk0lg0UQ20u2pqDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFCrtQ%253D%253D&md5=e2394ca26e6a60bc403dbcd626e19174</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fjo052368q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052368q%26sid%3Dliteratum%253Aachs%26aulast%3DJansson%26aufirst%3DK.%26aulast%3DFristedt%26aufirst%3DT.%26aulast%3DOlsson%26aufirst%3DA.%26aulast%3DSvensson%26aufirst%3DB.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520reactivity%2520of%2520laquinimod%252C%2520a%2520quinoline-3-carboxamide%253A%2520intramolecular%2520transfer%2520of%2520the%2520enol%2520proton%2520to%2520a%2520nitrogen%2520atom%2520as%2520a%2520plausible%2520mechanism%2520for%2520ketene%2520formation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D1658%26epage%3D1667%26doi%3D10.1021%2Fjo052368q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aghazadeh
Tabrizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saponaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corciulo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological properties of new heteroarylpyridine/heteroarylpyrimidine derivatives as CB<sub>2</sub> cannabinoid receptor partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1098</span>– <span class="NLM_lpage">1112</span>, <span class="refDoi"> DOI: 10.1021/jm301527r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301527r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1098-1112&author=M.+Aghazadeh%0ATabriziauthor=P.+G.+Baraldiauthor=G.+Saponaroauthor=A.+R.+Moormanauthor=R.+Romagnoliauthor=D.+Pretiauthor=S.+Baraldiauthor=C.+Corciuloauthor=F.+Vincenziauthor=P.+A.+Boreaauthor=K.+Varani&title=Design%2C+synthesis%2C+and+pharmacological+properties+of+new+heteroarylpyridine%2Fheteroarylpyrimidine+derivatives+as+CB2+cannabinoid+receptor+partial+agonists&doi=10.1021%2Fjm301527r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists</span></div><div class="casAuthors">Aghazadeh Tabrizi, Mojgan; Baraldi, Pier Giovanni; Saponaro, Giulia; Moorman, Allan R.; Romagnoli, Romeo; Preti, Delia; Baraldi, Stefania; Corciulo, Carmen; Vincenzi, Fabrizio; Borea, Pier Andrea; Varani, Katia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1098-1112</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent developments indicate that CB2 receptor ligands have the potential to become therapeutically important.  To explore this potential, it is necessary to develop compds. with high affinity for the CB2 receptor.  Very recently, we have identified the oxazinoquinoline carboxamides as a novel class of CB2 receptor full agonists.  In this paper we describe the medicinal chem. of a new series of heteroaryl-4-oxopyridine/7-oxopyrimidine derivs.  Some of the reported compds. showed high affinity and potency at the CB2 receptor while showing only modest affinity for the centrally expressed CB1 cannabinoid receptor.  Moreover, we found that the functionality of these ligands is controlled by the nature of the heteroaryl function condensed with the pyridine ring.  In 3,5-cyclic adenosine monophosphate (cAMP) assays, the novel series show dose-dependent effects on the modulation of forskolin-induced cAMP prodn., revealing different behaviors as full agonists, partial agonists, and inverse agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIywppexKde7Vg90H21EOLACvtfcHk0lg0UQ20u2pqDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFaqtbs%253D&md5=9004698567573376ebc0ff17b3deed45</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301527r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301527r%26sid%3Dliteratum%253Aachs%26aulast%3DAghazadeh%2BTabrizi%26aufirst%3DM.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DCorciulo%26aufirst%3DC.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520properties%2520of%2520new%2520heteroarylpyridine%252Fheteroarylpyrimidine%2520derivatives%2520as%2520CB2%2520cannabinoid%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1098%26epage%3D1112%26doi%3D10.1021%2Fjm301527r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aghazadeh
Tabrizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saponaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moorman, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggiero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintori, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuccinardi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of 7-oxopyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxamides as potent and selective CB<sub>2</sub> cannabinoid receptor inverse agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4482</span>– <span class="NLM_lpage">4496</span>, <span class="refDoi"> DOI: 10.1021/jm400182t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400182t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotV2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4482-4496&author=M.+Aghazadeh%0ATabriziauthor=P.+G.+Baraldiauthor=G.+Saponaroauthor=A.+R.+Moormanauthor=R.+Romagnoliauthor=D.+Pretiauthor=S.+Baraldiauthor=E.+Ruggieroauthor=C.+Tintoriauthor=T.+Tuccinardiauthor=F.+Vincenziauthor=P.+A.+Boreaauthor=K.+Varani&title=Discovery+of+7-oxopyrazolo%5B1%2C5-a%5Dpyrimidine-6-carboxamides+as+potent+and+selective+CB2+cannabinoid+receptor+inverse+agonists&doi=10.1021%2Fjm400182t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 7-Oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists</span></div><div class="casAuthors">Aghazadeh Tabrizi, Mojgan; Baraldi, Pier Giovanni; Saponaro, Giulia; Moorman, Allan R.; Romagnoli, Romeo; Preti, Delia; Baraldi, Stefania; Ruggiero, Emanuela; Tintori, Cristina; Tuccinardi, Tiziano; Vincenzi, Fabrizio; Borea, Pier Andrea; Varani, Katia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4482-4496</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors recently described the medicinal chem. of a new series of heteroaryl-4-oxopyridine/7-oxopyrimidines as CB2 receptor partial agonists, showing that the functionality of these ligands is controlled by the nature of the heteroaryl function condensed with the pyridine ring.  They describe herein the design and synthesis of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides, structural isomers of their previously reported pyrazolo[3,4-b]pyridines.  All of the new compds. showed high affinity and selectivity for the CB2 receptor in the nanomolar range.  In 3,5-cyclic adenosine monophosphate (cAMP) assays, the novel series shows stimulatory effects on forskolin-induced cAMP prodn. acting as inverse agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8lM89CdRSlbVg90H21EOLACvtfcHk0ljrFYnnDGsRtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotV2nt7w%253D&md5=255d07e5bf6f193e79dd916944698fdb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm400182t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400182t%26sid%3Dliteratum%253Aachs%26aulast%3DAghazadeh%2BTabrizi%26aufirst%3DM.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DSaponaro%26aufirst%3DG.%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26aulast%3DRomagnoli%26aufirst%3DR.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DBaraldi%26aufirst%3DS.%26aulast%3DRuggiero%26aufirst%3DE.%26aulast%3DTintori%26aufirst%3DC.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DVarani%26aufirst%3DK.%26atitle%3DDiscovery%2520of%25207-oxopyrazolo%255B1%252C5-a%255Dpyrimidine-6-carboxamides%2520as%2520potent%2520and%2520selective%2520CB2%2520cannabinoid%2520receptor%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4482%26epage%3D4496%26doi%3D10.1021%2Fjm400182t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fristedt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and reactivity of laquinimod, a quinoline-3-carboxamide: intramolecular transfer of the enol proton to a nitrogen atom as a plausible mechanism for ketene formation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1658</span>– <span class="NLM_lpage">1667</span>, <span class="refDoi"> DOI: 10.1021/jo052368q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo052368q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFCrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=1658-1667&author=K.+Janssonauthor=T.+Fristedtauthor=A.+Olssonauthor=B.+Svenssonauthor=S.+J%C3%B6nsson&title=Synthesis+and+reactivity+of+laquinimod%2C+a+quinoline-3-carboxamide%3A+intramolecular+transfer+of+the+enol+proton+to+a+nitrogen+atom+as+a+plausible+mechanism+for+ketene+formation&doi=10.1021%2Fjo052368q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Reactivity of Laquinimod, a Quinoline-3-carboxamide: Intramolecular Transfer of the Enol Proton to a Nitrogen Atom as a Plausible Mechanism for Ketene Formation</span></div><div class="casAuthors">Jansson, Karl; Fristedt, Tomas; Olsson, Arne; Svensson, Bo; Joensson, Stig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1658-1667</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5-Chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinolinecarboxamide (laquinimod, 2) is an oral drug in clin. trials for the treatment of multiple sclerosis.  The final step in the synthesis of 2 is a high-yielding aminolysis reaction of ester 1 with N-ethylaniline.  An equil. exists between 1 and 2, and removal of formed methanol during the reaction is a prerequisite for obtaining high yields of 2 from 1.  The reactivity of 1 and 2 is explained by a mechanistic model that involves a transfer of the enol proton to the exocyclic carbonyl substituent with concomitant formation of ketene 3.  This proton transfer is esp. facilitated for 2 because the intramol. hydrogen bond to the carbonyl oxygen is weakened due to steric interactions.  Both 1 and 2 undergo solvolysis reactions that obey first-order reaction kinetics, further supporting the theory that these two mols. are able to decomp. unimolecularly into ketene 3.  The solvent-dependent spectroscopic features of 2 indicate that the mol. mainly resides in two conformations.  One conformation is favored in nonpolar solvents and is likely the result of intramol. hydrogen bonding.  The other conformation is favored in polar solvents and probably exhibits less intramol. hydrogen bonding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquE1LlpDtCn7Vg90H21EOLACvtfcHk0ljrFYnnDGsRtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFCrtQ%253D%253D&md5=e2394ca26e6a60bc403dbcd626e19174</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo052368q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052368q%26sid%3Dliteratum%253Aachs%26aulast%3DJansson%26aufirst%3DK.%26aulast%3DFristedt%26aufirst%3DT.%26aulast%3DOlsson%26aufirst%3DA.%26aulast%3DSvensson%26aufirst%3DB.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520reactivity%2520of%2520laquinimod%252C%2520a%2520quinoline-3-carboxamide%253A%2520intramolecular%2520transfer%2520of%2520the%2520enol%2520proton%2520to%2520a%2520nitrogen%2520atom%2520as%2520a%2520plausible%2520mechanism%2520for%2520ketene%2520formation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D1658%26epage%3D1667%26doi%3D10.1021%2Fjo052368q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rinaldi-Carmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derocq, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casellas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oustric, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouaboula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calandra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shire, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breliere, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Fur, G. L.</span></span> <span> </span><span class="NLM_article-title">SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=9454810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaK1cXhtFWkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1998&pages=644-650&author=M.+Rinaldi-Carmonaauthor=F.+Barthauthor=J.+Millanauthor=J.+M.+Derocqauthor=P.+Casellasauthor=C.+Congyauthor=D.+Oustricauthor=M.+Sarranauthor=M.+Bouaboulaauthor=B.+Calandraauthor=M.+Portierauthor=D.+Shireauthor=J.+C.+Breliereauthor=G.+L.+Le+Fur&title=SR144528%2C+the+first+potent+and+selective+antagonist+of+the+CB2+cannabinoid+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor</span></div><div class="casAuthors">Rinaldi-Carmona, Murielle; Barth, Francis; Millan, Jose; Derocq, Jean-Marie; Casellas, Pierre; Congy, Christian; Oustric, Didier; Sarran, Martine; Bouaboula, Monsif; Calandra, Bernard; Portier, Marielle; Shire, David; Breliere, Jean-Claude; Le Fur, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">644-650</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Based on both binding and functional data, this study introduces SR 144528 as the first, highly potent, selective and orally active antagonist for the CB2 receptor.  This compd. which displays subnanomolar affinity (Ki = 0.6 nM) for both the rat spleen and cloned human CB2 receptors has a 700-fold lower affinity (Ki = 400 nM) for both the rat brain and cloned human CB1 receptors.  Furthermore it shows no affinity for any of the more than 70 receptors, ion channels or enzymes investigated (IC50 > 10 μM).  In vitro, SR 144528 antagonizes the inhibitory effects of the cannabinoid receptor agonist CP 55,940 on forskolin-stimulated adenylyl cyclase activity in cell lines permanently expressing the h CB2 receptor (EC50 = 10 nM) but not in cells expressing the h CB1 (no effect at 10 μM).  Furthermore, SR 144528 is able to selectively block the mitogen-activated protein kinase activity induced by CP 55,940 in cell lines expressing h CB2 (IC50 = 39 nM) whereas in cells expressing h CB1 an IC50 value of more than 1 μM is found.  In addn., SR 144528 is shown to antagonize the stimulating effects of CP 55,940 on human tonsillar B-cell activation evoked by crosslinking of surface Igs (IC50 = 20 nM).  In vivo, after oral administration SR 144528 totally displaced the ex vivo [3H]-CP 55,940 binding to mouse spleen membranes (ED50 = 0.35 mg/kg) with a long duration of action.  In contrast, after the oral route it does not interact with the cannabinoid receptor expressed in the mouse brain (CB1).  It is expected that SR 144528 will provide a powerful tool to investigate the in vivo functions of the cannabinoid system in the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLyEa8bHfntbVg90H21EOLACvtfcHk0ljrFYnnDGsRtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtFWkt78%253D&md5=c7ec1ad25da2567c186099934e0bb758</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRinaldi-Carmona%26aufirst%3DM.%26aulast%3DBarth%26aufirst%3DF.%26aulast%3DMillan%26aufirst%3DJ.%26aulast%3DDerocq%26aufirst%3DJ.%2BM.%26aulast%3DCasellas%26aufirst%3DP.%26aulast%3DCongy%26aufirst%3DC.%26aulast%3DOustric%26aufirst%3DD.%26aulast%3DSarran%26aufirst%3DM.%26aulast%3DBouaboula%26aufirst%3DM.%26aulast%3DCalandra%26aufirst%3DB.%26aulast%3DPortier%26aufirst%3DM.%26aulast%3DShire%26aufirst%3DD.%26aulast%3DBreliere%26aufirst%3DJ.%2BC.%26aulast%3DLe%2BFur%26aufirst%3DG.%2BL.%26atitle%3DSR144528%252C%2520the%2520first%2520potent%2520and%2520selective%2520antagonist%2520of%2520the%2520CB2%2520cannabinoid%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D284%26spage%3D644%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Applications of fluorine in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8315</span>– <span class="NLM_lpage">8359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8315-8359&author=E.+P.+Gillisauthor=K.+J.+Eastmanauthor=M.+D.+Hillauthor=D.+J.+Donnellyauthor=N.+A.+Meanwell&title=Applications+of+fluorine+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b00258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Gillis, Eric P.; Eastman, Kyle J.; Hill, Matthew D.; Donnelly, David J.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8315-8359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with meta-anal. The role of fluorine in drug design and development is expanding rapidly as we learn more about the unique properties assocd. with this unusual element and how to deploy it with greater sophistication.  The judicious introduction of fluorine into a mol. can productively influence conformation, pKa, intrinsic potency, membrane permeability, metabolic pathways, and pharmacokinetic properties.  In addn., 18F has been established as a useful positron emitting isotope for use with in vivo imaging technol. that potentially has extensive application in drug discovery and development, often limited only by convenient synthetic accessibility to labeled compds.  The wide ranging applications of fluorine in drug design are providing a strong stimulus for the development of new synthetic methodologies that allow more facile access to a wide range of fluorinated compds.  In this review, we provide an update on the effects of the strategic incorporation of fluorine in drug mols. and applications in positron emission tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8fUUtkPB4L7Vg90H21EOLACvtfcHk0ljWogfr6TxEhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajs7%252FK&md5=9995829a94a8c0b8d9fb0d21bdfd5a1d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DEastman%26aufirst%3DK.%2BJ.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DApplications%2520of%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8315%26epage%3D8359%26doi%3D10.1021%2Facs.jmedchem.5b00258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span> <span> </span><span class="NLM_article-title">Quantitative assessment of the impact of fluorine substitution on P-glycoprotein (P-gp) mediated efflux, permeability, lipophilicity, and metabolic stability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5284</span>– <span class="NLM_lpage">5296</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1Kjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5284-5296&author=M.+Petterssonauthor=X.+Houauthor=M.+Kuhnauthor=T.+T.+Wagerauthor=G.+W.+Kauffmanauthor=P.+R.+Verhoest&title=Quantitative+assessment+of+the+impact+of+fluorine+substitution+on+P-glycoprotein+%28P-gp%29+mediated+efflux%2C+permeability%2C+lipophilicity%2C+and+metabolic+stability&doi=10.1021%2Facs.jmedchem.6b00027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Assessment of the Impact of Fluorine Substitution on P-Glycoprotein (P-gp) Mediated Efflux, Permeability, Lipophilicity, and Metabolic Stability</span></div><div class="casAuthors">Pettersson, Martin; Hou, Xinjun; Kuhn, Max; Wager, Travis T.; Kauffman, Gregory W.; Verhoest, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5284-5296</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Strategic replacement of one or more hydrogen atoms with fluorine atom(s) is a common tactic to improve potency at a given target and/or to modulate parameters such as metabolic stability and pKa.  Mol. wt. (MW) is a key parameter in design, and incorporation of fluorine is assocd. with a disproportionate increase in MW considering the van der Waals radius of fluorine vs. hydrogen.  Herein we examine a large compd. data set to understand the effect of introducing fluorine on the risk of encountering P-glycoprotein mediated efflux (as measured by MDR efflux ratio), passive permeability, lipophilicity, and metabolic stability.  Statistical modeling of the MDR ER data demonstrated that an increase in MW as a result of introducing fluorine atoms does not lead to higher risk of P-gp mediated efflux.  Fluorine-cor. mol. wt. (MWFC), where the mol. wt. of fluorine has been subtracted, was found to be a more relevant descriptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo732pO8BsloLVg90H21EOLACvtfcHk0ljWogfr6TxEhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1Kjsro%253D&md5=7ca62f3c1100c6623d082d88b3113cf8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00027%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKuhn%26aufirst%3DM.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DQuantitative%2520assessment%2520of%2520the%2520impact%2520of%2520fluorine%2520substitution%2520on%2520P-glycoprotein%2520%2528P-gp%2529%2520mediated%2520efflux%252C%2520permeability%252C%2520lipophilicity%252C%2520and%2520metabolic%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5284%26epage%3D5296%26doi%3D10.1021%2Facs.jmedchem.6b00027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0ljWogfr6TxEhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopple, K. D.</span></span> <span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2615</span>– <span class="NLM_lpage">2623</span>, <span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0ljzWgvzDgHzPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keserü, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, N. J.</span></span> <span> </span><span class="NLM_article-title">Validity of ligand efficiency metrics</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1021/ml500146d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500146d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=616-618&author=C.+W.+Murrayauthor=D.+A.+Erlansonauthor=A.+L.+Hopkinsauthor=G.+M.+Keser%C3%BCauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynoldsauthor=N.+J.+Richmond&title=Validity+of+ligand+efficiency+metrics&doi=10.1021%2Fml500146d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Validity of Ligand Efficiency Metrics</span></div><div class="casAuthors">Murray, Christopher W.; Erlanson, Daniel A.; Hopkins, Andrew L.; Keseru, Gyorgy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.; Richmond, Nicola J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">616-618</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A recent viewpoint article (Improving the plausibility of success with inefficient metrics. ACS Med. Chem. Lett.2014, 5, 2-5) argued that the std. definition of ligand efficiency (LE) is math. invalid.  In this viewpoint, we address this criticism and show categorically that the definition of LE is math. valid.  LE and other metrics such as lipophilic ligand efficiency (LLE) can be useful during the multiparameter optimization challenge faced by medicinal chemists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraJHYI4FCEJbVg90H21EOLACvtfcHk0ljzWgvzDgHzPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVShsbs%253D&md5=5bc436490def9fa7af0f3e7ed241ee4e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fml500146d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500146d%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DRichmond%26aufirst%3DN.%2BJ.%26atitle%3DValidity%2520of%2520ligand%2520efficiency%2520metrics%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D616%26epage%3D618%26doi%3D10.1021%2Fml500146d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span> <span> </span><span class="NLM_article-title">A new paradigm for navigating compound property related drug attrition</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.drudis.2015.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=26404453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC283ltl2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=72-81&author=P.+Bartonauthor=R.+J.+Riley&title=A+new+paradigm+for+navigating+compound+property+related+drug+attrition&doi=10.1016%2Fj.drudis.2015.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">A new paradigm for navigating compound property related drug attrition</span></div><div class="casAuthors">Barton Patrick; Riley Robert J</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Improving the efficiency of drug discovery remains a major focus for the pharmaceutical industry.  Toxicity accounts for 90% of withdrawals and major early-stage terminations relate to suboptimal efficacy and safety.  Traditional oral drug space is well defined with respect to physicochemical properties and ADMET risks but increased focus on ligand-lipophilicity efficiency, maximizing enthalpy contributions and new target classes challenge this paradigm.  A hybrid space has been identified that combines physical properties and key interactions attributable to drug transporters.  A novel algorithm is proposed that incorporates drug-transporter interactions and its utility evaluated against popular ligand efficiency indices.  Simply reducing the bulk properties of compounds can exchange one problem for another and creates high-risk areas that challenge the successful delivery from a balanced portfolio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTw28fh-W5ywlm8bhe6roZYfW6udTcc2eaK9cPzdtXPCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283ltl2rtg%253D%253D&md5=8f9412912d498680db5bcc2d9880efe2</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DA%2520new%2520paradigm%2520for%2520navigating%2520compound%2520property%2520related%2520drug%2520attrition%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D72%26epage%3D81%26doi%3D10.1016%2Fj.drudis.2015.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgGB_r-A6GAEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span> <span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">7559</span>– <span class="NLM_lpage">7583</span>, <span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0lgGB_r-A6GAEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avdeef, A.</span></span> <span> </span><span class="NLM_article-title">Assessment of Distribution-pH Profiles</span>. In  <i>Lipophilicity in Drug Action</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pliska, V.</span>; <span class="NLM_string-name">Testa, B.</span>; <span class="NLM_string-name">Van de Waterbeemd, H.</span></span>, Eds.; <span class="NLM_publisher-name">VCH</span>: <span class="NLM_publisher-loc">Weinhem</span>, <span class="NLM_year">1995</span>; pp  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">139</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=109-139&author=A.+Avdeefauthor=V.+Pliska&author=B.+Testa&author=H.+Van+de+Waterbeemd&title=Lipophilicity+in+Drug+Action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeef%26aufirst%3DA.%26atitle%3DAssessment%2520of%2520Distribution-pH%2520Profiles%26btitle%3DLipophilicity%2520in%2520Drug%2520Action%26aulast%3DPliska%26aufirst%3DV.%26pub%3DVCH%26date%3D1995%26spage%3D109%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emans, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coolsen, M. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surtel, D. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rhijn, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welting, T. J. M.</span></span> <span> </span><span class="NLM_article-title">Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1170</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2012.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2012.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=22796508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC38fgtVertA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1170-1178&author=M.+M.+J.+Caronauthor=P.+J.+Emansauthor=M.+M.+E.+Coolsenauthor=L.+Vossauthor=D.+A.+M.+Surtelauthor=A.+Cremersauthor=L.+W.+van+Rhijnauthor=T.+J.+M.+Welting&title=Redifferentiation+of+dedifferentiated+human+articular+chondrocytes%3A+comparison+of+2D+and+3D+cultures&doi=10.1016%2Fj.joca.2012.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures</span></div><div class="casAuthors">Caron M M J; Emans P J; Coolsen M M E; Voss L; Surtel D A M; Cremers A; van Rhijn L W; Welting T J M</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1170-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Three-dimensional (3D) cultures are widely used to redifferentiate chondrocytes.  However, the rationale behind the choice for 3D above two-dimensional (2D) cultures is poorly systematically investigated and mainly based on mRNA expression and glycosaminoglycan (GAG) content.  The objective was to determine the differential redifferentiation characteristics of human articular chondrocytes (HACs) in monolayer, alginate beads and pellet culture by investigating mRNA expression, protein expression, GAG content and cell proliferation.  DESIGN:  Dedifferentiated HACs from six individuals were redifferentiated in identical medium conditions for 7 days in monolayer, alginate beads or pellet culture.  Read-out parameters were expression of chondrogenic and hypertrophic mRNAs and proteins, GAG content and cell proliferation.  RESULTS:  3D cultures specifically expressed chondrogenic mRNAs [collagen type II (COL2A1), SRY (sex determining region Y)-box 9 (SOX9), aggrecan (ACAN)), whereas 2D cultures did not.  Hypertrophic mRNAs (collagen type X (COL10A1), runt-related transcription factor 2 (RUNX2), matrix metalloproteinase 13 (MMP13), vascular endothelial growth factor A (VEGFA), osteopontin (OPN), alkaline phosphatase (ALP)) were highly increased in 2D cultures and lower in 3D cultures.  Collagen type I (COL1A1) mRNA expression was highest in 3D cultures.  Protein expression supports most of the mRNA data, although an important discrepancy was found between mRNA and protein expression of COL2A1 and SOX9 in monolayer culture, stressing on the importance of protein expression analysis.  GAG content was highest in 3D cultures, whereas chondrocyte proliferation was almost specific for 2D cultures.  CONCLUSIONS:  For redifferentiation of dedifferentiated HACs, 3D cultures exhibit the most potent chondrogenic potential, whereas a hypertrophic phenotype is best achieved in 2D cultures.  This is the first human study that systematically evaluates the differences between proliferation, GAG content, protein expression and mRNA expression of commonly used 2D and 3D chondrocyte culture techniques.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMGHYETnJ0Itts4TFFB11gfW6udTcc2eYiyHxzz_Rvy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fgtVertA%253D%253D&md5=3fc61862ae96c5495869be0471aec8e5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2012.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2012.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DCaron%26aufirst%3DM.%2BM.%2BJ.%26aulast%3DEmans%26aufirst%3DP.%2BJ.%26aulast%3DCoolsen%26aufirst%3DM.%2BM.%2BE.%26aulast%3DVoss%26aufirst%3DL.%26aulast%3DSurtel%26aufirst%3DD.%2BA.%2BM.%26aulast%3DCremers%26aufirst%3DA.%26aulast%3Dvan%2BRhijn%26aufirst%3DL.%2BW.%26aulast%3DWelting%26aufirst%3DT.%2BJ.%2BM.%26atitle%3DRedifferentiation%2520of%2520dedifferentiated%2520human%2520articular%2520chondrocytes%253A%2520comparison%2520of%25202D%2520and%25203D%2520cultures%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2012%26volume%3D20%26spage%3D1170%26epage%3D1178%26doi%3D10.1016%2Fj.joca.2012.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrzewa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starowicz, K.</span></span> <span> </span><span class="NLM_article-title">New tool to assess walking patterns in the development of OA pain: kinetic weight bearing</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">S136</span>– <span class="NLM_lpage">S137</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2017.02.221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2017.02.221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=S136-S137&author=N.+Malekauthor=J.+Mlostauthor=M.+Kostrzewaauthor=K.+Starowicz&title=New+tool+to+assess+walking+patterns+in+the+development+of+OA+pain%3A+kinetic+weight+bearing&doi=10.1016%2Fj.joca.2017.02.221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2017.02.221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2017.02.221%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DN.%26aulast%3DMlost%26aufirst%3DJ.%26aulast%3DKostrzewa%26aufirst%3DM.%26aulast%3DStarowicz%26aufirst%3DK.%26atitle%3DNew%2520tool%2520to%2520assess%2520walking%2520patterns%2520in%2520the%2520development%2520of%2520OA%2520pain%253A%2520kinetic%2520weight%2520bearing%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2017%26volume%3D25%26spage%3DS136%26epage%3DS137%26doi%3D10.1016%2Fj.joca.2017.02.221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leuchtweis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montechiaro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaible, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boettger, M. K.</span></span> <span> </span><span class="NLM_article-title">Validation of the digital pressure application measurement (PAM) device for detection of primary mechanical hyperalgesia in rat and mouse antigen-induced knee joint arthritis</span>. <i>Methods Find. Exp. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1358/mf.2010.32.8.1532102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1358%2Fmf.2010.32.8.1532102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=21132127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FhvFWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=575-583&author=J.+Leuchtweisauthor=A.-K.+Imhofauthor=F.+Montechiaroauthor=H.-G.+Schaibleauthor=M.+K.+Boettger&title=Validation+of+the+digital+pressure+application+measurement+%28PAM%29+device+for+detection+of+primary+mechanical+hyperalgesia+in+rat+and+mouse+antigen-induced+knee+joint+arthritis&doi=10.1358%2Fmf.2010.32.8.1532102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the digital pressure application measurement (PAM) device for detection of primary mechanical hyperalgesia in rat and mouse antigen-induced knee joint arthritis</span></div><div class="casAuthors">Leuchtweis J; Imhof A-K; Montechiaro F; Schaible H-G; Boettger M K</div><div class="citationInfo"><span class="NLM_cas:title">Methods and findings in experimental and clinical pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">575-83</span>
        ISSN:<span class="NLM_cas:issn">0379-0355</span>.
    </div><div class="casAbstract">Several tests have been developed to obtain mechanical nociceptive withdrawal thresholds for arthritis-associated pain research in preclinical animal models, which are routinely used for testing the efficacy of antinociceptive pharmaceutical candidates.  Here, we aimed to validate a recently introduced and commercially available digital pressure application measurement (PAM) device for the detection of primary mechanical hyperalgesia in a model of antigen-induced knee joint arthritis (AIA) in rats and mice.  Two particular advantages of the PAM device are visual feedback control of the force increase rate and the detection of the complete threshold range.  Using PAM, we were able to quantify mechanical thresholds at the knee joint in rats and mice (400 and 350 g, respectively) before and during the time course of AIA (approximately 100 g for rats and mice in the acute phase).  Inter-observer agreement was generally higher when using PAM instead of an analog dynamometer.  In conclusion, the digital PAM device is a suitable apparatus to detect primary mechanical hyperalgesia in experimental knee joint arthritis in rats and mice.  The use of this device allows visual feedback control of the stimulus rate, thus minimizing the chances of confounding factors arising from differences in ramp speed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTFggnlMhOZOkdrW1FkXG-fW6udTcc2ebwwW3lx8TmEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FhvFWltg%253D%253D&md5=13acdad20c1bb490b2f495daea1f6f50</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1358%2Fmf.2010.32.8.1532102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fmf.2010.32.8.1532102%26sid%3Dliteratum%253Aachs%26aulast%3DLeuchtweis%26aufirst%3DJ.%26aulast%3DImhof%26aufirst%3DA.-K.%26aulast%3DMontechiaro%26aufirst%3DF.%26aulast%3DSchaible%26aufirst%3DH.-G.%26aulast%3DBoettger%26aufirst%3DM.%2BK.%26atitle%3DValidation%2520of%2520the%2520digital%2520pressure%2520application%2520measurement%2520%2528PAM%2529%2520device%2520for%2520detection%2520of%2520primary%2520mechanical%2520hyperalgesia%2520in%2520rat%2520and%2520mouse%2520antigen-induced%2520knee%2520joint%2520arthritis%26jtitle%3DMethods%2520Find.%2520Exp.%2520Clin.%2520Pharmacol.%26date%3D2010%26volume%3D32%26spage%3D575%26epage%3D583%26doi%3D10.1358%2Fmf.2010.32.8.1532102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit40c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brash, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bate, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessell, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeve, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQueen, D. S.</span></span> <span> </span><span class="NLM_article-title">Pressure application measurement (PAM): A novel behavioural technique for measuring hypersensitivity in a rat model of joint pain</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.jneumeth.2007.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.jneumeth.2007.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=17383008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mvVamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2007&pages=67-75&author=N.+J.+Bartonauthor=I.+T.+Stricklandauthor=S.+M.+Bondauthor=H.+M.+Brashauthor=S.+T.+Bateauthor=A.+W.+Wilsonauthor=I.+P.+Chessellauthor=A.+J.+Reeveauthor=D.+S.+McQueen&title=Pressure+application+measurement+%28PAM%29%3A+A+novel+behavioural+technique+for+measuring+hypersensitivity+in+a+rat+model+of+joint+pain&doi=10.1016%2Fj.jneumeth.2007.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40cR"><div class="casContent"><span class="casTitleNuber">40c</span><div class="casTitle"><span class="NLM_cas:atitle">Pressure application measurement (PAM): a novel behavioural technique for measuring hypersensitivity in a rat model of joint pain</span></div><div class="casAuthors">Barton Nicola J; Strickland Iain T; Bond Susan M; Brash Harry M; Bate Simon T; Wilson Alex W; Chessell Iain P; Reeve Alison J; McQueen Daniel S</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-75</span>
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">Chronic joint pain affects physical well being and can lead to severe psychological and social problems, therefore successful long-term management is highly sought-after.  No current behavioural measures of pain used in pre-clinical models mimic the clinical dolorimeter, which provides an objective measure of joint hypersensitivity.  In this study we aim to use a novel behavioural readout alongside an established measure to mimic the multifactorial measurements taken in the clinic.  Using the pressure application measurement (PAM) device a gradually increasing squeeze was applied across the knee joint of rats until the animal gave an indication of pain or discomfort.  PAM and the incapacitance tester were used to detect joint hypersensitivity in a well-established rodent model of adjuvant-induced arthritis.  Subsequently, the analgesic effects of prednisolone (1, 3 or 10 mg kg(-1)), morphine (3 mg kg(-1)) and celecoxib (15 mg kg(-1)) were assessed.  Both PAM and the incapacitance tester detected a reversal of hypersensitivity 1h post-drug administration.  Furthermore, the two readouts were highly correlated, and power analysis indicated that PAM was highly reproducible.  In conclusion, PAM provides a novel, accurate behavioural tool for detecting a primary mechanical hypersensitivity in a rat model of chronic inflammatory joint pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROrJznTHfjh8ERNNga7KD-fW6udTcc2ebwwW3lx8TmEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mvVamtQ%253D%253D&md5=88318b1b76edecc4fb113673c2111d22</span></div><a href="/servlet/linkout?suffix=cit40c&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2007.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2007.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DN.%2BJ.%26aulast%3DStrickland%26aufirst%3DI.%2BT.%26aulast%3DBond%26aufirst%3DS.%2BM.%26aulast%3DBrash%26aufirst%3DH.%2BM.%26aulast%3DBate%26aufirst%3DS.%2BT.%26aulast%3DWilson%26aufirst%3DA.%2BW.%26aulast%3DChessell%26aufirst%3DI.%2BP.%26aulast%3DReeve%26aufirst%3DA.%2BJ.%26aulast%3DMcQueen%26aufirst%3DD.%2BS.%26atitle%3DPressure%2520application%2520measurement%2520%2528PAM%2529%253A%2520A%2520novel%2520behavioural%2520technique%2520for%2520measuring%2520hypersensitivity%2520in%2520a%2520rat%2520model%2520of%2520joint%2520pain%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2007%26volume%3D163%26spage%3D67%26epage%3D75%26doi%3D10.1016%2Fj.jneumeth.2007.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrzewa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starowicz, K.</span></span> <span> </span><span class="NLM_article-title">New tool to assess walking patterns in the development of OA pain: kinetic weight bearing</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">S136</span>– <span class="NLM_lpage">S137</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2017.02.221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.joca.2017.02.221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=S136-S137&author=N.+Malekauthor=J.+Mlostauthor=M.+Kostrzewaauthor=K.+Starowicz&title=New+tool+to+assess+walking+patterns+in+the+development+of+OA+pain%3A+kinetic+weight+bearing&doi=10.1016%2Fj.joca.2017.02.221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2017.02.221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2017.02.221%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DN.%26aulast%3DMlost%26aufirst%3DJ.%26aulast%3DKostrzewa%26aufirst%3DM.%26aulast%3DStarowicz%26aufirst%3DK.%26atitle%3DNew%2520tool%2520to%2520assess%2520walking%2520patterns%2520in%2520the%2520development%2520of%2520OA%2520pain%253A%2520kinetic%2520weight%2520bearing%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2017%26volume%3D25%26spage%3DS136%26epage%3DS137%26doi%3D10.1016%2Fj.joca.2017.02.221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leuchtweis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imhof, A.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montechiaro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaible, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boettger, M. K.</span></span> <span> </span><span class="NLM_article-title">Validation of the digital pressure application measurement (PAM) device for detection of primary mechanical hyperalgesia in rat and mouse antigen-induced knee joint arthritis</span>. <i>Methods Find. Exp. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1358/mf.2010.32.8.1532102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1358%2Fmf.2010.32.8.1532102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=21132127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FhvFWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=575-583&author=J.+Leuchtweisauthor=A.-K.+Imhofauthor=F.+Montechiaroauthor=H.-G.+Schaibleauthor=M.+K.+Boettger&title=Validation+of+the+digital+pressure+application+measurement+%28PAM%29+device+for+detection+of+primary+mechanical+hyperalgesia+in+rat+and+mouse+antigen-induced+knee+joint+arthritis&doi=10.1358%2Fmf.2010.32.8.1532102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the digital pressure application measurement (PAM) device for detection of primary mechanical hyperalgesia in rat and mouse antigen-induced knee joint arthritis</span></div><div class="casAuthors">Leuchtweis J; Imhof A-K; Montechiaro F; Schaible H-G; Boettger M K</div><div class="citationInfo"><span class="NLM_cas:title">Methods and findings in experimental and clinical pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">575-83</span>
        ISSN:<span class="NLM_cas:issn">0379-0355</span>.
    </div><div class="casAbstract">Several tests have been developed to obtain mechanical nociceptive withdrawal thresholds for arthritis-associated pain research in preclinical animal models, which are routinely used for testing the efficacy of antinociceptive pharmaceutical candidates.  Here, we aimed to validate a recently introduced and commercially available digital pressure application measurement (PAM) device for the detection of primary mechanical hyperalgesia in a model of antigen-induced knee joint arthritis (AIA) in rats and mice.  Two particular advantages of the PAM device are visual feedback control of the force increase rate and the detection of the complete threshold range.  Using PAM, we were able to quantify mechanical thresholds at the knee joint in rats and mice (400 and 350 g, respectively) before and during the time course of AIA (approximately 100 g for rats and mice in the acute phase).  Inter-observer agreement was generally higher when using PAM instead of an analog dynamometer.  In conclusion, the digital PAM device is a suitable apparatus to detect primary mechanical hyperalgesia in experimental knee joint arthritis in rats and mice.  The use of this device allows visual feedback control of the stimulus rate, thus minimizing the chances of confounding factors arising from differences in ramp speed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTFggnlMhOZOkdrW1FkXG-fW6udTcc2eaUcFwp8lZ93rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FhvFWltg%253D%253D&md5=13acdad20c1bb490b2f495daea1f6f50</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1358%2Fmf.2010.32.8.1532102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fmf.2010.32.8.1532102%26sid%3Dliteratum%253Aachs%26aulast%3DLeuchtweis%26aufirst%3DJ.%26aulast%3DImhof%26aufirst%3DA.-K.%26aulast%3DMontechiaro%26aufirst%3DF.%26aulast%3DSchaible%26aufirst%3DH.-G.%26aulast%3DBoettger%26aufirst%3DM.%2BK.%26atitle%3DValidation%2520of%2520the%2520digital%2520pressure%2520application%2520measurement%2520%2528PAM%2529%2520device%2520for%2520detection%2520of%2520primary%2520mechanical%2520hyperalgesia%2520in%2520rat%2520and%2520mouse%2520antigen-induced%2520knee%2520joint%2520arthritis%26jtitle%3DMethods%2520Find.%2520Exp.%2520Clin.%2520Pharmacol.%26date%3D2010%26volume%3D32%26spage%3D575%26epage%3D583%26doi%3D10.1358%2Fmf.2010.32.8.1532102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kostrzewa, M.</span>; <span class="NLM_string-name">Malek, N.</span>; <span class="NLM_string-name">Pajak, A.</span>; <span class="NLM_string-name">Starowicz, K.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Benefits of Targeting CB2 Receptors in the MIA Model of Osteoarthritis. 16th World Congress on Pain, Yokohama, Japan, Sep 26-30</span> <span class="NLM_year">2016</span>, Poster Number PTH120.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+Kostrzewa&author=N.+Malek&author=A.+Pajak&author=K.+Starowicz&title=Therapeutic+Benefits+of+Targeting+CB2+Receptors+in+the+MIA+Model+of+Osteoarthritis.+16th+World+Congress+on+Pain%2C+Yokohama%2C+Japan%2C+Sep+26-30"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKostrzewa%26aufirst%3DM.%26atitle%3DTherapeutic%2520Benefits%2520of%2520Targeting%2520CB2%2520Receptors%2520in%2520the%2520MIA%2520Model%2520of%2520Osteoarthritis.%252016th%2520World%2520Congress%2520on%2520Pain%252C%2520Yokohama%252C%2520Japan%252C%2520Sep%252026-30%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pajak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrzewa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korostynski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starowicz, K.</span></span> <span> </span><span class="NLM_article-title">Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritis</span>. <i>J. Pain Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1973</span>– <span class="NLM_lpage">1989</span>, <span class="refDoi"> DOI: 10.2147/JPR.S132682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.2147%2FJPR.S132682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=28860852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktlGltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=1973-1989&author=A.+Pajakauthor=M.+Kostrzewaauthor=N.+Malekauthor=M.+Korostynskiauthor=K.+Starowicz&title=Expression+of+matrix+metalloproteinases+and+components+of+the+endocannabinoid+system+in+the+knee+joint+are+associated+with+biphasic+pain+progression+in+a+rat+model+of+osteoarthritis&doi=10.2147%2FJPR.S132682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritis</span></div><div class="casAuthors">Pajak, Agnieszka; Kostrzewa, Magdalena; Malek, Natalia; Korostynski, Michal; Starowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1973-1989</span>CODEN:
                <span class="NLM_cas:coden">JPROEV</span>;
        ISSN:<span class="NLM_cas:issn">1178-7090</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are considered important in articular cartilage breakdown during osteoarthritis (OA).  Similarly, the endocannabinoid system (ECS) is implicated in joint function and modulation of nociceptive processing.  Functional interplay between ECS and MMPs has been recently indicated.  Here, we tested if changes in the expression of selected MMPs and major ECS elements temporally correlate with the intensity of OA-related pain.  Knee OA was induced in male Wistar rats by intra-articular sodium monoiodoacetate injection.  OA-like pain behavior was tested using the dynamic wt. bearing.  Joint tissue samples at different time points after OA induction were subjected to gene (quant. polymerase chain reaction) and protein (Western blot) expression analyses.  Monoiodoacetate-induced nocifensive responses in rats showed a biphasic progression pattern.  The alterations in expression of selected MMPs elegantly corresponded to the two-stage development of OA pain.  The most substantial changes in the expression of the ECS system were revealed at a later stage of OA progression.  Alterations within ECS are involved in the process of adaptation to persistent painful stimuli.  The accumulation of MMPs in osteoarthritic cartilage may have a role in the biphasic progression of OA-related pain.  Temporal assocn. of changes in ECS and MMPs expression shows a potential therapeutic approach that utilizes the concept of combining indirect ECS-mediated MMP inhibition and ECS modulation of pain transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonhr9634T6ELVg90H21EOLACvtfcHk0lhuACgFoI1Zgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktlGltLc%253D&md5=31cc9d5693d569d761b8675b434ed737</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.2147%2FJPR.S132682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJPR.S132682%26sid%3Dliteratum%253Aachs%26aulast%3DPajak%26aufirst%3DA.%26aulast%3DKostrzewa%26aufirst%3DM.%26aulast%3DMalek%26aufirst%3DN.%26aulast%3DKorostynski%26aufirst%3DM.%26aulast%3DStarowicz%26aufirst%3DK.%26atitle%3DExpression%2520of%2520matrix%2520metalloproteinases%2520and%2520components%2520of%2520the%2520endocannabinoid%2520system%2520in%2520the%2520knee%2520joint%2520are%2520associated%2520with%2520biphasic%2520pain%2520progression%2520in%2520a%2520rat%2520model%2520of%2520osteoarthritis%26jtitle%3DJ.%2520Pain%2520Res.%26date%3D2017%26volume%3D10%26spage%3D1973%26epage%3D1989%26doi%3D10.2147%2FJPR.S132682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepartz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">The ecstasy and agony of assay interference compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2165</span>– <span class="NLM_lpage">2168</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00229</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00229" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2165-2168&author=C.+Aldrichauthor=C.+Bertozziauthor=G.+I.+Georgauthor=L.+Kiesslingauthor=C.+Lindsleyauthor=D.+Liottaauthor=K.+M.+Merzauthor=A.+Schepartzauthor=S.+Wang&title=The+ecstasy+and+agony+of+assay+interference+compounds&doi=10.1021%2Facs.jmedchem.7b00229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Ecstasy and Agony of Assay Interference Compounds</span></div><div class="casAuthors">Aldrich, Courtney; Bertozzi, Carolyn; Georg, Gunda I.; Kiessling, Laura; Lindsley, Craig; Liotta, Dennis; Merz, Kenneth M.; Schepartz, Alanna; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2165-2168</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ecstasy of discovering a new hit from screening can lead to a highly productive research effort to discover new bioactive compds.  However, in too many cases this ecstasy is followed by the agony of realizing that the compds. are not active against the desired target.  Many of these false hits are Pan Assay INterference compds. (PAINS) 1 or colloidal aggregators.  Whether the screen is conducted in silico or in the lab. and whether screening libraries, natural products, or drugs are used, all discovery efforts that rely on some form of screening to identify bioactivity are susceptible to this phenomenon.  Studies that omit crit. controls against exptl. artifacts caused by PAINS may waste years of research effort as useless compds. are progressed.  The American Chem. Society (ACS) is eager to alert the scientific community to this problem and to recommend protocols that will eliminate the publication of research articles based on compds. with artificial activity.  This editorial aims to summarize relevant concepts and to set the framework by which relevant ACS journals will address this issue going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUf5u51VEpbVg90H21EOLACvtfcHk0lhuACgFoI1Zgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D&md5=64bf087659a47fe7769208217ef8c989</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00229%26sid%3Dliteratum%253Aachs%26aulast%3DAldrich%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DC.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DKiessling%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DSchepartz%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DThe%2520ecstasy%2520and%2520agony%2520of%2520assay%2520interference%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2165%26epage%3D2168%26doi%3D10.1021%2Facs.jmedchem.7b00229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regiec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastalarz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastalarz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochel, A.</span></span> <span> </span><span class="NLM_article-title">Methylation of 4-nitro-3(5)-pyrazolecarboxylic acid</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2624</span>– <span class="NLM_lpage">2627</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2009.02.223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1016%2Fj.tetlet.2009.02.223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslygu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=2624-2627&author=A.+Regiecauthor=H.+Mastalarzauthor=A.+Mastalarzauthor=A.+Kochel&title=Methylation+of+4-nitro-3%285%29-pyrazolecarboxylic+acid&doi=10.1016%2Fj.tetlet.2009.02.223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Methylation of 4-nitro-3(5)-pyrazolecarboxylic acid</span></div><div class="casAuthors">Regiec, Andrzej; Mastalarz, Henryk; Mastalarz, Agnieszka; Kochel, Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2624-2627</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Reactions of 4-nitro-3(5)-pyrazolecarboxylic acid dipotassium salt with different methylating agents in various solvents were investigated to improve the synthesis of isomeric 1-methyl-4-nitro-3- and -5-pyrazolecarboxylates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCJWQVZw-F47Vg90H21EOLACvtfcHk0lij_n9Gkl7m6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslygu74%253D&md5=c4cc72d9ddfb134b088617602d1911b3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.02.223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.02.223%26sid%3Dliteratum%253Aachs%26aulast%3DRegiec%26aufirst%3DA.%26aulast%3DMastalarz%26aufirst%3DH.%26aulast%3DMastalarz%26aufirst%3DA.%26aulast%3DKochel%26aufirst%3DA.%26atitle%3DMethylation%2520of%25204-nitro-3%25285%2529-pyrazolecarboxylic%2520acid%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D2624%26epage%3D2627%26doi%3D10.1016%2Fj.tetlet.2009.02.223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span> </span><span class="NLM_article-title">ISO 10993-5:2009. Biological Evaluation of Medical
Devices - Part
5: Tests for in Vitro Cytotoxicity</span>. <a href="https://www.iso.org/standard/36406.html" class="extLink">https://www.iso.org/standard/36406.html</a>, (accessed Mar, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ISO+10993-5%3A2009.+Biological+Evaluation+of+Medical%0ADevices+-+Part%0A5%3A+Tests+for+in+Vitro+Cytotoxicity.+https%3A%2F%2Fwww.iso.org%2Fstandard%2F36406.html%2C+%28accessed+Mar%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DISO%252010993-5%253A2009.%2520Biological%2520Evaluation%2520of%2520Medical%250ADevices%2520-%2520Part%250A5%253A%2520Tests%2520for%2520in%2520Vitro%2520Cytotoxicity%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farndale, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayers, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, A. J.</span></span> <span> </span><span class="NLM_article-title">A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures</span>. <i>Connect. Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.3109/03008208209160269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.3109%2F03008208209160269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=6215207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaL38XlslyitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1982&pages=247-248&author=R.+W.+Farndaleauthor=C.+A.+Sayersauthor=A.+J.+Barrett&title=A+direct+spectrophotometric+microassay+for+sulfated+glycosaminoglycans+in+cartilage+cultures&doi=10.3109%2F03008208209160269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures</span></div><div class="casAuthors">Farndale, Richard W.; Sayers, Christine A.; Barrett, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Connective Tissue Research</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">247-8</span>CODEN:
                <span class="NLM_cas:coden">CVTRBC</span>;
        ISSN:<span class="NLM_cas:issn">0300-8207</span>.
    </div><div class="casAbstract">Sulfated glycosaminoglycans (GAGs) were detd. in cartilage or cartilage cultures by an improved microspectrophotometric method with 1,9-dimethylmethylene blue (DMB).  The reagent was stabilized by dissolving the DMB in formate buffer, instead of the citrate-phosphate buffer previously used.  The samples were digested with papain in phosphate buffer contg. N-acetylcysteine and EDTA and, following addn. of DMB and mixing, the absorbance was measured immediately at 535 nm.  The method is simple, rapid, and reproducible. It is substantially free from interferences, and the sensitivity was 1 μg (4 μg/mL chondroitin sulfate).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru0KlPe79ZK7Vg90H21EOLACvtfcHk0lij_n9Gkl7m6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XlslyitLY%253D&md5=9164ecb7d6a84c7b1c2464befe891e51</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3109%2F03008208209160269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03008208209160269%26sid%3Dliteratum%253Aachs%26aulast%3DFarndale%26aufirst%3DR.%2BW.%26aulast%3DSayers%26aufirst%3DC.%2BA.%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26atitle%3DA%2520direct%2520spectrophotometric%2520microassay%2520for%2520sulfated%2520glycosaminoglycans%2520in%2520cartilage%2520cultures%26jtitle%3DConnect.%2520Tissue%2520Res.%26date%3D1982%26volume%3D9%26spage%3D247%26epage%3D248%26doi%3D10.3109%2F03008208209160269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guingamp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gegout-Pottie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terlain, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillet, P.</span></span> <span> </span><span class="NLM_article-title">Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1670</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.1002/art.1780400917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1002%2Fart.1780400917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=9324022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADyaK2sXms1eit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1670-1679&author=C.+Guingampauthor=P.+Gegout-Pottieauthor=L.+Philippeauthor=B.+Terlainauthor=P.+Netterauthor=P.+Gillet&title=Mono-iodoacetate-induced+experimental+osteoarthritis%3A+a+dose-response+study+of+loss+of+mobility%2C+morphology%2C+and+biochemistry&doi=10.1002%2Fart.1780400917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47aR"><div class="casContent"><span class="casTitleNuber">47a</span><div class="casTitle"><span class="NLM_cas:atitle">Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry</span></div><div class="casAuthors">Guingamp, Corinne; Gegout-Pottie, Pascale; Philippe, Lionel; Terlain, Bernard; Netter, Patrick; Gillet, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1670-1679</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">To characterize the dose-responsiveness of morphol. and biochem. chondral changes relative to mobility in mono-iodoacetate (MIA)-induced osteoarthritis (OA) in rats, rat mobility was assessed by biotelemetry.  Articular lesions were characterized by macroscopic and histol. examns.  Cartilage proteoglycan metab. was evaluated by the 1,9-dimethylmethylene blue dye binding assay and by radiosulfate incorporation in patellar cartilage.  Spontaneous locomotor activity was rapidly, transiently, and dose-dependently decreased after MIA injection into rat knees (primary response).  Thereafter, only high doses (0.3 mg and 3.0 mg) led to a secondary progressive long-term loss of spontaneous mobility on day 15, when subchondral bone was exposed.  These 2 doses resulted in significant changes in cartilage proteoglycan concn. at day 15 and a strong inhibition of anabolism in the peripheral patellae by day 2, contrasting with the effects of lower doses (0.01, 0.03, and 0.1 mg).  When a sufficient dose of MIA is used, this model can easily and quickly reproduce OA-like lesions and functional impairment in rats, similar to that obsd. in human disease.  These parameters, as well as proteoglycan metab., could serve as indicators for studying chondroprotective drugs, or for evaluating the ability of imaging techniques to detect and evaluate chondral lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3wKbDs2TonrVg90H21EOLACvtfcHk0lij_n9Gkl7m6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXms1eit7w%253D&md5=1e37fe9fae0bcc612f44fd27149b6138</span></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=10.1002%2Fart.1780400917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.1780400917%26sid%3Dliteratum%253Aachs%26aulast%3DGuingamp%26aufirst%3DC.%26aulast%3DGegout-Pottie%26aufirst%3DP.%26aulast%3DPhilippe%26aufirst%3DL.%26aulast%3DTerlain%26aufirst%3DB.%26aulast%3DNetter%26aufirst%3DP.%26aulast%3DGillet%26aufirst%3DP.%26atitle%3DMono-iodoacetate-induced%2520experimental%2520osteoarthritis%253A%2520a%2520dose-response%2520study%2520of%2520loss%2520of%2520mobility%252C%2520morphology%252C%2520and%2520biochemistry%26jtitle%3DArthritis%2520Rheum.%26date%3D1997%26volume%3D40%26spage%3D1670%26epage%3D1679%26doi%3D10.1002%2Fart.1780400917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit47b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Janusz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hookfin, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitmeyer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woessner, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freemont, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyland, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almstead, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natchus, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pikul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taiwo, Y. O.</span></span> <span> </span><span class="NLM_article-title">Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors</span>. <i>Osteoarthritis Cartilage</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.1053/joca.2001.0472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1053%2Fjoca.2001.0472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=11795995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FmvVyluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=751-760&author=M.+J.+Januszauthor=E.+B.+Hookfinauthor=S.+A.+Heitmeyerauthor=J.+F.+Woessnerauthor=A.+J.+Freemontauthor=J.+A.+Hoylandauthor=K.+K.+Brownauthor=L.+C.+Hsiehauthor=N.+G.+Almsteadauthor=B.+Deauthor=M.+G.+Natchusauthor=S.+Pikulauthor=Y.+O.+Taiwo&title=Moderation+of+iodoacetate-induced+experimental+osteoarthritis+in+rats+by+matrix+metalloproteinase+inhibitors&doi=10.1053%2Fjoca.2001.0472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47bR"><div class="casContent"><span class="casTitleNuber">47b</span><div class="casTitle"><span class="NLM_cas:atitle">Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Janusz M J; Hookfin E B; Heitmeyer S A; Woessner J F; Freemont A J; Hoyland J A; Brown K K; Hsieh L C; Almstead N G; De B; Natchus M G; Pikul S; Taiwo Y O</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">751-60</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine the effect of matrix metalloproteinase (MMP) inhibitors in mono-iodoacetate-induced arthritis in rats.  DESIGN:  The ability of compounds to inhibit MMPs in vitro was assessed kinetically using a quenched fluorescent substrate.  Rats were injected with iodoacetate intraarticularly in one knee joint and damage to the tibial plateau was evaluated from digitized images captured using an image analyser and by histology.  Collagenase and gelatinase activity in cartilage from iodoacetate injected knees were evaluated using(3)H-rat type I collagen and gelatin zymography, respectively.  RESULTS:  Collagenase and gelatinase activity significantly increased in the knee cartilage of rats injected with iodoacetate with peak activity by day 7.  Three MMP inhibitors were examined for their efficacy in the rat iodoacetate-induced arthritis model.  Significant (P< 0.05) inhibition of cartilage damage was observed in animals treated orally with 35 mg/kg b.i.d. of the three different MMP inhibitors.  Inhibition of cartilage damage by the MMP inhibitors ranged from 36-42%.  CONCLUSION:  MMP inhibitors are partially protective against cartilage and subchondral bone damage induced by iodoacetate.  These results support an important role for MMPs in mediating the joint damage in this model of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTG5mJMbt3ZGNHxxy173TfNfW6udTcc2eYv4ppARh99X7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FmvVyluw%253D%253D&md5=3413cc14d140f1cb499e0e34d6fbc40a</span></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=10.1053%2Fjoca.2001.0472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fjoca.2001.0472%26sid%3Dliteratum%253Aachs%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26aulast%3DHookfin%26aufirst%3DE.%2BB.%26aulast%3DHeitmeyer%26aufirst%3DS.%2BA.%26aulast%3DWoessner%26aufirst%3DJ.%2BF.%26aulast%3DFreemont%26aufirst%3DA.%2BJ.%26aulast%3DHoyland%26aufirst%3DJ.%2BA.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DHsieh%26aufirst%3DL.%2BC.%26aulast%3DAlmstead%26aufirst%3DN.%2BG.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DPikul%26aufirst%3DS.%26aulast%3DTaiwo%26aufirst%3DY.%2BO.%26atitle%3DModeration%2520of%2520iodoacetate-induced%2520experimental%2520osteoarthritis%2520in%2520rats%2520by%2520matrix%2520metalloproteinase%2520inhibitors%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2001%26volume%3D9%26spage%3D751%26epage%3D760%26doi%3D10.1053%2Fjoca.2001.0472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrugala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makuch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolosowska, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przewlocka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czaja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morera, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starowicz, K.</span></span> <span> </span><span class="NLM_article-title">A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">903</span>, <span class="refDoi"> DOI: 10.1097/j.pain.0000000000000132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=10.1097%2Fj.pain.0000000000000132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=25719612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1Cmu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2015&pages=890-903&author=N.+Malekauthor=M.+Mrugalaauthor=W.+Makuchauthor=N.+Kolosowskaauthor=B.+Przewlockaauthor=M.+Binkowskiauthor=M.+Czajaauthor=E.+Moreraauthor=V.+Di+Marzoauthor=K.+Starowicz&title=A+multi-target+approach+for+pain+treatment%3A+dual+inhibition+of+fatty+acid+amide+hydrolase+and+TRPV1+in+a+rat+model+of+osteoarthritis&doi=10.1097%2Fj.pain.0000000000000132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis</span></div><div class="casAuthors">Malek, Natalia; Mrugala, Monika; Makuch, Wioletta; Kolosowska, Natalia; Przewlocka, Barbara; Binkowski, Marcin; Czaja, Martyna; Morera, Enrico; Di Marzo, Vincenzo; Starowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">890-903</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The pharmacol. inhibition of anandamide (AEA) hydrolysis by fatty acid amide hydrolase (FAAH) attenuates pain in animal models of osteoarthritis (OA) but has failed in clin. trials.  This may have occurred because AEA also activates transient receptor potential vanilloid type 1 (TRPV1), which contributes to pain development.  Therefore, we investigated the effectiveness of the dual FAAH-TRPV1 blocker OMDM-198 in an MIA-model of osteoarthritic pain.  We first investigated the MIA-induced model of OA by (1) characterizing the pain phenotype and degenerative changes within the joint using X-ray microtomog. and (2) evaluating nerve injury and inflammation marker (ATF-3 and IL-6) expression in the lumbar dorsal root ganglia of osteoarthritic rats and differences in gene and protein expression of the cannabinoid CB1 receptors FAAH and TRPV1.  Furthermore, we compared OMDM-198 with compds. acting exclusively on FAAH or TRPV1.  Osteoarthritis was accompanied by the fragmentation of bone microstructure and destroyed cartilage.  An increase of the mRNA levels of ATF3 and IL-6 and an upregulation of AEA receptors and FAAH in the dorsal root ganglia were obsd.  OMDM-198 showed antihyperalgesic effects in the OA model, which were comparable with those of a selective TRPV1 antagonist, SB-366,791, and a selective FAAH inhibitor, URB-597.  The effect of OMDM-198 was attenuated by the CB1 receptor antagonist, AM-251, and by the nonpungent TRPV1 agonist, olvanil, suggesting its action as an "indirect" CB1 agonist and TRPV1 antagonist.  These results suggest an innovative strategy for the treatment of OA, which may yield more satisfactory results than those obtained so far with selective FAAH inhibitors in human OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFhqnavzLgp7Vg90H21EOLACvtfcHk0ljQBm-CK_yT2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1Cmu78%253D&md5=d02e442c4b7afec3fd514aed9efe70a2</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1097%2Fj.pain.0000000000000132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fj.pain.0000000000000132%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DN.%26aulast%3DMrugala%26aufirst%3DM.%26aulast%3DMakuch%26aufirst%3DW.%26aulast%3DKolosowska%26aufirst%3DN.%26aulast%3DPrzewlocka%26aufirst%3DB.%26aulast%3DBinkowski%26aufirst%3DM.%26aulast%3DCzaja%26aufirst%3DM.%26aulast%3DMorera%26aufirst%3DE.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DStarowicz%26aufirst%3DK.%26atitle%3DA%2520multi-target%2520approach%2520for%2520pain%2520treatment%253A%2520dual%2520inhibition%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520and%2520TRPV1%2520in%2520a%2520rat%2520model%2520of%2520osteoarthritis%26jtitle%3DPain%26date%3D2015%26volume%3D156%26spage%3D890%26epage%3D903%26doi%3D10.1097%2Fj.pain.0000000000000132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i92"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00595">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81108"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00595?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00595</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figures illustrating X-ray crystallographic data for compounds <b>4</b> and <b>6;</b> tautomeric equilibrium data for compound <b>51</b>; HPLC-MS traces and elemental analysis of compounds <b>45–62;</b> Table 1S, estimated physicochemical characteristics of compounds <b>45</b>–<b>62</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_001.pdf">jm0c00595_si_001.pdf (1.8 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00595/suppl_file/jm0c00595_si_002.csv">jm0c00595_si_002.csv (3.65 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00595&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-13%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00595%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00595" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996a59ff323cbe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
